data_2k6d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k6d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 121.571 0.7 . . . . 137.64 110.331 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.895 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.85 -56.86 10.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.515 -0.766 . . . . 89.76 111.381 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.895 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.54 12.65 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.81 -0.556 . . . . 143.71 109.59 -177.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.13 135.78 51.13 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.445 -0.576 . . . . 82.42 109.445 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.459 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.7 m-85 -107.16 134.46 50.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.529 -0.915 . . . . 82.42 108.529 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.64 135.38 48.46 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.723 -0.844 . . . . 82.42 108.723 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.501 ' H ' ' CD1' ' A' ' 326' ' ' LEU . 40.7 tttp -92.7 135.59 33.97 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.254 -1.017 . . . . 88.16 108.254 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.646 HG23 ' CG1' ' A' ' 323' ' ' VAL . 93.0 t -100.99 114.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 117.93 -1.508 . . . . 82.42 110.724 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.404 HG13 ' N ' ' A' ' 276' ' ' PHE . 8.3 pt -79.25 -34.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.954 -1.021 . . . . 138.48 112.981 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . 0.585 ' CG ' ' HD2' ' B' ' 68' ' ' HIS . 2.4 m-85 -108.23 90.52 6.96 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.478 0.18 . . . . 82.42 110.806 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.501 ' HB3' ' N ' ' A' ' 290' ' ' GLU . 65.6 Cg_endo -72.28 141.37 35.49 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.762 2.308 . . . . 82.42 113.375 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 -150.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.393 -0.821 . . . . 82.87 109.435 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -159.62 144.3 15.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.522 -0.918 . . . . 82.42 108.522 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . 0.56 ' HA ' ' HG1' ' A' ' 287' ' ' THR . . . -28.67 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.497 1.123 . . . . 82.42 113.574 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . 0.552 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.48 -42.53 12.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.831 -0.622 . . . . 128.65 109.421 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.34 177.26 9.58 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.77 -0.582 . . . . 82.42 111.377 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.45 -34.4 28.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.309 -0.859 . . . . 82.42 110.443 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.13 -5.43 59.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 82.42 111.151 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.552 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 73.9 mt-10 -102.55 147.51 26.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.329 0.585 . . . . 82.42 109.533 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 309' ' ' GLY . 17.3 tp -85.69 133.12 34.04 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.135 -0.939 . . . . 82.42 110.196 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.56 ' HG1' ' HA ' ' A' ' 280' ' ' ALA . 90.1 m -96.72 124.58 40.75 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.812 -1.555 . . . . 82.42 107.739 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.29 141.42 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.554 -0.906 . . . . 82.42 108.554 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 14.4 mmtt -118.69 162.72 17.96 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.798 -0.815 . . . . 97.85 108.798 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . 0.501 ' N ' ' HB3' ' A' ' 277' ' ' PRO . 13.5 pt-20 -75.18 141.53 43.62 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.101 -1.439 . . . . 88.32 108.734 -174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.44 21.48 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.646 -0.982 . . . . 82.42 110.646 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.49 151.9 50.46 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.398 1.099 . . . . 82.42 109.829 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.459 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.0 mm -109.52 134.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.777 -1.194 . . . . 105.08 107.777 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.3 t -122.8 134.84 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.669 -0.863 . . . . 82.42 108.669 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.84 126.56 34.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.096 -1.042 . . . . 128.84 108.846 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -72.0 113.27 8.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.886 -0.783 . . . . 82.42 108.886 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.38 -52.45 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 123.765 0.826 . . . . 82.42 110.924 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.03 149.12 27.83 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.42 -0.955 . . . . 82.42 108.42 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.61 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.87 23.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.546 0.688 . . . . 125.5 110.581 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.699 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.19 171.22 9.96 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 125.86 1.664 . . . . 82.42 109.961 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 6.2 p -64.12 -133.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.665 -0.698 . . . . 91.46 112.29 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.9 mm -79.85 -53.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 112.898 0.703 . . . . 103.65 112.898 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.91 113.26 1.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.419 0.526 . . . . 115.16 112.419 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.87 106.48 13.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.583 -0.735 . . . . 82.42 109.971 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 165.21 -11.06 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.458 -0.792 . . . . 82.42 111.292 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . 0.699 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 83.4 m95 -122.74 156.04 35.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.273 . . . . 82.42 110.485 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.61 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.6 m0 -168.22 -175.71 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 93.81 108.328 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -144.41 143.05 30.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.847 -0.797 . . . . 89.72 108.847 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . 0.404 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -152.8 169.03 31.82 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.441 -1.864 . . . . 82.42 108.441 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.794 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.93 129.66 56.4 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.567 -0.853 . . . . 82.42 109.649 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.438 HD22 ' O ' ' A' ' 287' ' ' THR . 61.9 tp -142.63 135.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.102 -1.073 . . . . 82.42 108.102 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.11 37.77 29.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.552 -0.536 . . . . 82.42 109.552 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.09 35.07 88.39 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.269 -0.967 . . . . 82.42 110.745 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . 0.794 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.44 160.35 36.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.989 -1.084 . . . . 98.99 108.521 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.29 124.74 35.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.749 -1.204 . . . . 109.22 107.749 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.74 163.71 36.47 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.082 -1.607 . . . . 82.42 109.082 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.09 151.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.65 0.38 . . . . 82.42 111.445 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.75 151.43 26.63 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 120.999 0.428 . . . . 82.42 110.42 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.2 Cg_endo -70.19 122.02 8.6 Favored 'Trans proline' 0 CA--C 1.487 -1.825 0 C-N-CA 120.097 0.532 . . . . 111.89 112.041 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -78.92 -6.25 55.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 123.995 0.809 . . . . 119.27 111.833 -178.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.493 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.1 -40.77 97.01 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.386 -0.598 . . . . 96.63 109.386 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.42 2.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.852 -1.067 . . . . 82.42 111.788 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.646 ' CG1' HG23 ' A' ' 274' ' ' VAL . 1.9 m -132.24 155.54 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.555 -0.535 . . . . 82.42 109.555 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -116.61 163.96 15.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.143 -0.688 . . . . 130.62 109.143 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.543 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -93.67 135.17 35.22 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 108.127 -1.064 . . . . 82.42 108.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.07 44.55 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 105.785 -1.931 . . . . 97.62 105.785 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.3 Cg_exo -63.88 -33.87 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 N-CA-C 115.523 1.316 . . . . 152.83 115.523 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--N 1.302 -1.918 0 CA-C-N 121.387 1.531 . . . . 82.42 109.248 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.5 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.476 -0.564 . . . . 1.86 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.9 140.23 32.57 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.397 0.618 . . . . 29.01 110.121 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' B' ' 65' ' ' SER . 12.7 pt -119.21 156.15 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.908 -1.042 . . . . 1.86 110.021 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' B' ' 13' ' ' ILE . 97.9 m-85 -121.12 139.31 53.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.65 0.262 . . . . 1.86 110.931 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.29 124.16 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.671 -0.863 . . . . 4.99 108.671 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -100.99 137.56 39.2 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.059 0.457 . . . . 5.68 110.411 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -90.87 -149.95 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.543 -0.753 . . . . 26.89 111.6 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.417 HD22 ' CD1' ' A' ' 306' ' ' TRP . 0.4 OUTLIER -62.57 -47.89 81.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.856 -0.611 . . . . 23.29 111.448 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -91.27 2.26 56.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.477 -0.489 . . . . 1.86 111.556 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.663 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.48 16.37 49.75 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.417 -0.42 . . . . 1.86 113.881 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 82.6 tttt -43.62 150.05 0.25 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 122.223 -0.574 . . . . 8.51 111.778 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -106.54 128.1 53.85 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.718 -0.845 . . . . 1.88 108.718 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' B' ' 4' ' ' PHE . 69.4 mt -123.96 121.67 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 O-C-N 123.289 0.368 . . . . 37.69 110.953 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.47 131.22 47.72 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.988 -0.745 . . . . 1.86 108.988 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.638 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.0 mt -127.19 149.9 49.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.624 0.25 . . . . 9.46 110.935 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.57 122.13 43.77 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.271 -1.751 . . . . 1.86 106.271 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.95 168.32 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.487 0.66 . . . . 1.86 111.493 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.84 149.2 44.82 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 107.18 -1.415 . . . . 1.86 107.18 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.2 -24.47 59.27 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 CA-C-N 120.772 1.311 . . . . 1.86 112.954 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.21 -2.56 58.17 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 116.172 -0.467 . . . . 1.86 112.069 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.63 50.52 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.94 -1.133 . . . . 1.86 107.94 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -87.03 157.89 19.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.471 -1.241 . . . . 1.86 109.687 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.29 -39.91 84.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.077 -0.965 . . . . 1.86 109.921 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.04 -37.64 80.38 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.654 -0.869 . . . . 1.86 108.654 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.36 -42.85 87.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.456 -0.572 . . . . 1.86 109.456 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.64 -41.68 89.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.416 -0.587 . . . . 1.86 109.416 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.377 -0.601 . . . . 1.86 109.377 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.27 89.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.666 . . . . 1.86 110.451 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.3 -39.13 92.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.572 -0.529 . . . . 1.86 109.572 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.474 HG22 ' OE1' ' B' ' 41' ' ' GLN . 32.6 mt -65.05 -40.04 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.622 -0.51 . . . . 1.86 109.622 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.04 -44.04 94.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.518 0.675 . . . . 1.86 109.39 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.85 -40.35 92.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.006 -0.997 . . . . 1.86 111.036 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.638 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.55 -41.22 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.033 1.123 . . . . 1.86 114.033 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -110.93 -14.7 13.92 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.049 1.87 . . . . 6.12 116.049 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.06 82.93 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 120.912 -0.661 . . . . 1.86 113.322 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -85.82 116.48 65.83 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 109.507 -0.553 . . . . 3.54 109.507 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.93 134.64 61.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.086 1.19 . . . . 1.86 112.339 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.32 -32.22 25.08 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.751 2.301 . . . . 1.86 114.654 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.71 -15.99 62.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.976 0.807 . . . . 2.88 112.182 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.08 8.69 43.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.732 0.271 . . . . 7.17 111.732 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.474 ' OE1' HG22 ' B' ' 30' ' ' ILE . 44.0 mt-30 -117.65 125.84 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.13 0.789 . . . . 13.42 113.13 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -111.83 124.03 51.49 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.019 -1.104 . . . . 27.09 108.019 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.41 132.69 43.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.289 0.566 . . . . 1.87 110.836 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.04 135.57 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.062 -0.399 . . . . 17.75 111.631 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.511 ' CD1' HG12 ' B' ' 61' ' ' ILE . 15.0 t80 -152.92 143.26 22.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.114 -0.494 . . . . 16.98 109.944 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.5 34.75 25.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.784 -0.644 . . . . 1.86 111.681 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 73.1 -10.74 5.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.013 -0.994 . . . . 48.66 114.863 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -107.94 132.64 53.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 120.005 -0.678 . . . . 4.25 111.76 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -58.82 116.98 4.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.14 -0.482 . . . . 30.57 110.126 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 21.3 mt -66.6 131.49 46.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.957 -0.565 . . . . 22.77 112.046 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.622 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -97.53 149.43 22.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.851 -0.613 . . . . 9.34 111.45 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.64 -20.2 63.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.596 0.962 . . . . 1.86 113.596 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.96 68.7 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 121.025 -0.607 . . . . 1.86 112.54 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.43 163.91 13.89 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.17 0.485 . . . . 1.86 111.581 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.2 p -105.33 166.33 10.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.611 0.719 . . . . 1.86 112.604 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.9 mt -60.04 -41.99 93.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.672 -1.149 . . . . 2.28 110.763 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.33 -31.21 71.07 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.111 -0.636 . . . . 2.98 111.763 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -62.14 -28.87 69.94 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.687 -0.405 . . . . 1.86 110.477 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.622 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -98.98 14.56 28.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.697 0.258 . . . . 1.86 111.697 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.4 19.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.9 0.48 . . . . 1.86 112.207 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.511 HG12 ' CD1' ' B' ' 45' ' ' PHE . 96.8 mt -81.46 123.92 38.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.106 -1.072 . . . . 4.01 108.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.88 169.21 8.68 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.281 0.563 . . . . 5.74 112.097 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.5 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 56.9 pttt -51.59 141.41 16.31 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.184 -0.916 . . . . 4.31 111.502 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.04 23.21 9.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.05 -0.977 . . . . 10.13 112.845 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' B' ' 3' ' ' ILE . 38.1 m -77.3 146.93 36.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.87 -1.159 . . . . 4.1 107.87 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 78.0 m -122.64 132.2 54.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.322 -1.308 . . . . 1.86 111.583 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.4 171.74 7.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 19.21 109.789 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . 0.585 ' HD2' ' CG ' ' A' ' 276' ' ' PHE . 1.3 m-70 -119.96 135.59 54.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.512 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 12.6 tp -138.42 157.18 46.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.043 0.449 . . . . 21.58 111.193 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.563 ' CG1' ' HG3' ' A' ' 319' ' ' PRO . 2.1 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.873 -0.603 . . . . 25.97 109.848 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 121.589 0.709 . . . . 137.64 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.883 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 51.8 p -64.87 -56.99 10.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.528 -0.76 . . . . 89.76 111.26 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.883 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.88 166.63 12.63 Favored 'General case' 0 CA--C 1.491 -1.302 0 O-C-N 121.826 -0.546 . . . . 143.71 109.592 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.18 135.8 51.17 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.437 -0.579 . . . . 82.42 109.437 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.578 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 61.0 m-85 -107.18 134.44 50.29 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.515 -0.921 . . . . 82.42 108.515 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.6 135.4 48.5 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.747 -0.834 . . . . 82.42 108.747 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.489 ' HB3' HD13 ' A' ' 326' ' ' LEU . 40.7 tttp -92.66 135.52 34.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.251 -1.018 . . . . 88.16 108.251 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 90.4 t -100.84 116.46 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 118.038 -1.465 . . . . 82.42 110.782 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 33.0 mm -78.38 -78.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.9 -0.591 . . . . 138.48 112.099 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' B' ' 68' ' ' HIS . 20.7 m-85 -68.95 131.71 90.79 Favored Pre-proline 0 N--CA 1.462 0.147 0 N-CA-C 109.692 -0.484 . . . . 82.42 109.692 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.518 ' CD ' ' HA2' ' B' ' 47' ' ' GLY . 30.8 Cg_endo -63.78 149.75 90.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.727 2.285 . . . . 82.42 111.807 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.458 ' HB3' ' CG1' ' A' ' 288' ' ' ILE . 63.6 t80 -121.41 92.45 3.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.955 -0.566 . . . . 82.87 110.446 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -68.18 116.14 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.873 -0.603 . . . . 82.42 109.729 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.35 104.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.403 1.065 . . . . 82.42 112.98 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . 0.529 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -81.71 -40.28 23.0 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.398 -0.593 . . . . 128.65 109.398 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -144.85 175.39 10.23 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.281 -0.887 . . . . 82.42 111.691 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.67 -31.03 32.43 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.334 -0.848 . . . . 82.42 109.696 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 -3.59 43.96 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.327 -0.851 . . . . 82.42 110.939 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.529 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.5 146.51 37.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.401 0.62 . . . . 82.42 109.486 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.42 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.7 tp -76.79 138.72 40.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.525 -0.762 . . . . 82.42 110.066 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.476 ' O ' HD22 ' A' ' 311' ' ' LEU . 89.8 m -96.45 124.49 40.47 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.33 -1.348 . . . . 82.42 107.767 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.458 ' CG1' ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.2 142.16 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.542 -0.91 . . . . 82.42 108.542 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -113.82 158.3 21.19 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.396 -0.964 . . . . 97.85 108.396 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.48 141.52 41.26 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 118.077 -1.449 . . . . 88.32 108.642 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.63 21.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.572 -1.011 . . . . 82.42 110.572 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.49 151.87 50.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.436 1.118 . . . . 82.42 109.825 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.564 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.3 mm -109.56 133.95 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.817 -1.179 . . . . 105.08 107.817 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.74 134.8 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.718 -0.845 . . . . 82.42 108.718 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.578 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.82 126.61 34.16 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.131 -1.028 . . . . 128.84 108.825 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.97 113.22 8.78 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.899 -0.778 . . . . 82.42 108.899 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.41 -52.43 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.733 0.813 . . . . 82.42 110.92 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.97 149.2 27.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.475 -0.935 . . . . 82.42 108.475 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.514 ' HG3' ' NE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.79 23.62 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.433 0.635 . . . . 125.5 110.594 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.18 174.3 7.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.801 1.64 . . . . 82.42 109.93 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.413 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 3.9 p -58.0 -144.72 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.994 0.739 . . . . 91.46 112.994 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.413 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 45.8 mm -71.02 -57.52 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.907 1.077 . . . . 103.65 113.907 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -50.53 127.57 18.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.096 0.776 . . . . 115.16 113.096 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.88 112.82 26.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.408 -0.815 . . . . 82.42 110.446 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 158.3 -13.56 0.25 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.922 -0.871 . . . . 82.42 110.922 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . 0.543 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 92.4 m95 -122.7 147.56 46.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.372 -0.414 . . . . 82.42 110.913 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.628 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 7.2 m0 -157.81 -177.48 6.61 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.782 0.676 . . . . 93.81 109.435 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 296' ' ' LEU . 23.0 mt-10 -138.14 143.06 40.14 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.851 -0.796 . . . . 89.72 108.851 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.86 168.89 31.84 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 108.448 -1.861 . . . . 82.42 108.448 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.78 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.84 129.75 56.34 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 119.503 -0.879 . . . . 82.42 109.673 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.68 135.57 28.17 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.1 -1.074 . . . . 82.42 108.1 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.13 37.78 29.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.499 -0.556 . . . . 82.42 109.499 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.13 35.04 88.1 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.193 -1.004 . . . . 82.42 110.699 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . 0.78 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.4 160.3 36.78 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 119.029 -1.069 . . . . 98.99 108.598 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -129.22 124.78 35.38 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.738 -1.208 . . . . 109.22 107.738 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.82 163.96 36.67 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.071 -1.612 . . . . 82.42 109.071 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 1.6 m -96.42 151.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 122.734 0.413 . . . . 82.42 111.456 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -155.23 151.4 22.68 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 120.634 -0.427 . . . . 82.42 110.425 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.22 121.89 8.46 Favored 'Trans proline' 0 CA--C 1.486 -1.88 0 C-N-CA 120.053 0.502 . . . . 111.89 112.094 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.628 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.1 OUTLIER -74.76 -0.44 18.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 124.158 0.912 . . . . 119.27 111.976 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.512 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.95 -42.64 98.61 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.448 -0.575 . . . . 96.63 109.448 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 68' ' ' HIS . 4.6 m-85 -73.55 9.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.523 -0.762 . . . . 82.42 112.683 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.57 164.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.589 -0.523 . . . . 82.42 109.589 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.08 154.67 47.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.341 -0.614 . . . . 130.62 109.341 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.54 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -92.22 135.26 34.15 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.11 -1.07 . . . . 82.42 108.11 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 273' ' ' LYS . 4.9 mp -91.35 129.05 44.61 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 105.803 -1.925 . . . . 97.62 105.803 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.97 -33.82 61.64 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.59 1.342 . . . . 152.83 115.59 -175.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 CA--C 1.486 -1.908 0 CA-C-N 121.385 1.53 . . . . 82.42 109.308 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.414 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.479 -0.563 . . . . 1.86 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.88 140.7 31.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.243 0.545 . . . . 29.01 110.197 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.8 pt -116.27 161.55 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.87 -1.059 . . . . 1.86 109.827 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.84 139.3 53.79 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.585 0.231 . . . . 1.86 110.975 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.24 124.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.641 -0.874 . . . . 4.99 108.641 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.13 139.57 36.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 5.68 110.471 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -91.3 -142.59 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.612 -0.722 . . . . 26.89 111.788 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.49 -42.13 62.23 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.119 -0.491 . . . . 23.29 111.572 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -94.25 2.35 55.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.072 -0.651 . . . . 1.86 111.527 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.46 16.32 49.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.363 -0.446 . . . . 1.86 113.786 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 77.6 tttt -46.8 153.45 0.4 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.363 -0.492 . . . . 8.51 111.568 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -107.06 127.77 53.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.722 -0.844 . . . . 1.88 108.722 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.82 121.75 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.233 0.333 . . . . 37.69 110.931 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.45 131.18 47.7 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.024 -0.732 . . . . 1.86 109.024 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.636 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.2 mt -127.12 149.94 49.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.678 0.275 . . . . 9.46 110.935 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.6 122.12 43.75 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 106.185 -1.783 . . . . 1.86 106.185 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.92 168.41 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.524 0.678 . . . . 1.86 111.468 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.94 149.28 45.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.133 -1.432 . . . . 1.86 107.133 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.24 -24.43 59.36 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 CA-C-N 120.832 1.333 . . . . 1.86 112.93 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.28 -2.59 58.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.224 -0.444 . . . . 1.86 112.001 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.22 142.57 50.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.958 -1.127 . . . . 1.86 107.958 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.91 157.79 19.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.499 -1.228 . . . . 1.86 109.704 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.24 -39.88 84.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.087 -0.961 . . . . 1.86 110.011 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.71 80.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.699 -0.852 . . . . 1.86 108.699 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.32 -42.87 87.59 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.518 -0.549 . . . . 1.86 109.518 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -60.64 -41.7 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.472 -0.566 . . . . 1.86 109.472 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.96 -40.0 87.52 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.35 -0.611 . . . . 1.86 109.35 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.18 89.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.826 -0.625 . . . . 1.86 110.516 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.15 -39.25 92.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.55 -0.537 . . . . 1.86 109.55 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 mt -65.09 -40.03 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.638 -0.505 . . . . 1.86 109.638 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.98 -44.08 94.72 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.609 0.719 . . . . 1.86 109.441 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.82 -40.37 92.5 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.849 -1.069 . . . . 1.86 111.026 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.636 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.55 -41.13 22.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.108 1.151 . . . . 1.86 114.108 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.95 -14.57 13.93 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.15 1.907 . . . . 6.12 116.15 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.1 82.95 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.92 -0.657 . . . . 1.86 113.393 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.81 116.4 65.52 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.566 -0.531 . . . . 3.54 109.566 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.67 61.97 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.101 1.201 . . . . 1.86 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.48 -32.02 25.69 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.78 2.32 . . . . 1.86 114.694 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.75 -15.99 62.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.971 0.805 . . . . 2.88 112.189 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.07 5.65 44.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.709 0.262 . . . . 7.17 111.709 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -103.74 131.29 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.873 0.694 . . . . 13.42 112.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -119.3 113.86 21.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.256 -1.016 . . . . 27.09 108.256 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -101.72 128.7 47.92 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.336 0.589 . . . . 1.87 110.815 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 67.8 mt -143.87 136.05 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.278 -0.419 . . . . 17.75 111.109 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.594 ' CD2' HG12 ' B' ' 61' ' ' ILE . 94.5 t80 -131.72 134.92 46.4 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.307 -0.257 . . . . 16.98 110.307 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 39.31 21.7 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 123.435 0.459 . . . . 1.86 111.703 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.518 ' HA2' ' CD ' ' A' ' 277' ' ' PRO . . . 66.98 22.85 72.55 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.522 0.969 . . . . 48.66 115.522 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.5 132.55 56.52 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.605 -0.938 . . . . 4.25 111.784 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -67.51 118.58 11.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.82 -0.627 . . . . 30.57 110.703 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 50.3 mt -86.25 126.11 34.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.229 0.455 . . . . 22.77 112.229 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.601 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -100.07 149.53 23.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.835 -0.62 . . . . 9.34 111.433 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -69.65 -20.26 63.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.611 0.967 . . . . 1.86 113.611 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.05 5.91 68.85 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.075 -0.583 . . . . 1.86 112.572 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.92 13.87 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.179 0.49 . . . . 1.86 111.637 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.33 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.576 0.703 . . . . 1.86 112.67 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.91 -42.05 93.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.759 -1.109 . . . . 2.28 110.747 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.4 -31.13 71.04 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.187 -0.605 . . . . 2.98 111.826 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.06 -28.94 69.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.773 -0.371 . . . . 1.86 110.459 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.601 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -99.01 14.51 28.93 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.62 0.23 . . . . 1.86 111.62 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.16 39.28 19.16 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 122.977 0.511 . . . . 1.86 112.207 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.37 123.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.092 -1.077 . . . . 4.01 108.092 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.96 169.15 8.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.23 0.538 . . . . 5.74 112.114 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.0 pttt -51.56 141.45 16.11 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.19 -0.914 . . . . 4.31 111.482 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.9 23.34 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.01 -0.996 . . . . 10.13 112.817 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.27 146.57 36.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 4.1 107.952 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -123.45 133.06 54.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.012 -0.995 . . . . 1.86 111.296 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.13 179.01 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 19.21 109.927 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . 1.1 m170 -115.96 139.17 50.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.964 -0.384 . . . . 50.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -133.19 144.73 50.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 21.58 111.012 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.414 HG12 ' CZ ' ' A' ' 322' ' ' PHE . 3.7 m . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 25.97 110.661 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 121.529 0.681 . . . . 137.64 110.358 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.899 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.506 -0.77 . . . . 89.76 111.342 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.899 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.56 12.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 O-C-N 121.739 -0.601 . . . . 143.71 109.508 -177.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.11 135.81 51.08 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.48 -0.563 . . . . 82.42 109.48 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.554 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.0 m-85 -107.25 134.48 50.28 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.413 -0.958 . . . . 82.42 108.413 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.57 135.37 48.49 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.784 -0.821 . . . . 82.42 108.784 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.475 ' HB3' HD23 ' A' ' 326' ' ' LEU . 40.6 tttp -92.76 135.65 33.93 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.151 -1.055 . . . . 88.16 108.151 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 323' ' ' VAL . 91.6 t -100.98 117.13 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 117.96 -1.496 . . . . 82.42 110.833 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.429 ' H ' HD11 ' A' ' 275' ' ' ILE . 0.1 OUTLIER -96.71 -0.54 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.668 0.988 . . . . 138.48 113.668 -178.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . 0.675 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 5.1 m-85 -117.67 145.31 36.14 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 117.98 0.355 . . . . 82.42 111.089 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.35 135.22 16.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.575 2.183 . . . . 82.42 112.352 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 288' ' ' ILE . 64.6 t80 -130.58 111.2 12.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 82.87 110.585 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.39 127.27 40.18 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.187 -0.672 . . . . 82.42 109.187 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.05 108.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.134 0.896 . . . . 82.42 112.683 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . 0.561 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.0 mt-30 -85.61 -43.04 13.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.468 -0.567 . . . . 128.65 109.468 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.23 178.56 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.435 -0.791 . . . . 82.42 111.815 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.34 -35.06 25.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.185 -0.916 . . . . 82.42 109.76 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -79.53 3.79 17.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.634 -0.712 . . . . 82.42 110.693 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.561 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 73.9 mt-10 -117.14 146.29 43.27 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.853 -0.612 . . . . 82.42 109.522 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.7 tp -83.08 140.98 32.35 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.613 -0.721 . . . . 82.42 110.032 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.427 ' O ' HD22 ' A' ' 311' ' ' LEU . 89.2 m -95.66 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 118.514 -1.275 . . . . 82.42 107.765 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.21 141.79 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.555 -0.906 . . . . 82.42 108.555 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 31.7 mmtt -118.93 162.0 19.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.628 -0.879 . . . . 97.85 108.628 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.36 141.52 43.29 Favored 'General case' 0 CA--C 1.483 -1.619 0 C-N-CA 118.114 -1.434 . . . . 88.32 108.68 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.61 21.53 21.41 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.667 -0.973 . . . . 82.42 110.667 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.47 151.89 50.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 118.377 1.089 . . . . 82.42 109.87 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.554 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.1 mm -109.54 133.97 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.77 -1.196 . . . . 105.08 107.77 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 91.9 t -122.79 134.82 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.704 -0.85 . . . . 82.42 108.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.87 126.54 34.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.814 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.01 113.33 8.93 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.937 -0.764 . . . . 82.42 108.937 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.44 -52.41 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 123.682 0.793 . . . . 82.42 110.869 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.0 149.19 27.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.394 -0.965 . . . . 82.42 108.394 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.567 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.78 23.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.465 0.65 . . . . 125.5 110.585 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.651 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.12 172.74 8.87 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.847 1.659 . . . . 82.42 109.884 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 5.7 p -61.93 -149.5 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.939 -1.028 . . . . 91.46 111.402 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.02 -55.44 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.248 0.833 . . . . 103.65 113.248 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -56.65 117.74 4.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.336 0.589 . . . . 115.16 112.277 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.6 t -82.92 113.21 21.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.434 -0.803 . . . . 82.42 110.254 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 166.8 -22.97 0.12 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.951 -0.642 . . . . 82.42 111.827 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . 0.651 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 15.7 m95 -112.75 154.36 26.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.48 -0.563 . . . . 82.42 109.48 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.567 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 0.8 OUTLIER -164.7 174.5 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.352 -0.61 . . . . 93.81 109.352 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.98 143.13 42.65 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.85 -0.796 . . . . 89.72 108.85 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.91 168.96 31.87 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.452 -1.859 . . . . 82.42 108.452 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.788 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.91 129.64 56.4 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.628 -0.829 . . . . 82.42 109.684 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 287' ' ' THR . 62.2 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.08 -1.081 . . . . 82.42 108.08 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.06 37.79 29.22 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.503 -0.554 . . . . 82.42 109.503 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.05 88.06 Favored Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.698 -0.961 . . . . 82.42 110.698 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . 0.788 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.1 mmm-85 -132.43 160.29 36.84 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 118.348 1.074 . . . . 98.99 108.649 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -129.25 124.69 35.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.773 -1.195 . . . . 109.22 107.773 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.49 36.32 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.06 -1.616 . . . . 82.42 109.06 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.37 148.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.691 0.281 . . . . 82.42 111.27 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.53 151.4 23.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 120.982 0.42 . . . . 82.42 110.375 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -70.16 121.44 8.05 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.113 0.542 . . . . 111.89 112.027 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.12 -0.9 56.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.253 0.971 . . . . 119.27 112.018 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.502 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.24 -37.91 87.21 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.38 -0.6 . . . . 96.63 109.38 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 6.5 m-30 -56.87 -7.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.231 -0.895 . . . . 82.42 112.135 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 274' ' ' VAL . 0.8 OUTLIER -132.17 142.77 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 109.205 -0.665 . . . . 82.42 109.205 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -96.49 179.31 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.852 -0.425 . . . . 130.62 109.852 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.548 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.2 mt -89.15 135.19 33.7 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 108.086 -1.079 . . . . 82.42 108.086 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.4 129.05 44.52 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 105.817 -1.92 . . . . 97.62 105.817 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.8 Cg_exo -63.87 -33.85 62.65 Favored 'Trans proline' 0 N--CA 1.436 -1.911 0 N-CA-C 115.601 1.346 . . . . 152.83 115.601 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.947 0 CA-C-N 121.35 1.518 . . . . 82.42 109.234 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.499 -0.556 . . . . 1.86 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.94 140.68 31.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.42 0.629 . . . . 29.01 110.117 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -117.83 165.2 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.734 -1.121 . . . . 1.86 109.818 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.41 139.31 53.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.618 0.247 . . . . 1.86 111.059 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.23 124.18 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.661 -0.866 . . . . 4.99 108.661 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.3 mttt -101.01 137.89 38.78 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.026 0.441 . . . . 5.68 110.487 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -90.35 -146.35 0.18 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.595 -0.73 . . . . 26.89 111.854 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -45.89 76.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.969 -0.56 . . . . 23.29 111.832 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -93.15 2.47 56.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.3 . . . . 1.86 111.511 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.33 16.6 49.38 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.426 -0.416 . . . . 1.86 113.915 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 80.1 tttt -46.96 154.41 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.317 -0.519 . . . . 8.51 111.699 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -107.31 128.19 54.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.682 -0.858 . . . . 1.88 108.682 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 77.3 mt -120.31 122.8 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 123.343 0.402 . . . . 37.69 111.039 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.75 131.24 48.15 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.849 -0.797 . . . . 1.86 108.849 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.628 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.2 mt -127.25 149.92 49.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.69 0.281 . . . . 9.46 110.905 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.57 122.19 43.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.19 -1.782 . . . . 1.86 106.19 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.98 168.34 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.495 0.664 . . . . 1.86 111.553 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.88 149.3 45.07 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 107.127 -1.435 . . . . 1.86 107.127 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.18 -24.53 59.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 CA-C-N 120.767 1.31 . . . . 1.86 112.901 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 p -85.21 -2.6 58.22 Favored 'General case' 0 CA--C 1.526 0.03 0 CA-C-N 116.253 -0.431 . . . . 1.86 112.04 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -71.17 142.53 50.67 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.036 -1.098 . . . . 1.86 108.036 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -86.93 157.89 19.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.524 -1.216 . . . . 1.86 109.704 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.25 -39.83 83.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 1.86 110.04 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.12 -37.64 80.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.664 -0.865 . . . . 1.86 108.664 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.31 -42.88 87.66 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.311 -0.555 . . . . 1.86 109.534 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.53 -41.72 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.532 -0.544 . . . . 1.86 109.532 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.98 -39.96 87.46 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.404 -0.591 . . . . 1.86 109.404 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.18 89.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 1.86 110.445 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.28 -39.12 92.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.621 -0.511 . . . . 1.86 109.621 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 33.1 mt -65.03 -40.07 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.688 -0.486 . . . . 1.86 109.688 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.1 -43.99 95.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.484 0.659 . . . . 1.86 109.416 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.87 -40.35 92.64 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.946 -1.025 . . . . 1.86 110.97 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.628 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.56 -41.23 21.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.091 1.145 . . . . 1.86 114.091 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.58 13.93 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.115 1.894 . . . . 6.12 116.115 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.11 82.86 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.973 -0.632 . . . . 1.86 113.232 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.35 65.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.592 -0.521 . . . . 3.54 109.592 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.63 61.72 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.119 1.213 . . . . 1.86 112.423 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -32.16 24.62 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.771 2.314 . . . . 1.86 114.723 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.82 -15.96 62.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.92 0.782 . . . . 2.88 112.19 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.14 7.43 44.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.777 0.288 . . . . 7.17 111.777 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -110.44 129.24 55.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.806 0.669 . . . . 13.42 112.806 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.437 ' HB2' ' CG2' ' B' ' 70' ' ' VAL . 7.0 mtt-85 -119.08 121.19 39.25 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.694 -1.225 . . . . 27.09 107.694 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -98.89 129.5 45.24 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.351 0.596 . . . . 1.87 110.85 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.466 ' O ' ' HE2' ' A' ' 276' ' ' PHE . 0.6 OUTLIER -144.01 133.47 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.35 -0.387 . . . . 17.75 111.369 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.709 ' CD2' HG12 ' B' ' 61' ' ' ILE . 84.2 t80 -136.48 143.4 43.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.459 -0.337 . . . . 16.98 110.353 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.23 38.72 21.99 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.6 0.563 . . . . 1.86 111.639 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.59 18.13 60.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.524 0.97 . . . . 48.66 115.524 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.84 134.11 55.34 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.898 0.849 . . . . 4.25 111.798 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -65.2 119.03 10.13 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.149 -0.478 . . . . 30.57 110.87 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' B' ' 44' ' ' ILE . 47.4 mt -86.14 126.25 34.09 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.037 0.446 . . . . 22.77 111.829 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.595 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -97.84 149.47 22.33 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 9.34 111.467 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -69.59 -20.22 63.64 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.596 0.962 . . . . 1.86 113.596 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.1 5.96 68.75 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 121.022 -0.608 . . . . 1.86 112.504 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.93 13.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.225 0.513 . . . . 1.86 111.585 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.36 10.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.655 0.741 . . . . 1.86 112.625 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.02 -41.8 92.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.69 -1.141 . . . . 2.28 110.892 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -61.57 -31.11 71.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 120.053 -0.659 . . . . 2.98 111.794 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.98 -28.95 69.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.614 -0.435 . . . . 1.86 110.526 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.595 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -98.98 14.52 28.85 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.673 0.249 . . . . 1.86 111.673 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.07 39.39 19.06 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.254 0.464 . . . . 1.86 112.254 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.709 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.95 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.097 -1.075 . . . . 4.01 108.097 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.98 169.19 8.7 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.249 0.547 . . . . 5.74 112.103 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.57 141.4 16.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.185 -0.916 . . . . 4.31 111.454 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.95 23.32 9.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.991 -1.004 . . . . 10.13 112.803 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.479 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.27 145.7 37.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.929 -1.138 . . . . 4.1 107.929 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 89.8 m -122.32 134.77 54.65 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.967 -1.015 . . . . 1.86 111.297 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.03 -175.27 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 19.21 110.414 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -118.71 139.08 52.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 50.0 109.941 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 16.5 tp -108.7 163.83 12.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 21.58 111.163 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' B' ' 42' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 25.97 110.503 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.555 0.693 . . . . 137.64 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.896 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.2 p -64.88 -56.86 10.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.486 -0.779 . . . . 89.76 111.319 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.896 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.99 166.6 12.61 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 121.784 -0.573 . . . . 143.71 109.509 -177.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.21 135.83 51.17 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.424 -0.584 . . . . 82.42 109.424 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.56 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.23 134.45 50.31 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.475 -0.935 . . . . 82.42 108.475 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.61 135.43 48.55 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.756 -0.831 . . . . 82.42 108.756 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 293' ' ' ILE . 40.6 tttp -92.74 135.62 33.95 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.245 -1.02 . . . . 88.16 108.245 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.475 HG13 HG13 ' A' ' 323' ' ' VAL . 92.4 t -101.02 116.27 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 C-N-CA 117.96 -1.496 . . . . 82.42 110.768 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -4.18 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.68 0.622 . . . . 138.48 112.68 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -117.16 127.7 26.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.736 0.303 . . . . 82.42 110.997 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.19 139.51 50.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.212 2.608 . . . . 82.42 112.188 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -129.97 82.63 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.955 -0.566 . . . . 82.87 110.585 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.13 126.63 29.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.092 -0.707 . . . . 82.42 109.092 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.99 104.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.393 1.058 . . . . 82.42 113.452 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . 0.458 ' HG2' ' HE ' ' B' ' 42' ' ' ARG . 26.1 mt-30 -90.63 -41.34 11.39 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.935 -0.575 . . . . 128.65 109.491 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -146.96 177.21 9.31 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.159 -0.963 . . . . 82.42 111.673 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -82.0 -35.39 28.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.431 -0.804 . . . . 82.42 110.164 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -77.11 -3.67 40.54 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.684 -0.689 . . . . 82.42 111.028 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -111.36 146.54 36.93 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.428 0.632 . . . . 82.42 109.475 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.76 142.46 28.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 82.42 110.016 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.573 ' O ' HD22 ' A' ' 311' ' ' LEU . 89.7 m -96.03 124.55 40.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.335 -1.346 . . . . 82.42 107.688 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.21 141.82 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.556 -0.905 . . . . 82.42 108.556 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -116.2 156.61 26.23 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.428 -0.953 . . . . 97.85 108.428 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.67 141.56 42.72 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 118.275 -1.37 . . . . 88.32 108.697 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.54 21.36 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.65 -0.98 . . . . 82.42 110.65 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.52 151.94 50.45 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.397 1.098 . . . . 82.42 109.805 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.56 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 43.9 mm -109.52 134.02 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.807 -1.183 . . . . 105.08 107.807 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.82 134.84 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.671 -0.863 . . . . 82.42 108.671 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.85 126.61 34.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.799 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 308' ' ' GLU . 23.9 tp -72.02 113.29 8.89 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.877 -0.786 . . . . 82.42 108.877 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.8 mt -74.43 -52.43 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 123.596 0.758 . . . . 82.42 110.866 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.93 149.18 27.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.362 -0.977 . . . . 82.42 108.362 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.436 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.37 163.89 23.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.515 0.674 . . . . 125.5 110.554 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.532 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.22 173.65 8.29 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.856 1.663 . . . . 82.42 109.936 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 2.5 p -61.8 -158.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.514 -0.766 . . . . 91.46 111.398 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.441 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 48.7 mm -59.94 -50.48 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.19 1.182 . . . . 103.65 114.19 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.27 123.11 10.97 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.63 0.604 . . . . 115.16 112.63 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.67 111.7 24.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.563 -0.744 . . . . 82.42 110.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . 0.493 ' HA2' ' ND2' ' A' ' 321' ' ' ASN . . . 158.74 -16.8 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.06 -0.816 . . . . 82.42 111.06 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . 0.594 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 98.6 m95 -118.79 148.26 43.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.175 -0.513 . . . . 82.42 110.377 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.436 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 2.9 m0 -157.49 174.48 15.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.712 -0.847 . . . . 93.81 108.712 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.452 ' O ' HD13 ' A' ' 296' ' ' LEU . 23.0 mt-10 -132.42 143.11 49.58 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.829 -0.804 . . . . 89.72 108.829 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 169.0 31.83 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 108.437 -1.865 . . . . 82.42 108.437 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.79 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.97 129.63 56.42 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 119.571 -0.851 . . . . 82.42 109.684 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.61 135.66 28.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.088 -1.079 . . . . 82.42 108.088 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.75 29.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.584 -0.524 . . . . 82.42 109.584 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.07 88.11 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.19 -1.005 . . . . 82.42 110.623 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . 0.79 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.51 160.27 36.99 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 118.397 1.099 . . . . 98.99 108.627 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.19 124.77 35.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.758 -1.201 . . . . 109.22 107.758 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.81 164.12 36.77 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.028 -1.629 . . . . 82.42 109.028 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 5.0 m -90.72 146.8 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.377 -0.412 . . . . 82.42 111.511 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.77 151.41 23.36 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.461 -0.495 . . . . 82.42 110.436 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.594 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.1 122.38 8.96 Favored 'Trans proline' 0 CA--C 1.488 -1.8 0 C-N-CA 120.139 0.559 . . . . 111.89 112.068 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.58 -10.41 43.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.321 1.013 . . . . 119.27 111.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.42 -38.91 91.5 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.417 -0.586 . . . . 96.63 109.417 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.96 -1.38 0.29 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.379 -1.282 . . . . 82.42 112.325 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.475 HG13 HG13 ' A' ' 274' ' ' VAL . 0.7 OUTLIER -131.94 155.2 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.491 -0.559 . . . . 82.42 109.491 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -108.04 152.76 24.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.428 -0.582 . . . . 130.62 109.428 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.54 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.4 mt -88.0 135.19 33.52 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.097 -1.075 . . . . 82.42 108.097 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.14 44.15 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.752 -1.944 . . . . 97.62 105.752 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.86 -33.96 62.46 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 N-CA-C 115.547 1.326 . . . . 152.83 115.547 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.3 -1.987 0 CA-C-N 121.386 1.531 . . . . 82.42 109.292 179.528 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.587 -0.523 . . . . 1.86 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.93 140.46 32.25 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.336 0.589 . . . . 29.01 110.062 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -118.73 163.4 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 114.581 -1.19 . . . . 1.86 110.051 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.407 ' HB2' HG21 ' B' ' 66' ' ' THR . 97.9 m-85 -120.26 139.27 52.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.601 0.239 . . . . 1.86 111.007 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.29 124.21 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.643 -0.873 . . . . 4.99 108.643 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.1 mttt -101.1 135.93 41.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.989 0.423 . . . . 5.68 110.483 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -78.97 -140.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.547 -0.751 . . . . 26.89 111.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.16 -41.65 22.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 23.29 111.044 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -89.93 2.41 55.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.712 -0.395 . . . . 1.86 111.519 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.47 16.18 50.42 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.376 -0.44 . . . . 1.86 113.865 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 65.4 tttt -50.09 157.84 0.6 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.454 -0.439 . . . . 8.51 111.557 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -106.37 127.95 53.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.72 -0.844 . . . . 1.88 108.72 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 88.8 mt -123.06 123.6 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.315 . . . . 37.69 110.82 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.79 131.19 48.24 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.98 -0.748 . . . . 1.86 108.98 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.635 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 87.7 mt -127.17 149.94 49.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.578 0.228 . . . . 9.46 110.988 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.64 122.16 43.86 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.258 -1.756 . . . . 1.86 106.258 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.93 168.3 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.485 0.659 . . . . 1.86 111.511 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.83 149.35 45.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 107.194 -1.41 . . . . 1.86 107.194 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.3 -24.42 59.81 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 CA-C-N 120.764 1.308 . . . . 1.86 112.966 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 p -85.18 -2.63 58.24 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.163 -0.471 . . . . 1.86 112.046 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.24 142.64 50.57 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.003 -1.11 . . . . 1.86 108.003 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -87.03 157.82 19.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.599 -1.182 . . . . 1.86 109.679 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.26 -39.85 84.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.107 -0.951 . . . . 1.86 109.954 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.13 -37.57 80.46 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.674 -0.862 . . . . 1.86 108.674 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.4 -42.85 87.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.492 -0.558 . . . . 1.86 109.492 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.55 -41.7 88.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.517 -0.549 . . . . 1.86 109.517 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -60.08 -39.87 87.6 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.344 -0.613 . . . . 1.86 109.344 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.29 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.63 . . . . 1.86 110.457 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.531 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.24 -39.22 92.43 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.497 -0.557 . . . . 1.86 109.497 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -64.99 -40.04 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.741 -0.466 . . . . 1.86 109.741 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -44.13 94.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.614 0.721 . . . . 1.86 109.407 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.33 92.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.889 -1.05 . . . . 1.86 110.994 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.635 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.2 mttp -81.59 -41.23 21.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.01 1.115 . . . . 1.86 114.01 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.91 -14.65 13.93 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.052 1.871 . . . . 6.12 116.052 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.11 82.92 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 120.932 -0.651 . . . . 1.86 113.263 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.77 116.49 65.87 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 109.518 -0.549 . . . . 3.54 109.518 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.83 134.68 61.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.062 1.174 . . . . 1.86 112.39 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 -32.28 24.87 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.8 2.333 . . . . 1.86 114.699 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.67 -16.06 62.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 118.955 0.798 . . . . 2.88 112.205 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -100.06 6.09 44.99 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.783 0.29 . . . . 7.17 111.783 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -105.79 153.49 21.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.039 0.755 . . . . 13.42 113.039 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 281' ' ' GLN . 4.0 mtt180 -146.68 118.55 8.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.8 -1.091 . . . . 27.09 108.316 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -100.59 129.41 46.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.315 0.579 . . . . 1.87 110.831 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.489 HG21 ' O ' ' B' ' 48' ' ' LYS . 17.2 mt -141.08 136.23 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.084 -0.385 . . . . 17.75 111.194 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' B' ' 61' ' ' ILE . 62.2 t80 -135.0 137.62 43.19 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.597 -0.274 . . . . 16.98 110.27 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.69 39.34 21.52 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 123.405 0.441 . . . . 1.86 111.674 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 22.62 68.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.576 0.99 . . . . 48.66 115.576 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.489 ' O ' HG21 ' B' ' 44' ' ' ILE . 44.8 mtmt -117.19 132.64 56.6 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.999 0.9 . . . . 4.25 111.775 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -68.45 116.6 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 30.57 110.295 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -85.94 130.22 34.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.201 0.524 . . . . 22.77 112.047 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.608 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -101.22 149.55 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.459 -0.791 . . . . 9.34 111.471 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.66 -20.17 63.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.65 0.982 . . . . 1.86 113.65 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.2 5.99 68.53 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 121.056 -0.593 . . . . 1.86 112.514 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 164.0 13.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.204 0.502 . . . . 1.86 111.652 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -105.45 166.41 10.45 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.582 0.706 . . . . 1.86 112.572 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.97 -42.01 93.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.707 -1.133 . . . . 2.28 110.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.41 -31.13 71.05 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.138 -0.625 . . . . 2.98 111.77 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.1 -28.94 69.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.689 -0.405 . . . . 1.86 110.468 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.608 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -99.04 14.6 28.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.611 0.244 . . . . 1.86 111.629 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.01 39.39 18.8 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.918 0.487 . . . . 1.86 112.22 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.43 123.93 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.136 -1.061 . . . . 4.01 108.136 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.97 169.18 8.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.326 0.584 . . . . 5.74 112.114 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.54 141.42 16.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.234 -0.894 . . . . 4.31 111.443 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.01 23.26 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.937 -1.029 . . . . 10.13 112.824 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.34 146.69 36.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.898 -1.149 . . . . 4.1 107.898 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.407 HG21 ' HB2' ' B' ' 4' ' ' PHE . 99.8 m -121.52 135.0 55.06 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.231 -0.895 . . . . 1.86 111.658 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.6 -176.2 2.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 19.21 110.584 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -125.35 148.77 48.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 50.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.72 139.6 46.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.048 0.452 . . . . 21.58 111.727 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.53 0.201 0 CA-C-N 115.82 -0.627 . . . . 25.97 110.321 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 121.528 0.68 . . . . 137.64 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.899 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.7 p -64.86 -56.8 11.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.527 -0.761 . . . . 89.76 111.413 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.899 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.51 12.64 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.726 -0.609 . . . . 143.71 109.482 -177.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.12 135.78 51.13 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.448 -0.575 . . . . 82.42 109.448 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.491 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.8 m-85 -107.2 134.5 50.22 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.513 -0.921 . . . . 82.42 108.513 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . 0.448 ' SG ' HD21 ' A' ' 325' ' ' LEU . 50.2 m -129.59 135.37 48.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.791 -0.818 . . . . 82.42 108.791 -175.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.675 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.61 33.96 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.214 -1.032 . . . . 88.16 108.214 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 91.2 t -100.87 115.95 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 118.11 -1.436 . . . . 82.42 110.722 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.459 ' H ' HD11 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -96.59 4.89 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.647 0.98 . . . . 138.48 113.647 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -126.2 135.02 26.55 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 117.97 0.35 . . . . 82.42 110.924 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.21 134.74 19.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 82.42 111.861 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.429 ' HB3' HG13 ' A' ' 288' ' ' ILE . 81.2 t80 -128.18 137.85 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 82.87 110.793 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -113.63 121.52 44.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.088 -0.506 . . . . 82.42 109.658 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -32.64 114.43 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.005 0.815 . . . . 82.42 113.133 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . 0.542 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.35 -41.73 12.66 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.411 -0.588 . . . . 128.65 109.411 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.98 179.91 7.68 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.288 -0.882 . . . . 82.42 111.328 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -83.03 -33.25 26.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.412 -0.813 . . . . 82.42 109.994 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -75.13 -5.19 42.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.714 -0.676 . . . . 82.42 111.153 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -112.48 147.14 37.17 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.368 0.604 . . . . 82.42 109.47 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.6 tp -78.1 135.2 37.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.523 -0.762 . . . . 82.42 110.194 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.539 ' O ' HD22 ' A' ' 311' ' ' LEU . 90.0 m -94.87 124.52 38.96 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 118.343 -1.343 . . . . 82.42 107.805 -176.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.1 pt -128.28 141.88 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.483 -0.932 . . . . 82.42 108.483 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -118.55 160.69 21.31 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.56 -0.904 . . . . 97.85 108.56 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.53 141.53 41.18 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.065 -1.454 . . . . 88.32 108.75 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.68 21.5 21.32 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.692 -0.963 . . . . 82.42 110.692 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -130.54 151.91 50.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 118.348 1.074 . . . . 82.42 109.768 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.675 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.55 133.99 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.775 -1.194 . . . . 105.08 107.775 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.81 134.8 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.746 -0.835 . . . . 82.42 108.746 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.491 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 12.9 t -85.82 126.5 34.08 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.153 -1.019 . . . . 128.84 108.858 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -71.91 113.24 8.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.964 -0.754 . . . . 82.42 108.964 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.39 -52.43 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.639 0.776 . . . . 82.42 110.946 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.95 149.22 28.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.387 -0.968 . . . . 82.42 108.387 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.589 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.84 23.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.441 0.639 . . . . 125.5 110.585 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' A' ' 299' ' ' LYS . 39.6 t0 -89.24 174.77 7.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.834 1.654 . . . . 82.42 109.895 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 20.7 p -55.79 -155.95 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.044 -0.98 . . . . 91.46 112.222 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.99 -68.16 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 113.742 1.016 . . . . 103.65 113.742 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.61 134.43 57.01 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.521 0.563 . . . . 115.16 112.521 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.8 36.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.629 -0.714 . . . . 82.42 110.814 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 178.71 -28.75 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.355 -0.839 . . . . 82.42 111.05 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . 0.557 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 85.7 m95 -123.24 156.83 34.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.458 -0.371 . . . . 82.42 110.775 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.589 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.1 m0 -163.61 -179.05 6.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.797 -0.816 . . . . 93.81 108.797 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -137.59 143.04 41.31 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.833 -0.803 . . . . 89.72 108.833 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.93 31.81 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 108.418 -1.873 . . . . 82.42 108.418 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.787 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.89 129.58 56.41 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.567 -0.853 . . . . 82.42 109.728 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.49 135.69 28.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.038 -1.097 . . . . 82.42 108.038 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.69 29.11 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.588 -0.523 . . . . 82.42 109.588 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.0 87.79 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.659 -0.977 . . . . 82.42 110.659 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . 0.787 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.43 160.37 36.61 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 118.957 -1.097 . . . . 98.99 108.583 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.25 124.71 35.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.704 -1.221 . . . . 109.22 107.704 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.95 36.6 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.09 -1.604 . . . . 82.42 109.09 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.19 151.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.053 0.541 . . . . 82.42 111.716 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -153.4 151.42 25.55 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 120.55 -0.46 . . . . 82.42 110.439 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.557 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.12 122.13 8.72 Favored 'Trans proline' 0 CA--C 1.488 -1.819 0 C-N-CA 120.103 0.535 . . . . 111.89 112.111 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -77.63 -0.83 28.08 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.92 0.762 . . . . 119.27 111.893 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.507 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.75 -39.99 90.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.391 -0.596 . . . . 96.63 109.391 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.701 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 4.7 m-30 -77.93 10.34 2.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.135 -0.939 . . . . 82.42 112.167 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.25 163.9 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.339 -0.615 . . . . 82.42 109.339 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -139.34 147.27 41.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.93 -0.767 . . . . 130.62 108.93 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.548 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 mt -87.62 135.23 33.45 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.102 -1.073 . . . . 82.42 108.102 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.33 129.07 44.57 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.847 -1.909 . . . . 97.62 105.847 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 74.7 Cg_exo -63.86 -34.0 62.31 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.516 1.314 . . . . 152.83 115.516 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.958 0 CA-C-N 121.408 1.539 . . . . 82.42 109.283 179.547 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.516 -0.55 . . . . 1.86 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.89 139.83 33.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.223 0.535 . . . . 29.01 110.108 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.7 pt -123.62 167.81 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 114.542 -1.208 . . . . 1.86 110.079 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.94 139.35 52.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.7 0.286 . . . . 1.86 111.0 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.25 124.22 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.643 -0.873 . . . . 4.99 108.643 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.11 137.31 39.65 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.988 0.423 . . . . 5.68 110.444 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -84.91 -149.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.468 -0.787 . . . . 26.89 111.355 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -43.27 81.65 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.966 0.358 . . . . 23.29 111.966 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.1 p -92.85 2.38 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 120.668 -0.413 . . . . 1.86 111.524 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.4 16.74 48.66 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.412 -0.423 . . . . 1.86 113.909 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 74.1 tttt -49.22 157.2 0.48 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.468 -0.431 . . . . 8.51 111.578 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.412 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.6 m -106.35 127.82 53.55 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.701 -0.852 . . . . 1.88 108.701 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.04 123.64 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.49 -0.323 . . . . 37.69 110.813 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.79 131.23 48.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.953 -0.758 . . . . 1.86 108.953 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.637 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 87.9 mt -127.16 149.89 49.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 9.46 110.96 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.63 122.15 43.84 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 106.204 -1.776 . . . . 1.86 106.204 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.9 168.32 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.475 0.655 . . . . 1.86 111.542 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.92 149.29 45.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 107.185 -1.413 . . . . 1.86 107.185 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.23 -24.5 59.73 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 CA-C-N 120.808 1.324 . . . . 1.86 112.869 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.1 p -85.2 -2.56 58.17 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 116.276 -0.42 . . . . 1.86 112.01 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.29 142.67 50.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.001 -1.111 . . . . 1.86 108.001 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -87.01 157.83 19.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.498 -1.228 . . . . 1.86 109.709 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.28 -39.8 83.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.17 -0.923 . . . . 1.86 110.029 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.06 -37.65 80.49 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.69 -0.856 . . . . 1.86 108.69 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.37 -42.83 87.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.521 -0.548 . . . . 1.86 109.521 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.57 -41.79 89.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.532 -0.544 . . . . 1.86 109.532 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.97 -40.04 87.71 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.362 -0.607 . . . . 1.86 109.362 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.18 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.442 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.3 -39.16 92.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.563 -0.532 . . . . 1.86 109.563 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mt -64.98 -40.1 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.645 -0.502 . . . . 1.86 109.645 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -60.06 -44.08 94.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.577 0.703 . . . . 1.86 109.395 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.82 -40.34 92.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.952 -1.022 . . . . 1.86 111.021 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.637 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.6 -41.05 22.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.096 1.147 . . . . 1.86 114.096 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -111.09 -14.57 13.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.01 1.855 . . . . 6.12 116.01 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.04 11.12 82.97 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 120.977 -0.63 . . . . 1.86 113.345 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.7 116.29 65.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.511 -0.551 . . . . 3.54 109.511 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.77 134.66 61.93 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.107 1.204 . . . . 1.86 112.35 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.37 -32.13 25.25 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 122.758 2.306 . . . . 1.86 114.679 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.71 -16.03 62.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.964 0.802 . . . . 2.88 112.197 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.08 5.85 44.96 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.698 0.258 . . . . 7.17 111.698 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -98.24 127.51 44.22 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.599 0.592 . . . . 13.42 112.599 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.433 ' NH1' ' HG2' ' A' ' 281' ' ' GLN . 0.8 OUTLIER -117.71 109.79 17.05 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 27.09 108.398 177.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.58 128.99 45.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.353 0.597 . . . . 1.87 110.746 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.32 133.78 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.129 -0.487 . . . . 17.75 111.545 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.654 ' CD2' HG12 ' B' ' 61' ' ' ILE . 88.0 t80 -135.59 140.34 44.55 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.469 -0.332 . . . . 16.98 110.245 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 38.68 23.73 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.444 0.465 . . . . 1.86 111.65 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.97 19.8 66.08 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 115.47 0.948 . . . . 48.66 115.47 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -117.38 133.75 55.62 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.664 0.732 . . . . 4.25 111.759 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' B' ' 49' ' ' GLN . 0.0 OUTLIER -65.84 120.26 12.73 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.739 -0.664 . . . . 30.57 111.017 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 59.4 mt -86.96 124.19 32.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.117 0.484 . . . . 22.77 112.208 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.591 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -99.06 149.5 22.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 9.34 111.412 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -69.66 -20.08 63.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.709 1.003 . . . . 1.86 113.709 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.24 5.97 68.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.018 -0.611 . . . . 1.86 112.575 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 163.96 13.81 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.124 0.462 . . . . 1.86 111.619 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -105.46 166.28 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.688 0.756 . . . . 1.86 112.542 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.99 -41.85 92.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.616 -1.174 . . . . 2.28 110.781 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -61.5 -31.08 71.06 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 120.045 -0.662 . . . . 2.98 111.875 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.05 -28.96 69.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.773 -0.371 . . . . 1.86 110.489 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.591 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.8 m-85 -98.98 14.5 28.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.733 0.271 . . . . 1.86 111.733 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.39 19.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.961 0.504 . . . . 1.86 112.161 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.654 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.175 -1.046 . . . . 4.01 108.175 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -106.95 169.09 8.76 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.367 0.604 . . . . 5.74 112.044 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.49 141.37 15.97 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.108 -0.951 . . . . 4.31 111.489 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.99 23.34 9.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.072 -0.967 . . . . 10.13 112.818 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.31 145.52 37.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.933 -1.136 . . . . 4.1 107.933 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 31.9 m -126.94 141.75 51.72 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.086 -0.961 . . . . 1.86 111.629 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 -165.89 1.46 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.27 -0.423 . . . . 19.21 110.473 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.34 160.72 35.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.99 -0.374 . . . . 50.0 109.99 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mt -135.42 172.11 13.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.19 0.519 . . . . 21.58 111.513 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' A' ' 322' ' ' PHE . 2.8 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.366 -0.834 . . . . 25.97 110.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 121.532 0.682 . . . . 137.64 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.891 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.95 -56.88 10.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.581 -0.736 . . . . 89.76 111.281 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.891 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.03 166.6 12.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 O-C-N 121.753 -0.592 . . . . 143.71 109.525 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -111.13 135.82 51.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.4 -0.593 . . . . 82.42 109.4 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.513 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.2 134.44 50.3 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.534 -0.913 . . . . 82.42 108.534 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . 0.529 ' SG ' HD21 ' A' ' 325' ' ' LEU . 51.2 m -129.61 135.42 48.53 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.697 -0.853 . . . . 82.42 108.697 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.501 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.6 33.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.197 -1.038 . . . . 88.16 108.197 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.479 ' HA ' ' HB ' ' A' ' 323' ' ' VAL . 92.2 t -100.97 118.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 117.981 -1.488 . . . . 82.42 110.744 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 42.7 mm -82.74 -66.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.652 -0.704 . . . . 138.48 111.313 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.39 126.34 87.78 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 82.42 110.633 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.413 ' CD ' ' HA2' ' B' ' 47' ' ' GLY . 30.6 Cg_endo -63.05 150.01 89.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.505 . . . . 82.42 112.279 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -129.7 107.91 9.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 82.87 111.184 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -84.01 120.51 26.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.564 -0.532 . . . . 82.42 109.564 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . 0.512 ' HB1' ' HG1' ' A' ' 287' ' ' THR . . . -34.34 110.46 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.178 0.924 . . . . 82.42 112.832 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . 0.681 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -82.38 -41.58 19.76 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.725 -0.671 . . . . 128.65 109.458 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -137.21 172.41 13.04 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.003 -1.06 . . . . 82.42 112.035 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.37 -38.25 56.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.262 -0.881 . . . . 82.42 110.058 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -76.41 3.07 11.89 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.601 -0.727 . . . . 82.42 110.94 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.681 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -109.74 146.43 34.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.448 0.642 . . . . 82.42 109.475 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.4 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 16.1 tp -77.02 141.07 40.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.696 . . . . 82.42 110.11 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.512 ' HG1' ' HB1' ' A' ' 280' ' ' ALA . 89.7 m -96.06 124.57 40.12 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.331 -1.347 . . . . 82.42 107.771 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.22 142.15 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.507 -0.923 . . . . 82.42 108.507 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -113.35 157.27 22.06 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 108.507 -0.923 . . . . 97.85 108.507 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.27 141.51 41.65 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.199 -1.4 . . . . 88.32 108.634 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.52 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.637 -0.985 . . . . 82.42 110.637 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -130.53 151.92 50.47 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 118.389 1.095 . . . . 82.42 109.791 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.513 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.2 mm -109.63 133.99 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 107.799 -1.186 . . . . 105.08 107.799 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.85 134.76 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.735 -0.839 . . . . 82.42 108.735 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.76 126.53 34.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.822 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.92 113.18 8.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.974 -0.75 . . . . 82.42 108.974 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.4 -52.35 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 123.624 0.77 . . . . 82.42 110.942 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.99 149.24 27.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.345 -0.983 . . . . 82.42 108.345 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.475 ' CG ' ' H ' ' A' ' 300' ' ' ASP . 2.3 ttmt -80.42 163.89 23.48 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.485 0.66 . . . . 125.5 110.515 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.2 172.54 8.99 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.782 1.633 . . . . 82.42 109.907 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 23.2 p -59.79 -136.4 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.934 -1.03 . . . . 91.46 112.269 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 18.1 mm -84.73 -22.79 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 121.693 -0.63 . . . . 103.65 112.121 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.62 119.28 7.8 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.098 0.407 . . . . 115.16 112.098 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 25.2 t -92.89 92.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.899 -0.591 . . . . 82.42 110.011 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . 0.515 ' HA2' ' ND2' ' A' ' 321' ' ' ASN . . . 160.21 -12.15 0.17 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.358 -0.837 . . . . 82.42 111.294 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . 0.552 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 96.6 m95 -117.45 150.2 39.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.872 0.368 . . . . 82.42 111.093 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.46 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 1.1 m0 -159.76 174.4 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.109 -0.951 . . . . 93.81 108.739 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.559 ' O ' HD13 ' A' ' 296' ' ' LEU . 23.0 mt-10 -133.68 143.13 48.35 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.767 -0.827 . . . . 89.72 108.767 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.9 168.95 31.87 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.38 -1.888 . . . . 82.42 108.38 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.86 129.59 56.4 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.588 -0.845 . . . . 82.42 109.707 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 61.9 tp -142.52 135.65 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.104 -1.073 . . . . 82.42 108.104 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.14 37.69 29.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.546 -0.538 . . . . 82.42 109.546 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.02 87.78 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.148 -1.025 . . . . 82.42 110.723 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.5 160.29 36.92 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.378 1.089 . . . . 98.99 108.632 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.2 124.85 35.63 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.655 -1.239 . . . . 109.22 107.655 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.8 164.12 36.76 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.125 -1.59 . . . . 82.42 109.125 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 11.5 m -89.17 145.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 122.75 0.42 . . . . 82.42 111.497 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.11 151.36 24.32 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 120.525 -0.47 . . . . 82.42 110.47 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.455 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.2 Cg_endo -70.23 123.37 9.88 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.071 0.514 . . . . 111.89 112.062 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.87 -15.27 18.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.518 1.136 . . . . 119.27 111.462 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.515 ' ND2' ' HA2' ' A' ' 305' ' ' GLY . 1.3 m120 -62.52 -39.35 93.28 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 109.347 -0.612 . . . . 96.63 109.347 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -56.76 -4.16 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.363 -0.835 . . . . 82.42 112.642 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 274' ' ' VAL . 0.7 OUTLIER -127.56 145.91 34.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.684 -0.487 . . . . 82.42 109.684 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER -90.07 139.96 30.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.122 -0.695 . . . . 130.62 109.122 178.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.546 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.5 mt -89.1 135.21 33.68 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.116 -1.068 . . . . 82.42 108.116 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.08 44.5 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 105.751 -1.944 . . . . 97.62 105.751 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.1 Cg_exo -64.02 -33.8 61.13 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.547 1.326 . . . . 152.83 115.547 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.301 -1.933 0 CA-C-N 121.352 1.519 . . . . 82.42 109.279 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.477 -0.564 . . . . 1.86 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.86 140.22 32.55 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.292 0.568 . . . . 29.01 110.136 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -120.61 168.21 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 114.586 -1.188 . . . . 1.86 110.011 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.38 139.26 53.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.598 0.237 . . . . 1.86 111.045 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.23 124.19 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.659 -0.867 . . . . 4.99 108.659 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.08 135.75 42.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.008 0.432 . . . . 5.68 110.422 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -79.89 -155.05 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.615 -0.72 . . . . 26.89 111.274 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.61 -40.81 89.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.658 0.614 . . . . 23.29 112.658 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -92.14 2.41 56.61 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.762 0.315 . . . . 1.86 111.581 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.42 15.73 52.2 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.335 -0.459 . . . . 1.86 113.957 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 73.5 tttt -49.76 157.99 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.2 -0.588 . . . . 8.51 111.619 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -106.33 128.24 53.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.682 -0.858 . . . . 1.88 108.682 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.03 122.64 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 123.31 0.381 . . . . 37.69 110.83 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -101.97 131.26 48.49 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.908 -0.775 . . . . 1.86 108.908 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.635 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 87.7 mt -127.21 149.85 49.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.592 0.234 . . . . 9.46 110.998 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.53 122.19 43.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.25 -1.759 . . . . 1.86 106.25 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.07 168.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.486 0.66 . . . . 1.86 111.467 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.86 149.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 107.236 -1.394 . . . . 1.86 107.236 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.12 -24.45 58.53 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 CA-C-N 120.836 1.334 . . . . 1.86 112.97 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -85.25 -2.6 58.22 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.145 -0.48 . . . . 1.86 112.001 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.5 50.53 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.961 -1.126 . . . . 1.86 107.961 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -86.88 157.79 19.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.524 -1.216 . . . . 1.86 109.747 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.2 -39.89 84.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.04 -0.982 . . . . 1.86 109.947 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.08 -37.69 80.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.69 -0.856 . . . . 1.86 108.69 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.24 -42.85 88.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.536 -0.542 . . . . 1.86 109.536 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.61 -41.79 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.369 -0.604 . . . . 1.86 109.369 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.0 -39.93 87.46 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.414 -0.587 . . . . 1.86 109.414 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.25 89.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.757 -0.656 . . . . 1.86 110.441 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.31 -39.07 92.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.567 -0.531 . . . . 1.86 109.567 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -65.11 -40.03 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.688 -0.486 . . . . 1.86 109.688 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.05 -44.05 94.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.493 0.663 . . . . 1.86 109.36 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.88 -40.4 92.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.022 -0.99 . . . . 1.86 110.957 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.635 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.081 1.141 . . . . 1.86 114.081 -177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.95 -14.51 13.94 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.156 1.91 . . . . 6.12 116.156 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.2 11.02 82.95 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.964 -0.636 . . . . 1.86 113.245 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.26 64.94 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.632 -0.507 . . . . 3.54 109.632 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.65 134.68 62.33 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.098 1.199 . . . . 1.86 112.433 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.33 -32.21 25.17 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.887 2.391 . . . . 1.86 114.643 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.85 -15.91 62.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.913 0.779 . . . . 2.88 112.126 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -100.12 8.13 44.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.754 0.279 . . . . 7.17 111.754 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.81 144.29 31.34 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.598 0.592 . . . . 13.42 112.598 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -138.82 114.8 10.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.341 -0.985 . . . . 27.09 108.341 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 130.39 43.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.364 0.602 . . . . 1.87 110.837 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -139.43 130.66 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.932 -0.48 . . . . 17.75 110.931 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' B' ' 61' ' ' ILE . 91.5 t80 -132.25 136.4 46.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.555 -0.293 . . . . 16.98 110.244 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.9 39.77 26.6 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 123.474 0.484 . . . . 1.86 111.709 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.413 ' HA2' ' CD ' ' A' ' 277' ' ' PRO . . . 65.35 22.27 69.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 115.605 1.002 . . . . 48.66 115.605 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.94 132.1 56.44 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.07 0.935 . . . . 4.25 111.737 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -68.2 115.58 7.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.896 -0.593 . . . . 30.57 110.158 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -81.93 134.22 35.37 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.122 0.487 . . . . 22.77 111.787 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.598 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -101.81 149.43 24.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.5 -0.773 . . . . 9.34 111.467 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.64 -20.12 63.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.58 0.955 . . . . 1.86 113.58 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.22 6.03 68.49 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 121.005 -0.617 . . . . 1.86 112.533 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.89 13.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.152 0.476 . . . . 1.86 111.621 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.6 p -105.37 166.43 10.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.657 0.741 . . . . 1.86 112.596 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.11 -41.9 93.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.674 -1.148 . . . . 2.28 110.659 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.55 -30.98 71.0 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.063 -0.655 . . . . 2.98 111.811 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.14 -29.0 70.04 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.715 -0.394 . . . . 1.86 110.419 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.598 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -98.94 14.52 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.698 0.258 . . . . 1.86 111.698 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.03 39.4 18.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.264 0.468 . . . . 1.86 112.264 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.095 -1.076 . . . . 4.01 108.095 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.17 8.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.303 0.573 . . . . 5.74 112.155 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.55 141.37 16.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.222 -0.899 . . . . 4.31 111.458 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 67.12 23.15 9.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.978 -1.01 . . . . 10.13 112.81 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.417 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.2 m -77.27 146.72 36.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.972 -1.121 . . . . 4.1 107.972 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m -120.86 131.35 54.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.449 -0.796 . . . . 1.86 111.75 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mp -111.09 -177.68 3.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.667 -0.697 . . . . 19.21 110.669 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -124.45 144.15 50.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.978 -0.379 . . . . 50.0 109.978 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 69' ' ' LEU . 4.2 mt -129.95 154.55 47.24 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.08 0.467 . . . . 21.58 111.638 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.693 -0.685 . . . . 25.97 110.07 178.879 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 121.585 0.707 . . . . 137.64 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.886 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.523 -0.762 . . . . 89.76 111.346 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.886 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.6 12.62 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 121.777 -0.577 . . . . 143.71 109.549 -177.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.21 135.8 51.21 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.454 -0.573 . . . . 82.42 109.454 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.9 m-85 -107.23 134.44 50.32 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.505 -0.924 . . . . 82.42 108.505 176.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 52.1 m -129.63 135.45 48.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.726 -0.842 . . . . 82.42 108.726 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' A' ' 293' ' ' ILE . 40.6 tttp -92.71 135.57 33.99 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.203 -1.036 . . . . 88.16 108.203 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.422 HG11 ' H ' ' A' ' 276' ' ' PHE . 89.8 t -100.85 115.95 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 C-N-CA 118.028 -1.469 . . . . 82.42 110.823 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.469 ' H ' HD11 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -98.12 16.58 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.655 0.983 . . . . 138.48 113.655 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . 0.704 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 10.8 m-85 -136.63 143.01 41.22 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 122.261 -0.275 . . . . 82.42 110.456 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.86 134.53 12.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.573 2.182 . . . . 82.42 112.281 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.61 96.39 4.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.794 -0.639 . . . . 82.87 110.776 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.55 120.58 21.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.125 -0.488 . . . . 82.42 109.732 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.52 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.288 0.847 . . . . 82.42 113.288 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . 0.555 ' OE1' HG21 ' B' ' 70' ' ' VAL . 26.1 mt-30 -85.17 -41.99 15.14 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.448 -0.575 . . . . 128.65 109.448 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -146.83 176.39 9.92 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.872 -1.143 . . . . 82.42 111.455 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.89 -30.82 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.152 -0.931 . . . . 82.42 110.621 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.37 -6.26 57.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.924 -0.58 . . . . 82.42 110.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -108.75 147.09 32.52 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.31 0.576 . . . . 82.42 109.479 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 13.9 tp -83.42 137.93 33.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.599 -0.728 . . . . 82.42 110.014 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.6 m -95.78 124.53 39.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.311 -1.356 . . . . 82.42 107.793 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.25 141.68 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.489 -0.93 . . . . 82.42 108.489 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -120.7 162.98 18.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.713 -0.847 . . . . 97.85 108.713 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.19 141.53 41.78 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 118.028 -1.469 . . . . 88.32 108.744 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.64 21.59 21.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.582 -1.007 . . . . 82.42 110.582 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.5 151.91 50.46 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 118.459 1.13 . . . . 82.42 109.873 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.457 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.1 mm -109.54 133.99 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.724 -1.213 . . . . 105.08 107.724 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.82 134.75 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.759 -0.83 . . . . 82.42 108.759 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.582 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.1 t -85.74 126.56 34.07 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.886 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.97 113.23 8.79 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.885 -0.783 . . . . 82.42 108.885 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.6 mt -74.49 -52.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.655 0.782 . . . . 82.42 110.891 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.96 149.21 27.97 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.471 -0.937 . . . . 82.42 108.471 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.663 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.32 163.79 23.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.551 0.691 . . . . 125.5 110.533 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 306' ' ' TRP . 39.7 t0 -89.2 170.6 10.46 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.795 1.638 . . . . 82.42 109.908 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 14.5 p -60.16 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.72 -1.127 . . . . 91.46 111.769 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.87 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 121.733 -0.604 . . . . 103.65 112.49 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -59.52 116.3 3.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.224 0.535 . . . . 115.16 111.757 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.4 t -79.26 115.61 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.604 -0.725 . . . . 82.42 110.123 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 175.74 -21.2 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.69 -0.686 . . . . 82.42 111.688 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . 0.634 ' O ' ' HB2' ' A' ' 300' ' ' ASP . 99.0 m95 -118.48 153.25 34.45 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.391 0.139 . . . . 82.42 110.877 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.663 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.9 m0 -165.46 175.71 8.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.447 -0.946 . . . . 93.81 108.447 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -137.02 143.16 42.58 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.792 -0.818 . . . . 89.72 108.792 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.97 31.88 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 108.404 -1.878 . . . . 82.42 108.404 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.778 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.96 129.67 56.4 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 119.521 -0.872 . . . . 82.42 109.652 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 62.1 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.128 -1.064 . . . . 82.42 108.128 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.08 37.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.625 -0.509 . . . . 82.42 109.625 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.11 35.06 88.23 Favored Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.231 -0.985 . . . . 82.42 110.71 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . 0.778 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.35 36.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 118.358 1.079 . . . . 98.99 108.609 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.27 124.71 35.13 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.744 -1.206 . . . . 109.22 107.744 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.78 164.31 36.87 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.077 -1.609 . . . . 82.42 109.077 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 1.7 m -96.52 150.97 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.327 0.651 . . . . 82.42 111.887 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -153.69 151.37 25.0 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 120.287 -0.565 . . . . 82.42 110.495 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.665 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.88 8.47 Favored 'Trans proline' 0 CA--C 1.488 -1.824 0 C-N-CA 120.087 0.524 . . . . 111.89 112.085 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.528 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -71.08 -2.44 15.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 124.35 1.031 . . . . 119.27 112.035 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' B' ' 68' ' ' HIS . 1.3 m120 -61.94 -39.92 93.76 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.361 -0.607 . . . . 96.63 109.361 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 9.3 m-30 -74.98 7.24 3.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 82.42 112.061 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.01 159.29 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.252 -0.647 . . . . 82.42 109.252 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.88 146.66 43.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.688 -0.856 . . . . 130.62 108.688 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.547 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -86.79 135.29 33.41 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 108.104 -1.073 . . . . 82.42 108.104 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.06 44.44 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 105.748 -1.945 . . . . 97.62 105.748 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.7 Cg_exo -63.97 -33.76 61.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 N-CA-C 115.564 1.332 . . . . 152.83 115.564 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.302 -1.895 0 CA-C-N 121.385 1.531 . . . . 82.42 109.223 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.508 ' HE2' ' O ' ' B' ' 61' ' ' ILE . 4.2 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.6 -0.518 . . . . 1.86 109.6 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.59 32.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.377 0.608 . . . . 29.01 110.158 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -119.3 164.38 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.599 -1.182 . . . . 1.86 109.946 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.462 ' O ' HD12 ' B' ' 67' ' ' LEU . 97.9 m-85 -120.73 139.34 53.22 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.644 0.259 . . . . 1.86 111.03 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.402 HG13 HD13 ' B' ' 30' ' ' ILE . 47.2 t -121.36 124.27 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.623 -0.881 . . . . 4.99 108.623 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.07 138.4 38.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.948 0.404 . . . . 5.68 110.428 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -81.21 -153.21 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.618 -0.719 . . . . 26.89 111.899 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -36.11 72.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.285 -0.416 . . . . 23.29 111.837 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -96.38 2.37 52.62 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.596 -0.442 . . . . 1.86 111.587 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.97 51.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.365 -0.445 . . . . 1.86 113.856 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 78.9 tttt -49.8 157.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.33 -0.512 . . . . 8.51 111.649 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -106.69 127.99 53.82 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.785 -0.821 . . . . 1.88 108.785 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.14 123.07 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 123.347 0.404 . . . . 37.69 110.9 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.87 131.25 48.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.924 -0.769 . . . . 1.86 108.924 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.629 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.0 mt -127.13 149.99 49.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.644 0.259 . . . . 9.46 110.906 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.72 122.14 43.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.14 -1.8 . . . . 1.86 106.14 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.93 168.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.563 0.697 . . . . 1.86 111.503 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.74 149.26 44.82 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.259 -1.385 . . . . 1.86 107.259 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.19 -24.48 59.27 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.872 1.347 . . . . 1.86 112.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.27 -2.48 58.1 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.237 -0.438 . . . . 1.86 111.97 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 142.6 50.35 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.961 -1.126 . . . . 1.86 107.961 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -86.96 157.91 19.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.558 -1.201 . . . . 1.86 109.631 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.35 -39.82 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.114 -0.948 . . . . 1.86 109.942 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.19 -37.45 80.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.723 -0.843 . . . . 1.86 108.723 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.4 t-20 -66.41 -42.91 87.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.474 -0.565 . . . . 1.86 109.474 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.6 -41.71 88.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.513 -0.551 . . . . 1.86 109.513 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -59.94 -39.97 87.37 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 109.459 -0.571 . . . . 1.86 109.459 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 1.86 110.427 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.27 -39.08 92.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.621 -0.511 . . . . 1.86 109.621 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.402 HD13 HG13 ' B' ' 5' ' ' VAL . 32.2 mt -65.13 -40.02 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.621 -0.511 . . . . 1.86 109.621 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.06 -44.0 95.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.517 0.675 . . . . 1.86 109.424 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.9 -40.4 92.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.965 -1.016 . . . . 1.86 110.963 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.629 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.44 -41.2 22.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.129 1.159 . . . . 1.86 114.129 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.63 13.92 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.163 1.912 . . . . 6.12 116.163 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.0 82.95 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 120.88 -0.676 . . . . 1.86 113.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.31 65.15 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.58 -0.526 . . . . 3.54 109.58 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.71 134.67 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.167 1.244 . . . . 1.86 112.444 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.46 -32.07 25.69 Favored 'Trans proline' 0 N--CA 1.507 2.307 0 C-N-CA 122.789 2.326 . . . . 1.86 114.662 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.78 -16.09 62.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 118.973 0.806 . . . . 2.88 112.068 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.02 6.33 45.06 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.707 0.262 . . . . 7.17 111.707 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -106.67 131.28 53.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.47 0.544 . . . . 13.42 112.47 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -117.72 114.73 23.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 27.09 107.811 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -100.57 128.99 46.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.37 0.605 . . . . 1.87 110.825 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' B' ' 49' ' ' GLN . 2.6 pt -149.7 132.59 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.85 -0.614 . . . . 17.75 111.609 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.666 ' CD2' HG12 ' B' ' 61' ' ' ILE . 83.2 t80 -124.99 139.72 53.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.413 -0.358 . . . . 16.98 110.247 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.96 39.06 21.98 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 123.54 0.525 . . . . 1.86 111.717 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 65.35 21.75 68.75 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 115.865 1.106 . . . . 48.66 115.865 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.43 134.28 55.24 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.992 0.896 . . . . 4.25 111.879 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.452 ' HA ' HG22 ' B' ' 44' ' ' ILE . 24.8 mt-30 -65.89 119.2 10.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.911 -0.586 . . . . 30.57 111.053 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . 0.431 ' HG ' ' HA ' ' B' ' 44' ' ' ILE . 63.5 mt -89.3 125.54 35.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.065 0.459 . . . . 22.77 112.009 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.6 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -99.35 149.54 23.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 9.34 111.386 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.67 -20.15 63.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.669 0.988 . . . . 1.86 113.669 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.18 6.03 68.59 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 120.99 -0.624 . . . . 1.86 112.609 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.98 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.162 0.481 . . . . 1.86 111.706 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -105.45 166.48 10.4 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.753 0.787 . . . . 1.86 112.523 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.3 mt -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.662 -1.154 . . . . 2.28 110.803 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.54 -31.04 71.04 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.086 -0.646 . . . . 2.98 111.809 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.09 -28.96 69.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.744 -0.383 . . . . 1.86 110.448 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.6 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -99.02 14.53 28.89 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.624 0.231 . . . . 1.86 111.624 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.09 39.33 19.01 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.879 0.472 . . . . 1.86 112.19 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.666 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.4 124.09 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.049 -1.093 . . . . 4.01 108.049 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 169.13 8.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.318 0.58 . . . . 5.74 112.083 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.48 141.47 15.75 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.127 -0.942 . . . . 4.31 111.485 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.97 23.19 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.04 -0.982 . . . . 10.13 112.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.459 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.21 146.7 36.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.963 -1.125 . . . . 4.1 107.963 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 52.9 m -125.47 136.93 53.89 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.029 -0.987 . . . . 1.86 111.533 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.462 HD12 ' O ' ' B' ' 4' ' ' PHE . 0.2 OUTLIER -112.25 -172.71 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.294 -0.412 . . . . 19.21 110.208 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . 0.494 ' CD2' ' HB3' ' A' ' 321' ' ' ASN . 0.0 OUTLIER -132.56 153.67 50.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.939 -0.393 . . . . 50.0 109.939 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tp -126.55 158.05 37.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.835 0.35 . . . . 21.58 111.436 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 322' ' ' PHE . 7.8 p . . . . . 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 25.97 110.607 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.515 0.674 . . . . 137.64 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.876 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.8 p -64.93 -56.75 11.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.523 -0.762 . . . . 89.76 111.375 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.876 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.07 166.57 12.6 Favored 'General case' 0 CA--C 1.494 -1.189 0 O-C-N 121.762 -0.586 . . . . 143.71 109.481 -177.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.19 135.77 51.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.489 -0.56 . . . . 82.42 109.489 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.467 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.9 m-85 -107.16 134.39 50.34 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.484 -0.932 . . . . 82.42 108.484 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.4 m -129.55 135.39 48.53 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.789 -0.819 . . . . 82.42 108.789 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.489 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.6 tttp -92.72 135.58 33.98 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.217 -1.031 . . . . 88.16 108.217 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.89 116.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 117.956 -1.498 . . . . 82.42 110.801 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -81.99 -41.62 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 121.622 -0.674 . . . . 138.48 112.277 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' PHE . . . . . 0.642 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -102.44 122.5 46.23 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 121.143 -0.223 . . . . 82.42 110.862 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.81 159.56 52.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.591 2.194 . . . . 82.42 112.264 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -124.45 86.74 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.626 -0.715 . . . . 82.87 109.995 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -56.78 116.46 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.414 -0.587 . . . . 82.42 109.414 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.59 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.646 1.216 . . . . 82.42 113.309 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . 0.45 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -87.02 -39.18 15.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.844 -0.616 . . . . 128.65 109.369 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -148.38 175.52 11.04 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.064 -1.022 . . . . 82.42 111.736 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.04 -33.63 29.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.228 -0.896 . . . . 82.42 110.235 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.23 -2.77 42.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.688 -0.687 . . . . 82.42 111.087 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.379 0.609 . . . . 82.42 109.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.402 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.5 tp -85.57 135.82 33.65 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.343 -0.844 . . . . 82.42 110.156 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.525 ' O ' HD22 ' A' ' 311' ' ' LEU . 89.7 m -95.68 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.106 -1.438 . . . . 82.42 107.805 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.21 141.68 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.556 -0.905 . . . . 82.42 108.556 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.4 mmtt -117.04 158.96 23.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.419 -0.956 . . . . 97.85 108.419 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -76.08 141.56 41.98 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 118.458 -1.297 . . . . 88.32 108.665 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.58 21.66 21.11 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.65 -0.98 . . . . 82.42 110.65 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -130.51 151.91 50.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 118.393 1.097 . . . . 82.42 109.818 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.56 133.93 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.834 -1.173 . . . . 105.08 107.834 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 310' ' ' GLU . 92.4 t -122.73 134.81 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.743 -0.836 . . . . 82.42 108.743 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.81 126.64 34.17 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.189 -1.004 . . . . 128.84 108.783 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.08 113.27 8.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.894 -0.78 . . . . 82.42 108.894 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.46 -52.37 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 123.562 0.745 . . . . 82.42 110.919 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.95 149.15 27.92 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.474 -0.936 . . . . 82.42 108.474 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.544 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.43 163.82 23.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.533 0.683 . . . . 125.5 110.498 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.507 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.13 172.83 8.8 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.77 1.628 . . . . 82.42 109.868 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 4.7 p -60.77 -155.54 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.498 -0.774 . . . . 91.46 111.546 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 43.4 mm -64.42 -50.41 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 113.883 1.068 . . . . 103.65 113.883 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.18 120.67 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.647 0.61 . . . . 115.16 112.647 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -89.41 106.27 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.61 -0.723 . . . . 82.42 110.245 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 168.4 -14.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.217 -0.902 . . . . 82.42 110.88 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . 0.507 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 92.6 m95 -126.33 156.06 41.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.279 -0.461 . . . . 82.42 111.253 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.544 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.2 m0 -163.81 -171.3 2.44 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.817 0.847 . . . . 93.81 108.772 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -145.85 143.06 29.38 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.869 -0.789 . . . . 89.72 108.869 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.88 168.97 31.86 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 108.448 -1.861 . . . . 82.42 108.448 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.792 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.92 129.7 56.38 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.558 -0.857 . . . . 82.42 109.688 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.65 135.69 28.35 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.039 -1.097 . . . . 82.42 108.039 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.01 37.82 29.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.597 -0.519 . . . . 82.42 109.597 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.01 35.18 88.97 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 110.683 -0.967 . . . . 82.42 110.683 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ARG . . . . . 0.792 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.31 36.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 118.349 1.074 . . . . 98.99 108.627 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.24 124.72 35.2 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.761 -1.199 . . . . 109.22 107.761 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.77 164.48 36.97 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 108.997 -1.641 . . . . 82.42 108.997 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 3.3 m -94.68 151.94 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.309 0.643 . . . . 82.42 112.041 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -152.98 151.41 26.21 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 120.206 -0.598 . . . . 82.42 110.49 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.2 Cg_endo -70.17 122.12 8.7 Favored 'Trans proline' 0 CA--C 1.488 -1.793 0 C-N-CA 120.105 0.537 . . . . 111.89 112.081 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -71.07 -14.71 62.41 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.3 1.0 . . . . 119.27 111.98 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.5 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -61.57 -40.34 94.38 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.926 -0.71 . . . . 96.63 109.422 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.642 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 2.9 m-30 -64.51 0.08 1.19 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.213 -0.903 . . . . 82.42 111.706 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.53 171.46 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.513 -0.551 . . . . 82.42 109.513 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.461 ' N ' HD13 ' A' ' 275' ' ' ILE . 0.6 OUTLIER -145.96 146.41 31.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 130.62 108.869 178.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.545 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -87.95 135.22 33.5 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 108.052 -1.092 . . . . 82.42 108.052 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.12 44.36 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 105.813 -1.921 . . . . 97.62 105.813 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.3 Cg_exo -64.0 -33.86 61.17 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 N-CA-C 115.54 1.323 . . . . 152.83 115.54 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.925 0 CA-C-N 121.393 1.533 . . . . 82.42 109.234 179.502 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.467 ' HE2' ' O ' ' B' ' 61' ' ' ILE . 4.1 ptt? . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.525 -0.546 . . . . 1.86 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.47 32.19 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.287 0.565 . . . . 29.01 110.149 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.9 pt -120.95 162.31 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.751 -1.113 . . . . 1.86 109.966 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.449 ' HB2' ' OG1' ' B' ' 66' ' ' THR . 97.9 m-85 -120.92 139.36 53.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.618 0.247 . . . . 1.86 110.977 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.423 HG23 HD12 ' B' ' 30' ' ' ILE . 47.1 t -121.33 124.13 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.64 -0.874 . . . . 4.99 108.64 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.3 mttt -101.02 138.92 37.42 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.966 0.412 . . . . 5.68 110.458 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -77.61 -157.65 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.693 -0.685 . . . . 26.89 111.898 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.403 ' HG ' ' CG1' ' B' ' 70' ' ' VAL . 1.3 tt -68.35 -37.81 80.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.705 -0.679 . . . . 23.29 111.671 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -94.94 2.44 55.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.841 -0.344 . . . . 1.86 111.555 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.9 51.71 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.365 -0.445 . . . . 1.86 113.905 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 79.6 tttt -50.42 158.36 0.61 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.329 -0.513 . . . . 8.51 111.492 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -106.61 128.06 53.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.741 -0.837 . . . . 1.88 108.741 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.42 121.93 56.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 O-C-N 123.372 0.42 . . . . 37.69 110.836 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.96 131.34 48.42 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.934 -0.765 . . . . 1.86 108.934 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.637 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.5 mt -127.24 149.95 49.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.61 0.243 . . . . 9.46 110.943 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.64 122.17 43.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.223 -1.769 . . . . 1.86 106.223 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.03 168.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.455 0.645 . . . . 1.86 111.478 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.86 149.35 45.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 107.179 -1.415 . . . . 1.86 107.179 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.29 -24.46 59.91 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 CA-C-N 120.799 1.321 . . . . 1.86 112.899 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -85.22 -2.54 58.16 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.215 -0.448 . . . . 1.86 112.071 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.28 142.59 50.5 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.906 -1.146 . . . . 1.86 107.906 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -86.92 157.79 19.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.493 -1.23 . . . . 1.86 109.79 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.22 -39.93 84.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.132 -0.94 . . . . 1.86 109.948 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.67 80.29 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.742 -0.836 . . . . 1.86 108.742 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.33 -42.91 87.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.463 -0.569 . . . . 1.86 109.463 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.56 -41.76 89.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.471 -0.566 . . . . 1.86 109.471 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.01 -39.85 87.25 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.443 -0.577 . . . . 1.86 109.443 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.26 89.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.728 -0.669 . . . . 1.86 110.458 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.19 -39.2 92.53 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.545 -0.539 . . . . 1.86 109.545 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.423 HD12 HG23 ' B' ' 5' ' ' VAL . 32.8 mt -65.01 -40.07 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.68 -0.489 . . . . 1.86 109.68 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.03 -44.1 94.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.493 0.663 . . . . 1.86 109.344 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.87 -40.29 92.44 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.015 -0.993 . . . . 1.86 110.98 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.637 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.2 mttp -81.58 -41.34 21.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.009 1.114 . . . . 1.86 114.009 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.86 -14.59 13.96 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.167 1.914 . . . . 6.12 116.167 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.07 82.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.97 -0.633 . . . . 1.86 113.244 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.69 116.36 65.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.612 -0.514 . . . . 3.54 109.612 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.8 134.68 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 CA-C-N 120.361 1.165 . . . . 1.86 112.373 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.22 -32.31 24.65 Favored 'Trans proline' 0 N--CA 1.506 2.255 0 C-N-CA 122.818 2.345 . . . . 1.86 114.716 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.7 -16.02 62.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.829 0.74 . . . . 2.88 112.171 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.07 6.3 44.98 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.741 0.274 . . . . 7.17 111.741 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.33 121.23 42.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.82 0.674 . . . . 13.42 112.82 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -103.94 115.07 29.78 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.286 -1.005 . . . . 27.09 108.286 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -102.59 127.64 49.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.305 0.574 . . . . 1.87 110.886 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -153.84 130.45 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.142 -0.481 . . . . 17.75 111.406 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.709 ' CD2' HG12 ' B' ' 61' ' ' ILE . 59.2 t80 -124.95 142.76 51.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.561 -0.29 . . . . 16.98 110.368 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.79 38.78 16.48 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.501 0.5 . . . . 1.86 111.653 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 60.3 28.25 66.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 115.164 0.826 . . . . 48.66 115.164 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.58 ' O ' HG22 ' B' ' 44' ' ' ILE . 44.8 mtmt -119.2 134.29 55.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 117.474 0.637 . . . . 4.25 111.747 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -64.47 114.69 4.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.424 -0.807 . . . . 30.57 110.684 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.59 125.75 34.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.943 0.402 . . . . 22.77 111.79 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.612 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -100.21 149.47 23.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.867 -0.606 . . . . 9.34 111.493 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.67 -20.05 63.58 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.693 0.998 . . . . 1.86 113.693 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.8 68.6 Favored Glycine 0 N--CA 1.476 1.309 0 C-N-CA 121.119 -0.562 . . . . 1.86 112.491 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.36 163.93 13.85 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.295 0.548 . . . . 1.86 111.674 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 49.6 p -105.35 166.3 10.52 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.679 0.752 . . . . 1.86 112.602 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.01 -41.91 93.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.664 -1.153 . . . . 2.28 110.794 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.0 70.96 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 120.058 -0.657 . . . . 2.98 111.902 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.05 -29.09 70.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.728 -0.389 . . . . 1.86 110.467 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.612 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -98.87 14.45 28.9 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.757 0.28 . . . . 1.86 111.757 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.13 39.36 19.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.923 0.489 . . . . 1.86 112.218 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.709 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.189 -1.041 . . . . 4.01 108.189 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.09 8.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.27 0.557 . . . . 5.74 112.191 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.46 141.38 15.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.25 -0.887 . . . . 4.31 111.471 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.03 23.23 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.074 -0.967 . . . . 10.13 112.856 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.3 m -77.28 146.27 36.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.984 -1.117 . . . . 4.1 107.984 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 53.2 m -126.31 136.29 52.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.148 -0.933 . . . . 1.86 111.596 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' B' ' 45' ' ' PHE . 0.0 OUTLIER -109.01 -177.78 3.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.232 -0.44 . . . . 19.21 110.256 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -118.55 147.33 43.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.956 -0.387 . . . . 50.0 109.956 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.2 113.91 3.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.945 0.402 . . . . 21.58 110.973 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 319' ' ' PRO . 72.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 25.97 110.821 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 121.571 0.7 . . . . 137.64 110.331 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.895 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.85 -56.86 10.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.515 -0.766 . . . . 89.76 111.381 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.895 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.54 12.65 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.81 -0.556 . . . . 143.71 109.59 -177.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.13 135.78 51.13 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.445 -0.576 . . . . 82.42 109.445 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.459 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.7 m-85 -107.16 134.46 50.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.529 -0.915 . . . . 82.42 108.529 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.64 135.38 48.46 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.723 -0.844 . . . . 82.42 108.723 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.501 ' H ' ' CD1' ' A' ' 326' ' ' LEU . 40.7 tttp -92.7 135.59 33.97 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.254 -1.017 . . . . 88.16 108.254 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.646 HG23 ' CG1' ' A' ' 323' ' ' VAL . 93.0 t -100.99 114.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 117.93 -1.508 . . . . 82.42 110.724 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.404 HG13 ' N ' ' A' ' 276' ' ' PHE . 8.3 pt -79.25 -34.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.954 -1.021 . . . . 138.48 112.981 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . 0.585 ' CG ' ' HD2' ' B' ' 68' ' ' HIS . 2.4 m-85 -108.23 90.52 6.96 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.478 0.18 . . . . 82.42 110.806 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.501 ' HB3' ' N ' ' A' ' 290' ' ' GLU . 65.6 Cg_endo -72.28 141.37 35.49 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.762 2.308 . . . . 82.42 113.375 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 -150.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.393 -0.821 . . . . 82.87 109.435 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -159.62 144.3 15.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.522 -0.918 . . . . 82.42 108.522 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.56 ' HA ' ' HG1' ' A' ' 287' ' ' THR . . . -28.67 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.497 1.123 . . . . 82.42 113.574 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . 0.552 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.48 -42.53 12.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.831 -0.622 . . . . 128.65 109.421 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.34 177.26 9.58 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.77 -0.582 . . . . 82.42 111.377 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.45 -34.4 28.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.309 -0.859 . . . . 82.42 110.443 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.13 -5.43 59.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 82.42 111.151 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.56 ' HG2' HH21 ' B' ' 74' ' ' ARG . 73.9 mt-10 -102.55 147.51 26.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.329 0.585 . . . . 82.42 109.533 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 309' ' ' GLY . 17.3 tp -85.69 133.12 34.04 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.135 -0.939 . . . . 82.42 110.196 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.56 ' HG1' ' HA ' ' A' ' 280' ' ' ALA . 90.1 m -96.72 124.58 40.75 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.812 -1.555 . . . . 82.42 107.739 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.29 141.42 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.554 -0.906 . . . . 82.42 108.554 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 14.4 mmtt -118.69 162.72 17.96 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.798 -0.815 . . . . 97.85 108.798 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . 0.501 ' N ' ' HB3' ' A' ' 277' ' ' PRO . 13.5 pt-20 -75.18 141.53 43.62 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.101 -1.439 . . . . 88.32 108.734 -174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.44 21.48 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.646 -0.982 . . . . 82.42 110.646 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.49 151.9 50.46 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.398 1.099 . . . . 82.42 109.829 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.459 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.0 mm -109.52 134.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.777 -1.194 . . . . 105.08 107.777 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.3 t -122.8 134.84 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.669 -0.863 . . . . 82.42 108.669 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.84 126.56 34.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.096 -1.042 . . . . 128.84 108.846 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -72.0 113.27 8.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.886 -0.783 . . . . 82.42 108.886 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.38 -52.45 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 123.765 0.826 . . . . 82.42 110.924 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.03 149.12 27.83 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.42 -0.955 . . . . 82.42 108.42 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.61 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.87 23.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.546 0.688 . . . . 125.5 110.581 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.699 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.19 171.22 9.96 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 125.86 1.664 . . . . 82.42 109.961 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 6.2 p -64.12 -133.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.665 -0.698 . . . . 91.46 112.29 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.9 mm -79.85 -53.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 112.898 0.703 . . . . 103.65 112.898 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.91 113.26 1.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.419 0.526 . . . . 115.16 112.419 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.87 106.48 13.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.583 -0.735 . . . . 82.42 109.971 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 165.21 -11.06 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.458 -0.792 . . . . 82.42 111.292 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . 0.699 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 83.4 m95 -122.74 156.04 35.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.273 . . . . 82.42 110.485 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.61 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.6 m0 -168.22 -175.71 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 93.81 108.328 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -144.41 143.05 30.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.847 -0.797 . . . . 89.72 108.847 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . 0.404 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -152.8 169.03 31.82 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.441 -1.864 . . . . 82.42 108.441 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.794 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.93 129.66 56.4 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.567 -0.853 . . . . 82.42 109.649 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.438 HD22 ' O ' ' A' ' 287' ' ' THR . 61.9 tp -142.63 135.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.102 -1.073 . . . . 82.42 108.102 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.11 37.77 29.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.552 -0.536 . . . . 82.42 109.552 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.09 35.07 88.39 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.269 -0.967 . . . . 82.42 110.745 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . 0.794 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.44 160.35 36.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.989 -1.084 . . . . 98.99 108.521 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.29 124.74 35.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.749 -1.204 . . . . 109.22 107.749 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.74 163.71 36.47 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.082 -1.607 . . . . 82.42 109.082 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.488 HG22 HH21 ' B' ' 74' ' ' ARG . 0.8 OUTLIER -98.09 151.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.65 0.38 . . . . 82.42 111.445 -178.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.75 151.43 26.63 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 120.999 0.428 . . . . 82.42 110.42 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.2 Cg_endo -70.19 122.02 8.6 Favored 'Trans proline' 0 CA--C 1.487 -1.825 0 C-N-CA 120.097 0.532 . . . . 111.89 112.041 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -78.92 -6.25 55.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 123.995 0.809 . . . . 119.27 111.833 -178.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.493 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.1 -40.77 97.01 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.386 -0.598 . . . . 96.63 109.386 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.42 2.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.852 -1.067 . . . . 82.42 111.788 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.646 ' CG1' HG23 ' A' ' 274' ' ' VAL . 1.9 m -132.24 155.54 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.555 -0.535 . . . . 82.42 109.555 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -116.61 163.96 15.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.143 -0.688 . . . . 130.62 109.143 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.543 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -93.67 135.17 35.22 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 108.127 -1.064 . . . . 82.42 108.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.07 44.55 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 105.785 -1.931 . . . . 97.62 105.785 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.3 Cg_exo -63.88 -33.87 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 N-CA-C 115.523 1.316 . . . . 152.83 115.523 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--N 1.302 -1.918 0 CA-C-N 121.387 1.531 . . . . 82.42 109.248 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.5 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.476 -0.564 . . . . 1.86 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.9 140.23 32.57 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.397 0.618 . . . . 29.01 110.121 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' B' ' 65' ' ' SER . 12.7 pt -119.21 156.15 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.908 -1.042 . . . . 1.86 110.021 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' B' ' 13' ' ' ILE . 97.9 m-85 -121.12 139.31 53.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.65 0.262 . . . . 1.86 110.931 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.29 124.16 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.671 -0.863 . . . . 4.99 108.671 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -100.99 137.56 39.2 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.059 0.457 . . . . 5.68 110.411 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -90.87 -149.95 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.543 -0.753 . . . . 26.89 111.6 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.538 HD11 HD22 ' B' ' 71' ' ' LEU . 0.4 OUTLIER -62.57 -47.89 81.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.856 -0.611 . . . . 23.29 111.448 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -91.27 2.26 56.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.477 -0.489 . . . . 1.86 111.556 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.663 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.48 16.37 49.75 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.417 -0.42 . . . . 1.86 113.881 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 82.6 tttt -43.62 150.05 0.25 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 122.223 -0.574 . . . . 8.51 111.778 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -106.54 128.1 53.85 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.718 -0.845 . . . . 1.88 108.718 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' B' ' 4' ' ' PHE . 69.4 mt -123.96 121.67 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 O-C-N 123.289 0.368 . . . . 37.69 110.953 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.47 131.22 47.72 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.988 -0.745 . . . . 1.86 108.988 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.638 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.0 mt -127.19 149.9 49.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.624 0.25 . . . . 9.46 110.935 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.57 122.13 43.77 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.271 -1.751 . . . . 1.86 106.271 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.95 168.32 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.487 0.66 . . . . 1.86 111.493 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.84 149.2 44.82 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 107.18 -1.415 . . . . 1.86 107.18 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.2 -24.47 59.27 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 CA-C-N 120.772 1.311 . . . . 1.86 112.954 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.21 -2.56 58.17 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 116.172 -0.467 . . . . 1.86 112.069 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.63 50.52 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.94 -1.133 . . . . 1.86 107.94 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -87.03 157.89 19.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.471 -1.241 . . . . 1.86 109.687 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.29 -39.91 84.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.077 -0.965 . . . . 1.86 109.921 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.04 -37.64 80.38 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.654 -0.869 . . . . 1.86 108.654 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.36 -42.85 87.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.456 -0.572 . . . . 1.86 109.456 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.64 -41.68 89.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.416 -0.587 . . . . 1.86 109.416 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.377 -0.601 . . . . 1.86 109.377 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.27 89.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.666 . . . . 1.86 110.451 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.3 -39.13 92.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.572 -0.529 . . . . 1.86 109.572 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.474 HG22 ' OE1' ' B' ' 41' ' ' GLN . 32.6 mt -65.05 -40.04 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.622 -0.51 . . . . 1.86 109.622 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.04 -44.04 94.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.518 0.675 . . . . 1.86 109.39 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.85 -40.35 92.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.006 -0.997 . . . . 1.86 111.036 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.638 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.55 -41.22 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.033 1.123 . . . . 1.86 114.033 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -110.93 -14.7 13.92 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.049 1.87 . . . . 6.12 116.049 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.06 82.93 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 120.912 -0.661 . . . . 1.86 113.322 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -85.82 116.48 65.83 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 109.507 -0.553 . . . . 3.54 109.507 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.93 134.64 61.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.086 1.19 . . . . 1.86 112.339 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.32 -32.22 25.08 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.751 2.301 . . . . 1.86 114.654 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.71 -15.99 62.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.976 0.807 . . . . 2.88 112.182 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.08 8.69 43.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.732 0.271 . . . . 7.17 111.732 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.474 ' OE1' HG22 ' B' ' 30' ' ' ILE . 44.0 mt-30 -117.65 125.84 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.13 0.789 . . . . 13.42 113.13 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -111.83 124.03 51.49 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.019 -1.104 . . . . 27.09 108.019 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.41 132.69 43.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.289 0.566 . . . . 1.87 110.836 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.04 135.57 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.062 -0.399 . . . . 17.75 111.631 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.511 ' CD1' HG12 ' B' ' 61' ' ' ILE . 15.0 t80 -152.92 143.26 22.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.114 -0.494 . . . . 16.98 109.944 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.5 34.75 25.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.784 -0.644 . . . . 1.86 111.681 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 73.1 -10.74 5.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.013 -0.994 . . . . 48.66 114.863 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -107.94 132.64 53.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 120.005 -0.678 . . . . 4.25 111.76 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -58.82 116.98 4.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.14 -0.482 . . . . 30.57 110.126 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 21.3 mt -66.6 131.49 46.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.957 -0.565 . . . . 22.77 112.046 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.622 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -97.53 149.43 22.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.851 -0.613 . . . . 9.34 111.45 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.64 -20.2 63.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.596 0.962 . . . . 1.86 113.596 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.96 68.7 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 121.025 -0.607 . . . . 1.86 112.54 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.43 163.91 13.89 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.17 0.485 . . . . 1.86 111.581 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.2 p -105.33 166.33 10.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.611 0.719 . . . . 1.86 112.604 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.9 mt -60.04 -41.99 93.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.672 -1.149 . . . . 2.28 110.763 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.33 -31.21 71.07 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.111 -0.636 . . . . 2.98 111.763 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -62.14 -28.87 69.94 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.687 -0.405 . . . . 1.86 110.477 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.622 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -98.98 14.56 28.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.697 0.258 . . . . 1.86 111.697 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.4 19.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.9 0.48 . . . . 1.86 112.207 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.511 HG12 ' CD1' ' B' ' 45' ' ' PHE . 96.8 mt -81.46 123.92 38.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.106 -1.072 . . . . 4.01 108.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.88 169.21 8.68 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.281 0.563 . . . . 5.74 112.097 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.5 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 56.9 pttt -51.59 141.41 16.31 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.184 -0.916 . . . . 4.31 111.502 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.04 23.21 9.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.05 -0.977 . . . . 10.13 112.845 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' B' ' 3' ' ' ILE . 38.1 m -77.3 146.93 36.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.87 -1.159 . . . . 4.1 107.87 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 78.0 m -122.64 132.2 54.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.322 -1.308 . . . . 1.86 111.583 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.4 171.74 7.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 19.21 109.789 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.585 ' HD2' ' CG ' ' A' ' 276' ' ' PHE . 1.3 m-70 -119.96 135.59 54.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.512 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 12.6 tp -138.42 157.18 46.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.043 0.449 . . . . 21.58 111.193 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.563 ' CG1' ' HG3' ' A' ' 319' ' ' PRO . 2.1 t -110.03 164.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.873 -0.603 . . . . 25.97 109.848 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' B' ' 72' ' ' ARG . 37.4 tp -78.46 -96.16 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 119.461 -0.304 . . . . 1.86 110.285 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' B' ' 71' ' ' LEU . 0.2 OUTLIER 156.69 64.04 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.114 0.884 . . . . 23.71 110.518 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.406 HD11 ' NE1' ' A' ' 306' ' ' TRP . 18.5 mt -95.06 -26.62 15.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.955 0.407 . . . . 15.09 110.235 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.56 HH21 ' HG2' ' A' ' 285' ' ' GLU . 3.1 tmm_? -131.37 -60.89 0.93 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.909 -0.587 . . . . 1.86 110.766 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 34.0 1.02 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.754 -0.736 . . . . 1.86 112.594 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.546 -0.74 . . . . 1.86 111.072 -179.81 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 121.589 0.709 . . . . 137.64 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.883 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 51.8 p -64.87 -56.99 10.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.528 -0.76 . . . . 89.76 111.26 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.883 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.88 166.63 12.63 Favored 'General case' 0 CA--C 1.491 -1.302 0 O-C-N 121.826 -0.546 . . . . 143.71 109.592 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.18 135.8 51.17 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.437 -0.579 . . . . 82.42 109.437 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.578 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 61.0 m-85 -107.18 134.44 50.29 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.515 -0.921 . . . . 82.42 108.515 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.6 135.4 48.5 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.747 -0.834 . . . . 82.42 108.747 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.489 ' HB3' HD13 ' A' ' 326' ' ' LEU . 40.7 tttp -92.66 135.52 34.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.251 -1.018 . . . . 88.16 108.251 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 90.4 t -100.84 116.46 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 118.038 -1.465 . . . . 82.42 110.782 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 33.0 mm -78.38 -78.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.9 -0.591 . . . . 138.48 112.099 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' B' ' 68' ' ' HIS . 20.7 m-85 -68.95 131.71 90.79 Favored Pre-proline 0 N--CA 1.462 0.147 0 N-CA-C 109.692 -0.484 . . . . 82.42 109.692 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.518 ' CD ' ' HA2' ' B' ' 47' ' ' GLY . 30.8 Cg_endo -63.78 149.75 90.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.727 2.285 . . . . 82.42 111.807 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.458 ' HB3' ' CG1' ' A' ' 288' ' ' ILE . 63.6 t80 -121.41 92.45 3.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.955 -0.566 . . . . 82.87 110.446 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -68.18 116.14 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.873 -0.603 . . . . 82.42 109.729 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.35 104.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.403 1.065 . . . . 82.42 112.98 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . 0.529 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -81.71 -40.28 23.0 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.398 -0.593 . . . . 128.65 109.398 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -144.85 175.39 10.23 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.281 -0.887 . . . . 82.42 111.691 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.67 -31.03 32.43 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.334 -0.848 . . . . 82.42 109.696 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 -3.59 43.96 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.327 -0.851 . . . . 82.42 110.939 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.529 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.5 146.51 37.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.401 0.62 . . . . 82.42 109.486 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.42 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.7 tp -76.79 138.72 40.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.525 -0.762 . . . . 82.42 110.066 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.476 ' O ' HD22 ' A' ' 311' ' ' LEU . 89.8 m -96.45 124.49 40.47 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.33 -1.348 . . . . 82.42 107.767 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.458 ' CG1' ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.2 142.16 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.542 -0.91 . . . . 82.42 108.542 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -113.82 158.3 21.19 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.396 -0.964 . . . . 97.85 108.396 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.48 141.52 41.26 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 118.077 -1.449 . . . . 88.32 108.642 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.63 21.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.572 -1.011 . . . . 82.42 110.572 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.49 151.87 50.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.436 1.118 . . . . 82.42 109.825 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.564 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.3 mm -109.56 133.95 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.817 -1.179 . . . . 105.08 107.817 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.74 134.8 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.718 -0.845 . . . . 82.42 108.718 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.578 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.82 126.61 34.16 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.131 -1.028 . . . . 128.84 108.825 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.97 113.22 8.78 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.899 -0.778 . . . . 82.42 108.899 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.41 -52.43 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.733 0.813 . . . . 82.42 110.92 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.97 149.2 27.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.475 -0.935 . . . . 82.42 108.475 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.514 ' HG3' ' NE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.79 23.62 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.433 0.635 . . . . 125.5 110.594 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.18 174.3 7.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.801 1.64 . . . . 82.42 109.93 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.413 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 3.9 p -58.0 -144.72 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.994 0.739 . . . . 91.46 112.994 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.413 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 45.8 mm -71.02 -57.52 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.907 1.077 . . . . 103.65 113.907 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -50.53 127.57 18.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.096 0.776 . . . . 115.16 113.096 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.88 112.82 26.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.408 -0.815 . . . . 82.42 110.446 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 158.3 -13.56 0.25 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.922 -0.871 . . . . 82.42 110.922 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . 0.543 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 92.4 m95 -122.7 147.56 46.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.372 -0.414 . . . . 82.42 110.913 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.628 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 7.2 m0 -157.81 -177.48 6.61 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.782 0.676 . . . . 93.81 109.435 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 296' ' ' LEU . 23.0 mt-10 -138.14 143.06 40.14 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.851 -0.796 . . . . 89.72 108.851 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.86 168.89 31.84 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 108.448 -1.861 . . . . 82.42 108.448 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.78 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.84 129.75 56.34 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 119.503 -0.879 . . . . 82.42 109.673 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.68 135.57 28.17 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.1 -1.074 . . . . 82.42 108.1 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.13 37.78 29.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.499 -0.556 . . . . 82.42 109.499 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.13 35.04 88.1 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.193 -1.004 . . . . 82.42 110.699 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . 0.78 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.4 160.3 36.78 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 119.029 -1.069 . . . . 98.99 108.598 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -129.22 124.78 35.38 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.738 -1.208 . . . . 109.22 107.738 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.82 163.96 36.67 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.071 -1.612 . . . . 82.42 109.071 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 1.6 m -96.42 151.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 122.734 0.413 . . . . 82.42 111.456 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -155.23 151.4 22.68 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 120.634 -0.427 . . . . 82.42 110.425 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.22 121.89 8.46 Favored 'Trans proline' 0 CA--C 1.486 -1.88 0 C-N-CA 120.053 0.502 . . . . 111.89 112.094 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.628 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.1 OUTLIER -74.76 -0.44 18.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 124.158 0.912 . . . . 119.27 111.976 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.512 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.95 -42.64 98.61 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.448 -0.575 . . . . 96.63 109.448 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 68' ' ' HIS . 4.6 m-85 -73.55 9.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.523 -0.762 . . . . 82.42 112.683 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.57 164.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.589 -0.523 . . . . 82.42 109.589 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.08 154.67 47.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.341 -0.614 . . . . 130.62 109.341 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.54 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -92.22 135.26 34.15 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.11 -1.07 . . . . 82.42 108.11 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 273' ' ' LYS . 4.9 mp -91.35 129.05 44.61 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 105.803 -1.925 . . . . 97.62 105.803 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.97 -33.82 61.64 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.59 1.342 . . . . 152.83 115.59 -175.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 CA--C 1.486 -1.908 0 CA-C-N 121.385 1.53 . . . . 82.42 109.308 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.414 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.479 -0.563 . . . . 1.86 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.88 140.7 31.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.243 0.545 . . . . 29.01 110.197 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.8 pt -116.27 161.55 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.87 -1.059 . . . . 1.86 109.827 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.84 139.3 53.79 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.585 0.231 . . . . 1.86 110.975 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.24 124.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.641 -0.874 . . . . 4.99 108.641 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.13 139.57 36.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 5.68 110.471 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -91.3 -142.59 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.612 -0.722 . . . . 26.89 111.788 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.49 -42.13 62.23 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.119 -0.491 . . . . 23.29 111.572 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -94.25 2.35 55.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.072 -0.651 . . . . 1.86 111.527 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.46 16.32 49.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.363 -0.446 . . . . 1.86 113.786 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 77.6 tttt -46.8 153.45 0.4 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.363 -0.492 . . . . 8.51 111.568 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -107.06 127.77 53.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.722 -0.844 . . . . 1.88 108.722 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.82 121.75 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.233 0.333 . . . . 37.69 110.931 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.45 131.18 47.7 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.024 -0.732 . . . . 1.86 109.024 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.636 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.2 mt -127.12 149.94 49.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.678 0.275 . . . . 9.46 110.935 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.6 122.12 43.75 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 106.185 -1.783 . . . . 1.86 106.185 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.92 168.41 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.524 0.678 . . . . 1.86 111.468 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.94 149.28 45.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.133 -1.432 . . . . 1.86 107.133 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.24 -24.43 59.36 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 CA-C-N 120.832 1.333 . . . . 1.86 112.93 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.28 -2.59 58.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.224 -0.444 . . . . 1.86 112.001 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.22 142.57 50.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.958 -1.127 . . . . 1.86 107.958 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.91 157.79 19.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.499 -1.228 . . . . 1.86 109.704 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.24 -39.88 84.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.087 -0.961 . . . . 1.86 110.011 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.71 80.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.699 -0.852 . . . . 1.86 108.699 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.32 -42.87 87.59 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.518 -0.549 . . . . 1.86 109.518 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -60.64 -41.7 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.472 -0.566 . . . . 1.86 109.472 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.96 -40.0 87.52 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.35 -0.611 . . . . 1.86 109.35 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.18 89.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.826 -0.625 . . . . 1.86 110.516 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.15 -39.25 92.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.55 -0.537 . . . . 1.86 109.55 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 mt -65.09 -40.03 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.638 -0.505 . . . . 1.86 109.638 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.98 -44.08 94.72 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.609 0.719 . . . . 1.86 109.441 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.82 -40.37 92.5 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.849 -1.069 . . . . 1.86 111.026 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.636 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.55 -41.13 22.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.108 1.151 . . . . 1.86 114.108 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.95 -14.57 13.93 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.15 1.907 . . . . 6.12 116.15 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.1 82.95 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.92 -0.657 . . . . 1.86 113.393 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.81 116.4 65.52 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.566 -0.531 . . . . 3.54 109.566 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.67 61.97 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.101 1.201 . . . . 1.86 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.48 -32.02 25.69 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.78 2.32 . . . . 1.86 114.694 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.75 -15.99 62.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.971 0.805 . . . . 2.88 112.189 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.07 5.65 44.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.709 0.262 . . . . 7.17 111.709 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -103.74 131.29 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.873 0.694 . . . . 13.42 112.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -119.3 113.86 21.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.256 -1.016 . . . . 27.09 108.256 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -101.72 128.7 47.92 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.336 0.589 . . . . 1.87 110.815 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 67.8 mt -143.87 136.05 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.278 -0.419 . . . . 17.75 111.109 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.594 ' CD2' HG12 ' B' ' 61' ' ' ILE . 94.5 t80 -131.72 134.92 46.4 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.307 -0.257 . . . . 16.98 110.307 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 39.31 21.7 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 123.435 0.459 . . . . 1.86 111.703 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.518 ' HA2' ' CD ' ' A' ' 277' ' ' PRO . . . 66.98 22.85 72.55 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.522 0.969 . . . . 48.66 115.522 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.5 132.55 56.52 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.605 -0.938 . . . . 4.25 111.784 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -67.51 118.58 11.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.82 -0.627 . . . . 30.57 110.703 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 50.3 mt -86.25 126.11 34.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.229 0.455 . . . . 22.77 112.229 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.601 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -100.07 149.53 23.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.835 -0.62 . . . . 9.34 111.433 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -69.65 -20.26 63.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.611 0.967 . . . . 1.86 113.611 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.05 5.91 68.85 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.075 -0.583 . . . . 1.86 112.572 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.92 13.87 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.179 0.49 . . . . 1.86 111.637 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.33 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.576 0.703 . . . . 1.86 112.67 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.91 -42.05 93.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.759 -1.109 . . . . 2.28 110.747 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.4 -31.13 71.04 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.187 -0.605 . . . . 2.98 111.826 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.06 -28.94 69.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.773 -0.371 . . . . 1.86 110.459 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.601 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -99.01 14.51 28.93 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.62 0.23 . . . . 1.86 111.62 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.16 39.28 19.16 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 122.977 0.511 . . . . 1.86 112.207 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.37 123.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.092 -1.077 . . . . 4.01 108.092 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.96 169.15 8.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.23 0.538 . . . . 5.74 112.114 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.0 pttt -51.56 141.45 16.11 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.19 -0.914 . . . . 4.31 111.482 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.9 23.34 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.01 -0.996 . . . . 10.13 112.817 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.27 146.57 36.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 4.1 107.952 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -123.45 133.06 54.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.012 -0.995 . . . . 1.86 111.296 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.13 179.01 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 19.21 109.927 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . 1.1 m170 -115.96 139.17 50.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.964 -0.384 . . . . 50.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -133.19 144.73 50.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 21.58 111.012 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.414 HG12 ' CZ ' ' A' ' 322' ' ' PHE . 3.7 m -99.92 152.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 25.97 110.661 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 tp -144.93 107.98 4.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.504 -0.317 . . . . 1.86 111.368 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.43 ' CZ ' ' HA ' ' B' ' 76' ' ' CYS . 1.3 mmp_? -64.44 125.38 24.46 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.968 -0.56 . . . . 23.71 110.516 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 -62.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 15.09 110.832 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.07 147.73 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 1.86 110.521 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.54 -87.09 1.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.928 -0.653 . . . . 1.86 111.873 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.43 ' HA ' ' CZ ' ' B' ' 72' ' ' ARG . 36.9 m . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.968 -1.015 . . . . 1.86 111.508 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 121.529 0.681 . . . . 137.64 110.358 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.899 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.506 -0.77 . . . . 89.76 111.342 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.899 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.56 12.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 O-C-N 121.739 -0.601 . . . . 143.71 109.508 -177.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.11 135.81 51.08 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.48 -0.563 . . . . 82.42 109.48 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.554 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.0 m-85 -107.25 134.48 50.28 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.413 -0.958 . . . . 82.42 108.413 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.57 135.37 48.49 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.784 -0.821 . . . . 82.42 108.784 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.475 ' HB3' HD23 ' A' ' 326' ' ' LEU . 40.6 tttp -92.76 135.65 33.93 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.151 -1.055 . . . . 88.16 108.151 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 323' ' ' VAL . 91.6 t -100.98 117.13 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 117.96 -1.496 . . . . 82.42 110.833 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.429 ' H ' HD11 ' A' ' 275' ' ' ILE . 0.1 OUTLIER -96.71 -0.54 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.668 0.988 . . . . 138.48 113.668 -178.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . 0.675 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 5.1 m-85 -117.67 145.31 36.14 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 117.98 0.355 . . . . 82.42 111.089 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.35 135.22 16.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.575 2.183 . . . . 82.42 112.352 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 288' ' ' ILE . 64.6 t80 -130.58 111.2 12.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 82.87 110.585 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.39 127.27 40.18 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.187 -0.672 . . . . 82.42 109.187 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.05 108.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.134 0.896 . . . . 82.42 112.683 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . 0.561 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.0 mt-30 -85.61 -43.04 13.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.468 -0.567 . . . . 128.65 109.468 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.23 178.56 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.435 -0.791 . . . . 82.42 111.815 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.34 -35.06 25.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.185 -0.916 . . . . 82.42 109.76 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -79.53 3.79 17.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.634 -0.712 . . . . 82.42 110.693 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.701 ' OE2' ' HA ' ' B' ' 73' ' ' LEU . 73.9 mt-10 -117.14 146.29 43.27 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.853 -0.612 . . . . 82.42 109.522 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.7 tp -83.08 140.98 32.35 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.613 -0.721 . . . . 82.42 110.032 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.427 ' O ' HD22 ' A' ' 311' ' ' LEU . 89.2 m -95.66 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 118.514 -1.275 . . . . 82.42 107.765 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.21 141.79 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.555 -0.906 . . . . 82.42 108.555 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 31.7 mmtt -118.93 162.0 19.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.628 -0.879 . . . . 97.85 108.628 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.36 141.52 43.29 Favored 'General case' 0 CA--C 1.483 -1.619 0 C-N-CA 118.114 -1.434 . . . . 88.32 108.68 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.61 21.53 21.41 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.667 -0.973 . . . . 82.42 110.667 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.47 151.89 50.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 118.377 1.089 . . . . 82.42 109.87 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.554 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.1 mm -109.54 133.97 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.77 -1.196 . . . . 105.08 107.77 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 91.9 t -122.79 134.82 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.704 -0.85 . . . . 82.42 108.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.87 126.54 34.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.814 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.01 113.33 8.93 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.937 -0.764 . . . . 82.42 108.937 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.44 -52.41 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 123.682 0.793 . . . . 82.42 110.869 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.0 149.19 27.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.394 -0.965 . . . . 82.42 108.394 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.567 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.78 23.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.465 0.65 . . . . 125.5 110.585 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.651 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.12 172.74 8.87 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.847 1.659 . . . . 82.42 109.884 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 5.7 p -61.93 -149.5 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.939 -1.028 . . . . 91.46 111.402 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.02 -55.44 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.248 0.833 . . . . 103.65 113.248 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -56.65 117.74 4.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.336 0.589 . . . . 115.16 112.277 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.6 t -82.92 113.21 21.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.434 -0.803 . . . . 82.42 110.254 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 166.8 -22.97 0.12 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.951 -0.642 . . . . 82.42 111.827 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . 0.651 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 15.7 m95 -112.75 154.36 26.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.48 -0.563 . . . . 82.42 109.48 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.567 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 0.8 OUTLIER -164.7 174.5 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.352 -0.61 . . . . 93.81 109.352 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.98 143.13 42.65 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.85 -0.796 . . . . 89.72 108.85 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.91 168.96 31.87 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.452 -1.859 . . . . 82.42 108.452 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.788 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.91 129.64 56.4 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.628 -0.829 . . . . 82.42 109.684 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 287' ' ' THR . 62.2 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.08 -1.081 . . . . 82.42 108.08 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.06 37.79 29.22 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.503 -0.554 . . . . 82.42 109.503 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.05 88.06 Favored Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.698 -0.961 . . . . 82.42 110.698 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . 0.788 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.1 mmm-85 -132.43 160.29 36.84 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 118.348 1.074 . . . . 98.99 108.649 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -129.25 124.69 35.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.773 -1.195 . . . . 109.22 107.773 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.49 36.32 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.06 -1.616 . . . . 82.42 109.06 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.671 HG23 ' HB2' ' B' ' 74' ' ' ARG . 0.7 OUTLIER -95.37 148.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.691 0.281 . . . . 82.42 111.27 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.53 151.4 23.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 120.982 0.42 . . . . 82.42 110.375 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -70.16 121.44 8.05 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.113 0.542 . . . . 111.89 112.027 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.12 -0.9 56.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.253 0.971 . . . . 119.27 112.018 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.502 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.24 -37.91 87.21 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.38 -0.6 . . . . 96.63 109.38 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 6.5 m-30 -56.87 -7.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.231 -0.895 . . . . 82.42 112.135 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 274' ' ' VAL . 0.8 OUTLIER -132.17 142.77 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 109.205 -0.665 . . . . 82.42 109.205 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -96.49 179.31 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.852 -0.425 . . . . 130.62 109.852 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.548 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.2 mt -89.15 135.19 33.7 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 108.086 -1.079 . . . . 82.42 108.086 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.4 129.05 44.52 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 105.817 -1.92 . . . . 97.62 105.817 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.8 Cg_exo -63.87 -33.85 62.65 Favored 'Trans proline' 0 N--CA 1.436 -1.911 0 N-CA-C 115.601 1.346 . . . . 152.83 115.601 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.947 0 CA-C-N 121.35 1.518 . . . . 82.42 109.234 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.499 -0.556 . . . . 1.86 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.94 140.68 31.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.42 0.629 . . . . 29.01 110.117 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -117.83 165.2 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.734 -1.121 . . . . 1.86 109.818 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.41 139.31 53.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.618 0.247 . . . . 1.86 111.059 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.23 124.18 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.661 -0.866 . . . . 4.99 108.661 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.3 mttt -101.01 137.89 38.78 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.026 0.441 . . . . 5.68 110.487 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -90.35 -146.35 0.18 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.595 -0.73 . . . . 26.89 111.854 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.415 ' HG ' HD11 ' B' ' 71' ' ' LEU . 1.0 OUTLIER -66.8 -45.89 76.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.969 -0.56 . . . . 23.29 111.832 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -93.15 2.47 56.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.3 . . . . 1.86 111.511 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.33 16.6 49.38 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.426 -0.416 . . . . 1.86 113.915 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 80.1 tttt -46.96 154.41 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.317 -0.519 . . . . 8.51 111.699 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -107.31 128.19 54.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.682 -0.858 . . . . 1.88 108.682 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 77.3 mt -120.31 122.8 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 123.343 0.402 . . . . 37.69 111.039 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.75 131.24 48.15 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.849 -0.797 . . . . 1.86 108.849 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.628 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.2 mt -127.25 149.92 49.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.69 0.281 . . . . 9.46 110.905 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.57 122.19 43.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.19 -1.782 . . . . 1.86 106.19 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.98 168.34 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.495 0.664 . . . . 1.86 111.553 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.88 149.3 45.07 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 107.127 -1.435 . . . . 1.86 107.127 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.18 -24.53 59.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 CA-C-N 120.767 1.31 . . . . 1.86 112.901 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 p -85.21 -2.6 58.22 Favored 'General case' 0 CA--C 1.526 0.03 0 CA-C-N 116.253 -0.431 . . . . 1.86 112.04 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -71.17 142.53 50.67 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.036 -1.098 . . . . 1.86 108.036 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -86.93 157.89 19.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.524 -1.216 . . . . 1.86 109.704 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.25 -39.83 83.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 1.86 110.04 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.12 -37.64 80.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.664 -0.865 . . . . 1.86 108.664 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.31 -42.88 87.66 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.311 -0.555 . . . . 1.86 109.534 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.53 -41.72 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.532 -0.544 . . . . 1.86 109.532 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.98 -39.96 87.46 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.404 -0.591 . . . . 1.86 109.404 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.18 89.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 1.86 110.445 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.28 -39.12 92.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.621 -0.511 . . . . 1.86 109.621 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 33.1 mt -65.03 -40.07 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.688 -0.486 . . . . 1.86 109.688 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.1 -43.99 95.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.484 0.659 . . . . 1.86 109.416 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.87 -40.35 92.64 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.946 -1.025 . . . . 1.86 110.97 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.628 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.56 -41.23 21.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.091 1.145 . . . . 1.86 114.091 -177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.58 13.93 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.115 1.894 . . . . 6.12 116.115 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.11 82.86 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.973 -0.632 . . . . 1.86 113.232 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.35 65.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.592 -0.521 . . . . 3.54 109.592 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.63 61.72 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.119 1.213 . . . . 1.86 112.423 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -32.16 24.62 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.771 2.314 . . . . 1.86 114.723 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.82 -15.96 62.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.92 0.782 . . . . 2.88 112.19 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.14 7.43 44.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.777 0.288 . . . . 7.17 111.777 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -110.44 129.24 55.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.806 0.669 . . . . 13.42 112.806 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.437 ' HB2' ' CG2' ' B' ' 70' ' ' VAL . 7.0 mtt-85 -119.08 121.19 39.25 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.694 -1.225 . . . . 27.09 107.694 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -98.89 129.5 45.24 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.351 0.596 . . . . 1.87 110.85 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.466 ' O ' ' HE2' ' A' ' 276' ' ' PHE . 0.6 OUTLIER -144.01 133.47 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.35 -0.387 . . . . 17.75 111.369 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.709 ' CD2' HG12 ' B' ' 61' ' ' ILE . 84.2 t80 -136.48 143.4 43.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.459 -0.337 . . . . 16.98 110.353 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.23 38.72 21.99 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.6 0.563 . . . . 1.86 111.639 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.59 18.13 60.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.524 0.97 . . . . 48.66 115.524 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.84 134.11 55.34 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.898 0.849 . . . . 4.25 111.798 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -65.2 119.03 10.13 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.149 -0.478 . . . . 30.57 110.87 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' B' ' 44' ' ' ILE . 47.4 mt -86.14 126.25 34.09 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.037 0.446 . . . . 22.77 111.829 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.595 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -97.84 149.47 22.33 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 9.34 111.467 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -69.59 -20.22 63.64 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.596 0.962 . . . . 1.86 113.596 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.1 5.96 68.75 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 121.022 -0.608 . . . . 1.86 112.504 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.93 13.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.225 0.513 . . . . 1.86 111.585 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.36 10.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.655 0.741 . . . . 1.86 112.625 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.02 -41.8 92.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.69 -1.141 . . . . 2.28 110.892 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -61.57 -31.11 71.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 120.053 -0.659 . . . . 2.98 111.794 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.98 -28.95 69.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.614 -0.435 . . . . 1.86 110.526 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.595 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -98.98 14.52 28.85 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.673 0.249 . . . . 1.86 111.673 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.07 39.39 19.06 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.254 0.464 . . . . 1.86 112.254 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.709 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.95 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.097 -1.075 . . . . 4.01 108.097 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.98 169.19 8.7 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.249 0.547 . . . . 5.74 112.103 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.57 141.4 16.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.185 -0.916 . . . . 4.31 111.454 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.95 23.32 9.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.991 -1.004 . . . . 10.13 112.803 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.479 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.27 145.7 37.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.929 -1.138 . . . . 4.1 107.929 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 89.8 m -122.32 134.77 54.65 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.967 -1.015 . . . . 1.86 111.297 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.03 -175.27 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 19.21 110.414 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -118.71 139.08 52.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 50.0 109.941 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 16.5 tp -108.7 163.83 12.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 21.58 111.163 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' B' ' 42' ' ' ARG . 0.6 OUTLIER -129.47 158.94 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 25.97 110.503 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.415 HD11 ' HG ' ' B' ' 8' ' ' LEU . 39.4 mt -125.17 -73.02 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 1.86 111.07 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.18 -154.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.194 -0.457 . . . . 23.71 110.352 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.701 ' HA ' ' OE2' ' A' ' 285' ' ' GLU . 1.9 pt? -91.51 -173.2 3.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 15.09 110.083 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.671 ' HB2' HG23 ' A' ' 317' ' ' VAL . 50.2 ttm-85 -64.37 -34.14 77.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.601 0.239 . . . . 1.86 111.353 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.77 22.51 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.711 -0.757 . . . . 1.86 111.917 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.549 -0.739 . . . . 1.86 111.317 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.555 0.693 . . . . 137.64 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.896 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.2 p -64.88 -56.86 10.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.486 -0.779 . . . . 89.76 111.319 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.896 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.99 166.6 12.61 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 121.784 -0.573 . . . . 143.71 109.509 -177.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.21 135.83 51.17 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.424 -0.584 . . . . 82.42 109.424 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.56 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.23 134.45 50.31 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.475 -0.935 . . . . 82.42 108.475 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.61 135.43 48.55 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.756 -0.831 . . . . 82.42 108.756 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 293' ' ' ILE . 40.6 tttp -92.74 135.62 33.95 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.245 -1.02 . . . . 88.16 108.245 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.475 HG13 HG13 ' A' ' 323' ' ' VAL . 92.4 t -101.02 116.27 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 C-N-CA 117.96 -1.496 . . . . 82.42 110.768 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -4.18 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.68 0.622 . . . . 138.48 112.68 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -117.16 127.7 26.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.736 0.303 . . . . 82.42 110.997 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.19 139.51 50.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.212 2.608 . . . . 82.42 112.188 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -129.97 82.63 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.955 -0.566 . . . . 82.87 110.585 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.13 126.63 29.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.092 -0.707 . . . . 82.42 109.092 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.99 104.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.393 1.058 . . . . 82.42 113.452 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . 0.458 ' HG2' ' HE ' ' B' ' 42' ' ' ARG . 26.1 mt-30 -90.63 -41.34 11.39 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.935 -0.575 . . . . 128.65 109.491 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -146.96 177.21 9.31 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.159 -0.963 . . . . 82.42 111.673 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -82.0 -35.39 28.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.431 -0.804 . . . . 82.42 110.164 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -77.11 -3.67 40.54 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.684 -0.689 . . . . 82.42 111.028 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -111.36 146.54 36.93 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.428 0.632 . . . . 82.42 109.475 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.76 142.46 28.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 82.42 110.016 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.573 ' O ' HD22 ' A' ' 311' ' ' LEU . 89.7 m -96.03 124.55 40.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.335 -1.346 . . . . 82.42 107.688 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.21 141.82 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.556 -0.905 . . . . 82.42 108.556 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -116.2 156.61 26.23 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.428 -0.953 . . . . 97.85 108.428 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.67 141.56 42.72 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 118.275 -1.37 . . . . 88.32 108.697 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.54 21.36 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.65 -0.98 . . . . 82.42 110.65 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.52 151.94 50.45 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.397 1.098 . . . . 82.42 109.805 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.56 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 43.9 mm -109.52 134.02 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.807 -1.183 . . . . 105.08 107.807 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.82 134.84 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.671 -0.863 . . . . 82.42 108.671 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.85 126.61 34.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.799 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 308' ' ' GLU . 23.9 tp -72.02 113.29 8.89 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.877 -0.786 . . . . 82.42 108.877 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.8 mt -74.43 -52.43 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 123.596 0.758 . . . . 82.42 110.866 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.93 149.18 27.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.362 -0.977 . . . . 82.42 108.362 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.436 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.37 163.89 23.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.515 0.674 . . . . 125.5 110.554 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.532 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.22 173.65 8.29 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.856 1.663 . . . . 82.42 109.936 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 2.5 p -61.8 -158.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.514 -0.766 . . . . 91.46 111.398 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.441 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 48.7 mm -59.94 -50.48 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.19 1.182 . . . . 103.65 114.19 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.27 123.11 10.97 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.63 0.604 . . . . 115.16 112.63 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.67 111.7 24.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.563 -0.744 . . . . 82.42 110.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . 0.493 ' HA2' ' ND2' ' A' ' 321' ' ' ASN . . . 158.74 -16.8 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.06 -0.816 . . . . 82.42 111.06 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . 0.594 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 98.6 m95 -118.79 148.26 43.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.175 -0.513 . . . . 82.42 110.377 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.436 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 2.9 m0 -157.49 174.48 15.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.712 -0.847 . . . . 93.81 108.712 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.452 ' O ' HD13 ' A' ' 296' ' ' LEU . 23.0 mt-10 -132.42 143.11 49.58 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.829 -0.804 . . . . 89.72 108.829 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 169.0 31.83 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 108.437 -1.865 . . . . 82.42 108.437 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.79 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.97 129.63 56.42 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 119.571 -0.851 . . . . 82.42 109.684 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.61 135.66 28.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.088 -1.079 . . . . 82.42 108.088 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.75 29.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.584 -0.524 . . . . 82.42 109.584 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.07 88.11 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.19 -1.005 . . . . 82.42 110.623 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . 0.79 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.51 160.27 36.99 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 118.397 1.099 . . . . 98.99 108.627 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.19 124.77 35.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.758 -1.201 . . . . 109.22 107.758 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.81 164.12 36.77 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.028 -1.629 . . . . 82.42 109.028 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 5.0 m -90.72 146.8 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.377 -0.412 . . . . 82.42 111.511 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.77 151.41 23.36 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.461 -0.495 . . . . 82.42 110.436 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.594 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.1 122.38 8.96 Favored 'Trans proline' 0 CA--C 1.488 -1.8 0 C-N-CA 120.139 0.559 . . . . 111.89 112.068 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.58 -10.41 43.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.321 1.013 . . . . 119.27 111.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.42 -38.91 91.5 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.417 -0.586 . . . . 96.63 109.417 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.96 -1.38 0.29 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.379 -1.282 . . . . 82.42 112.325 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.475 HG13 HG13 ' A' ' 274' ' ' VAL . 0.7 OUTLIER -131.94 155.2 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.491 -0.559 . . . . 82.42 109.491 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -108.04 152.76 24.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.428 -0.582 . . . . 130.62 109.428 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.54 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.4 mt -88.0 135.19 33.52 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.097 -1.075 . . . . 82.42 108.097 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.14 44.15 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.752 -1.944 . . . . 97.62 105.752 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.86 -33.96 62.46 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 N-CA-C 115.547 1.326 . . . . 152.83 115.547 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.3 -1.987 0 CA-C-N 121.386 1.531 . . . . 82.42 109.292 179.528 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.587 -0.523 . . . . 1.86 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.93 140.46 32.25 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.336 0.589 . . . . 29.01 110.062 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -118.73 163.4 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 114.581 -1.19 . . . . 1.86 110.051 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.407 ' HB2' HG21 ' B' ' 66' ' ' THR . 97.9 m-85 -120.26 139.27 52.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.601 0.239 . . . . 1.86 111.007 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.29 124.21 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.643 -0.873 . . . . 4.99 108.643 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.1 mttt -101.1 135.93 41.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.989 0.423 . . . . 5.68 110.483 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -78.97 -140.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.547 -0.751 . . . . 26.89 111.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' B' ' 76' ' ' CYS . 0.7 OUTLIER -81.16 -41.65 22.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 23.29 111.044 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -89.93 2.41 55.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.712 -0.395 . . . . 1.86 111.519 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.47 16.18 50.42 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.376 -0.44 . . . . 1.86 113.865 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 65.4 tttt -50.09 157.84 0.6 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.454 -0.439 . . . . 8.51 111.557 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -106.37 127.95 53.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.72 -0.844 . . . . 1.88 108.72 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 88.8 mt -123.06 123.6 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.315 . . . . 37.69 110.82 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.79 131.19 48.24 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.98 -0.748 . . . . 1.86 108.98 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.635 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 87.7 mt -127.17 149.94 49.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.578 0.228 . . . . 9.46 110.988 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.64 122.16 43.86 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.258 -1.756 . . . . 1.86 106.258 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.93 168.3 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.485 0.659 . . . . 1.86 111.511 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.83 149.35 45.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 107.194 -1.41 . . . . 1.86 107.194 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.3 -24.42 59.81 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 CA-C-N 120.764 1.308 . . . . 1.86 112.966 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 p -85.18 -2.63 58.24 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.163 -0.471 . . . . 1.86 112.046 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.24 142.64 50.57 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.003 -1.11 . . . . 1.86 108.003 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -87.03 157.82 19.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.599 -1.182 . . . . 1.86 109.679 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.26 -39.85 84.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.107 -0.951 . . . . 1.86 109.954 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.13 -37.57 80.46 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.674 -0.862 . . . . 1.86 108.674 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.4 -42.85 87.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.492 -0.558 . . . . 1.86 109.492 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.55 -41.7 88.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.517 -0.549 . . . . 1.86 109.517 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -60.08 -39.87 87.6 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.344 -0.613 . . . . 1.86 109.344 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.29 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.63 . . . . 1.86 110.457 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.531 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.24 -39.22 92.43 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.497 -0.557 . . . . 1.86 109.497 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -64.99 -40.04 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.741 -0.466 . . . . 1.86 109.741 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -44.13 94.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.614 0.721 . . . . 1.86 109.407 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.33 92.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.889 -1.05 . . . . 1.86 110.994 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.635 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.2 mttp -81.59 -41.23 21.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.01 1.115 . . . . 1.86 114.01 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.91 -14.65 13.93 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.052 1.871 . . . . 6.12 116.052 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.11 82.92 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 120.932 -0.651 . . . . 1.86 113.263 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.77 116.49 65.87 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 109.518 -0.549 . . . . 3.54 109.518 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.83 134.68 61.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.062 1.174 . . . . 1.86 112.39 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 -32.28 24.87 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.8 2.333 . . . . 1.86 114.699 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.67 -16.06 62.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 118.955 0.798 . . . . 2.88 112.205 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -100.06 6.09 44.99 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.783 0.29 . . . . 7.17 111.783 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -105.79 153.49 21.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.039 0.755 . . . . 13.42 113.039 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 281' ' ' GLN . 4.0 mtt180 -146.68 118.55 8.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.8 -1.091 . . . . 27.09 108.316 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -100.59 129.41 46.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.315 0.579 . . . . 1.87 110.831 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.489 HG21 ' O ' ' B' ' 48' ' ' LYS . 17.2 mt -141.08 136.23 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.084 -0.385 . . . . 17.75 111.194 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' B' ' 61' ' ' ILE . 62.2 t80 -135.0 137.62 43.19 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.597 -0.274 . . . . 16.98 110.27 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.69 39.34 21.52 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 123.405 0.441 . . . . 1.86 111.674 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 22.62 68.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.576 0.99 . . . . 48.66 115.576 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.489 ' O ' HG21 ' B' ' 44' ' ' ILE . 44.8 mtmt -117.19 132.64 56.6 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.999 0.9 . . . . 4.25 111.775 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -68.45 116.6 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 30.57 110.295 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -85.94 130.22 34.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.201 0.524 . . . . 22.77 112.047 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.608 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -101.22 149.55 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.459 -0.791 . . . . 9.34 111.471 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.66 -20.17 63.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.65 0.982 . . . . 1.86 113.65 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.2 5.99 68.53 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 121.056 -0.593 . . . . 1.86 112.514 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 164.0 13.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.204 0.502 . . . . 1.86 111.652 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -105.45 166.41 10.45 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.582 0.706 . . . . 1.86 112.572 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.97 -42.01 93.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.707 -1.133 . . . . 2.28 110.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.41 -31.13 71.05 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.138 -0.625 . . . . 2.98 111.77 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.1 -28.94 69.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.689 -0.405 . . . . 1.86 110.468 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.608 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -99.04 14.6 28.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.611 0.244 . . . . 1.86 111.629 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.01 39.39 18.8 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.918 0.487 . . . . 1.86 112.22 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.43 123.93 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.136 -1.061 . . . . 4.01 108.136 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.97 169.18 8.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.326 0.584 . . . . 5.74 112.114 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.54 141.42 16.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.234 -0.894 . . . . 4.31 111.443 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.01 23.26 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.937 -1.029 . . . . 10.13 112.824 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.34 146.69 36.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.898 -1.149 . . . . 4.1 107.898 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.407 HG21 ' HB2' ' B' ' 4' ' ' PHE . 99.8 m -121.52 135.0 55.06 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.231 -0.895 . . . . 1.86 111.658 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.6 -176.2 2.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 19.21 110.584 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -125.35 148.77 48.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 50.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.72 139.6 46.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.048 0.452 . . . . 21.58 111.727 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.93 157.13 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.82 -0.627 . . . . 25.97 110.321 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.4 -76.79 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.648 -0.251 . . . . 1.86 111.556 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.38 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.495 -0.32 . . . . 23.71 110.558 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tp -135.45 -30.52 1.01 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.164 -0.214 . . . . 15.09 111.432 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -165.45 146.25 7.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.73 -0.213 . . . . 1.86 110.755 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.37 -165.61 24.93 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.674 -0.774 . . . . 1.86 112.935 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.443 ' HB2' ' HB2' ' B' ' 8' ' ' LEU . 8.8 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.498 -0.763 . . . . 1.86 111.479 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 121.528 0.68 . . . . 137.64 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.899 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.7 p -64.86 -56.8 11.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.527 -0.761 . . . . 89.76 111.413 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.899 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.51 12.64 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.726 -0.609 . . . . 143.71 109.482 -177.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.12 135.78 51.13 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.448 -0.575 . . . . 82.42 109.448 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.491 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.8 m-85 -107.2 134.5 50.22 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.513 -0.921 . . . . 82.42 108.513 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . 0.448 ' SG ' HD21 ' A' ' 325' ' ' LEU . 50.2 m -129.59 135.37 48.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.791 -0.818 . . . . 82.42 108.791 -175.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.675 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.61 33.96 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.214 -1.032 . . . . 88.16 108.214 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 91.2 t -100.87 115.95 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 118.11 -1.436 . . . . 82.42 110.722 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.459 ' H ' HD11 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -96.59 4.89 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.647 0.98 . . . . 138.48 113.647 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -126.2 135.02 26.55 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 117.97 0.35 . . . . 82.42 110.924 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.21 134.74 19.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 82.42 111.861 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.429 ' HB3' HG13 ' A' ' 288' ' ' ILE . 81.2 t80 -128.18 137.85 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 82.87 110.793 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -113.63 121.52 44.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.088 -0.506 . . . . 82.42 109.658 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -32.64 114.43 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.005 0.815 . . . . 82.42 113.133 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . 0.542 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.35 -41.73 12.66 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.411 -0.588 . . . . 128.65 109.411 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.98 179.91 7.68 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.288 -0.882 . . . . 82.42 111.328 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -83.03 -33.25 26.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.412 -0.813 . . . . 82.42 109.994 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -75.13 -5.19 42.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.714 -0.676 . . . . 82.42 111.153 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -112.48 147.14 37.17 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.368 0.604 . . . . 82.42 109.47 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.6 tp -78.1 135.2 37.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.523 -0.762 . . . . 82.42 110.194 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.539 ' O ' HD22 ' A' ' 311' ' ' LEU . 90.0 m -94.87 124.52 38.96 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 118.343 -1.343 . . . . 82.42 107.805 -176.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.1 pt -128.28 141.88 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.483 -0.932 . . . . 82.42 108.483 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -118.55 160.69 21.31 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.56 -0.904 . . . . 97.85 108.56 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.53 141.53 41.18 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.065 -1.454 . . . . 88.32 108.75 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.68 21.5 21.32 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.692 -0.963 . . . . 82.42 110.692 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -130.54 151.91 50.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 118.348 1.074 . . . . 82.42 109.768 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.675 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.55 133.99 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.775 -1.194 . . . . 105.08 107.775 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.81 134.8 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.746 -0.835 . . . . 82.42 108.746 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.491 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 12.9 t -85.82 126.5 34.08 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.153 -1.019 . . . . 128.84 108.858 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -71.91 113.24 8.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.964 -0.754 . . . . 82.42 108.964 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.39 -52.43 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.639 0.776 . . . . 82.42 110.946 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.95 149.22 28.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.387 -0.968 . . . . 82.42 108.387 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.589 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.84 23.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.441 0.639 . . . . 125.5 110.585 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' A' ' 299' ' ' LYS . 39.6 t0 -89.24 174.77 7.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.834 1.654 . . . . 82.42 109.895 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 20.7 p -55.79 -155.95 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.044 -0.98 . . . . 91.46 112.222 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.99 -68.16 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 113.742 1.016 . . . . 103.65 113.742 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.61 134.43 57.01 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.521 0.563 . . . . 115.16 112.521 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.8 36.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.629 -0.714 . . . . 82.42 110.814 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 178.71 -28.75 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.355 -0.839 . . . . 82.42 111.05 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . 0.557 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 85.7 m95 -123.24 156.83 34.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.458 -0.371 . . . . 82.42 110.775 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.589 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.1 m0 -163.61 -179.05 6.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.797 -0.816 . . . . 93.81 108.797 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -137.59 143.04 41.31 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.833 -0.803 . . . . 89.72 108.833 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.93 31.81 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 108.418 -1.873 . . . . 82.42 108.418 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.787 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.89 129.58 56.41 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.567 -0.853 . . . . 82.42 109.728 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.49 135.69 28.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.038 -1.097 . . . . 82.42 108.038 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.69 29.11 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.588 -0.523 . . . . 82.42 109.588 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.0 87.79 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.659 -0.977 . . . . 82.42 110.659 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . 0.787 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.43 160.37 36.61 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 118.957 -1.097 . . . . 98.99 108.583 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.25 124.71 35.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.704 -1.221 . . . . 109.22 107.704 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.95 36.6 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.09 -1.604 . . . . 82.42 109.09 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.19 151.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.053 0.541 . . . . 82.42 111.716 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -153.4 151.42 25.55 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 120.55 -0.46 . . . . 82.42 110.439 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.557 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.12 122.13 8.72 Favored 'Trans proline' 0 CA--C 1.488 -1.819 0 C-N-CA 120.103 0.535 . . . . 111.89 112.111 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -77.63 -0.83 28.08 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.92 0.762 . . . . 119.27 111.893 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.507 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.75 -39.99 90.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.391 -0.596 . . . . 96.63 109.391 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.701 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 4.7 m-30 -77.93 10.34 2.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.135 -0.939 . . . . 82.42 112.167 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.25 163.9 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.339 -0.615 . . . . 82.42 109.339 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -139.34 147.27 41.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.93 -0.767 . . . . 130.62 108.93 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.548 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 mt -87.62 135.23 33.45 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.102 -1.073 . . . . 82.42 108.102 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.33 129.07 44.57 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.847 -1.909 . . . . 97.62 105.847 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 74.7 Cg_exo -63.86 -34.0 62.31 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.516 1.314 . . . . 152.83 115.516 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.958 0 CA-C-N 121.408 1.539 . . . . 82.42 109.283 179.547 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.516 -0.55 . . . . 1.86 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.89 139.83 33.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.223 0.535 . . . . 29.01 110.108 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.7 pt -123.62 167.81 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 114.542 -1.208 . . . . 1.86 110.079 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.94 139.35 52.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.7 0.286 . . . . 1.86 111.0 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.25 124.22 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.643 -0.873 . . . . 4.99 108.643 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.11 137.31 39.65 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.988 0.423 . . . . 5.68 110.444 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -84.91 -149.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.468 -0.787 . . . . 26.89 111.355 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -43.27 81.65 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.966 0.358 . . . . 23.29 111.966 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.1 p -92.85 2.38 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 120.668 -0.413 . . . . 1.86 111.524 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.4 16.74 48.66 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.412 -0.423 . . . . 1.86 113.909 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 74.1 tttt -49.22 157.2 0.48 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.468 -0.431 . . . . 8.51 111.578 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.412 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.6 m -106.35 127.82 53.55 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.701 -0.852 . . . . 1.88 108.701 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.04 123.64 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.49 -0.323 . . . . 37.69 110.813 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.79 131.23 48.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.953 -0.758 . . . . 1.86 108.953 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.637 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 87.9 mt -127.16 149.89 49.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 9.46 110.96 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.63 122.15 43.84 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 106.204 -1.776 . . . . 1.86 106.204 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.9 168.32 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.475 0.655 . . . . 1.86 111.542 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.92 149.29 45.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 107.185 -1.413 . . . . 1.86 107.185 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.23 -24.5 59.73 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 CA-C-N 120.808 1.324 . . . . 1.86 112.869 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.1 p -85.2 -2.56 58.17 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 116.276 -0.42 . . . . 1.86 112.01 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.29 142.67 50.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.001 -1.111 . . . . 1.86 108.001 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -87.01 157.83 19.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.498 -1.228 . . . . 1.86 109.709 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.28 -39.8 83.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.17 -0.923 . . . . 1.86 110.029 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.06 -37.65 80.49 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.69 -0.856 . . . . 1.86 108.69 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.37 -42.83 87.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.521 -0.548 . . . . 1.86 109.521 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.57 -41.79 89.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.532 -0.544 . . . . 1.86 109.532 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.97 -40.04 87.71 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.362 -0.607 . . . . 1.86 109.362 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.18 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.442 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.3 -39.16 92.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.563 -0.532 . . . . 1.86 109.563 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mt -64.98 -40.1 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.645 -0.502 . . . . 1.86 109.645 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -60.06 -44.08 94.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.577 0.703 . . . . 1.86 109.395 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.82 -40.34 92.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.952 -1.022 . . . . 1.86 111.021 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.637 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.6 -41.05 22.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.096 1.147 . . . . 1.86 114.096 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -111.09 -14.57 13.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.01 1.855 . . . . 6.12 116.01 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.04 11.12 82.97 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 120.977 -0.63 . . . . 1.86 113.345 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.7 116.29 65.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.511 -0.551 . . . . 3.54 109.511 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.77 134.66 61.93 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.107 1.204 . . . . 1.86 112.35 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.37 -32.13 25.25 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 122.758 2.306 . . . . 1.86 114.679 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.71 -16.03 62.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.964 0.802 . . . . 2.88 112.197 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.407 ' CD ' ' HD3' ' B' ' 72' ' ' ARG . 25.3 mt-30 -100.08 5.85 44.96 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.698 0.258 . . . . 7.17 111.698 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -98.24 127.51 44.22 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.599 0.592 . . . . 13.42 112.599 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.433 ' NH1' ' HG2' ' A' ' 281' ' ' GLN . 0.8 OUTLIER -117.71 109.79 17.05 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 27.09 108.398 177.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.58 128.99 45.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.353 0.597 . . . . 1.87 110.746 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.32 133.78 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.129 -0.487 . . . . 17.75 111.545 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.654 ' CD2' HG12 ' B' ' 61' ' ' ILE . 88.0 t80 -135.59 140.34 44.55 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.469 -0.332 . . . . 16.98 110.245 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 38.68 23.73 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.444 0.465 . . . . 1.86 111.65 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.97 19.8 66.08 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 115.47 0.948 . . . . 48.66 115.47 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -117.38 133.75 55.62 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.664 0.732 . . . . 4.25 111.759 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' B' ' 49' ' ' GLN . 0.0 OUTLIER -65.84 120.26 12.73 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.739 -0.664 . . . . 30.57 111.017 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 59.4 mt -86.96 124.19 32.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.117 0.484 . . . . 22.77 112.208 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.591 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -99.06 149.5 22.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 9.34 111.412 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -69.66 -20.08 63.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.709 1.003 . . . . 1.86 113.709 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.24 5.97 68.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.018 -0.611 . . . . 1.86 112.575 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 163.96 13.81 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.124 0.462 . . . . 1.86 111.619 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -105.46 166.28 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.688 0.756 . . . . 1.86 112.542 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.99 -41.85 92.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.616 -1.174 . . . . 2.28 110.781 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -61.5 -31.08 71.06 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 120.045 -0.662 . . . . 2.98 111.875 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.05 -28.96 69.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.773 -0.371 . . . . 1.86 110.489 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.591 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.8 m-85 -98.98 14.5 28.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.733 0.271 . . . . 1.86 111.733 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.39 19.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.961 0.504 . . . . 1.86 112.161 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.654 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.175 -1.046 . . . . 4.01 108.175 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -106.95 169.09 8.76 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.367 0.604 . . . . 5.74 112.044 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.49 141.37 15.97 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.108 -0.951 . . . . 4.31 111.489 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.99 23.34 9.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.072 -0.967 . . . . 10.13 112.818 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.31 145.52 37.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.933 -1.136 . . . . 4.1 107.933 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 31.9 m -126.94 141.75 51.72 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.086 -0.961 . . . . 1.86 111.629 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 -165.89 1.46 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.27 -0.423 . . . . 19.21 110.473 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.34 160.72 35.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.99 -0.374 . . . . 50.0 109.99 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mt -135.42 172.11 13.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.19 0.519 . . . . 21.58 111.513 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' A' ' 322' ' ' PHE . 2.8 t -120.26 134.74 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.366 -0.834 . . . . 25.97 110.401 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.42 -172.43 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.208 -0.451 . . . . 1.86 110.942 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.506 ' HD2' ' HG ' ' B' ' 76' ' ' CYS . 17.9 mtm180 -138.55 99.84 3.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.005 -0.543 . . . . 23.71 109.879 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 tp -132.78 -34.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 15.09 110.814 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.49 HH21 ' HB2' ' A' ' 306' ' ' TRP . 31.2 ttp-105 -152.95 91.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 1.86 110.766 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.31 -123.73 2.73 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.897 -0.668 . . . . 1.86 112.33 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.506 ' HG ' ' HD2' ' B' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.225 -0.893 . . . . 1.86 111.235 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 121.532 0.682 . . . . 137.64 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.891 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.95 -56.88 10.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.581 -0.736 . . . . 89.76 111.281 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.891 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.03 166.6 12.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 O-C-N 121.753 -0.592 . . . . 143.71 109.525 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -111.13 135.82 51.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.4 -0.593 . . . . 82.42 109.4 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.513 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.2 134.44 50.3 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.534 -0.913 . . . . 82.42 108.534 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . 0.529 ' SG ' HD21 ' A' ' 325' ' ' LEU . 51.2 m -129.61 135.42 48.53 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.697 -0.853 . . . . 82.42 108.697 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.501 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.6 33.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.197 -1.038 . . . . 88.16 108.197 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.479 ' HA ' ' HB ' ' A' ' 323' ' ' VAL . 92.2 t -100.97 118.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 117.981 -1.488 . . . . 82.42 110.744 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 42.7 mm -82.74 -66.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.652 -0.704 . . . . 138.48 111.313 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.39 126.34 87.78 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 82.42 110.633 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.413 ' CD ' ' HA2' ' B' ' 47' ' ' GLY . 30.6 Cg_endo -63.05 150.01 89.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.505 . . . . 82.42 112.279 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -129.7 107.91 9.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 82.87 111.184 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -84.01 120.51 26.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.564 -0.532 . . . . 82.42 109.564 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.512 ' HB1' ' HG1' ' A' ' 287' ' ' THR . . . -34.34 110.46 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.178 0.924 . . . . 82.42 112.832 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . 0.681 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -82.38 -41.58 19.76 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.725 -0.671 . . . . 128.65 109.458 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -137.21 172.41 13.04 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.003 -1.06 . . . . 82.42 112.035 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.37 -38.25 56.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.262 -0.881 . . . . 82.42 110.058 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -76.41 3.07 11.89 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.601 -0.727 . . . . 82.42 110.94 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.681 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -109.74 146.43 34.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.448 0.642 . . . . 82.42 109.475 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.4 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 16.1 tp -77.02 141.07 40.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.696 . . . . 82.42 110.11 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.512 ' HG1' ' HB1' ' A' ' 280' ' ' ALA . 89.7 m -96.06 124.57 40.12 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.331 -1.347 . . . . 82.42 107.771 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.22 142.15 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.507 -0.923 . . . . 82.42 108.507 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -113.35 157.27 22.06 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 108.507 -0.923 . . . . 97.85 108.507 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.27 141.51 41.65 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.199 -1.4 . . . . 88.32 108.634 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.52 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.637 -0.985 . . . . 82.42 110.637 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -130.53 151.92 50.47 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 118.389 1.095 . . . . 82.42 109.791 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.513 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.2 mm -109.63 133.99 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 107.799 -1.186 . . . . 105.08 107.799 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.85 134.76 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.735 -0.839 . . . . 82.42 108.735 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.76 126.53 34.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.822 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.92 113.18 8.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.974 -0.75 . . . . 82.42 108.974 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.4 -52.35 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 123.624 0.77 . . . . 82.42 110.942 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.99 149.24 27.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.345 -0.983 . . . . 82.42 108.345 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.475 ' CG ' ' H ' ' A' ' 300' ' ' ASP . 2.3 ttmt -80.42 163.89 23.48 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.485 0.66 . . . . 125.5 110.515 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.2 172.54 8.99 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.782 1.633 . . . . 82.42 109.907 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 23.2 p -59.79 -136.4 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.934 -1.03 . . . . 91.46 112.269 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 18.1 mm -84.73 -22.79 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 121.693 -0.63 . . . . 103.65 112.121 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.62 119.28 7.8 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.098 0.407 . . . . 115.16 112.098 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 25.2 t -92.89 92.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.899 -0.591 . . . . 82.42 110.011 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . 0.515 ' HA2' ' ND2' ' A' ' 321' ' ' ASN . . . 160.21 -12.15 0.17 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.358 -0.837 . . . . 82.42 111.294 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . 0.552 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 96.6 m95 -117.45 150.2 39.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.872 0.368 . . . . 82.42 111.093 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.46 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 1.1 m0 -159.76 174.4 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.109 -0.951 . . . . 93.81 108.739 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.559 ' O ' HD13 ' A' ' 296' ' ' LEU . 23.0 mt-10 -133.68 143.13 48.35 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.767 -0.827 . . . . 89.72 108.767 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.9 168.95 31.87 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.38 -1.888 . . . . 82.42 108.38 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.86 129.59 56.4 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.588 -0.845 . . . . 82.42 109.707 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 61.9 tp -142.52 135.65 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.104 -1.073 . . . . 82.42 108.104 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.14 37.69 29.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.546 -0.538 . . . . 82.42 109.546 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.02 87.78 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.148 -1.025 . . . . 82.42 110.723 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.5 160.29 36.92 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.378 1.089 . . . . 98.99 108.632 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.2 124.85 35.63 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.655 -1.239 . . . . 109.22 107.655 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.8 164.12 36.76 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.125 -1.59 . . . . 82.42 109.125 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 11.5 m -89.17 145.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 122.75 0.42 . . . . 82.42 111.497 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.11 151.36 24.32 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 120.525 -0.47 . . . . 82.42 110.47 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.455 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.2 Cg_endo -70.23 123.37 9.88 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.071 0.514 . . . . 111.89 112.062 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.87 -15.27 18.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.518 1.136 . . . . 119.27 111.462 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.515 ' ND2' ' HA2' ' A' ' 305' ' ' GLY . 1.3 m120 -62.52 -39.35 93.28 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 109.347 -0.612 . . . . 96.63 109.347 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -56.76 -4.16 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.363 -0.835 . . . . 82.42 112.642 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 274' ' ' VAL . 0.7 OUTLIER -127.56 145.91 34.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.684 -0.487 . . . . 82.42 109.684 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER -90.07 139.96 30.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.122 -0.695 . . . . 130.62 109.122 178.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.546 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.5 mt -89.1 135.21 33.68 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.116 -1.068 . . . . 82.42 108.116 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.08 44.5 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 105.751 -1.944 . . . . 97.62 105.751 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.1 Cg_exo -64.02 -33.8 61.13 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.547 1.326 . . . . 152.83 115.547 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.301 -1.933 0 CA-C-N 121.352 1.519 . . . . 82.42 109.279 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.477 -0.564 . . . . 1.86 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.86 140.22 32.55 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.292 0.568 . . . . 29.01 110.136 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -120.61 168.21 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 114.586 -1.188 . . . . 1.86 110.011 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.38 139.26 53.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.598 0.237 . . . . 1.86 111.045 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.23 124.19 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.659 -0.867 . . . . 4.99 108.659 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.08 135.75 42.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.008 0.432 . . . . 5.68 110.422 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -79.89 -155.05 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.615 -0.72 . . . . 26.89 111.274 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' B' ' 71' ' ' LEU . 4.0 mt -66.61 -40.81 89.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.658 0.614 . . . . 23.29 112.658 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -92.14 2.41 56.61 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.762 0.315 . . . . 1.86 111.581 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.42 15.73 52.2 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.335 -0.459 . . . . 1.86 113.957 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 73.5 tttt -49.76 157.99 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.2 -0.588 . . . . 8.51 111.619 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -106.33 128.24 53.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.682 -0.858 . . . . 1.88 108.682 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.03 122.64 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 123.31 0.381 . . . . 37.69 110.83 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -101.97 131.26 48.49 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.908 -0.775 . . . . 1.86 108.908 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.635 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 87.7 mt -127.21 149.85 49.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.592 0.234 . . . . 9.46 110.998 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.53 122.19 43.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.25 -1.759 . . . . 1.86 106.25 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.07 168.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.486 0.66 . . . . 1.86 111.467 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.86 149.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 107.236 -1.394 . . . . 1.86 107.236 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.12 -24.45 58.53 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 CA-C-N 120.836 1.334 . . . . 1.86 112.97 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -85.25 -2.6 58.22 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.145 -0.48 . . . . 1.86 112.001 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.5 50.53 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.961 -1.126 . . . . 1.86 107.961 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -86.88 157.79 19.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.524 -1.216 . . . . 1.86 109.747 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.2 -39.89 84.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.04 -0.982 . . . . 1.86 109.947 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.08 -37.69 80.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.69 -0.856 . . . . 1.86 108.69 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.24 -42.85 88.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.536 -0.542 . . . . 1.86 109.536 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.61 -41.79 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.369 -0.604 . . . . 1.86 109.369 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.0 -39.93 87.46 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.414 -0.587 . . . . 1.86 109.414 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.25 89.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.757 -0.656 . . . . 1.86 110.441 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.31 -39.07 92.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.567 -0.531 . . . . 1.86 109.567 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -65.11 -40.03 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.688 -0.486 . . . . 1.86 109.688 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.05 -44.05 94.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.493 0.663 . . . . 1.86 109.36 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.88 -40.4 92.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.022 -0.99 . . . . 1.86 110.957 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.635 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.081 1.141 . . . . 1.86 114.081 -177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.95 -14.51 13.94 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.156 1.91 . . . . 6.12 116.156 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.2 11.02 82.95 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.964 -0.636 . . . . 1.86 113.245 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.26 64.94 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.632 -0.507 . . . . 3.54 109.632 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.65 134.68 62.33 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.098 1.199 . . . . 1.86 112.433 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.33 -32.21 25.17 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.887 2.391 . . . . 1.86 114.643 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.85 -15.91 62.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.913 0.779 . . . . 2.88 112.126 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -100.12 8.13 44.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.754 0.279 . . . . 7.17 111.754 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.81 144.29 31.34 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.598 0.592 . . . . 13.42 112.598 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -138.82 114.8 10.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.341 -0.985 . . . . 27.09 108.341 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 130.39 43.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.364 0.602 . . . . 1.87 110.837 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -139.43 130.66 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.932 -0.48 . . . . 17.75 110.931 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' B' ' 61' ' ' ILE . 91.5 t80 -132.25 136.4 46.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.555 -0.293 . . . . 16.98 110.244 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.9 39.77 26.6 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 123.474 0.484 . . . . 1.86 111.709 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.413 ' HA2' ' CD ' ' A' ' 277' ' ' PRO . . . 65.35 22.27 69.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 115.605 1.002 . . . . 48.66 115.605 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.94 132.1 56.44 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.07 0.935 . . . . 4.25 111.737 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -68.2 115.58 7.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.896 -0.593 . . . . 30.57 110.158 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -81.93 134.22 35.37 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.122 0.487 . . . . 22.77 111.787 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.598 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -101.81 149.43 24.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.5 -0.773 . . . . 9.34 111.467 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.64 -20.12 63.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.58 0.955 . . . . 1.86 113.58 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.22 6.03 68.49 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 121.005 -0.617 . . . . 1.86 112.533 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.89 13.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.152 0.476 . . . . 1.86 111.621 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.6 p -105.37 166.43 10.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.657 0.741 . . . . 1.86 112.596 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.11 -41.9 93.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.674 -1.148 . . . . 2.28 110.659 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.55 -30.98 71.0 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.063 -0.655 . . . . 2.98 111.811 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.14 -29.0 70.04 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.715 -0.394 . . . . 1.86 110.419 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.598 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -98.94 14.52 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.698 0.258 . . . . 1.86 111.698 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.03 39.4 18.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.264 0.468 . . . . 1.86 112.264 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.095 -1.076 . . . . 4.01 108.095 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.17 8.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.303 0.573 . . . . 5.74 112.155 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.55 141.37 16.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.222 -0.899 . . . . 4.31 111.458 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 67.12 23.15 9.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.978 -1.01 . . . . 10.13 112.81 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.417 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.2 m -77.27 146.72 36.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.972 -1.121 . . . . 4.1 107.972 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m -120.86 131.35 54.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.449 -0.796 . . . . 1.86 111.75 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mp -111.09 -177.68 3.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.667 -0.697 . . . . 19.21 110.669 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -124.45 144.15 50.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.978 -0.379 . . . . 50.0 109.978 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 69' ' ' LEU . 4.2 mt -129.95 154.55 47.24 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.08 0.467 . . . . 21.58 111.638 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.86 167.03 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.693 -0.685 . . . . 25.97 110.07 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.494 ' HB2' ' CD1' ' B' ' 8' ' ' LEU . 3.8 mt -135.68 -79.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.007 0.373 . . . . 1.86 112.007 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -158.51 -166.14 1.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.87 0.367 . . . . 23.71 111.009 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.58 -46.96 57.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.888 -0.596 . . . . 15.09 110.409 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.472 ' NH2' ' OD2' ' A' ' 300' ' ' ASP . 1.1 ttt85 -174.21 159.69 3.22 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.124 -0.489 . . . . 1.86 110.751 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.85 -100.47 1.87 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.885 -0.674 . . . . 1.86 112.661 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.442 ' HG ' HD23 ' B' ' 71' ' ' LEU . 72.1 m . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.566 -0.731 . . . . 1.86 111.372 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 121.585 0.707 . . . . 137.64 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.886 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.523 -0.762 . . . . 89.76 111.346 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.886 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.6 12.62 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 121.777 -0.577 . . . . 143.71 109.549 -177.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.21 135.8 51.21 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.454 -0.573 . . . . 82.42 109.454 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.9 m-85 -107.23 134.44 50.32 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.505 -0.924 . . . . 82.42 108.505 176.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 52.1 m -129.63 135.45 48.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.726 -0.842 . . . . 82.42 108.726 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' A' ' 293' ' ' ILE . 40.6 tttp -92.71 135.57 33.99 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.203 -1.036 . . . . 88.16 108.203 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.422 HG11 ' H ' ' A' ' 276' ' ' PHE . 89.8 t -100.85 115.95 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 C-N-CA 118.028 -1.469 . . . . 82.42 110.823 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.469 ' H ' HD11 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -98.12 16.58 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.655 0.983 . . . . 138.48 113.655 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . 0.704 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 10.8 m-85 -136.63 143.01 41.22 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 122.261 -0.275 . . . . 82.42 110.456 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.86 134.53 12.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.573 2.182 . . . . 82.42 112.281 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.61 96.39 4.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.794 -0.639 . . . . 82.87 110.776 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.55 120.58 21.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.125 -0.488 . . . . 82.42 109.732 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.52 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.288 0.847 . . . . 82.42 113.288 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . 0.555 ' OE1' HG21 ' B' ' 70' ' ' VAL . 26.1 mt-30 -85.17 -41.99 15.14 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.448 -0.575 . . . . 128.65 109.448 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -146.83 176.39 9.92 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.872 -1.143 . . . . 82.42 111.455 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.89 -30.82 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.152 -0.931 . . . . 82.42 110.621 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.37 -6.26 57.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.924 -0.58 . . . . 82.42 110.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -108.75 147.09 32.52 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.31 0.576 . . . . 82.42 109.479 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 13.9 tp -83.42 137.93 33.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.599 -0.728 . . . . 82.42 110.014 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.6 m -95.78 124.53 39.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.311 -1.356 . . . . 82.42 107.793 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.25 141.68 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.489 -0.93 . . . . 82.42 108.489 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -120.7 162.98 18.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.713 -0.847 . . . . 97.85 108.713 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.19 141.53 41.78 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 118.028 -1.469 . . . . 88.32 108.744 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.64 21.59 21.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.582 -1.007 . . . . 82.42 110.582 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.5 151.91 50.46 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 118.459 1.13 . . . . 82.42 109.873 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.457 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.1 mm -109.54 133.99 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.724 -1.213 . . . . 105.08 107.724 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.82 134.75 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.759 -0.83 . . . . 82.42 108.759 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.582 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.1 t -85.74 126.56 34.07 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.886 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.97 113.23 8.79 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.885 -0.783 . . . . 82.42 108.885 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.6 mt -74.49 -52.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.655 0.782 . . . . 82.42 110.891 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.96 149.21 27.97 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.471 -0.937 . . . . 82.42 108.471 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.663 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.32 163.79 23.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.551 0.691 . . . . 125.5 110.533 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 306' ' ' TRP . 39.7 t0 -89.2 170.6 10.46 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.795 1.638 . . . . 82.42 109.908 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 14.5 p -60.16 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.72 -1.127 . . . . 91.46 111.769 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.87 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 121.733 -0.604 . . . . 103.65 112.49 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -59.52 116.3 3.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.224 0.535 . . . . 115.16 111.757 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.4 t -79.26 115.61 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.604 -0.725 . . . . 82.42 110.123 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 175.74 -21.2 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.69 -0.686 . . . . 82.42 111.688 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . 0.634 ' O ' ' HB2' ' A' ' 300' ' ' ASP . 99.0 m95 -118.48 153.25 34.45 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.391 0.139 . . . . 82.42 110.877 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.663 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.9 m0 -165.46 175.71 8.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.447 -0.946 . . . . 93.81 108.447 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -137.02 143.16 42.58 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.792 -0.818 . . . . 89.72 108.792 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.97 31.88 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 108.404 -1.878 . . . . 82.42 108.404 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.778 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.96 129.67 56.4 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 119.521 -0.872 . . . . 82.42 109.652 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 62.1 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.128 -1.064 . . . . 82.42 108.128 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.08 37.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.625 -0.509 . . . . 82.42 109.625 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.11 35.06 88.23 Favored Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.231 -0.985 . . . . 82.42 110.71 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . 0.778 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.35 36.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 118.358 1.079 . . . . 98.99 108.609 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.27 124.71 35.13 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.744 -1.206 . . . . 109.22 107.744 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.78 164.31 36.87 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.077 -1.609 . . . . 82.42 109.077 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 1.7 m -96.52 150.97 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.327 0.651 . . . . 82.42 111.887 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -153.69 151.37 25.0 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 120.287 -0.565 . . . . 82.42 110.495 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.665 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.88 8.47 Favored 'Trans proline' 0 CA--C 1.488 -1.824 0 C-N-CA 120.087 0.524 . . . . 111.89 112.085 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.528 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -71.08 -2.44 15.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 124.35 1.031 . . . . 119.27 112.035 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' B' ' 68' ' ' HIS . 1.3 m120 -61.94 -39.92 93.76 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.361 -0.607 . . . . 96.63 109.361 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 9.3 m-30 -74.98 7.24 3.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 82.42 112.061 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.01 159.29 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.252 -0.647 . . . . 82.42 109.252 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.88 146.66 43.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.688 -0.856 . . . . 130.62 108.688 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.547 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -86.79 135.29 33.41 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 108.104 -1.073 . . . . 82.42 108.104 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.06 44.44 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 105.748 -1.945 . . . . 97.62 105.748 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.7 Cg_exo -63.97 -33.76 61.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 N-CA-C 115.564 1.332 . . . . 152.83 115.564 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.302 -1.895 0 CA-C-N 121.385 1.531 . . . . 82.42 109.223 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.508 ' HE2' ' O ' ' B' ' 61' ' ' ILE . 4.2 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.6 -0.518 . . . . 1.86 109.6 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.59 32.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.377 0.608 . . . . 29.01 110.158 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -119.3 164.38 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.599 -1.182 . . . . 1.86 109.946 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.462 ' O ' HD12 ' B' ' 67' ' ' LEU . 97.9 m-85 -120.73 139.34 53.22 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.644 0.259 . . . . 1.86 111.03 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.402 HG13 HD13 ' B' ' 30' ' ' ILE . 47.2 t -121.36 124.27 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.623 -0.881 . . . . 4.99 108.623 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.07 138.4 38.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.948 0.404 . . . . 5.68 110.428 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -81.21 -153.21 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.618 -0.719 . . . . 26.89 111.899 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -36.11 72.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.285 -0.416 . . . . 23.29 111.837 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -96.38 2.37 52.62 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.596 -0.442 . . . . 1.86 111.587 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.97 51.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.365 -0.445 . . . . 1.86 113.856 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 78.9 tttt -49.8 157.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.33 -0.512 . . . . 8.51 111.649 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -106.69 127.99 53.82 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.785 -0.821 . . . . 1.88 108.785 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.14 123.07 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 123.347 0.404 . . . . 37.69 110.9 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.87 131.25 48.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.924 -0.769 . . . . 1.86 108.924 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.629 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.0 mt -127.13 149.99 49.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.644 0.259 . . . . 9.46 110.906 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.72 122.14 43.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.14 -1.8 . . . . 1.86 106.14 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.93 168.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.563 0.697 . . . . 1.86 111.503 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.74 149.26 44.82 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.259 -1.385 . . . . 1.86 107.259 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.19 -24.48 59.27 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.872 1.347 . . . . 1.86 112.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.27 -2.48 58.1 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.237 -0.438 . . . . 1.86 111.97 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 142.6 50.35 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.961 -1.126 . . . . 1.86 107.961 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -86.96 157.91 19.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.558 -1.201 . . . . 1.86 109.631 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.35 -39.82 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.114 -0.948 . . . . 1.86 109.942 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.19 -37.45 80.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.723 -0.843 . . . . 1.86 108.723 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.4 t-20 -66.41 -42.91 87.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.474 -0.565 . . . . 1.86 109.474 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.6 -41.71 88.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.513 -0.551 . . . . 1.86 109.513 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -59.94 -39.97 87.37 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 109.459 -0.571 . . . . 1.86 109.459 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 1.86 110.427 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.27 -39.08 92.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.621 -0.511 . . . . 1.86 109.621 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.402 HD13 HG13 ' B' ' 5' ' ' VAL . 32.2 mt -65.13 -40.02 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.621 -0.511 . . . . 1.86 109.621 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.06 -44.0 95.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.517 0.675 . . . . 1.86 109.424 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.9 -40.4 92.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.965 -1.016 . . . . 1.86 110.963 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.629 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.3 mttp -81.44 -41.2 22.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.129 1.159 . . . . 1.86 114.129 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.63 13.92 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.163 1.912 . . . . 6.12 116.163 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.0 82.95 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 120.88 -0.676 . . . . 1.86 113.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.31 65.15 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.58 -0.526 . . . . 3.54 109.58 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.71 134.67 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.167 1.244 . . . . 1.86 112.444 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.46 -32.07 25.69 Favored 'Trans proline' 0 N--CA 1.507 2.307 0 C-N-CA 122.789 2.326 . . . . 1.86 114.662 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.78 -16.09 62.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 118.973 0.806 . . . . 2.88 112.068 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.02 6.33 45.06 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.707 0.262 . . . . 7.17 111.707 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -106.67 131.28 53.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.47 0.544 . . . . 13.42 112.47 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -117.72 114.73 23.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 27.09 107.811 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -100.57 128.99 46.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.37 0.605 . . . . 1.87 110.825 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' B' ' 49' ' ' GLN . 2.6 pt -149.7 132.59 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.85 -0.614 . . . . 17.75 111.609 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.666 ' CD2' HG12 ' B' ' 61' ' ' ILE . 83.2 t80 -124.99 139.72 53.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.413 -0.358 . . . . 16.98 110.247 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.96 39.06 21.98 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 123.54 0.525 . . . . 1.86 111.717 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 65.35 21.75 68.75 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 115.865 1.106 . . . . 48.66 115.865 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.43 134.28 55.24 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.992 0.896 . . . . 4.25 111.879 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.452 ' HA ' HG22 ' B' ' 44' ' ' ILE . 24.8 mt-30 -65.89 119.2 10.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.911 -0.586 . . . . 30.57 111.053 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.431 ' HG ' ' HA ' ' B' ' 44' ' ' ILE . 63.5 mt -89.3 125.54 35.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.065 0.459 . . . . 22.77 112.009 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.6 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -99.35 149.54 23.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 9.34 111.386 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.67 -20.15 63.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.669 0.988 . . . . 1.86 113.669 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.18 6.03 68.59 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 120.99 -0.624 . . . . 1.86 112.609 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.98 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.162 0.481 . . . . 1.86 111.706 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -105.45 166.48 10.4 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.753 0.787 . . . . 1.86 112.523 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.3 mt -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.662 -1.154 . . . . 2.28 110.803 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.54 -31.04 71.04 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.086 -0.646 . . . . 2.98 111.809 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.09 -28.96 69.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.744 -0.383 . . . . 1.86 110.448 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.6 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -99.02 14.53 28.89 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.624 0.231 . . . . 1.86 111.624 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.09 39.33 19.01 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.879 0.472 . . . . 1.86 112.19 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.666 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.4 124.09 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.049 -1.093 . . . . 4.01 108.049 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 169.13 8.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.318 0.58 . . . . 5.74 112.083 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.48 141.47 15.75 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.127 -0.942 . . . . 4.31 111.485 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.97 23.19 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.04 -0.982 . . . . 10.13 112.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.459 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.21 146.7 36.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.963 -1.125 . . . . 4.1 107.963 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 52.9 m -125.47 136.93 53.89 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.029 -0.987 . . . . 1.86 111.533 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.462 HD12 ' O ' ' B' ' 4' ' ' PHE . 0.2 OUTLIER -112.25 -172.71 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.294 -0.412 . . . . 19.21 110.208 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.494 ' CD2' ' HB3' ' A' ' 321' ' ' ASN . 0.0 OUTLIER -132.56 153.67 50.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.939 -0.393 . . . . 50.0 109.939 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tp -126.55 158.05 37.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.835 0.35 . . . . 21.58 111.436 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 322' ' ' PHE . 7.8 p -115.11 140.7 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 25.97 110.607 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 70' ' ' VAL . 1.1 mp -147.6 114.92 6.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.313 -0.403 . . . . 1.86 111.014 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -83.04 87.25 6.89 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.191 0.519 . . . . 23.71 110.05 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -151.57 -157.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.502 -0.772 . . . . 15.09 110.108 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.52 20.83 4.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 1.86 110.62 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.22 105.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.92 -0.657 . . . . 1.86 112.977 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.252 -0.88 . . . . 1.86 110.391 179.185 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.515 0.674 . . . . 137.64 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.876 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.8 p -64.93 -56.75 11.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.523 -0.762 . . . . 89.76 111.375 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.876 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.07 166.57 12.6 Favored 'General case' 0 CA--C 1.494 -1.189 0 O-C-N 121.762 -0.586 . . . . 143.71 109.481 -177.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.19 135.77 51.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.489 -0.56 . . . . 82.42 109.489 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.467 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.9 m-85 -107.16 134.39 50.34 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.484 -0.932 . . . . 82.42 108.484 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.4 m -129.55 135.39 48.53 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.789 -0.819 . . . . 82.42 108.789 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.489 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.6 tttp -92.72 135.58 33.98 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.217 -1.031 . . . . 88.16 108.217 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.89 116.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 117.956 -1.498 . . . . 82.42 110.801 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -81.99 -41.62 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 121.622 -0.674 . . . . 138.48 112.277 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' PHE . . . . . 0.642 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -102.44 122.5 46.23 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 121.143 -0.223 . . . . 82.42 110.862 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.81 159.56 52.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.591 2.194 . . . . 82.42 112.264 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -124.45 86.74 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.626 -0.715 . . . . 82.87 109.995 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -56.78 116.46 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.414 -0.587 . . . . 82.42 109.414 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.59 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.646 1.216 . . . . 82.42 113.309 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . 0.45 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -87.02 -39.18 15.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.844 -0.616 . . . . 128.65 109.369 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -148.38 175.52 11.04 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.064 -1.022 . . . . 82.42 111.736 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.04 -33.63 29.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.228 -0.896 . . . . 82.42 110.235 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.23 -2.77 42.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.688 -0.687 . . . . 82.42 111.087 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.379 0.609 . . . . 82.42 109.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.402 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.5 tp -85.57 135.82 33.65 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.343 -0.844 . . . . 82.42 110.156 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.525 ' O ' HD22 ' A' ' 311' ' ' LEU . 89.7 m -95.68 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.106 -1.438 . . . . 82.42 107.805 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.21 141.68 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.556 -0.905 . . . . 82.42 108.556 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.4 mmtt -117.04 158.96 23.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.419 -0.956 . . . . 97.85 108.419 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -76.08 141.56 41.98 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 118.458 -1.297 . . . . 88.32 108.665 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.58 21.66 21.11 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.65 -0.98 . . . . 82.42 110.65 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -130.51 151.91 50.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 118.393 1.097 . . . . 82.42 109.818 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.56 133.93 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.834 -1.173 . . . . 105.08 107.834 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 310' ' ' GLU . 92.4 t -122.73 134.81 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.743 -0.836 . . . . 82.42 108.743 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 295' ' ' THR . 13.0 t -85.81 126.64 34.17 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.189 -1.004 . . . . 128.84 108.783 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.08 113.27 8.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.894 -0.78 . . . . 82.42 108.894 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.46 -52.37 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 123.562 0.745 . . . . 82.42 110.919 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.95 149.15 27.92 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.474 -0.936 . . . . 82.42 108.474 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.544 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.43 163.82 23.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.533 0.683 . . . . 125.5 110.498 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.507 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.13 172.83 8.8 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.77 1.628 . . . . 82.42 109.868 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 4.7 p -60.77 -155.54 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.498 -0.774 . . . . 91.46 111.546 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 43.4 mm -64.42 -50.41 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 113.883 1.068 . . . . 103.65 113.883 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.18 120.67 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.647 0.61 . . . . 115.16 112.647 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -89.41 106.27 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.61 -0.723 . . . . 82.42 110.245 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 168.4 -14.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.217 -0.902 . . . . 82.42 110.88 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . 0.507 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 92.6 m95 -126.33 156.06 41.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.279 -0.461 . . . . 82.42 111.253 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.544 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.2 m0 -163.81 -171.3 2.44 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.817 0.847 . . . . 93.81 108.772 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -145.85 143.06 29.38 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.869 -0.789 . . . . 89.72 108.869 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.88 168.97 31.86 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 108.448 -1.861 . . . . 82.42 108.448 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.792 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.92 129.7 56.38 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.558 -0.857 . . . . 82.42 109.688 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.65 135.69 28.35 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.039 -1.097 . . . . 82.42 108.039 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.01 37.82 29.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.597 -0.519 . . . . 82.42 109.597 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.01 35.18 88.97 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 110.683 -0.967 . . . . 82.42 110.683 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ARG . . . . . 0.792 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.31 36.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 118.349 1.074 . . . . 98.99 108.627 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.24 124.72 35.2 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.761 -1.199 . . . . 109.22 107.761 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.77 164.48 36.97 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 108.997 -1.641 . . . . 82.42 108.997 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' B' ' 74' ' ' ARG . 3.3 m -94.68 151.94 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.309 0.643 . . . . 82.42 112.041 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -152.98 151.41 26.21 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 120.206 -0.598 . . . . 82.42 110.49 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.2 Cg_endo -70.17 122.12 8.7 Favored 'Trans proline' 0 CA--C 1.488 -1.793 0 C-N-CA 120.105 0.537 . . . . 111.89 112.081 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -71.07 -14.71 62.41 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.3 1.0 . . . . 119.27 111.98 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.5 HD21 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -61.57 -40.34 94.38 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.926 -0.71 . . . . 96.63 109.422 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.642 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 2.9 m-30 -64.51 0.08 1.19 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.213 -0.903 . . . . 82.42 111.706 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.53 171.46 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.513 -0.551 . . . . 82.42 109.513 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.461 ' N ' HD13 ' A' ' 275' ' ' ILE . 0.6 OUTLIER -145.96 146.41 31.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 130.62 108.869 178.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.545 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -87.95 135.22 33.5 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 108.052 -1.092 . . . . 82.42 108.052 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.12 44.36 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 105.813 -1.921 . . . . 97.62 105.813 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.3 Cg_exo -64.0 -33.86 61.17 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 N-CA-C 115.54 1.323 . . . . 152.83 115.54 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.925 0 CA-C-N 121.393 1.533 . . . . 82.42 109.234 179.502 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.467 ' HE2' ' O ' ' B' ' 61' ' ' ILE . 4.1 ptt? . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.525 -0.546 . . . . 1.86 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.47 32.19 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.287 0.565 . . . . 29.01 110.149 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.9 pt -120.95 162.31 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.751 -1.113 . . . . 1.86 109.966 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.449 ' HB2' ' OG1' ' B' ' 66' ' ' THR . 97.9 m-85 -120.92 139.36 53.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.618 0.247 . . . . 1.86 110.977 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.423 HG23 HD12 ' B' ' 30' ' ' ILE . 47.1 t -121.33 124.13 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.64 -0.874 . . . . 4.99 108.64 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.3 mttt -101.02 138.92 37.42 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.966 0.412 . . . . 5.68 110.458 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -77.61 -157.65 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.693 -0.685 . . . . 26.89 111.898 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.403 ' HG ' ' CG1' ' B' ' 70' ' ' VAL . 1.3 tt -68.35 -37.81 80.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.705 -0.679 . . . . 23.29 111.671 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -94.94 2.44 55.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.841 -0.344 . . . . 1.86 111.555 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.9 51.71 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.365 -0.445 . . . . 1.86 113.905 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 79.6 tttt -50.42 158.36 0.61 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.329 -0.513 . . . . 8.51 111.492 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -106.61 128.06 53.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.741 -0.837 . . . . 1.88 108.741 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.42 121.93 56.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 O-C-N 123.372 0.42 . . . . 37.69 110.836 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.96 131.34 48.42 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.934 -0.765 . . . . 1.86 108.934 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.637 ' CD2' ' HZ2' ' B' ' 33' ' ' LYS . 88.5 mt -127.24 149.95 49.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.61 0.243 . . . . 9.46 110.943 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.64 122.17 43.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.223 -1.769 . . . . 1.86 106.223 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.03 168.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.455 0.645 . . . . 1.86 111.478 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.86 149.35 45.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 107.179 -1.415 . . . . 1.86 107.179 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.29 -24.46 59.91 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 CA-C-N 120.799 1.321 . . . . 1.86 112.899 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -85.22 -2.54 58.16 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.215 -0.448 . . . . 1.86 112.071 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.28 142.59 50.5 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.906 -1.146 . . . . 1.86 107.906 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -86.92 157.79 19.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.493 -1.23 . . . . 1.86 109.79 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.22 -39.93 84.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.132 -0.94 . . . . 1.86 109.948 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.67 80.29 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.742 -0.836 . . . . 1.86 108.742 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.33 -42.91 87.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.463 -0.569 . . . . 1.86 109.463 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.56 -41.76 89.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.471 -0.566 . . . . 1.86 109.471 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.01 -39.85 87.25 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.443 -0.577 . . . . 1.86 109.443 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.26 89.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.728 -0.669 . . . . 1.86 110.458 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.19 -39.2 92.53 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.545 -0.539 . . . . 1.86 109.545 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.423 HD12 HG23 ' B' ' 5' ' ' VAL . 32.8 mt -65.01 -40.07 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.68 -0.489 . . . . 1.86 109.68 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.03 -44.1 94.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.493 0.663 . . . . 1.86 109.344 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.87 -40.29 92.44 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.015 -0.993 . . . . 1.86 110.98 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.637 ' HZ2' ' CD2' ' B' ' 15' ' ' LEU . 17.2 mttp -81.58 -41.34 21.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.009 1.114 . . . . 1.86 114.009 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.86 -14.59 13.96 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.167 1.914 . . . . 6.12 116.167 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.07 82.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.97 -0.633 . . . . 1.86 113.244 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.69 116.36 65.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.612 -0.514 . . . . 3.54 109.612 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.8 134.68 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 CA-C-N 120.361 1.165 . . . . 1.86 112.373 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.22 -32.31 24.65 Favored 'Trans proline' 0 N--CA 1.506 2.255 0 C-N-CA 122.818 2.345 . . . . 1.86 114.716 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.7 -16.02 62.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.829 0.74 . . . . 2.88 112.171 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.07 6.3 44.98 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.741 0.274 . . . . 7.17 111.741 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.33 121.23 42.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.82 0.674 . . . . 13.42 112.82 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -103.94 115.07 29.78 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.286 -1.005 . . . . 27.09 108.286 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -102.59 127.64 49.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.305 0.574 . . . . 1.87 110.886 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -153.84 130.45 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.142 -0.481 . . . . 17.75 111.406 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.709 ' CD2' HG12 ' B' ' 61' ' ' ILE . 59.2 t80 -124.95 142.76 51.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.561 -0.29 . . . . 16.98 110.368 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.79 38.78 16.48 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.501 0.5 . . . . 1.86 111.653 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 60.3 28.25 66.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 115.164 0.826 . . . . 48.66 115.164 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.58 ' O ' HG22 ' B' ' 44' ' ' ILE . 44.8 mtmt -119.2 134.29 55.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 117.474 0.637 . . . . 4.25 111.747 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -64.47 114.69 4.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.424 -0.807 . . . . 30.57 110.684 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.59 125.75 34.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.943 0.402 . . . . 22.77 111.79 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.612 ' H ' ' HH ' ' B' ' 59' ' ' TYR . 97.0 mt-10 -100.21 149.47 23.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.867 -0.606 . . . . 9.34 111.493 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.67 -20.05 63.58 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.693 0.998 . . . . 1.86 113.693 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.8 68.6 Favored Glycine 0 N--CA 1.476 1.309 0 C-N-CA 121.119 -0.562 . . . . 1.86 112.491 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.36 163.93 13.85 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.295 0.548 . . . . 1.86 111.674 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 49.6 p -105.35 166.3 10.52 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.679 0.752 . . . . 1.86 112.602 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.01 -41.91 93.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.664 -1.153 . . . . 2.28 110.794 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.0 70.96 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 120.058 -0.657 . . . . 2.98 111.902 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.05 -29.09 70.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.728 -0.389 . . . . 1.86 110.467 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.612 ' HH ' ' H ' ' B' ' 51' ' ' GLU . 96.7 m-85 -98.87 14.45 28.9 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.757 0.28 . . . . 1.86 111.757 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.13 39.36 19.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.923 0.489 . . . . 1.86 112.218 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.709 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.189 -1.041 . . . . 4.01 108.189 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.09 8.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.27 0.557 . . . . 5.74 112.191 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.46 141.38 15.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.25 -0.887 . . . . 4.31 111.471 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.03 23.23 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.074 -0.967 . . . . 10.13 112.856 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.3 m -77.28 146.27 36.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.984 -1.117 . . . . 4.1 107.984 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 53.2 m -126.31 136.29 52.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.148 -0.933 . . . . 1.86 111.596 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' B' ' 45' ' ' PHE . 0.0 OUTLIER -109.01 -177.78 3.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.232 -0.44 . . . . 19.21 110.256 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -118.55 147.33 43.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.956 -0.387 . . . . 50.0 109.956 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.2 113.91 3.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.945 0.402 . . . . 21.58 110.973 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 319' ' ' PRO . 72.4 t -123.14 135.68 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 25.97 110.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.13 130.65 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 1.86 111.636 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -63.68 135.98 57.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.868 -0.606 . . . . 23.71 110.59 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.89 -63.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 15.09 110.745 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 306' ' ' TRP . 6.0 ptp180 -99.02 10.66 41.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 1.86 110.893 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.87 33.13 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.839 -0.696 . . . . 1.86 112.821 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.492 -0.766 . . . . 1.86 110.823 179.304 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 121.571 0.7 . . . . 137.63999999999999 110.331 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.91 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.85 -56.86 10.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.515 -0.766 . . . . 89.760000000000005 111.381 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.91 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.54 12.65 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.81 -0.556 . . . . 143.71000000000001 109.59 -177.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.13 135.78 51.13 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.445 -0.576 . . . . 62.810000000000002 109.445 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.455 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.7 m-85 -107.16 134.46 50.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.529 -0.915 . . . . 73.75 108.529 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.64 135.38 48.46 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.723 -0.844 . . . . 54.439999999999998 108.723 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.545 ' H ' ' CD1' ' A' ' 326' ' ' LEU . 40.7 tttp -92.7 135.59 33.97 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.254 -1.017 . . . . 88.159999999999997 108.254 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 323' ' ' VAL . 93.0 t -100.99 114.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 117.93 -1.508 . . . . 73.900000000000006 110.724 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 276' ' ' PHE . 8.3 pt -79.25 -34.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.954 -1.021 . . . . 138.47999999999999 112.981 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' B' ' 68' ' ' HIS . 2.4 m-85 -108.23 90.52 6.96 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.478 0.18 . . . . 67.980000000000004 110.806 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 290' ' ' GLU . 65.6 Cg_endo -72.28 141.37 35.49 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.762 2.308 . . . . 72.540000000000006 113.375 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.402 ' CZ ' HD11 ' B' ' 44' ' ' ILE . 0.2 OUTLIER -101.74 -150.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.393 -0.821 . . . . 82.870000000000005 109.435 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -159.62 144.3 15.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.522 -0.918 . . . . 66.180000000000007 108.522 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -28.67 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.497 1.123 . . . . 50.240000000000002 113.574 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.569 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 79.6 mt-30 -88.48 -42.53 12.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.831 -0.622 . . . . 128.65000000000001 109.421 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.34 177.26 9.58 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.77 -0.582 . . . . 67.609999999999999 111.377 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.45 -34.4 28.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.309 -0.859 . . . . 78.629999999999995 110.443 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.13 -5.43 59.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 42.490000000000002 111.151 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.569 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 73.9 mt-10 -102.55 147.51 26.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.329 0.585 . . . . 53.210000000000001 109.533 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 309' ' ' GLY . 17.3 tp -85.69 133.12 34.04 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.135 -0.939 . . . . 57.0 110.196 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.442 ' O ' HD23 ' A' ' 311' ' ' LEU . 90.1 m -96.72 124.58 40.75 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.812 -1.555 . . . . 53.009999999999998 107.739 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.404 HD12 HG21 ' A' ' 274' ' ' VAL . 49.2 pt -128.29 141.42 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.554 -0.906 . . . . 56.119999999999997 108.554 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 14.4 mmtt -118.69 162.72 17.96 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.798 -0.815 . . . . 97.849999999999994 108.798 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' GLU . . . . . 0.529 ' N ' ' HB3' ' A' ' 277' ' ' PRO . 13.5 pt-20 -75.18 141.53 43.62 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.101 -1.439 . . . . 88.319999999999993 108.734 -174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.44 21.48 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.646 -0.982 . . . . 35.810000000000002 110.646 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.49 151.9 50.46 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.398 1.099 . . . . 61.780000000000001 109.829 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.455 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.0 mm -109.52 134.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.777 -1.194 . . . . 105.08 107.777 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.3 t -122.8 134.84 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.669 -0.863 . . . . 48.770000000000003 108.669 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.84 126.56 34.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.096 -1.042 . . . . 128.84 108.846 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -72.0 113.27 8.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.886 -0.783 . . . . 81.370000000000005 108.886 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.38 -52.45 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 123.765 0.826 . . . . 70.599999999999994 110.924 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.03 149.12 27.83 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.42 -0.955 . . . . 65.189999999999998 108.42 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.646 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.87 23.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.546 0.688 . . . . 125.5 110.581 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.714 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.19 171.22 9.96 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 125.86 1.664 . . . . 66.569999999999993 109.961 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 6.2 p -64.12 -133.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.665 -0.698 . . . . 91.459999999999994 112.29 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.9 mm -79.85 -53.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 112.898 0.703 . . . . 103.65000000000001 112.898 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.91 113.26 1.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.419 0.526 . . . . 115.16 112.419 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.87 106.48 13.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.583 -0.735 . . . . 50.439999999999998 109.971 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 165.21 -11.06 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.458 -0.792 . . . . 34.159999999999997 111.292 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.714 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 83.4 m95 -122.74 156.04 35.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.273 . . . . 81.450000000000003 110.485 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.646 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.6 m0 -168.22 -175.71 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 93.810000000000002 108.328 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.655 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -144.41 143.05 30.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.847 -0.797 . . . . 89.719999999999999 108.847 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -152.8 169.03 31.82 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.441 -1.864 . . . . 24.219999999999999 108.441 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.803 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.93 129.66 56.4 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.567 -0.853 . . . . 56.969999999999999 109.649 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 287' ' ' THR . 61.9 tp -142.63 135.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.102 -1.073 . . . . 59.329999999999998 108.102 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.11 37.77 29.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.552 -0.536 . . . . 46.140000000000001 109.552 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.09 35.07 88.39 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.269 -0.967 . . . . 26.489999999999998 110.745 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.803 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.44 160.35 36.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.989 -1.084 . . . . 98.989999999999995 108.521 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.29 124.74 35.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.749 -1.204 . . . . 109.22 107.749 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.74 163.71 36.47 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.082 -1.607 . . . . 26.510000000000002 109.082 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 308' ' ' GLU . 0.8 OUTLIER -98.09 151.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.65 0.38 . . . . 54.609999999999999 111.445 -178.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.75 151.43 26.63 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 120.999 0.428 . . . . 74.469999999999999 110.42 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.2 Cg_endo -70.19 122.02 8.6 Favored 'Trans proline' 0 CA--C 1.487 -1.825 0 C-N-CA 120.097 0.532 . . . . 111.89 112.041 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -78.92 -6.25 55.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 123.995 0.809 . . . . 119.27 111.833 -178.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 323' ' ' VAL . 12.5 m-20 -62.1 -40.77 97.01 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.386 -0.598 . . . . 96.629999999999995 109.386 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.42 2.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.852 -1.067 . . . . 74.849999999999994 111.788 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.637 ' HB ' HG22 ' A' ' 274' ' ' VAL . 1.9 m -132.24 155.54 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.555 -0.535 . . . . 67.239999999999995 109.555 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -116.61 163.96 15.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.143 -0.688 . . . . 130.62 109.143 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.557 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -93.67 135.17 35.22 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 108.127 -1.064 . . . . 63.159999999999997 108.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.07 44.55 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 105.785 -1.931 . . . . 97.620000000000005 105.785 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.3 Cg_exo -63.88 -33.87 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 N-CA-C 115.523 1.316 . . . . 152.83000000000001 115.523 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--N 1.302 -1.918 0 CA-C-N 121.387 1.531 . . . . 59.969999999999999 109.248 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.541 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.9 140.23 32.57 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.397 0.618 . . . . 29.010000000000002 110.121 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' B' ' 65' ' ' SER . 12.7 pt -119.21 156.15 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.021 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.577 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -121.12 139.31 53.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.931 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.528 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.29 124.16 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.671 -0.863 . . . . 4.9900000000000002 108.671 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -100.99 137.56 39.2 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.059 0.457 . . . . 5.6799999999999997 110.411 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -90.87 -149.95 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.543 -0.753 . . . . 26.890000000000001 111.6 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 306' ' ' TRP . 0.4 OUTLIER -62.57 -47.89 81.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.856 -0.611 . . . . 23.289999999999999 111.448 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -91.27 2.26 56.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.556 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.48 16.37 49.75 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.881 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 82.6 tttt -43.62 150.05 0.25 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 122.223 -0.574 . . . . 8.5099999999999998 111.778 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -106.54 128.1 53.85 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.718 -0.845 . . . . 1.8799999999999999 108.718 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' B' ' 4' ' ' PHE . 69.4 mt -123.96 121.67 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 O-C-N 123.289 0.368 . . . . 37.689999999999998 110.953 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.47 131.22 47.72 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -127.19 149.9 49.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.624 0.25 . . . . 9.4600000000000009 110.935 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.57 122.13 43.77 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.271 -1.751 . . . . 1.54 106.271 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.95 168.32 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.487 0.66 . . . . 0.0 111.493 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.84 149.2 44.82 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.2 -24.47 59.27 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 CA-C-N 120.772 1.311 . . . . 0.0 112.954 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.21 -2.56 58.17 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.069 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.63 50.52 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.94 -1.133 . . . . 1.4299999999999999 107.94 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -87.03 157.89 19.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.687 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.447 HG23 HD12 ' B' ' 43' ' ' LEU . 35.8 mm -61.29 -39.91 84.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.921 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.04 -37.64 80.38 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.36 -42.85 87.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.64 -41.68 89.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.27 89.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.451 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.3 -39.13 92.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.528 HD11 HG21 ' B' ' 5' ' ' VAL . 32.6 mt -65.05 -40.04 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.04 -44.04 94.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.518 0.675 . . . . 1.3200000000000001 109.39 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.85 -40.35 92.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.036 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -41.22 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.033 1.123 . . . . 0.82999999999999996 114.033 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -110.93 -14.7 13.92 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.049 1.87 . . . . 6.1200000000000001 116.049 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.06 82.93 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.322 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -85.82 116.48 65.83 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 109.507 -0.553 . . . . 3.54 109.507 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.93 134.64 61.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.086 1.19 . . . . 0.0 112.339 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.32 -32.22 25.08 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.751 2.301 . . . . 0.0 114.654 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.71 -15.99 62.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.976 0.807 . . . . 2.8799999999999999 112.182 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.08 8.69 43.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.732 0.271 . . . . 7.1699999999999999 111.732 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.469 ' OE1' HG21 ' B' ' 30' ' ' ILE . 44.0 mt-30 -117.65 125.84 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.13 0.789 . . . . 13.42 113.13 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -111.83 124.03 51.49 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.019 -1.104 . . . . 27.09 108.019 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.447 HD12 HG23 ' B' ' 23' ' ' ILE . 84.8 mt -98.41 132.69 43.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.289 0.566 . . . . 1.8700000000000001 110.836 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.402 HD11 ' CZ ' ' A' ' 278' ' ' TYR . 3.6 mp -132.04 135.57 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.062 -0.399 . . . . 17.75 111.631 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.52 ' CD1' HG12 ' B' ' 61' ' ' ILE . 15.0 t80 -152.92 143.26 22.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.114 -0.494 . . . . 16.98 109.944 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.5 34.75 25.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.681 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.487 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 73.1 -10.74 5.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.013 -0.994 . . . . 48.659999999999997 114.863 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -107.94 132.64 53.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 120.005 -0.678 . . . . 4.25 111.76 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -58.82 116.98 4.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.14 -0.482 . . . . 30.57 110.126 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 45' ' ' PHE . 21.3 mt -66.6 131.49 46.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.957 -0.565 . . . . 22.77 112.046 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -97.53 149.43 22.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.851 -0.613 . . . . 9.3399999999999999 111.45 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.64 -20.2 63.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.96 68.7 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.54 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.43 163.91 13.89 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.17 0.485 . . . . 1.8600000000000001 111.581 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.2 p -105.33 166.33 10.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.611 0.719 . . . . 0.0 112.604 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.9 mt -60.04 -41.99 93.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.672 -1.149 . . . . 2.2799999999999998 110.763 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.33 -31.21 71.07 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.111 -0.636 . . . . 2.98 111.763 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -62.14 -28.87 69.94 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.687 -0.405 . . . . 1.77 110.477 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.98 14.56 28.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.4 19.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.9 0.48 . . . . 0.0 112.207 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.52 HG12 ' CD1' ' B' ' 45' ' ' PHE . 96.8 mt -81.46 123.92 38.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.106 -1.072 . . . . 4.0099999999999998 108.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.88 169.21 8.68 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.281 0.563 . . . . 5.7400000000000002 112.097 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 56.9 pttt -51.59 141.41 16.31 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.184 -0.916 . . . . 4.3099999999999996 111.502 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.04 23.21 9.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.05 -0.977 . . . . 10.130000000000001 112.845 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' B' ' 3' ' ' ILE . 38.1 m -77.3 146.93 36.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.87 -1.159 . . . . 4.0999999999999996 107.87 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.577 HG23 ' HB2' ' B' ' 4' ' ' PHE . 78.0 m -122.64 132.2 54.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.4 171.74 7.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 19.210000000000001 109.789 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' HIS . . . . . 0.453 ' HB2' ' CD2' ' A' ' 276' ' ' PHE . 0.4 OUTLIER -119.96 135.59 54.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 12.6 tp -138.42 157.18 46.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.043 0.449 . . . . 21.579999999999998 111.193 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' HG3' ' A' ' 319' ' ' PRO . 2.1 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.873 -0.603 . . . . 25.969999999999999 109.848 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 121.589 0.709 . . . . 137.63999999999999 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.9 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 51.8 p -64.87 -56.99 10.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.528 -0.76 . . . . 89.760000000000005 111.26 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.9 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.88 166.63 12.63 Favored 'General case' 0 CA--C 1.491 -1.302 0 O-C-N 121.826 -0.546 . . . . 143.71000000000001 109.592 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.18 135.8 51.17 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.437 -0.579 . . . . 62.810000000000002 109.437 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 61.0 m-85 -107.18 134.44 50.29 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.515 -0.921 . . . . 73.75 108.515 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.6 135.4 48.5 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.747 -0.834 . . . . 54.439999999999998 108.747 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.651 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.7 tttp -92.66 135.52 34.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.251 -1.018 . . . . 88.159999999999997 108.251 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 288' ' ' ILE . 90.4 t -100.84 116.46 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 118.038 -1.465 . . . . 73.900000000000006 110.782 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 33.0 mm -78.38 -78.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.9 -0.591 . . . . 138.47999999999999 112.099 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' B' ' 68' ' ' HIS . 20.7 m-85 -68.95 131.71 90.79 Favored Pre-proline 0 N--CA 1.462 0.147 0 N-CA-C 109.692 -0.484 . . . . 67.980000000000004 109.692 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.532 ' CD ' ' HA2' ' B' ' 47' ' ' GLY . 30.8 Cg_endo -63.78 149.75 90.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.727 2.285 . . . . 72.540000000000006 111.807 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 288' ' ' ILE . 63.6 t80 -121.41 92.45 3.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.955 -0.566 . . . . 82.870000000000005 110.446 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -68.18 116.14 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.873 -0.603 . . . . 66.180000000000007 109.729 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.35 104.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.403 1.065 . . . . 50.240000000000002 112.98 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.541 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -81.71 -40.28 23.0 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.398 -0.593 . . . . 128.65000000000001 109.398 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -144.85 175.39 10.23 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.281 -0.887 . . . . 67.609999999999999 111.691 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.67 -31.03 32.43 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.334 -0.848 . . . . 78.629999999999995 109.696 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 -3.59 43.96 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.327 -0.851 . . . . 42.490000000000002 110.939 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.5 146.51 37.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.401 0.62 . . . . 53.210000000000001 109.486 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.432 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.7 tp -76.79 138.72 40.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.525 -0.762 . . . . 57.0 110.066 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.8 m -96.45 124.49 40.47 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.33 -1.348 . . . . 53.009999999999998 107.767 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.2 142.16 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.542 -0.91 . . . . 56.119999999999997 108.542 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -113.82 158.3 21.19 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.396 -0.964 . . . . 97.849999999999994 108.396 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.48 141.52 41.26 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 118.077 -1.449 . . . . 88.319999999999993 108.642 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.63 21.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.572 -1.011 . . . . 35.810000000000002 110.572 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.49 151.87 50.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.436 1.118 . . . . 61.780000000000001 109.825 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.3 mm -109.56 133.95 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.817 -1.179 . . . . 105.08 107.817 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.74 134.8 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.718 -0.845 . . . . 48.770000000000003 108.718 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.82 126.61 34.16 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.131 -1.028 . . . . 128.84 108.825 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.97 113.22 8.78 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.899 -0.778 . . . . 81.370000000000005 108.899 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.41 -52.43 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.733 0.813 . . . . 70.599999999999994 110.92 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.97 149.2 27.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.475 -0.935 . . . . 65.189999999999998 108.475 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.524 ' HG3' ' NE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.79 23.62 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.433 0.635 . . . . 125.5 110.594 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.18 174.3 7.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.801 1.64 . . . . 66.569999999999993 109.93 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' CYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 3.9 p -58.0 -144.72 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.994 0.739 . . . . 91.459999999999994 112.994 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.414 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 45.8 mm -71.02 -57.52 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.907 1.077 . . . . 103.65000000000001 113.907 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -50.53 127.57 18.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.096 0.776 . . . . 115.16 113.096 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.88 112.82 26.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.408 -0.815 . . . . 50.439999999999998 110.446 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 158.3 -13.56 0.25 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.922 -0.871 . . . . 34.159999999999997 110.922 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 92.4 m95 -122.7 147.56 46.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.372 -0.414 . . . . 81.450000000000003 110.913 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.626 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 7.2 m0 -157.81 -177.48 6.61 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.782 0.676 . . . . 93.810000000000002 109.435 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.763 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -138.14 143.06 40.14 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.851 -0.796 . . . . 89.719999999999999 108.851 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.86 168.89 31.84 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 108.448 -1.861 . . . . 24.219999999999999 108.448 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.792 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.84 129.75 56.34 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 119.503 -0.879 . . . . 56.969999999999999 109.673 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.68 135.57 28.17 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.1 -1.074 . . . . 59.329999999999998 108.1 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.13 37.78 29.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.499 -0.556 . . . . 46.140000000000001 109.499 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.13 35.04 88.1 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.193 -1.004 . . . . 26.489999999999998 110.699 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.792 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.4 160.3 36.78 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 119.029 -1.069 . . . . 98.989999999999995 108.598 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -129.22 124.78 35.38 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.738 -1.208 . . . . 109.22 107.738 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.82 163.96 36.67 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.071 -1.612 . . . . 26.510000000000002 109.071 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.763 HG12 ' HG2' ' A' ' 308' ' ' GLU . 1.6 m -96.42 151.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 122.734 0.413 . . . . 54.609999999999999 111.456 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -155.23 151.4 22.68 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 120.634 -0.427 . . . . 74.469999999999999 110.425 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.22 121.89 8.46 Favored 'Trans proline' 0 CA--C 1.486 -1.88 0 C-N-CA 120.053 0.502 . . . . 111.89 112.094 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.626 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.1 OUTLIER -74.76 -0.44 18.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 124.158 0.912 . . . . 119.27 111.976 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -60.95 -42.64 98.61 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.448 -0.575 . . . . 96.629999999999995 109.448 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 68' ' ' HIS . 4.6 m-85 -73.55 9.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.523 -0.762 . . . . 74.849999999999994 112.683 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.57 164.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.589 -0.523 . . . . 67.239999999999995 109.589 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.08 154.67 47.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.341 -0.614 . . . . 130.62 109.341 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -92.22 135.26 34.15 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.11 -1.07 . . . . 63.159999999999997 108.11 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.05 44.61 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 105.803 -1.925 . . . . 97.620000000000005 105.803 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.97 -33.82 61.64 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.59 1.342 . . . . 152.83000000000001 115.59 -175.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 CA--C 1.486 -1.908 0 CA-C-N 121.385 1.53 . . . . 59.969999999999999 109.308 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.88 140.7 31.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.243 0.545 . . . . 29.010000000000002 110.197 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.8 pt -116.27 161.55 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.827 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.84 139.3 53.79 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.585 0.231 . . . . 0.0 110.975 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.577 HG21 HD11 ' B' ' 30' ' ' ILE . 46.9 t -121.24 124.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.641 -0.874 . . . . 4.9900000000000002 108.641 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.13 139.57 36.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 5.6799999999999997 110.471 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -91.3 -142.59 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.612 -0.722 . . . . 26.890000000000001 111.788 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 8' ' ' LEU . 1.1 tm? -73.49 -42.13 62.23 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.119 -0.491 . . . . 23.289999999999999 111.572 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -94.25 2.35 55.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.527 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.46 16.32 49.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.786 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 77.6 tttt -46.8 153.45 0.4 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.363 -0.492 . . . . 8.5099999999999998 111.568 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -107.06 127.77 53.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.722 -0.844 . . . . 1.8799999999999999 108.722 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.82 121.75 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.233 0.333 . . . . 37.689999999999998 110.931 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.45 131.18 47.7 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -127.12 149.94 49.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.678 0.275 . . . . 9.4600000000000009 110.935 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.6 122.12 43.75 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 106.185 -1.783 . . . . 1.54 106.185 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.92 168.41 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.524 0.678 . . . . 0.0 111.468 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.94 149.28 45.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.24 -24.43 59.36 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 CA-C-N 120.832 1.333 . . . . 0.0 112.93 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.28 -2.59 58.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.001 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.22 142.57 50.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.958 -1.127 . . . . 1.4299999999999999 107.958 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.91 157.79 19.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.704 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.24 -39.88 84.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.011 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.71 80.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.32 -42.87 87.59 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -60.64 -41.7 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.96 -40.0 87.52 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.18 89.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.516 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.15 -39.25 92.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.577 HD11 HG21 ' B' ' 5' ' ' VAL . 32.6 mt -65.09 -40.03 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.98 -44.08 94.72 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.609 0.719 . . . . 1.3200000000000001 109.441 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.82 -40.37 92.5 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.026 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -41.13 22.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.108 1.151 . . . . 0.82999999999999996 114.108 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.95 -14.57 13.93 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.15 1.907 . . . . 6.1200000000000001 116.15 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.1 82.95 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.393 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.81 116.4 65.52 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.566 -0.531 . . . . 3.54 109.566 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.67 61.97 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.101 1.201 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.48 -32.02 25.69 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.78 2.32 . . . . 0.0 114.694 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.75 -15.99 62.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.971 0.805 . . . . 2.8799999999999999 112.189 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.07 5.65 44.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.709 0.262 . . . . 7.1699999999999999 111.709 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -103.74 131.29 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.873 0.694 . . . . 13.42 112.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -119.3 113.86 21.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.256 -1.016 . . . . 27.09 108.256 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.417 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.3 mt -101.72 128.7 47.92 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.336 0.589 . . . . 1.8700000000000001 110.815 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 67.8 mt -143.87 136.05 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.278 -0.419 . . . . 17.75 111.109 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.605 ' CD2' HG12 ' B' ' 61' ' ' ILE . 94.5 t80 -131.72 134.92 46.4 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.307 -0.257 . . . . 16.98 110.307 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 39.31 21.7 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 123.435 0.459 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.532 ' HA2' ' CD ' ' A' ' 277' ' ' PRO . . . 66.98 22.85 72.55 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.522 0.969 . . . . 48.659999999999997 115.522 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.5 132.55 56.52 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.605 -0.938 . . . . 4.25 111.784 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -67.51 118.58 11.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.82 -0.627 . . . . 30.57 110.703 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' B' ' 43' ' ' LEU . 50.3 mt -86.25 126.11 34.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.229 0.455 . . . . 22.77 112.229 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -100.07 149.53 23.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.835 -0.62 . . . . 9.3399999999999999 111.433 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -69.65 -20.26 63.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.05 5.91 68.85 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.572 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.92 13.87 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.179 0.49 . . . . 1.8600000000000001 111.637 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.33 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.576 0.703 . . . . 0.0 112.67 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.91 -42.05 93.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.759 -1.109 . . . . 2.2799999999999998 110.747 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.4 -31.13 71.04 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.187 -0.605 . . . . 2.98 111.826 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.06 -28.94 69.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.773 -0.371 . . . . 1.77 110.459 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.01 14.51 28.93 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.16 39.28 19.16 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 122.977 0.511 . . . . 0.0 112.207 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.605 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.37 123.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.092 -1.077 . . . . 4.0099999999999998 108.092 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.96 169.15 8.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.23 0.538 . . . . 5.7400000000000002 112.114 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.0 pttt -51.56 141.45 16.11 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.19 -0.914 . . . . 4.3099999999999996 111.482 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.9 23.34 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.01 -0.996 . . . . 10.130000000000001 112.817 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.27 146.57 36.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 4.0999999999999996 107.952 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -123.45 133.06 54.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.13 179.01 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 19.210000000000001 109.927 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' HIS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . 1.1 m170 -115.96 139.17 50.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.964 -0.384 . . . . 50.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -133.19 144.73 50.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 21.579999999999998 111.012 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.408 HG13 ' CZ ' ' A' ' 322' ' ' PHE . 3.7 m . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 25.969999999999999 110.661 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 121.529 0.681 . . . . 137.63999999999999 110.358 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.914 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.506 -0.77 . . . . 89.760000000000005 111.342 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.914 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.56 12.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 O-C-N 121.739 -0.601 . . . . 143.71000000000001 109.508 -177.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.11 135.81 51.08 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.48 -0.563 . . . . 62.810000000000002 109.48 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.551 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.0 m-85 -107.25 134.48 50.28 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.413 -0.958 . . . . 73.75 108.413 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.57 135.37 48.49 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.784 -0.821 . . . . 54.439999999999998 108.784 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.525 ' HB3' HD21 ' A' ' 326' ' ' LEU . 40.6 tttp -92.76 135.65 33.93 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.151 -1.055 . . . . 88.159999999999997 108.151 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.5 HG22 HG11 ' A' ' 323' ' ' VAL . 91.6 t -100.98 117.13 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 117.96 -1.496 . . . . 73.900000000000006 110.833 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.1 OUTLIER -96.71 -0.54 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.668 0.988 . . . . 138.47999999999999 113.668 -178.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 276' ' ' PHE . . . . . 0.675 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 5.1 m-85 -117.67 145.31 36.14 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 117.98 0.355 . . . . 67.980000000000004 111.089 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' B' ' 44' ' ' ILE . 68.5 Cg_endo -76.35 135.22 16.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.575 2.183 . . . . 72.540000000000006 112.352 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.47 ' HB3' HG13 ' A' ' 288' ' ' ILE . 64.6 t80 -130.58 111.2 12.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 82.870000000000005 110.585 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.39 127.27 40.18 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.187 -0.672 . . . . 66.180000000000007 109.187 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.05 108.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.134 0.896 . . . . 50.240000000000002 112.683 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.576 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.0 mt-30 -85.61 -43.04 13.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.468 -0.567 . . . . 128.65000000000001 109.468 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.23 178.56 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.435 -0.791 . . . . 67.609999999999999 111.815 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.34 -35.06 25.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.185 -0.916 . . . . 78.629999999999995 109.76 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -79.53 3.79 17.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.634 -0.712 . . . . 42.490000000000002 110.693 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.576 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 73.9 mt-10 -117.14 146.29 43.27 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.853 -0.612 . . . . 53.210000000000001 109.522 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.7 tp -83.08 140.98 32.35 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.613 -0.721 . . . . 57.0 110.032 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.426 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.2 m -95.66 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 118.514 -1.275 . . . . 53.009999999999998 107.765 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.21 141.79 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.555 -0.906 . . . . 56.119999999999997 108.555 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 31.7 mmtt -118.93 162.0 19.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.628 -0.879 . . . . 97.849999999999994 108.628 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.36 141.52 43.29 Favored 'General case' 0 CA--C 1.483 -1.619 0 C-N-CA 118.114 -1.434 . . . . 88.319999999999993 108.68 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.61 21.53 21.41 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.667 -0.973 . . . . 35.810000000000002 110.667 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.47 151.89 50.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 118.377 1.089 . . . . 61.780000000000001 109.87 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.551 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.1 mm -109.54 133.97 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.77 -1.196 . . . . 105.08 107.77 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 91.9 t -122.79 134.82 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.704 -0.85 . . . . 48.770000000000003 108.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.87 126.54 34.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.814 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.01 113.33 8.93 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.937 -0.764 . . . . 81.370000000000005 108.937 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.44 -52.41 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 123.682 0.793 . . . . 70.599999999999994 110.869 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.0 149.19 27.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.394 -0.965 . . . . 65.189999999999998 108.394 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.609 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.78 23.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.465 0.65 . . . . 125.5 110.585 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.663 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.12 172.74 8.87 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.847 1.659 . . . . 66.569999999999993 109.884 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' CYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 5.7 p -61.93 -149.5 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.939 -1.028 . . . . 91.459999999999994 111.402 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.405 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 47.9 mm -69.02 -55.44 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.248 0.833 . . . . 103.65000000000001 113.248 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -56.65 117.74 4.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.336 0.589 . . . . 115.16 112.277 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.6 t -82.92 113.21 21.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.434 -0.803 . . . . 50.439999999999998 110.254 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 166.8 -22.97 0.12 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.951 -0.642 . . . . 34.159999999999997 111.827 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.663 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 15.7 m95 -112.75 154.36 26.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.48 -0.563 . . . . 81.450000000000003 109.48 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.609 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 0.8 OUTLIER -164.7 174.5 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.352 -0.61 . . . . 93.810000000000002 109.352 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.98 143.13 42.65 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.85 -0.796 . . . . 89.719999999999999 108.85 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.91 168.96 31.87 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.452 -1.859 . . . . 24.219999999999999 108.452 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.79 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.91 129.64 56.4 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.628 -0.829 . . . . 56.969999999999999 109.684 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 287' ' ' THR . 62.2 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.08 -1.081 . . . . 59.329999999999998 108.08 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.06 37.79 29.22 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.503 -0.554 . . . . 46.140000000000001 109.503 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.05 88.06 Favored Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.698 -0.961 . . . . 26.489999999999998 110.698 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.79 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.1 mmm-85 -132.43 160.29 36.84 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 118.348 1.074 . . . . 98.989999999999995 108.649 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -129.25 124.69 35.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.773 -1.195 . . . . 109.22 107.773 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.49 36.32 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.06 -1.616 . . . . 26.510000000000002 109.06 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.37 148.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.691 0.281 . . . . 54.609999999999999 111.27 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.53 151.4 23.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 120.982 0.42 . . . . 74.469999999999999 110.375 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.44 8.05 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.113 0.542 . . . . 111.89 112.027 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.12 -0.9 56.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.253 0.971 . . . . 119.27 112.018 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -62.24 -37.91 87.21 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.38 -0.6 . . . . 96.629999999999995 109.38 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 6.5 m-30 -56.87 -7.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.231 -0.895 . . . . 74.849999999999994 112.135 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 274' ' ' VAL . 0.8 OUTLIER -132.17 142.77 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 109.205 -0.665 . . . . 67.239999999999995 109.205 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -96.49 179.31 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.852 -0.425 . . . . 130.62 109.852 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.555 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.2 mt -89.15 135.19 33.7 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 108.086 -1.079 . . . . 63.159999999999997 108.086 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.4 129.05 44.52 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 105.817 -1.92 . . . . 97.620000000000005 105.817 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.8 Cg_exo -63.87 -33.85 62.65 Favored 'Trans proline' 0 N--CA 1.436 -1.911 0 N-CA-C 115.601 1.346 . . . . 152.83000000000001 115.601 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.947 0 CA-C-N 121.35 1.518 . . . . 59.969999999999999 109.234 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.488 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.94 140.68 31.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.42 0.629 . . . . 29.010000000000002 110.117 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -117.83 165.2 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.818 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.423 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -121.41 139.31 53.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.618 0.247 . . . . 0.0 111.059 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.546 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.23 124.18 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.661 -0.866 . . . . 4.9900000000000002 108.661 177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.3 mttt -101.01 137.89 38.78 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.026 0.441 . . . . 5.6799999999999997 110.487 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -90.35 -146.35 0.18 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.595 -0.73 . . . . 26.890000000000001 111.854 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -45.89 76.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.969 -0.56 . . . . 23.289999999999999 111.832 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -93.15 2.47 56.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.3 . . . . 0.0 111.511 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.33 16.6 49.38 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.426 -0.416 . . . . 0.0 113.915 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 80.1 tttt -46.96 154.41 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.317 -0.519 . . . . 8.5099999999999998 111.699 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -107.31 128.19 54.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.682 -0.858 . . . . 1.8799999999999999 108.682 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 77.3 mt -120.31 122.8 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 123.343 0.402 . . . . 37.689999999999998 111.039 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.75 131.24 48.15 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -127.25 149.92 49.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.69 0.281 . . . . 9.4600000000000009 110.905 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.57 122.19 43.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.19 -1.782 . . . . 1.54 106.19 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.98 168.34 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.495 0.664 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.88 149.3 45.07 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.18 -24.53 59.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 CA-C-N 120.767 1.31 . . . . 0.0 112.901 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 p -85.21 -2.6 58.22 Favored 'General case' 0 CA--C 1.526 0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.04 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -71.17 142.53 50.67 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.036 -1.098 . . . . 1.4299999999999999 108.036 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -86.93 157.89 19.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.704 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.25 -39.83 83.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.04 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.12 -37.64 80.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.31 -42.88 87.66 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.534 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.53 -41.72 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.98 -39.96 87.46 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.18 89.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.445 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.28 -39.12 92.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.546 HD11 HG21 ' B' ' 5' ' ' VAL . 33.1 mt -65.03 -40.07 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.1 -43.99 95.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.484 0.659 . . . . 1.3200000000000001 109.416 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.87 -40.35 92.64 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.97 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.56 -41.23 21.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.091 1.145 . . . . 0.82999999999999996 114.091 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.58 13.93 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.115 1.894 . . . . 6.1200000000000001 116.115 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.11 82.86 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.232 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.35 65.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.592 -0.521 . . . . 3.54 109.592 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.63 61.72 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.119 1.213 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -32.16 24.62 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.771 2.314 . . . . 0.0 114.723 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.82 -15.96 62.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.92 0.782 . . . . 2.8799999999999999 112.19 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.14 7.43 44.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.777 0.288 . . . . 7.1699999999999999 111.777 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -110.44 129.24 55.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.806 0.669 . . . . 13.42 112.806 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.625 ' HB2' HG21 ' B' ' 70' ' ' VAL . 7.0 mtt-85 -119.08 121.19 39.25 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.694 -1.225 . . . . 27.09 107.694 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.468 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.2 mt -98.89 129.5 45.24 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.351 0.596 . . . . 1.8700000000000001 110.85 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' B' ' 50' ' ' LEU . 0.6 OUTLIER -144.01 133.47 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.35 -0.387 . . . . 17.75 111.369 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.725 ' CD2' HG12 ' B' ' 61' ' ' ILE . 84.2 t80 -136.48 143.4 43.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.459 -0.337 . . . . 16.98 110.353 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.23 38.72 21.99 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.6 0.563 . . . . 0.0 111.639 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 63.59 18.13 60.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.524 0.97 . . . . 48.659999999999997 115.524 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.84 134.11 55.34 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.898 0.849 . . . . 4.25 111.798 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.446 ' HA ' HG22 ' B' ' 44' ' ' ILE . 97.8 mt-30 -65.2 119.03 10.13 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.149 -0.478 . . . . 30.57 110.87 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.468 HD12 ' HB3' ' B' ' 43' ' ' LEU . 47.4 mt -86.14 126.25 34.09 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.037 0.446 . . . . 22.77 111.829 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -97.84 149.47 22.33 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 9.3399999999999999 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -69.59 -20.22 63.64 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.1 5.96 68.75 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.93 13.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.225 0.513 . . . . 1.8600000000000001 111.585 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.36 10.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.655 0.741 . . . . 0.0 112.625 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.02 -41.8 92.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.69 -1.141 . . . . 2.2799999999999998 110.892 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -61.57 -31.11 71.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 120.053 -0.659 . . . . 2.98 111.794 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.98 -28.95 69.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.614 -0.435 . . . . 1.77 110.526 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.98 14.52 28.85 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.07 39.39 19.06 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.725 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.95 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.097 -1.075 . . . . 4.0099999999999998 108.097 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.98 169.19 8.7 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.249 0.547 . . . . 5.7400000000000002 112.103 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.57 141.4 16.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.185 -0.916 . . . . 4.3099999999999996 111.454 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.95 23.32 9.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.991 -1.004 . . . . 10.130000000000001 112.803 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.477 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.27 145.7 37.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.929 -1.138 . . . . 4.0999999999999996 107.929 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.423 HG23 ' HB2' ' B' ' 4' ' ' PHE . 89.8 m -122.32 134.77 54.65 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.297 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' B' ' 67' ' ' LEU . 0.0 OUTLIER -116.03 -175.27 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 19.210000000000001 110.414 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -118.71 139.08 52.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 50.0 109.941 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 16.5 tp -108.7 163.83 12.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 21.579999999999998 111.163 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.672 HG22 ' HZ ' ' A' ' 322' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 25.969999999999999 110.503 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.555 0.693 . . . . 137.63999999999999 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.909 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.2 p -64.88 -56.86 10.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.486 -0.779 . . . . 89.760000000000005 111.319 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.909 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.99 166.6 12.61 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 121.784 -0.573 . . . . 143.71000000000001 109.509 -177.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.21 135.83 51.17 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.424 -0.584 . . . . 62.810000000000002 109.424 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.561 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.23 134.45 50.31 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.475 -0.935 . . . . 73.75 108.475 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.61 135.43 48.55 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.756 -0.831 . . . . 54.439999999999998 108.756 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.681 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.74 135.62 33.95 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.245 -1.02 . . . . 88.159999999999997 108.245 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.534 HG22 HG11 ' A' ' 323' ' ' VAL . 92.4 t -101.02 116.27 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 C-N-CA 117.96 -1.496 . . . . 73.900000000000006 110.768 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -4.18 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.68 0.622 . . . . 138.47999999999999 112.68 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -117.16 127.7 26.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.736 0.303 . . . . 67.980000000000004 110.997 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.19 139.51 50.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.212 2.608 . . . . 72.540000000000006 112.188 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -129.97 82.63 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.955 -0.566 . . . . 82.870000000000005 110.585 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.13 126.63 29.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.092 -0.707 . . . . 66.180000000000007 109.092 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.99 104.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.393 1.058 . . . . 50.240000000000002 113.452 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.472 ' HG2' ' HE ' ' B' ' 42' ' ' ARG . 26.1 mt-30 -90.63 -41.34 11.39 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.935 -0.575 . . . . 128.65000000000001 109.491 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.96 177.21 9.31 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.159 -0.963 . . . . 67.609999999999999 111.673 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -82.0 -35.39 28.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.431 -0.804 . . . . 78.629999999999995 110.164 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -77.11 -3.67 40.54 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.684 -0.689 . . . . 42.490000000000002 111.028 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.36 146.54 36.93 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.428 0.632 . . . . 53.210000000000001 109.475 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.76 142.46 28.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 57.0 110.016 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.577 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.7 m -96.03 124.55 40.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.335 -1.346 . . . . 53.009999999999998 107.688 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.21 141.82 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.556 -0.905 . . . . 56.119999999999997 108.556 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 65.7 mmtt -116.2 156.61 26.23 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.428 -0.953 . . . . 97.849999999999994 108.428 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.67 141.56 42.72 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 118.275 -1.37 . . . . 88.319999999999993 108.697 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.54 21.36 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.65 -0.98 . . . . 35.810000000000002 110.65 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.52 151.94 50.45 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.397 1.098 . . . . 61.780000000000001 109.805 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.681 HD13 ' HA ' ' A' ' 273' ' ' LYS . 43.9 mm -109.52 134.02 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.807 -1.183 . . . . 105.08 107.807 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.82 134.84 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.671 -0.863 . . . . 48.770000000000003 108.671 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.85 126.61 34.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.799 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.02 113.29 8.89 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.877 -0.786 . . . . 81.370000000000005 108.877 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.8 mt -74.43 -52.43 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 123.596 0.758 . . . . 70.599999999999994 110.866 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.93 149.18 27.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.362 -0.977 . . . . 65.189999999999998 108.362 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.453 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.37 163.89 23.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.515 0.674 . . . . 125.5 110.554 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.22 173.65 8.29 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.856 1.663 . . . . 66.569999999999993 109.936 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 2.5 p -61.8 -158.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.514 -0.766 . . . . 91.459999999999994 111.398 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.416 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 48.7 mm -59.94 -50.48 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.19 1.182 . . . . 103.65000000000001 114.19 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.27 123.11 10.97 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.63 0.604 . . . . 115.16 112.63 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.67 111.7 24.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.563 -0.744 . . . . 50.439999999999998 110.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 158.74 -16.8 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.06 -0.816 . . . . 34.159999999999997 111.06 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.607 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 98.6 m95 -118.79 148.26 43.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.175 -0.513 . . . . 81.450000000000003 110.377 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.453 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 2.9 m0 -157.49 174.48 15.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.712 -0.847 . . . . 93.810000000000002 108.712 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.633 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -132.42 143.11 49.58 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.829 -0.804 . . . . 89.719999999999999 108.829 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 169.0 31.83 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 108.437 -1.865 . . . . 24.219999999999999 108.437 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.97 129.63 56.42 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 119.571 -0.851 . . . . 56.969999999999999 109.684 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.61 135.66 28.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.088 -1.079 . . . . 59.329999999999998 108.088 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.75 29.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.584 -0.524 . . . . 46.140000000000001 109.584 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.07 88.11 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.19 -1.005 . . . . 26.489999999999998 110.623 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.51 160.27 36.99 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 118.397 1.099 . . . . 98.989999999999995 108.627 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.19 124.77 35.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.758 -1.201 . . . . 109.22 107.758 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.81 164.12 36.77 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.028 -1.629 . . . . 26.510000000000002 109.028 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.633 HG12 ' HG2' ' A' ' 308' ' ' GLU . 5.0 m -90.72 146.8 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.377 -0.412 . . . . 54.609999999999999 111.511 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.77 151.41 23.36 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.461 -0.495 . . . . 74.469999999999999 110.436 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.607 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.1 122.38 8.96 Favored 'Trans proline' 0 CA--C 1.488 -1.8 0 C-N-CA 120.139 0.559 . . . . 111.89 112.068 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.58 -10.41 43.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.321 1.013 . . . . 119.27 111.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -62.42 -38.91 91.5 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.417 -0.586 . . . . 96.629999999999995 109.417 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.96 -1.38 0.29 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.379 -1.282 . . . . 74.849999999999994 112.325 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.534 HG11 HG22 ' A' ' 274' ' ' VAL . 0.7 OUTLIER -131.94 155.2 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.491 -0.559 . . . . 67.239999999999995 109.491 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -108.04 152.76 24.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.428 -0.582 . . . . 130.62 109.428 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.546 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.4 mt -88.0 135.19 33.52 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.097 -1.075 . . . . 63.159999999999997 108.097 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.14 44.15 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.752 -1.944 . . . . 97.620000000000005 105.752 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.86 -33.96 62.46 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 N-CA-C 115.547 1.326 . . . . 152.83000000000001 115.547 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.3 -1.987 0 CA-C-N 121.386 1.531 . . . . 59.969999999999999 109.292 179.528 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.93 140.46 32.25 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.336 0.589 . . . . 29.010000000000002 110.062 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -118.73 163.4 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.051 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.478 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -120.26 139.27 52.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.601 0.239 . . . . 0.0 111.007 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.652 HG21 HD11 ' B' ' 30' ' ' ILE . 47.2 t -121.29 124.21 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.643 -0.873 . . . . 4.9900000000000002 108.643 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.1 mttt -101.1 135.93 41.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.989 0.423 . . . . 5.6799999999999997 110.483 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -78.97 -140.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.547 -0.751 . . . . 26.890000000000001 111.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' B' ' 8' ' ' LEU . 0.7 OUTLIER -81.16 -41.65 22.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 23.289999999999999 111.044 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -89.93 2.41 55.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.519 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.47 16.18 50.42 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.865 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 65.4 tttt -50.09 157.84 0.6 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.454 -0.439 . . . . 8.5099999999999998 111.557 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.4 m -106.37 127.95 53.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.72 -0.844 . . . . 1.8799999999999999 108.72 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 88.8 mt -123.06 123.6 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.315 . . . . 37.689999999999998 110.82 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.79 131.19 48.24 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.17 149.94 49.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.578 0.228 . . . . 9.4600000000000009 110.988 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.64 122.16 43.86 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.258 -1.756 . . . . 1.54 106.258 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.93 168.3 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.485 0.659 . . . . 0.0 111.511 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.83 149.35 45.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.3 -24.42 59.81 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 CA-C-N 120.764 1.308 . . . . 0.0 112.966 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 p -85.18 -2.63 58.24 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.046 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.24 142.64 50.57 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.003 -1.11 . . . . 1.4299999999999999 108.003 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -87.03 157.82 19.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.679 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.26 -39.85 84.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.954 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.13 -37.57 80.46 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.4 -42.85 87.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.55 -41.7 88.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -60.08 -39.87 87.6 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.29 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.457 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.531 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.24 -39.22 92.43 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.652 HD11 HG21 ' B' ' 5' ' ' VAL . 33.0 mt -64.99 -40.04 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -44.13 94.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.614 0.721 . . . . 1.3200000000000001 109.407 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.33 92.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.994 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -81.59 -41.23 21.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.01 1.115 . . . . 0.82999999999999996 114.01 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.91 -14.65 13.93 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.052 1.871 . . . . 6.1200000000000001 116.052 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.11 82.92 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.263 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.77 116.49 65.87 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 109.518 -0.549 . . . . 3.54 109.518 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.83 134.68 61.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.062 1.174 . . . . 0.0 112.39 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 -32.28 24.87 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.8 2.333 . . . . 0.0 114.699 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.67 -16.06 62.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 118.955 0.798 . . . . 2.8799999999999999 112.205 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.06 6.09 44.99 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.783 0.29 . . . . 7.1699999999999999 111.783 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.434 ' HB3' HD11 ' B' ' 69' ' ' LEU . 75.1 mt-30 -105.79 153.49 21.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.039 0.755 . . . . 13.42 113.039 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.472 ' HE ' ' HG2' ' A' ' 281' ' ' GLN . 4.0 mtt180 -146.68 118.55 8.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.8 -1.091 . . . . 27.09 108.316 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.406 ' C ' HG13 ' B' ' 44' ' ' ILE . 84.8 mt -100.59 129.41 46.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.315 0.579 . . . . 1.8700000000000001 110.831 -177.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.469 HG23 ' O ' ' B' ' 48' ' ' LYS . 17.2 mt -141.08 136.23 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.084 -0.385 . . . . 17.75 111.194 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.591 ' CD2' HG12 ' B' ' 61' ' ' ILE . 62.2 t80 -135.0 137.62 43.19 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.597 -0.274 . . . . 16.98 110.27 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.69 39.34 21.52 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 123.405 0.441 . . . . 0.0 111.674 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 22.62 68.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.576 0.99 . . . . 48.659999999999997 115.576 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.469 ' O ' HG23 ' B' ' 44' ' ' ILE . 44.8 mtmt -117.19 132.64 56.6 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.999 0.9 . . . . 4.25 111.775 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -68.45 116.6 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 30.57 110.295 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -85.94 130.22 34.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.201 0.524 . . . . 22.77 112.047 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.22 149.55 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.459 -0.791 . . . . 9.3399999999999999 111.471 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.66 -20.17 63.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.2 5.99 68.53 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.514 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 164.0 13.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.204 0.502 . . . . 1.8600000000000001 111.652 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -105.45 166.41 10.45 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.582 0.706 . . . . 0.0 112.572 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.97 -42.01 93.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.707 -1.133 . . . . 2.2799999999999998 110.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.41 -31.13 71.05 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.138 -0.625 . . . . 2.98 111.77 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.1 -28.94 69.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.689 -0.405 . . . . 1.77 110.468 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.04 14.6 28.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.611 0.244 . . . . 0.0 111.629 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.01 39.39 18.8 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.918 0.487 . . . . 0.0 112.22 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.43 123.93 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.136 -1.061 . . . . 4.0099999999999998 108.136 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.97 169.18 8.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.326 0.584 . . . . 5.7400000000000002 112.114 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.54 141.42 16.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.234 -0.894 . . . . 4.3099999999999996 111.443 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.01 23.26 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.937 -1.029 . . . . 10.130000000000001 112.824 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.34 146.69 36.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.898 -1.149 . . . . 4.0999999999999996 107.898 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.478 HG23 ' HB2' ' B' ' 4' ' ' PHE . 99.8 m -121.52 135.0 55.06 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' B' ' 45' ' ' PHE . 1.2 mp -112.6 -176.2 2.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 19.210000000000001 110.584 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -125.35 148.77 48.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 50.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' B' ' 41' ' ' GLN . 15.7 tp -133.72 139.6 46.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.048 0.452 . . . . 21.579999999999998 111.727 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.53 0.201 0 CA-C-N 115.82 -0.627 . . . . 25.969999999999999 110.321 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 121.528 0.68 . . . . 137.63999999999999 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.914 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.7 p -64.86 -56.8 11.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.527 -0.761 . . . . 89.760000000000005 111.413 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.914 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.51 12.64 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.726 -0.609 . . . . 143.71000000000001 109.482 -177.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.12 135.78 51.13 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.448 -0.575 . . . . 62.810000000000002 109.448 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.504 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.8 m-85 -107.2 134.5 50.22 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.513 -0.921 . . . . 73.75 108.513 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.442 ' SG ' HD22 ' A' ' 325' ' ' LEU . 50.2 m -129.59 135.37 48.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.791 -0.818 . . . . 54.439999999999998 108.791 -175.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.731 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.61 33.96 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.214 -1.032 . . . . 88.159999999999997 108.214 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 91.2 t -100.87 115.95 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 118.11 -1.436 . . . . 73.900000000000006 110.722 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -96.59 4.89 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.647 0.98 . . . . 138.47999999999999 113.647 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 276' ' ' PHE . . . . . 0.718 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -126.2 135.02 26.55 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 117.97 0.35 . . . . 67.980000000000004 110.924 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.21 134.74 19.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 72.540000000000006 111.861 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.452 ' HB3' HG13 ' A' ' 288' ' ' ILE . 81.2 t80 -128.18 137.85 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 82.870000000000005 110.793 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -113.63 121.52 44.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.088 -0.506 . . . . 66.180000000000007 109.658 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -32.64 114.43 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.005 0.815 . . . . 50.240000000000002 113.133 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.553 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.35 -41.73 12.66 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.411 -0.588 . . . . 128.65000000000001 109.411 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.98 179.91 7.68 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.288 -0.882 . . . . 67.609999999999999 111.328 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -83.03 -33.25 26.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.412 -0.813 . . . . 78.629999999999995 109.994 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -75.13 -5.19 42.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.714 -0.676 . . . . 42.490000000000002 111.153 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -112.48 147.14 37.17 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.368 0.604 . . . . 53.210000000000001 109.47 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.6 tp -78.1 135.2 37.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.523 -0.762 . . . . 57.0 110.194 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.534 ' O ' HD23 ' A' ' 311' ' ' LEU . 90.0 m -94.87 124.52 38.96 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 118.343 -1.343 . . . . 53.009999999999998 107.805 -176.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.1 pt -128.28 141.88 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.483 -0.932 . . . . 56.119999999999997 108.483 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.3 mmtt -118.55 160.69 21.31 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.56 -0.904 . . . . 97.849999999999994 108.56 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.53 141.53 41.18 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.065 -1.454 . . . . 88.319999999999993 108.75 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.68 21.5 21.32 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.692 -0.963 . . . . 35.810000000000002 110.692 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -130.54 151.91 50.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 118.348 1.074 . . . . 61.780000000000001 109.768 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.55 133.99 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.775 -1.194 . . . . 105.08 107.775 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.81 134.8 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.746 -0.835 . . . . 48.770000000000003 108.746 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.504 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 12.9 t -85.82 126.5 34.08 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.153 -1.019 . . . . 128.84 108.858 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -71.91 113.24 8.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.964 -0.754 . . . . 81.370000000000005 108.964 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.635 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.3 mt -74.39 -52.43 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.639 0.776 . . . . 70.599999999999994 110.946 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.95 149.22 28.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.387 -0.968 . . . . 65.189999999999998 108.387 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.633 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.84 23.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.441 0.639 . . . . 125.5 110.585 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 39.6 t0 -89.24 174.77 7.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.834 1.654 . . . . 66.569999999999993 109.895 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 20.7 p -55.79 -155.95 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.044 -0.98 . . . . 91.459999999999994 112.222 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.99 -68.16 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 113.742 1.016 . . . . 103.65000000000001 113.742 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.61 134.43 57.01 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.521 0.563 . . . . 115.16 112.521 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.8 36.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.629 -0.714 . . . . 50.439999999999998 110.814 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 178.71 -28.75 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.355 -0.839 . . . . 34.159999999999997 111.05 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 85.7 m95 -123.24 156.83 34.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.458 -0.371 . . . . 81.450000000000003 110.775 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.633 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.1 m0 -163.61 -179.05 6.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.797 -0.816 . . . . 93.810000000000002 108.797 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.708 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.1 mt-10 -137.59 143.04 41.31 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.833 -0.803 . . . . 89.719999999999999 108.833 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.93 31.81 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 108.418 -1.873 . . . . 24.219999999999999 108.418 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.8 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.89 129.58 56.41 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.567 -0.853 . . . . 56.969999999999999 109.728 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.49 135.69 28.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.038 -1.097 . . . . 59.329999999999998 108.038 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.69 29.11 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.588 -0.523 . . . . 46.140000000000001 109.588 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.0 87.79 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.659 -0.977 . . . . 26.489999999999998 110.659 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.8 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.43 160.37 36.61 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 118.957 -1.097 . . . . 98.989999999999995 108.583 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.25 124.71 35.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.704 -1.221 . . . . 109.22 107.704 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.95 36.6 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.09 -1.604 . . . . 26.510000000000002 109.09 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.708 HG12 ' HG2' ' A' ' 308' ' ' GLU . 2.4 m -94.19 151.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.053 0.541 . . . . 54.609999999999999 111.716 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -153.4 151.42 25.55 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 120.55 -0.46 . . . . 74.469999999999999 110.439 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.566 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.12 122.13 8.72 Favored 'Trans proline' 0 CA--C 1.488 -1.819 0 C-N-CA 120.103 0.535 . . . . 111.89 112.111 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -77.63 -0.83 28.08 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.92 0.762 . . . . 119.27 111.893 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.75 -39.99 90.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.391 -0.596 . . . . 96.629999999999995 109.391 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.718 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 4.7 m-30 -77.93 10.34 2.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.135 -0.939 . . . . 74.849999999999994 112.167 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.25 163.9 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.339 -0.615 . . . . 67.239999999999995 109.339 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -139.34 147.27 41.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.93 -0.767 . . . . 130.62 108.93 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 mt -87.62 135.23 33.45 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.102 -1.073 . . . . 63.159999999999997 108.102 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.33 129.07 44.57 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.847 -1.909 . . . . 97.620000000000005 105.847 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 74.7 Cg_exo -63.86 -34.0 62.31 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.516 1.314 . . . . 152.83000000000001 115.516 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.958 0 CA-C-N 121.408 1.539 . . . . 59.969999999999999 109.283 179.547 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.89 139.83 33.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.223 0.535 . . . . 29.010000000000002 110.108 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.7 pt -123.62 167.81 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.415 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -119.94 139.35 52.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.7 0.286 . . . . 0.0 111.0 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.5 HG21 HD11 ' B' ' 30' ' ' ILE . 47.0 t -121.25 124.22 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.643 -0.873 . . . . 4.9900000000000002 108.643 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.11 137.31 39.65 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.988 0.423 . . . . 5.6799999999999997 110.444 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -84.91 -149.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.468 -0.787 . . . . 26.890000000000001 111.355 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.488 HD11 ' HE1' ' A' ' 306' ' ' TRP . 0.5 OUTLIER -67.41 -43.27 81.65 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.966 0.358 . . . . 23.289999999999999 111.966 -179.003 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.1 p -92.85 2.38 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.6 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.4 16.74 48.66 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.909 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 74.1 tttt -49.22 157.2 0.48 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.468 -0.431 . . . . 8.5099999999999998 111.578 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.42 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.6 m -106.35 127.82 53.55 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.701 -0.852 . . . . 1.8799999999999999 108.701 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.04 123.64 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.49 -0.323 . . . . 37.689999999999998 110.813 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.79 131.23 48.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -127.16 149.89 49.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 9.4600000000000009 110.96 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.63 122.15 43.84 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 106.204 -1.776 . . . . 1.54 106.204 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.9 168.32 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 111.542 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.92 149.29 45.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.23 -24.5 59.73 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 CA-C-N 120.808 1.324 . . . . 0.0 112.869 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.1 p -85.2 -2.56 58.17 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.01 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.29 142.67 50.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.001 -1.111 . . . . 1.4299999999999999 108.001 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -87.01 157.83 19.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.709 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.28 -39.8 83.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.029 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.06 -37.65 80.49 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.37 -42.83 87.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.57 -41.79 89.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.97 -40.04 87.71 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.18 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.442 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.3 -39.16 92.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.5 HD11 HG21 ' B' ' 5' ' ' VAL . 33.2 mt -64.98 -40.1 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -60.06 -44.08 94.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.577 0.703 . . . . 1.3200000000000001 109.395 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.82 -40.34 92.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.021 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.6 -41.05 22.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.096 1.147 . . . . 0.82999999999999996 114.096 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -111.09 -14.57 13.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.01 1.855 . . . . 6.1200000000000001 116.01 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.04 11.12 82.97 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.345 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.7 116.29 65.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.511 -0.551 . . . . 3.54 109.511 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.77 134.66 61.93 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.107 1.204 . . . . 0.0 112.35 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.37 -32.13 25.25 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 122.758 2.306 . . . . 0.0 114.679 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.71 -16.03 62.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.964 0.802 . . . . 2.8799999999999999 112.197 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.08 5.85 44.96 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.698 0.258 . . . . 7.1699999999999999 111.698 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -98.24 127.51 44.22 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.599 0.592 . . . . 13.42 112.599 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 281' ' ' GLN . 0.8 OUTLIER -117.71 109.79 17.05 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 27.09 108.398 177.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.583 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.0 mt -99.58 128.99 45.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.353 0.597 . . . . 1.8700000000000001 110.746 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.422 ' HA ' ' HG ' ' B' ' 50' ' ' LEU . 1.0 OUTLIER -146.32 133.78 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.129 -0.487 . . . . 17.75 111.545 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.664 ' CD2' HG12 ' B' ' 61' ' ' ILE . 88.0 t80 -135.59 140.34 44.55 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.469 -0.332 . . . . 16.98 110.245 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 38.68 23.73 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.444 0.465 . . . . 0.0 111.65 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.97 19.8 66.08 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 115.47 0.948 . . . . 48.659999999999997 115.47 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -117.38 133.75 55.62 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.664 0.732 . . . . 4.25 111.759 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.84 120.26 12.73 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.739 -0.664 . . . . 30.57 111.017 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' B' ' 43' ' ' LEU . 59.4 mt -86.96 124.19 32.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.117 0.484 . . . . 22.77 112.208 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -99.06 149.5 22.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 9.3399999999999999 111.412 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -69.66 -20.08 63.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.24 5.97 68.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.575 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 163.96 13.81 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.124 0.462 . . . . 1.8600000000000001 111.619 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -105.46 166.28 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.688 0.756 . . . . 0.0 112.542 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.99 -41.85 92.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.616 -1.174 . . . . 2.2799999999999998 110.781 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -61.5 -31.08 71.06 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 120.045 -0.662 . . . . 2.98 111.875 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.05 -28.96 69.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.773 -0.371 . . . . 1.77 110.489 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.98 14.5 28.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.39 19.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.961 0.504 . . . . 0.0 112.161 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.664 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.175 -1.046 . . . . 4.0099999999999998 108.175 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -106.95 169.09 8.76 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.367 0.604 . . . . 5.7400000000000002 112.044 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.49 141.37 15.97 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.108 -0.951 . . . . 4.3099999999999996 111.489 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.99 23.34 9.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.072 -0.967 . . . . 10.130000000000001 112.818 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.31 145.52 37.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.933 -1.136 . . . . 4.0999999999999996 107.933 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.415 HG23 ' HB2' ' B' ' 4' ' ' PHE . 31.9 m -126.94 141.75 51.72 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.629 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 -165.89 1.46 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.27 -0.423 . . . . 19.210000000000001 110.473 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.34 160.72 35.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.99 -0.374 . . . . 50.0 109.99 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 69' ' ' LEU . 4.8 mt -135.42 172.11 13.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.19 0.519 . . . . 21.579999999999998 111.513 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.524 HG23 ' CZ ' ' A' ' 322' ' ' PHE . 2.8 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.366 -0.834 . . . . 25.969999999999999 110.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 121.532 0.682 . . . . 137.63999999999999 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.906 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.95 -56.88 10.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.581 -0.736 . . . . 89.760000000000005 111.281 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.906 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.03 166.6 12.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 O-C-N 121.753 -0.592 . . . . 143.71000000000001 109.525 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -111.13 135.82 51.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.4 -0.593 . . . . 62.810000000000002 109.4 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.513 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.2 134.44 50.3 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.534 -0.913 . . . . 73.75 108.534 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.559 ' SG ' HD22 ' A' ' 325' ' ' LEU . 51.2 m -129.61 135.42 48.53 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.697 -0.853 . . . . 54.439999999999998 108.697 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.54 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.6 33.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.197 -1.038 . . . . 88.159999999999997 108.197 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 323' ' ' VAL . 92.2 t -100.97 118.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 117.981 -1.488 . . . . 73.900000000000006 110.744 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 42.7 mm -82.74 -66.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.652 -0.704 . . . . 138.47999999999999 111.313 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.39 126.34 87.78 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 67.980000000000004 110.633 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.458 ' HD2' ' HA2' ' B' ' 47' ' ' GLY . 30.6 Cg_endo -63.05 150.01 89.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.505 . . . . 72.540000000000006 112.279 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.52 ' HE1' HE21 ' A' ' 281' ' ' GLN . 89.2 t80 -129.7 107.91 9.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 82.870000000000005 111.184 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -84.01 120.51 26.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.564 -0.532 . . . . 66.180000000000007 109.564 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -34.34 110.46 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.178 0.924 . . . . 50.240000000000002 112.832 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.691 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 79.6 mt-30 -82.38 -41.58 19.76 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.725 -0.671 . . . . 128.65000000000001 109.458 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -137.21 172.41 13.04 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.003 -1.06 . . . . 67.609999999999999 112.035 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.37 -38.25 56.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.262 -0.881 . . . . 78.629999999999995 110.058 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -76.41 3.07 11.89 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.601 -0.727 . . . . 42.490000000000002 110.94 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.691 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -109.74 146.43 34.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.448 0.642 . . . . 53.210000000000001 109.475 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 16.1 tp -77.02 141.07 40.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.696 . . . . 57.0 110.11 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.7 m -96.06 124.57 40.12 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.331 -1.347 . . . . 53.009999999999998 107.771 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.22 142.15 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.507 -0.923 . . . . 56.119999999999997 108.507 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -113.35 157.27 22.06 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 108.507 -0.923 . . . . 97.849999999999994 108.507 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.27 141.51 41.65 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.199 -1.4 . . . . 88.319999999999993 108.634 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.52 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.637 -0.985 . . . . 35.810000000000002 110.637 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -130.53 151.92 50.47 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 118.389 1.095 . . . . 61.780000000000001 109.791 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.63 133.99 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 107.799 -1.186 . . . . 105.08 107.799 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.85 134.76 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.735 -0.839 . . . . 48.770000000000003 108.735 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.496 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.76 126.53 34.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.822 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.92 113.18 8.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.974 -0.75 . . . . 81.370000000000005 108.974 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.3 mt -74.4 -52.35 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 123.624 0.77 . . . . 70.599999999999994 110.942 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.99 149.24 27.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.345 -0.983 . . . . 65.189999999999998 108.345 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.482 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.42 163.89 23.48 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.485 0.66 . . . . 125.5 110.515 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.2 172.54 8.99 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.782 1.633 . . . . 66.569999999999993 109.907 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 23.2 p -59.79 -136.4 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.934 -1.03 . . . . 91.459999999999994 112.269 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 18.1 mm -84.73 -22.79 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 121.693 -0.63 . . . . 103.65000000000001 112.121 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.62 119.28 7.8 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.098 0.407 . . . . 115.16 112.098 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 25.2 t -92.89 92.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.899 -0.591 . . . . 50.439999999999998 110.011 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 160.21 -12.15 0.17 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.358 -0.837 . . . . 34.159999999999997 111.294 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.575 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 96.6 m95 -117.45 150.2 39.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.872 0.368 . . . . 81.450000000000003 111.093 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.482 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 1.1 m0 -159.76 174.4 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.109 -0.951 . . . . 93.810000000000002 108.739 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.59 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -133.68 143.13 48.35 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.767 -0.827 . . . . 89.719999999999999 108.767 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.9 168.95 31.87 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.38 -1.888 . . . . 24.219999999999999 108.38 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.803 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.86 129.59 56.4 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.588 -0.845 . . . . 56.969999999999999 109.707 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 61.9 tp -142.52 135.65 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.104 -1.073 . . . . 59.329999999999998 108.104 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.14 37.69 29.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.546 -0.538 . . . . 46.140000000000001 109.546 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.02 87.78 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.148 -1.025 . . . . 26.489999999999998 110.723 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.803 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.5 160.29 36.92 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.378 1.089 . . . . 98.989999999999995 108.632 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.2 124.85 35.63 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.655 -1.239 . . . . 109.22 107.655 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.8 164.12 36.76 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.125 -1.59 . . . . 26.510000000000002 109.125 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.59 HG12 ' HG2' ' A' ' 308' ' ' GLU . 11.5 m -89.17 145.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 122.75 0.42 . . . . 54.609999999999999 111.497 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.11 151.36 24.32 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 120.525 -0.47 . . . . 74.469999999999999 110.47 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.469 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.2 Cg_endo -70.23 123.37 9.88 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.071 0.514 . . . . 111.89 112.062 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.87 -15.27 18.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.518 1.136 . . . . 119.27 111.462 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 323' ' ' VAL . 12.5 m-20 -62.52 -39.35 93.28 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 109.347 -0.612 . . . . 96.629999999999995 109.347 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -56.76 -4.16 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.363 -0.835 . . . . 74.849999999999994 112.642 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 274' ' ' VAL . 0.7 OUTLIER -127.56 145.91 34.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.684 -0.487 . . . . 67.239999999999995 109.684 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER -90.07 139.96 30.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.122 -0.695 . . . . 130.62 109.122 178.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.559 HD22 ' SG ' ' A' ' 272' ' ' CYS . 36.5 mt -89.1 135.21 33.68 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.116 -1.068 . . . . 63.159999999999997 108.116 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.08 44.5 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 105.751 -1.944 . . . . 97.620000000000005 105.751 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.1 Cg_exo -64.02 -33.8 61.13 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.547 1.326 . . . . 152.83000000000001 115.547 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.301 -1.933 0 CA-C-N 121.352 1.519 . . . . 59.969999999999999 109.279 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.86 140.22 32.55 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.292 0.568 . . . . 29.010000000000002 110.136 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -120.61 168.21 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.011 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.38 139.26 53.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.598 0.237 . . . . 0.0 111.045 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.492 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.23 124.19 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.659 -0.867 . . . . 4.9900000000000002 108.659 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.08 135.75 42.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.008 0.432 . . . . 5.6799999999999997 110.422 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -79.89 -155.05 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.615 -0.72 . . . . 26.890000000000001 111.274 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.61 -40.81 89.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.658 0.614 . . . . 23.289999999999999 112.658 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -92.14 2.41 56.61 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.762 0.315 . . . . 0.0 111.581 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.42 15.73 52.2 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.335 -0.459 . . . . 0.0 113.957 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 73.5 tttt -49.76 157.99 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.2 -0.588 . . . . 8.5099999999999998 111.619 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -106.33 128.24 53.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.682 -0.858 . . . . 1.8799999999999999 108.682 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.03 122.64 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 123.31 0.381 . . . . 37.689999999999998 110.83 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -101.97 131.26 48.49 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.21 149.85 49.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.592 0.234 . . . . 9.4600000000000009 110.998 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.53 122.19 43.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.25 -1.759 . . . . 1.54 106.25 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.07 168.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.486 0.66 . . . . 0.0 111.467 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.86 149.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.12 -24.45 58.53 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 CA-C-N 120.836 1.334 . . . . 0.0 112.97 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -85.25 -2.6 58.22 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.001 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.5 50.53 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.961 -1.126 . . . . 1.4299999999999999 107.961 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -86.88 157.79 19.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.747 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.2 -39.89 84.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.947 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.08 -37.69 80.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.24 -42.85 88.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.61 -41.79 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.0 -39.93 87.46 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.25 89.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.31 -39.07 92.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.492 HD11 HG21 ' B' ' 5' ' ' VAL . 33.0 mt -65.11 -40.03 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.05 -44.05 94.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.493 0.663 . . . . 1.3200000000000001 109.36 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.88 -40.4 92.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.957 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.081 1.141 . . . . 0.82999999999999996 114.081 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.95 -14.51 13.94 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.156 1.91 . . . . 6.1200000000000001 116.156 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.2 11.02 82.95 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.245 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.26 64.94 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.632 -0.507 . . . . 3.54 109.632 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.65 134.68 62.33 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.098 1.199 . . . . 0.0 112.433 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.33 -32.21 25.17 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.887 2.391 . . . . 0.0 114.643 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.85 -15.91 62.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.913 0.779 . . . . 2.8799999999999999 112.126 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.12 8.13 44.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.754 0.279 . . . . 7.1699999999999999 111.754 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.81 144.29 31.34 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.598 0.592 . . . . 13.42 112.598 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -138.82 114.8 10.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.341 -0.985 . . . . 27.09 108.341 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 130.39 43.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.364 0.602 . . . . 1.8700000000000001 110.837 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -139.43 130.66 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.932 -0.48 . . . . 17.75 110.931 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.59 ' CD2' HG12 ' B' ' 61' ' ' ILE . 91.5 t80 -132.25 136.4 46.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.555 -0.293 . . . . 16.98 110.244 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.9 39.77 26.6 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 123.474 0.484 . . . . 0.0 111.709 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 65.35 22.27 69.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 115.605 1.002 . . . . 48.659999999999997 115.605 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.94 132.1 56.44 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.07 0.935 . . . . 4.25 111.737 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -68.2 115.58 7.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.896 -0.593 . . . . 30.57 110.158 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -81.93 134.22 35.37 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.122 0.487 . . . . 22.77 111.787 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.81 149.43 24.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.5 -0.773 . . . . 9.3399999999999999 111.467 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.64 -20.12 63.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.22 6.03 68.49 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.533 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.89 13.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.152 0.476 . . . . 1.8600000000000001 111.621 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.6 p -105.37 166.43 10.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.657 0.741 . . . . 0.0 112.596 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.11 -41.9 93.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.674 -1.148 . . . . 2.2799999999999998 110.659 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.55 -30.98 71.0 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.063 -0.655 . . . . 2.98 111.811 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.14 -29.0 70.04 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.715 -0.394 . . . . 1.77 110.419 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.94 14.52 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.03 39.4 18.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.095 -1.076 . . . . 4.0099999999999998 108.095 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.17 8.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.303 0.573 . . . . 5.7400000000000002 112.155 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.55 141.37 16.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.222 -0.899 . . . . 4.3099999999999996 111.458 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 67.12 23.15 9.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.978 -1.01 . . . . 10.130000000000001 112.81 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.2 m -77.27 146.72 36.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.972 -1.121 . . . . 4.0999999999999996 107.972 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m -120.86 131.35 54.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.75 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mp -111.09 -177.68 3.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.667 -0.697 . . . . 19.210000000000001 110.669 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -124.45 144.15 50.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.978 -0.379 . . . . 50.0 109.978 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 69' ' ' LEU . 4.2 mt -129.95 154.55 47.24 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.08 0.467 . . . . 21.579999999999998 111.638 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.693 -0.685 . . . . 25.969999999999999 110.07 178.879 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 121.585 0.707 . . . . 137.63999999999999 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.897 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.523 -0.762 . . . . 89.760000000000005 111.346 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.897 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.6 12.62 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 121.777 -0.577 . . . . 143.71000000000001 109.549 -177.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.21 135.8 51.21 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.454 -0.573 . . . . 62.810000000000002 109.454 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.599 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.9 m-85 -107.23 134.44 50.32 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.505 -0.924 . . . . 73.75 108.505 176.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 52.1 m -129.63 135.45 48.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.726 -0.842 . . . . 54.439999999999998 108.726 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.678 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.71 135.57 33.99 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.203 -1.036 . . . . 88.159999999999997 108.203 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 276' ' ' PHE . 89.8 t -100.85 115.95 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 C-N-CA 118.028 -1.469 . . . . 73.900000000000006 110.823 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.707 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -98.12 16.58 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.655 0.983 . . . . 138.47999999999999 113.655 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 276' ' ' PHE . . . . . 0.717 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 10.8 m-85 -136.63 143.01 41.22 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 122.261 -0.275 . . . . 67.980000000000004 110.456 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.86 134.53 12.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.573 2.182 . . . . 72.540000000000006 112.281 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.61 96.39 4.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.794 -0.639 . . . . 82.870000000000005 110.776 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.55 120.58 21.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.125 -0.488 . . . . 66.180000000000007 109.732 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.52 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.288 0.847 . . . . 50.240000000000002 113.288 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.542 ' OE1' HG21 ' B' ' 70' ' ' VAL . 26.1 mt-30 -85.17 -41.99 15.14 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.448 -0.575 . . . . 128.65000000000001 109.448 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -146.83 176.39 9.92 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.872 -1.143 . . . . 67.609999999999999 111.455 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.89 -30.82 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.152 -0.931 . . . . 78.629999999999995 110.621 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.37 -6.26 57.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.924 -0.58 . . . . 42.490000000000002 110.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.404 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -108.75 147.09 32.52 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.31 0.576 . . . . 53.210000000000001 109.479 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.405 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 13.9 tp -83.42 137.93 33.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.599 -0.728 . . . . 57.0 110.014 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.6 m -95.78 124.53 39.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.311 -1.356 . . . . 53.009999999999998 107.793 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.25 141.68 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.489 -0.93 . . . . 56.119999999999997 108.489 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 50.3 mmtt -120.7 162.98 18.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.713 -0.847 . . . . 97.849999999999994 108.713 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.19 141.53 41.78 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 118.028 -1.469 . . . . 88.319999999999993 108.744 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.64 21.59 21.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.582 -1.007 . . . . 35.810000000000002 110.582 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.5 151.91 50.46 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 118.459 1.13 . . . . 61.780000000000001 109.873 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.54 133.99 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.724 -1.213 . . . . 105.08 107.724 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.82 134.75 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.759 -0.83 . . . . 48.770000000000003 108.759 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.599 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.1 t -85.74 126.56 34.07 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.886 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.97 113.23 8.79 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.885 -0.783 . . . . 81.370000000000005 108.885 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.6 mt -74.49 -52.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.655 0.782 . . . . 70.599999999999994 110.891 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.96 149.21 27.97 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.471 -0.937 . . . . 65.189999999999998 108.471 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.719 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.32 163.79 23.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.551 0.691 . . . . 125.5 110.533 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 306' ' ' TRP . 39.7 t0 -89.2 170.6 10.46 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.795 1.638 . . . . 66.569999999999993 109.908 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 14.5 p -60.16 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.72 -1.127 . . . . 91.459999999999994 111.769 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.87 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 121.733 -0.604 . . . . 103.65000000000001 112.49 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -59.52 116.3 3.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.224 0.535 . . . . 115.16 111.757 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.4 t -79.26 115.61 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.604 -0.725 . . . . 50.439999999999998 110.123 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 175.74 -21.2 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.69 -0.686 . . . . 34.159999999999997 111.688 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.646 ' O ' ' HB2' ' A' ' 300' ' ' ASP . 99.0 m95 -118.48 153.25 34.45 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.391 0.139 . . . . 81.450000000000003 110.877 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.719 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.9 m0 -165.46 175.71 8.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.447 -0.946 . . . . 93.810000000000002 108.447 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.694 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -137.02 143.16 42.58 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.792 -0.818 . . . . 89.719999999999999 108.792 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.97 31.88 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 108.404 -1.878 . . . . 24.219999999999999 108.404 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.96 129.67 56.4 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 119.521 -0.872 . . . . 56.969999999999999 109.652 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 62.1 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.128 -1.064 . . . . 59.329999999999998 108.128 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.08 37.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.625 -0.509 . . . . 46.140000000000001 109.625 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.11 35.06 88.23 Favored Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.231 -0.985 . . . . 26.489999999999998 110.71 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.35 36.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 118.358 1.079 . . . . 98.989999999999995 108.609 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.27 124.71 35.13 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.744 -1.206 . . . . 109.22 107.744 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.405 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.78 164.31 36.87 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.077 -1.609 . . . . 26.510000000000002 109.077 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 308' ' ' GLU . 1.7 m -96.52 150.97 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.327 0.651 . . . . 54.609999999999999 111.887 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -153.69 151.37 25.0 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 120.287 -0.565 . . . . 74.469999999999999 110.495 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.88 8.47 Favored 'Trans proline' 0 CA--C 1.488 -1.824 0 C-N-CA 120.087 0.524 . . . . 111.89 112.085 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.524 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -71.08 -2.44 15.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 124.35 1.031 . . . . 119.27 112.035 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -61.94 -39.92 93.76 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.361 -0.607 . . . . 96.629999999999995 109.361 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 9.3 m-30 -74.98 7.24 3.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 74.849999999999994 112.061 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 274' ' ' VAL . 1.0 OUTLIER -136.01 159.29 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.252 -0.647 . . . . 67.239999999999995 109.252 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.88 146.66 43.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.688 -0.856 . . . . 130.62 108.688 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -86.79 135.29 33.41 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 108.104 -1.073 . . . . 63.159999999999997 108.104 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.06 44.44 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 105.748 -1.945 . . . . 97.620000000000005 105.748 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.7 Cg_exo -63.97 -33.76 61.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 N-CA-C 115.564 1.332 . . . . 152.83000000000001 115.564 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.302 -1.895 0 CA-C-N 121.385 1.531 . . . . 59.969999999999999 109.223 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.59 32.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.377 0.608 . . . . 29.010000000000002 110.158 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -119.3 164.38 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.946 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.464 ' O ' HD12 ' B' ' 67' ' ' LEU . 97.9 m-85 -120.73 139.34 53.22 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.644 0.259 . . . . 0.0 111.03 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.659 HG21 HD11 ' B' ' 30' ' ' ILE . 47.2 t -121.36 124.27 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.623 -0.881 . . . . 4.9900000000000002 108.623 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.07 138.4 38.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.948 0.404 . . . . 5.6799999999999997 110.428 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -81.21 -153.21 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.618 -0.719 . . . . 26.890000000000001 111.899 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -36.11 72.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.285 -0.416 . . . . 23.289999999999999 111.837 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -96.38 2.37 52.62 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.587 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.97 51.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.365 -0.445 . . . . 0.0 113.856 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 78.9 tttt -49.8 157.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.33 -0.512 . . . . 8.5099999999999998 111.649 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -106.69 127.99 53.82 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.785 -0.821 . . . . 1.8799999999999999 108.785 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.14 123.07 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 123.347 0.404 . . . . 37.689999999999998 110.9 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.87 131.25 48.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -127.13 149.99 49.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.644 0.259 . . . . 9.4600000000000009 110.906 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.72 122.14 43.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.14 -1.8 . . . . 1.54 106.14 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.93 168.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.563 0.697 . . . . 0.0 111.503 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.74 149.26 44.82 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.19 -24.48 59.27 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.872 1.347 . . . . 0.0 112.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.27 -2.48 58.1 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.97 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 142.6 50.35 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.961 -1.126 . . . . 1.4299999999999999 107.961 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -86.96 157.91 19.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.631 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.35 -39.82 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.942 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.19 -37.45 80.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.4 t-20 -66.41 -42.91 87.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.6 -41.71 88.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -59.94 -39.97 87.37 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.427 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.27 -39.08 92.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.659 HD11 HG21 ' B' ' 5' ' ' VAL . 32.2 mt -65.13 -40.02 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.06 -44.0 95.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.517 0.675 . . . . 1.3200000000000001 109.424 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.9 -40.4 92.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.963 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.44 -41.2 22.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.129 1.159 . . . . 0.82999999999999996 114.129 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.63 13.92 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.163 1.912 . . . . 6.1200000000000001 116.163 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.0 82.95 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.31 65.15 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.58 -0.526 . . . . 3.54 109.58 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.71 134.67 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.167 1.244 . . . . 0.0 112.444 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.46 -32.07 25.69 Favored 'Trans proline' 0 N--CA 1.507 2.307 0 C-N-CA 122.789 2.326 . . . . 0.0 114.662 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.78 -16.09 62.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 118.973 0.806 . . . . 2.8799999999999999 112.068 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.02 6.33 45.06 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.707 0.262 . . . . 7.1699999999999999 111.707 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.575 ' HB3' HD11 ' B' ' 69' ' ' LEU . 67.4 mt-30 -106.67 131.28 53.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.47 0.544 . . . . 13.42 112.47 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.539 ' HB3' HG12 ' B' ' 70' ' ' VAL . 40.2 ttm180 -117.72 114.73 23.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 27.09 107.811 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -100.57 128.99 46.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.37 0.605 . . . . 1.8700000000000001 110.825 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' B' ' 49' ' ' GLN . 2.6 pt -149.7 132.59 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.85 -0.614 . . . . 17.75 111.609 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.683 ' CD2' HG12 ' B' ' 61' ' ' ILE . 83.2 t80 -124.99 139.72 53.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.413 -0.358 . . . . 16.98 110.247 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.96 39.06 21.98 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 123.54 0.525 . . . . 0.0 111.717 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 65.35 21.75 68.75 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 115.865 1.106 . . . . 48.659999999999997 115.865 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.43 134.28 55.24 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.992 0.896 . . . . 4.25 111.879 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.521 ' HA ' HG22 ' B' ' 44' ' ' ILE . 88.5 mt-30 -65.89 119.2 10.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.911 -0.586 . . . . 30.57 111.053 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.449 ' HG ' ' HA ' ' B' ' 44' ' ' ILE . 63.5 mt -89.3 125.54 35.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.065 0.459 . . . . 22.77 112.009 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -99.35 149.54 23.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 9.3399999999999999 111.386 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.67 -20.15 63.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.18 6.03 68.59 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.609 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.98 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.162 0.481 . . . . 1.8600000000000001 111.706 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -105.45 166.48 10.4 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.753 0.787 . . . . 0.0 112.523 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.3 mt -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.662 -1.154 . . . . 2.2799999999999998 110.803 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.54 -31.04 71.04 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.086 -0.646 . . . . 2.98 111.809 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.09 -28.96 69.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.744 -0.383 . . . . 1.77 110.448 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.02 14.53 28.89 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.09 39.33 19.01 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.879 0.472 . . . . 0.0 112.19 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.683 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.4 124.09 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.049 -1.093 . . . . 4.0099999999999998 108.049 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 169.13 8.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.318 0.58 . . . . 5.7400000000000002 112.083 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.48 141.47 15.75 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.127 -0.942 . . . . 4.3099999999999996 111.485 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.97 23.19 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.04 -0.982 . . . . 10.130000000000001 112.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.456 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.21 146.7 36.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.963 -1.125 . . . . 4.0999999999999996 107.963 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 52.9 m -125.47 136.93 53.89 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.533 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' B' ' 45' ' ' PHE . 0.2 OUTLIER -112.25 -172.71 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.294 -0.412 . . . . 19.210000000000001 110.208 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.56 153.67 50.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.939 -0.393 . . . . 50.0 109.939 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' B' ' 41' ' ' GLN . 9.3 tp -126.55 158.05 37.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.835 0.35 . . . . 21.579999999999998 111.436 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 322' ' ' PHE . 7.8 p . . . . . 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 25.969999999999999 110.607 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.515 0.674 . . . . 137.63999999999999 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.894 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.8 p -64.93 -56.75 11.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.523 -0.762 . . . . 89.760000000000005 111.375 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.894 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.07 166.57 12.6 Favored 'General case' 0 CA--C 1.494 -1.189 0 O-C-N 121.762 -0.586 . . . . 143.71000000000001 109.481 -177.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.19 135.77 51.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.489 -0.56 . . . . 62.810000000000002 109.489 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.464 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.9 m-85 -107.16 134.39 50.34 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.484 -0.932 . . . . 73.75 108.484 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' CYS . . . . . 0.404 ' SG ' HD22 ' A' ' 325' ' ' LEU . 50.4 m -129.55 135.39 48.53 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.789 -0.819 . . . . 54.439999999999998 108.789 -176.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.738 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.72 135.58 33.98 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.217 -1.031 . . . . 88.159999999999997 108.217 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.73 HG11 HD12 ' A' ' 288' ' ' ILE . 91.3 t -100.89 116.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 117.956 -1.498 . . . . 73.900000000000006 110.801 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -81.99 -41.62 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 121.622 -0.674 . . . . 138.47999999999999 112.277 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 276' ' ' PHE . . . . . 0.646 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -102.44 122.5 46.23 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 121.143 -0.223 . . . . 67.980000000000004 110.862 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.81 159.56 52.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.591 2.194 . . . . 72.540000000000006 112.264 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -124.45 86.74 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.626 -0.715 . . . . 82.870000000000005 109.995 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -56.78 116.46 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.414 -0.587 . . . . 66.180000000000007 109.414 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.59 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.646 1.216 . . . . 50.240000000000002 113.309 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 79.6 mt-30 -87.02 -39.18 15.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.844 -0.616 . . . . 128.65000000000001 109.369 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -148.38 175.52 11.04 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.064 -1.022 . . . . 67.609999999999999 111.736 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.04 -33.63 29.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.228 -0.896 . . . . 78.629999999999995 110.235 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.23 -2.77 42.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.688 -0.687 . . . . 42.490000000000002 111.087 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.379 0.609 . . . . 53.210000000000001 109.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.5 tp -85.57 135.82 33.65 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.343 -0.844 . . . . 57.0 110.156 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.529 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.7 m -95.68 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.106 -1.438 . . . . 53.009999999999998 107.805 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.73 HD12 HG11 ' A' ' 274' ' ' VAL . 49.1 pt -128.21 141.68 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.556 -0.905 . . . . 56.119999999999997 108.556 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.4 mmtt -117.04 158.96 23.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.419 -0.956 . . . . 97.849999999999994 108.419 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -76.08 141.56 41.98 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 118.458 -1.297 . . . . 88.319999999999993 108.665 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.58 21.66 21.11 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.65 -0.98 . . . . 35.810000000000002 110.65 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -130.51 151.91 50.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 118.393 1.097 . . . . 61.780000000000001 109.818 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.738 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.56 133.93 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.834 -1.173 . . . . 105.08 107.834 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 310' ' ' GLU . 92.4 t -122.73 134.81 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.743 -0.836 . . . . 48.770000000000003 108.743 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.81 126.64 34.17 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.189 -1.004 . . . . 128.84 108.783 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.08 113.27 8.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.894 -0.78 . . . . 81.370000000000005 108.894 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.46 -52.37 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 123.562 0.745 . . . . 70.599999999999994 110.919 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.95 149.15 27.92 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.474 -0.936 . . . . 65.189999999999998 108.474 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.572 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.43 163.82 23.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.533 0.683 . . . . 125.5 110.498 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.529 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.13 172.83 8.8 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.77 1.628 . . . . 66.569999999999993 109.868 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 4.7 p -60.77 -155.54 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.498 -0.774 . . . . 91.459999999999994 111.546 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 43.4 mm -64.42 -50.41 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 113.883 1.068 . . . . 103.65000000000001 113.883 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.18 120.67 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.647 0.61 . . . . 115.16 112.647 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -89.41 106.27 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.61 -0.723 . . . . 50.439999999999998 110.245 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 168.4 -14.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.217 -0.902 . . . . 34.159999999999997 110.88 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.529 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 92.6 m95 -126.33 156.06 41.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.279 -0.461 . . . . 81.450000000000003 111.253 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.572 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.2 m0 -163.81 -171.3 2.44 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.817 0.847 . . . . 93.810000000000002 108.772 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.694 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.1 mt-10 -145.85 143.06 29.38 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.869 -0.789 . . . . 89.719999999999999 108.869 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.88 168.97 31.86 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 108.448 -1.861 . . . . 24.219999999999999 108.448 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.795 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.92 129.7 56.38 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.558 -0.857 . . . . 56.969999999999999 109.688 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.65 135.69 28.35 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.039 -1.097 . . . . 59.329999999999998 108.039 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.01 37.82 29.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.597 -0.519 . . . . 46.140000000000001 109.597 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.01 35.18 88.97 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 110.683 -0.967 . . . . 26.489999999999998 110.683 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ARG . . . . . 0.795 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.31 36.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 118.349 1.074 . . . . 98.989999999999995 108.627 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.24 124.72 35.2 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.761 -1.199 . . . . 109.22 107.761 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.77 164.48 36.97 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 108.997 -1.641 . . . . 26.510000000000002 108.997 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 308' ' ' GLU . 3.3 m -94.68 151.94 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.309 0.643 . . . . 54.609999999999999 112.041 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -152.98 151.41 26.21 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 120.206 -0.598 . . . . 74.469999999999999 110.49 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.946 ' HB3' HG11 ' B' ' 70' ' ' VAL . 6.2 Cg_endo -70.17 122.12 8.7 Favored 'Trans proline' 0 CA--C 1.488 -1.793 0 C-N-CA 120.105 0.537 . . . . 111.89 112.081 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -71.07 -14.71 62.41 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.3 1.0 . . . . 119.27 111.98 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -61.57 -40.34 94.38 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.926 -0.71 . . . . 96.629999999999995 109.422 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 2.9 m-30 -64.51 0.08 1.19 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.213 -0.903 . . . . 74.849999999999994 111.706 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 274' ' ' VAL . 1.0 OUTLIER -136.53 171.46 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.513 -0.551 . . . . 67.239999999999995 109.513 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HB2' HD11 ' A' ' 275' ' ' ILE . 0.6 OUTLIER -145.96 146.41 31.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 130.62 108.869 178.098 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.557 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -87.95 135.22 33.5 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 108.052 -1.092 . . . . 63.159999999999997 108.052 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.12 44.36 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 105.813 -1.921 . . . . 97.620000000000005 105.813 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.3 Cg_exo -64.0 -33.86 61.17 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 N-CA-C 115.54 1.323 . . . . 152.83000000000001 115.54 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.925 0 CA-C-N 121.393 1.533 . . . . 59.969999999999999 109.234 179.502 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.472 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.47 32.19 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.287 0.565 . . . . 29.010000000000002 110.149 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.9 pt -120.95 162.31 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.966 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' B' ' 66' ' ' THR . 97.9 m-85 -120.92 139.36 53.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.618 0.247 . . . . 0.0 110.977 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.646 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.33 124.13 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.64 -0.874 . . . . 4.9900000000000002 108.64 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.3 mttt -101.02 138.92 37.42 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.966 0.412 . . . . 5.6799999999999997 110.458 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -77.61 -157.65 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.693 -0.685 . . . . 26.890000000000001 111.898 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.937 ' HG ' HG13 ' B' ' 70' ' ' VAL . 1.3 tt -68.35 -37.81 80.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.705 -0.679 . . . . 23.289999999999999 111.671 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -94.94 2.44 55.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.555 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.9 51.71 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.365 -0.445 . . . . 0.0 113.905 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 79.6 tttt -50.42 158.36 0.61 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.329 -0.513 . . . . 8.5099999999999998 111.492 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -106.61 128.06 53.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.741 -0.837 . . . . 1.8799999999999999 108.741 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.42 121.93 56.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 O-C-N 123.372 0.42 . . . . 37.689999999999998 110.836 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.96 131.34 48.42 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -127.24 149.95 49.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.61 0.243 . . . . 9.4600000000000009 110.943 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.64 122.17 43.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.223 -1.769 . . . . 1.54 106.223 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.03 168.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.455 0.645 . . . . 0.0 111.478 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.86 149.35 45.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.29 -24.46 59.91 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 CA-C-N 120.799 1.321 . . . . 0.0 112.899 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -85.22 -2.54 58.16 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.071 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.28 142.59 50.5 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.906 -1.146 . . . . 1.4299999999999999 107.906 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -86.92 157.79 19.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.79 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.22 -39.93 84.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.948 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.67 80.29 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.33 -42.91 87.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.56 -41.76 89.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.495 ' HG2' HD11 ' B' ' 43' ' ' LEU . 20.5 mttt -60.01 -39.85 87.25 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.26 89.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.458 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.19 -39.2 92.53 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.646 HD11 HG21 ' B' ' 5' ' ' VAL . 32.8 mt -65.01 -40.07 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.03 -44.1 94.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.493 0.663 . . . . 1.3200000000000001 109.344 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.87 -40.29 92.44 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.98 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -81.58 -41.34 21.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.009 1.114 . . . . 0.82999999999999996 114.009 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.86 -14.59 13.96 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.167 1.914 . . . . 6.1200000000000001 116.167 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.07 82.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.244 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.69 116.36 65.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.612 -0.514 . . . . 3.54 109.612 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.8 134.68 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 CA-C-N 120.361 1.165 . . . . 0.0 112.373 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.22 -32.31 24.65 Favored 'Trans proline' 0 N--CA 1.506 2.255 0 C-N-CA 122.818 2.345 . . . . 0.0 114.716 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.7 -16.02 62.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.829 0.74 . . . . 2.8799999999999999 112.171 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.07 6.3 44.98 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.741 0.274 . . . . 7.1699999999999999 111.741 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.33 121.23 42.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.82 0.674 . . . . 13.42 112.82 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -103.94 115.07 29.78 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.286 -1.005 . . . . 27.09 108.286 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.495 HD11 ' HG2' ' B' ' 27' ' ' LYS . 84.8 mt -102.59 127.64 49.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.305 0.574 . . . . 1.8700000000000001 110.886 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.594 HG22 ' O ' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -153.84 130.45 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.142 -0.481 . . . . 17.75 111.406 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.721 ' CD2' HG12 ' B' ' 61' ' ' ILE . 59.2 t80 -124.95 142.76 51.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.561 -0.29 . . . . 16.98 110.368 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' HE2' ' B' ' 48' ' ' LYS . . . 49.79 38.78 16.48 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.501 0.5 . . . . 0.0 111.653 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 60.3 28.25 66.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 115.164 0.826 . . . . 48.659999999999997 115.164 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.594 ' O ' HG22 ' B' ' 44' ' ' ILE . 44.8 mtmt -119.2 134.29 55.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 117.474 0.637 . . . . 4.25 111.747 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -64.47 114.69 4.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.424 -0.807 . . . . 30.57 110.684 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.59 125.75 34.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.943 0.402 . . . . 22.77 111.79 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -100.21 149.47 23.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.867 -0.606 . . . . 9.3399999999999999 111.493 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.67 -20.05 63.58 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.8 68.6 Favored Glycine 0 N--CA 1.476 1.309 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.491 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.36 163.93 13.85 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.295 0.548 . . . . 1.8600000000000001 111.674 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 49.6 p -105.35 166.3 10.52 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.679 0.752 . . . . 0.0 112.602 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.01 -41.91 93.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.664 -1.153 . . . . 2.2799999999999998 110.794 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.0 70.96 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 120.058 -0.657 . . . . 2.98 111.902 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.05 -29.09 70.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.728 -0.389 . . . . 1.77 110.467 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.87 14.45 28.9 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.13 39.36 19.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.923 0.489 . . . . 0.0 112.218 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.721 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.189 -1.041 . . . . 4.0099999999999998 108.189 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.09 8.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.27 0.557 . . . . 5.7400000000000002 112.191 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.46 141.38 15.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.25 -0.887 . . . . 4.3099999999999996 111.471 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.03 23.23 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.074 -0.967 . . . . 10.130000000000001 112.856 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.425 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.3 m -77.28 146.27 36.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.984 -1.117 . . . . 4.0999999999999996 107.984 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 53.2 m -126.31 136.29 52.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.596 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' B' ' 45' ' ' PHE . 0.0 OUTLIER -109.01 -177.78 3.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.232 -0.44 . . . . 19.210000000000001 110.256 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -118.55 147.33 43.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.956 -0.387 . . . . 50.0 109.956 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.2 113.91 3.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.945 0.402 . . . . 21.579999999999998 110.973 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.946 HG11 ' HB3' ' A' ' 319' ' ' PRO . 72.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 25.969999999999999 110.821 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 121.571 0.7 . . . . 137.63999999999999 110.331 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.91 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.85 -56.86 10.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.515 -0.766 . . . . 89.760000000000005 111.381 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.91 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.54 12.65 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.81 -0.556 . . . . 143.71000000000001 109.59 -177.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.13 135.78 51.13 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.445 -0.576 . . . . 62.810000000000002 109.445 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.455 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.7 m-85 -107.16 134.46 50.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.529 -0.915 . . . . 73.75 108.529 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.64 135.38 48.46 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.723 -0.844 . . . . 54.439999999999998 108.723 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.545 ' H ' ' CD1' ' A' ' 326' ' ' LEU . 40.7 tttp -92.7 135.59 33.97 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.254 -1.017 . . . . 88.159999999999997 108.254 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 323' ' ' VAL . 93.0 t -100.99 114.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 117.93 -1.508 . . . . 73.900000000000006 110.724 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 276' ' ' PHE . 8.3 pt -79.25 -34.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.954 -1.021 . . . . 138.47999999999999 112.981 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' B' ' 68' ' ' HIS . 2.4 m-85 -108.23 90.52 6.96 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.478 0.18 . . . . 67.980000000000004 110.806 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 290' ' ' GLU . 65.6 Cg_endo -72.28 141.37 35.49 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.762 2.308 . . . . 72.540000000000006 113.375 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.402 ' CZ ' HD11 ' B' ' 44' ' ' ILE . 0.2 OUTLIER -101.74 -150.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.393 -0.821 . . . . 82.870000000000005 109.435 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -159.62 144.3 15.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.522 -0.918 . . . . 66.180000000000007 108.522 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -28.67 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.497 1.123 . . . . 50.240000000000002 113.574 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.569 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 79.6 mt-30 -88.48 -42.53 12.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.831 -0.622 . . . . 128.65000000000001 109.421 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.34 177.26 9.58 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.77 -0.582 . . . . 67.609999999999999 111.377 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.45 -34.4 28.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.309 -0.859 . . . . 78.629999999999995 110.443 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.13 -5.43 59.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 42.490000000000002 111.151 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.603 ' HG2' HH21 ' B' ' 74' ' ' ARG . 73.9 mt-10 -102.55 147.51 26.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.329 0.585 . . . . 53.210000000000001 109.533 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 309' ' ' GLY . 17.3 tp -85.69 133.12 34.04 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.135 -0.939 . . . . 57.0 110.196 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.442 ' O ' HD23 ' A' ' 311' ' ' LEU . 90.1 m -96.72 124.58 40.75 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.812 -1.555 . . . . 53.009999999999998 107.739 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.404 HD12 HG21 ' A' ' 274' ' ' VAL . 49.2 pt -128.29 141.42 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.554 -0.906 . . . . 56.119999999999997 108.554 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 14.4 mmtt -118.69 162.72 17.96 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.798 -0.815 . . . . 97.849999999999994 108.798 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLU . . . . . 0.529 ' N ' ' HB3' ' A' ' 277' ' ' PRO . 13.5 pt-20 -75.18 141.53 43.62 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.101 -1.439 . . . . 88.319999999999993 108.734 -174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.44 21.48 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.646 -0.982 . . . . 35.810000000000002 110.646 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.49 151.9 50.46 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.398 1.099 . . . . 61.780000000000001 109.829 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.455 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.0 mm -109.52 134.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.777 -1.194 . . . . 105.08 107.777 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.3 t -122.8 134.84 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.669 -0.863 . . . . 48.770000000000003 108.669 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.84 126.56 34.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.096 -1.042 . . . . 128.84 108.846 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -72.0 113.27 8.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.886 -0.783 . . . . 81.370000000000005 108.886 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.38 -52.45 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 123.765 0.826 . . . . 70.599999999999994 110.924 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.03 149.12 27.83 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.42 -0.955 . . . . 65.189999999999998 108.42 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.646 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.87 23.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.546 0.688 . . . . 125.5 110.581 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.714 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.19 171.22 9.96 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 125.86 1.664 . . . . 66.569999999999993 109.961 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 6.2 p -64.12 -133.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.665 -0.698 . . . . 91.459999999999994 112.29 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.9 mm -79.85 -53.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 112.898 0.703 . . . . 103.65000000000001 112.898 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.91 113.26 1.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.419 0.526 . . . . 115.16 112.419 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.87 106.48 13.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.583 -0.735 . . . . 50.439999999999998 109.971 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 165.21 -11.06 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.458 -0.792 . . . . 34.159999999999997 111.292 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.714 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 83.4 m95 -122.74 156.04 35.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.273 . . . . 81.450000000000003 110.485 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.646 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.6 m0 -168.22 -175.71 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 93.810000000000002 108.328 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.655 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -144.41 143.05 30.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.847 -0.797 . . . . 89.719999999999999 108.847 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -152.8 169.03 31.82 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.441 -1.864 . . . . 24.219999999999999 108.441 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.803 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.93 129.66 56.4 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.567 -0.853 . . . . 56.969999999999999 109.649 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 287' ' ' THR . 61.9 tp -142.63 135.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.102 -1.073 . . . . 59.329999999999998 108.102 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.11 37.77 29.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.552 -0.536 . . . . 46.140000000000001 109.552 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.09 35.07 88.39 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.269 -0.967 . . . . 26.489999999999998 110.745 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.803 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.44 160.35 36.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.989 -1.084 . . . . 98.989999999999995 108.521 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.29 124.74 35.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.749 -1.204 . . . . 109.22 107.749 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.74 163.71 36.47 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.082 -1.607 . . . . 26.510000000000002 109.082 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 308' ' ' GLU . 0.8 OUTLIER -98.09 151.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.65 0.38 . . . . 54.609999999999999 111.445 -178.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.75 151.43 26.63 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 120.999 0.428 . . . . 74.469999999999999 110.42 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.2 Cg_endo -70.19 122.02 8.6 Favored 'Trans proline' 0 CA--C 1.487 -1.825 0 C-N-CA 120.097 0.532 . . . . 111.89 112.041 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -78.92 -6.25 55.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 123.995 0.809 . . . . 119.27 111.833 -178.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 323' ' ' VAL . 12.5 m-20 -62.1 -40.77 97.01 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.386 -0.598 . . . . 96.629999999999995 109.386 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.42 2.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.852 -1.067 . . . . 74.849999999999994 111.788 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.637 ' HB ' HG22 ' A' ' 274' ' ' VAL . 1.9 m -132.24 155.54 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.555 -0.535 . . . . 67.239999999999995 109.555 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -116.61 163.96 15.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.143 -0.688 . . . . 130.62 109.143 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.557 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -93.67 135.17 35.22 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 108.127 -1.064 . . . . 63.159999999999997 108.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.07 44.55 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 105.785 -1.931 . . . . 97.620000000000005 105.785 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.3 Cg_exo -63.88 -33.87 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 N-CA-C 115.523 1.316 . . . . 152.83000000000001 115.523 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--N 1.302 -1.918 0 CA-C-N 121.387 1.531 . . . . 59.969999999999999 109.248 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.541 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.9 140.23 32.57 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.397 0.618 . . . . 29.010000000000002 110.121 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' B' ' 65' ' ' SER . 12.7 pt -119.21 156.15 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.021 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.577 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -121.12 139.31 53.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.931 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.528 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.29 124.16 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.671 -0.863 . . . . 4.9900000000000002 108.671 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -100.99 137.56 39.2 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.059 0.457 . . . . 5.6799999999999997 110.411 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -90.87 -149.95 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.543 -0.753 . . . . 26.890000000000001 111.6 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.787 HD12 HD22 ' B' ' 71' ' ' LEU . 0.4 OUTLIER -62.57 -47.89 81.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.856 -0.611 . . . . 23.289999999999999 111.448 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -91.27 2.26 56.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.556 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.48 16.37 49.75 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.881 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 82.6 tttt -43.62 150.05 0.25 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 122.223 -0.574 . . . . 8.5099999999999998 111.778 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -106.54 128.1 53.85 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.718 -0.845 . . . . 1.8799999999999999 108.718 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' B' ' 4' ' ' PHE . 69.4 mt -123.96 121.67 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 O-C-N 123.289 0.368 . . . . 37.689999999999998 110.953 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.47 131.22 47.72 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -127.19 149.9 49.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.624 0.25 . . . . 9.4600000000000009 110.935 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.57 122.13 43.77 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.271 -1.751 . . . . 1.54 106.271 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.95 168.32 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.487 0.66 . . . . 0.0 111.493 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.84 149.2 44.82 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.2 -24.47 59.27 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 CA-C-N 120.772 1.311 . . . . 0.0 112.954 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.21 -2.56 58.17 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.069 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.63 50.52 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.94 -1.133 . . . . 1.4299999999999999 107.94 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -87.03 157.89 19.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.687 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.447 HG23 HD12 ' B' ' 43' ' ' LEU . 35.8 mm -61.29 -39.91 84.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.921 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.04 -37.64 80.38 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.36 -42.85 87.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.64 -41.68 89.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.27 89.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.451 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.3 -39.13 92.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.528 HD11 HG21 ' B' ' 5' ' ' VAL . 32.6 mt -65.05 -40.04 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.04 -44.04 94.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.518 0.675 . . . . 1.3200000000000001 109.39 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.85 -40.35 92.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.036 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -41.22 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.033 1.123 . . . . 0.82999999999999996 114.033 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -110.93 -14.7 13.92 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.049 1.87 . . . . 6.1200000000000001 116.049 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.06 82.93 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.322 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -85.82 116.48 65.83 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 109.507 -0.553 . . . . 3.54 109.507 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.93 134.64 61.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.086 1.19 . . . . 0.0 112.339 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.32 -32.22 25.08 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.751 2.301 . . . . 0.0 114.654 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.71 -15.99 62.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.976 0.807 . . . . 2.8799999999999999 112.182 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.08 8.69 43.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.732 0.271 . . . . 7.1699999999999999 111.732 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.469 ' OE1' HG21 ' B' ' 30' ' ' ILE . 44.0 mt-30 -117.65 125.84 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.13 0.789 . . . . 13.42 113.13 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -111.83 124.03 51.49 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.019 -1.104 . . . . 27.09 108.019 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.447 HD12 HG23 ' B' ' 23' ' ' ILE . 84.8 mt -98.41 132.69 43.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.289 0.566 . . . . 1.8700000000000001 110.836 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.402 HD11 ' CZ ' ' A' ' 278' ' ' TYR . 3.6 mp -132.04 135.57 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.062 -0.399 . . . . 17.75 111.631 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.52 ' CD1' HG12 ' B' ' 61' ' ' ILE . 15.0 t80 -152.92 143.26 22.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.114 -0.494 . . . . 16.98 109.944 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.5 34.75 25.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.681 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.487 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 73.1 -10.74 5.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.013 -0.994 . . . . 48.659999999999997 114.863 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -107.94 132.64 53.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 120.005 -0.678 . . . . 4.25 111.76 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -58.82 116.98 4.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.14 -0.482 . . . . 30.57 110.126 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 45' ' ' PHE . 21.3 mt -66.6 131.49 46.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.957 -0.565 . . . . 22.77 112.046 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -97.53 149.43 22.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.851 -0.613 . . . . 9.3399999999999999 111.45 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.64 -20.2 63.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.96 68.7 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.54 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.43 163.91 13.89 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.17 0.485 . . . . 1.8600000000000001 111.581 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.2 p -105.33 166.33 10.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.611 0.719 . . . . 0.0 112.604 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.9 mt -60.04 -41.99 93.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.672 -1.149 . . . . 2.2799999999999998 110.763 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.33 -31.21 71.07 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.111 -0.636 . . . . 2.98 111.763 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -62.14 -28.87 69.94 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.687 -0.405 . . . . 1.77 110.477 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.98 14.56 28.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.4 19.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.9 0.48 . . . . 0.0 112.207 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.52 HG12 ' CD1' ' B' ' 45' ' ' PHE . 96.8 mt -81.46 123.92 38.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.106 -1.072 . . . . 4.0099999999999998 108.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.88 169.21 8.68 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.281 0.563 . . . . 5.7400000000000002 112.097 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 56.9 pttt -51.59 141.41 16.31 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.184 -0.916 . . . . 4.3099999999999996 111.502 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.04 23.21 9.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.05 -0.977 . . . . 10.130000000000001 112.845 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' B' ' 3' ' ' ILE . 38.1 m -77.3 146.93 36.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.87 -1.159 . . . . 4.0999999999999996 107.87 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.577 HG23 ' HB2' ' B' ' 4' ' ' PHE . 78.0 m -122.64 132.2 54.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.4 171.74 7.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 19.210000000000001 109.789 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.453 ' HB2' ' CD2' ' A' ' 276' ' ' PHE . 0.4 OUTLIER -119.96 135.59 54.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 12.6 tp -138.42 157.18 46.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.043 0.449 . . . . 21.579999999999998 111.193 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' HG3' ' A' ' 319' ' ' PRO . 2.1 t -110.03 164.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.873 -0.603 . . . . 25.969999999999999 109.848 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.787 HD22 HD12 ' B' ' 8' ' ' LEU . 37.4 tp -78.46 -96.16 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 119.461 -0.304 . . . . 1.6699999999999999 110.285 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' B' ' 71' ' ' LEU . 0.2 OUTLIER 156.69 64.04 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.114 0.884 . . . . 23.710000000000001 110.518 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.404 HD12 ' NE1' ' A' ' 306' ' ' TRP . 18.5 mt -95.06 -26.62 15.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.955 0.407 . . . . 15.09 110.235 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.603 HH21 ' HG2' ' A' ' 285' ' ' GLU . 3.1 tmm_? -131.37 -60.89 0.93 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.766 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 34.0 1.02 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.594 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.546 -0.74 . . . . 1.8600000000000001 111.072 -179.81 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 121.589 0.709 . . . . 137.63999999999999 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.9 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 51.8 p -64.87 -56.99 10.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.528 -0.76 . . . . 89.760000000000005 111.26 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.9 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.88 166.63 12.63 Favored 'General case' 0 CA--C 1.491 -1.302 0 O-C-N 121.826 -0.546 . . . . 143.71000000000001 109.592 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.18 135.8 51.17 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.437 -0.579 . . . . 62.810000000000002 109.437 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 61.0 m-85 -107.18 134.44 50.29 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.515 -0.921 . . . . 73.75 108.515 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.6 135.4 48.5 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.747 -0.834 . . . . 54.439999999999998 108.747 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.651 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.7 tttp -92.66 135.52 34.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.251 -1.018 . . . . 88.159999999999997 108.251 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 288' ' ' ILE . 90.4 t -100.84 116.46 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 118.038 -1.465 . . . . 73.900000000000006 110.782 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 33.0 mm -78.38 -78.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.9 -0.591 . . . . 138.47999999999999 112.099 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' B' ' 68' ' ' HIS . 20.7 m-85 -68.95 131.71 90.79 Favored Pre-proline 0 N--CA 1.462 0.147 0 N-CA-C 109.692 -0.484 . . . . 67.980000000000004 109.692 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.532 ' CD ' ' HA2' ' B' ' 47' ' ' GLY . 30.8 Cg_endo -63.78 149.75 90.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.727 2.285 . . . . 72.540000000000006 111.807 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 288' ' ' ILE . 63.6 t80 -121.41 92.45 3.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.955 -0.566 . . . . 82.870000000000005 110.446 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -68.18 116.14 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.873 -0.603 . . . . 66.180000000000007 109.729 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.35 104.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.403 1.065 . . . . 50.240000000000002 112.98 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.541 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -81.71 -40.28 23.0 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.398 -0.593 . . . . 128.65000000000001 109.398 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -144.85 175.39 10.23 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.281 -0.887 . . . . 67.609999999999999 111.691 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.67 -31.03 32.43 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.334 -0.848 . . . . 78.629999999999995 109.696 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 -3.59 43.96 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.327 -0.851 . . . . 42.490000000000002 110.939 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.5 146.51 37.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.401 0.62 . . . . 53.210000000000001 109.486 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.432 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.7 tp -76.79 138.72 40.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.525 -0.762 . . . . 57.0 110.066 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.8 m -96.45 124.49 40.47 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.33 -1.348 . . . . 53.009999999999998 107.767 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.2 142.16 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.542 -0.91 . . . . 56.119999999999997 108.542 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -113.82 158.3 21.19 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.396 -0.964 . . . . 97.849999999999994 108.396 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.48 141.52 41.26 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 118.077 -1.449 . . . . 88.319999999999993 108.642 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.63 21.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.572 -1.011 . . . . 35.810000000000002 110.572 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.49 151.87 50.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.436 1.118 . . . . 61.780000000000001 109.825 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.3 mm -109.56 133.95 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.817 -1.179 . . . . 105.08 107.817 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.74 134.8 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.718 -0.845 . . . . 48.770000000000003 108.718 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.82 126.61 34.16 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.131 -1.028 . . . . 128.84 108.825 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.97 113.22 8.78 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.899 -0.778 . . . . 81.370000000000005 108.899 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.41 -52.43 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.733 0.813 . . . . 70.599999999999994 110.92 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.97 149.2 27.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.475 -0.935 . . . . 65.189999999999998 108.475 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.524 ' HG3' ' NE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.79 23.62 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.433 0.635 . . . . 125.5 110.594 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.18 174.3 7.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.801 1.64 . . . . 66.569999999999993 109.93 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' CYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 3.9 p -58.0 -144.72 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.994 0.739 . . . . 91.459999999999994 112.994 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.414 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 45.8 mm -71.02 -57.52 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.907 1.077 . . . . 103.65000000000001 113.907 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -50.53 127.57 18.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.096 0.776 . . . . 115.16 113.096 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.88 112.82 26.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.408 -0.815 . . . . 50.439999999999998 110.446 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 158.3 -13.56 0.25 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.922 -0.871 . . . . 34.159999999999997 110.922 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 92.4 m95 -122.7 147.56 46.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.372 -0.414 . . . . 81.450000000000003 110.913 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.626 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 7.2 m0 -157.81 -177.48 6.61 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.782 0.676 . . . . 93.810000000000002 109.435 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.763 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -138.14 143.06 40.14 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.851 -0.796 . . . . 89.719999999999999 108.851 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.86 168.89 31.84 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 108.448 -1.861 . . . . 24.219999999999999 108.448 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.792 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.84 129.75 56.34 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 119.503 -0.879 . . . . 56.969999999999999 109.673 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.68 135.57 28.17 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.1 -1.074 . . . . 59.329999999999998 108.1 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.13 37.78 29.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.499 -0.556 . . . . 46.140000000000001 109.499 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.13 35.04 88.1 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.193 -1.004 . . . . 26.489999999999998 110.699 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.792 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.4 160.3 36.78 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 119.029 -1.069 . . . . 98.989999999999995 108.598 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -129.22 124.78 35.38 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.738 -1.208 . . . . 109.22 107.738 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.82 163.96 36.67 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.071 -1.612 . . . . 26.510000000000002 109.071 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.763 HG12 ' HG2' ' A' ' 308' ' ' GLU . 1.6 m -96.42 151.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 122.734 0.413 . . . . 54.609999999999999 111.456 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -155.23 151.4 22.68 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 120.634 -0.427 . . . . 74.469999999999999 110.425 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.22 121.89 8.46 Favored 'Trans proline' 0 CA--C 1.486 -1.88 0 C-N-CA 120.053 0.502 . . . . 111.89 112.094 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.626 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.1 OUTLIER -74.76 -0.44 18.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 124.158 0.912 . . . . 119.27 111.976 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -60.95 -42.64 98.61 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.448 -0.575 . . . . 96.629999999999995 109.448 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 68' ' ' HIS . 4.6 m-85 -73.55 9.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.523 -0.762 . . . . 74.849999999999994 112.683 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.57 164.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.589 -0.523 . . . . 67.239999999999995 109.589 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.08 154.67 47.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.341 -0.614 . . . . 130.62 109.341 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -92.22 135.26 34.15 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.11 -1.07 . . . . 63.159999999999997 108.11 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.05 44.61 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 105.803 -1.925 . . . . 97.620000000000005 105.803 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.97 -33.82 61.64 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.59 1.342 . . . . 152.83000000000001 115.59 -175.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 CA--C 1.486 -1.908 0 CA-C-N 121.385 1.53 . . . . 59.969999999999999 109.308 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.88 140.7 31.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.243 0.545 . . . . 29.010000000000002 110.197 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.8 pt -116.27 161.55 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.827 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.84 139.3 53.79 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.585 0.231 . . . . 0.0 110.975 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.577 HG21 HD11 ' B' ' 30' ' ' ILE . 46.9 t -121.24 124.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.641 -0.874 . . . . 4.9900000000000002 108.641 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.13 139.57 36.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 5.6799999999999997 110.471 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -91.3 -142.59 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.612 -0.722 . . . . 26.890000000000001 111.788 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 8' ' ' LEU . 1.1 tm? -73.49 -42.13 62.23 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.119 -0.491 . . . . 23.289999999999999 111.572 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -94.25 2.35 55.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.527 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.46 16.32 49.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.786 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 77.6 tttt -46.8 153.45 0.4 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.363 -0.492 . . . . 8.5099999999999998 111.568 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -107.06 127.77 53.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.722 -0.844 . . . . 1.8799999999999999 108.722 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.82 121.75 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.233 0.333 . . . . 37.689999999999998 110.931 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.45 131.18 47.7 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -127.12 149.94 49.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.678 0.275 . . . . 9.4600000000000009 110.935 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.6 122.12 43.75 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 106.185 -1.783 . . . . 1.54 106.185 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.92 168.41 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.524 0.678 . . . . 0.0 111.468 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.94 149.28 45.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.24 -24.43 59.36 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 CA-C-N 120.832 1.333 . . . . 0.0 112.93 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.28 -2.59 58.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.001 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.22 142.57 50.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.958 -1.127 . . . . 1.4299999999999999 107.958 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.91 157.79 19.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.704 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.24 -39.88 84.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.011 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.71 80.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.32 -42.87 87.59 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -60.64 -41.7 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.96 -40.0 87.52 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.18 89.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.516 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.15 -39.25 92.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.577 HD11 HG21 ' B' ' 5' ' ' VAL . 32.6 mt -65.09 -40.03 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.98 -44.08 94.72 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.609 0.719 . . . . 1.3200000000000001 109.441 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.82 -40.37 92.5 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.026 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -41.13 22.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.108 1.151 . . . . 0.82999999999999996 114.108 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.95 -14.57 13.93 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.15 1.907 . . . . 6.1200000000000001 116.15 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.1 82.95 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.393 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.81 116.4 65.52 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.566 -0.531 . . . . 3.54 109.566 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.67 61.97 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.101 1.201 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.48 -32.02 25.69 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.78 2.32 . . . . 0.0 114.694 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.75 -15.99 62.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.971 0.805 . . . . 2.8799999999999999 112.189 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.07 5.65 44.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.709 0.262 . . . . 7.1699999999999999 111.709 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -103.74 131.29 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.873 0.694 . . . . 13.42 112.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -119.3 113.86 21.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.256 -1.016 . . . . 27.09 108.256 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.417 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.3 mt -101.72 128.7 47.92 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.336 0.589 . . . . 1.8700000000000001 110.815 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 67.8 mt -143.87 136.05 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.278 -0.419 . . . . 17.75 111.109 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.605 ' CD2' HG12 ' B' ' 61' ' ' ILE . 94.5 t80 -131.72 134.92 46.4 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.307 -0.257 . . . . 16.98 110.307 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 39.31 21.7 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 123.435 0.459 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.532 ' HA2' ' CD ' ' A' ' 277' ' ' PRO . . . 66.98 22.85 72.55 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.522 0.969 . . . . 48.659999999999997 115.522 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.5 132.55 56.52 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.605 -0.938 . . . . 4.25 111.784 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -67.51 118.58 11.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.82 -0.627 . . . . 30.57 110.703 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' B' ' 43' ' ' LEU . 50.3 mt -86.25 126.11 34.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.229 0.455 . . . . 22.77 112.229 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -100.07 149.53 23.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.835 -0.62 . . . . 9.3399999999999999 111.433 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -69.65 -20.26 63.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.05 5.91 68.85 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.572 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.92 13.87 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.179 0.49 . . . . 1.8600000000000001 111.637 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.33 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.576 0.703 . . . . 0.0 112.67 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.91 -42.05 93.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.759 -1.109 . . . . 2.2799999999999998 110.747 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.4 -31.13 71.04 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.187 -0.605 . . . . 2.98 111.826 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.06 -28.94 69.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.773 -0.371 . . . . 1.77 110.459 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.01 14.51 28.93 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.16 39.28 19.16 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 122.977 0.511 . . . . 0.0 112.207 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.605 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.37 123.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.092 -1.077 . . . . 4.0099999999999998 108.092 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.96 169.15 8.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.23 0.538 . . . . 5.7400000000000002 112.114 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.0 pttt -51.56 141.45 16.11 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.19 -0.914 . . . . 4.3099999999999996 111.482 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.9 23.34 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.01 -0.996 . . . . 10.130000000000001 112.817 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.27 146.57 36.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 4.0999999999999996 107.952 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -123.45 133.06 54.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.13 179.01 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 19.210000000000001 109.927 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . 1.1 m170 -115.96 139.17 50.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.964 -0.384 . . . . 50.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -133.19 144.73 50.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 21.579999999999998 111.012 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.408 HG13 ' CZ ' ' A' ' 322' ' ' PHE . 3.7 m -99.92 152.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 25.969999999999999 110.661 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 tp -144.93 107.98 4.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.504 -0.317 . . . . 1.6699999999999999 111.368 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.432 ' CZ ' ' HA ' ' B' ' 76' ' ' CYS . 1.3 mmp_? -64.44 125.38 24.46 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.968 -0.56 . . . . 23.710000000000001 110.516 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 -62.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 15.09 110.832 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.07 147.73 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.521 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.54 -87.09 1.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.873 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.432 ' HA ' ' CZ ' ' B' ' 72' ' ' ARG . 36.9 m . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.968 -1.015 . . . . 1.8600000000000001 111.508 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 121.529 0.681 . . . . 137.63999999999999 110.358 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.914 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.506 -0.77 . . . . 89.760000000000005 111.342 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.914 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.56 12.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 O-C-N 121.739 -0.601 . . . . 143.71000000000001 109.508 -177.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.11 135.81 51.08 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.48 -0.563 . . . . 62.810000000000002 109.48 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.551 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.0 m-85 -107.25 134.48 50.28 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.413 -0.958 . . . . 73.75 108.413 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.57 135.37 48.49 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.784 -0.821 . . . . 54.439999999999998 108.784 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.525 ' HB3' HD21 ' A' ' 326' ' ' LEU . 40.6 tttp -92.76 135.65 33.93 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.151 -1.055 . . . . 88.159999999999997 108.151 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.5 HG22 HG11 ' A' ' 323' ' ' VAL . 91.6 t -100.98 117.13 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 117.96 -1.496 . . . . 73.900000000000006 110.833 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.1 OUTLIER -96.71 -0.54 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.668 0.988 . . . . 138.47999999999999 113.668 -178.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 276' ' ' PHE . . . . . 0.675 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 5.1 m-85 -117.67 145.31 36.14 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 117.98 0.355 . . . . 67.980000000000004 111.089 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' B' ' 44' ' ' ILE . 68.5 Cg_endo -76.35 135.22 16.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.575 2.183 . . . . 72.540000000000006 112.352 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.47 ' HB3' HG13 ' A' ' 288' ' ' ILE . 64.6 t80 -130.58 111.2 12.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 82.870000000000005 110.585 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.39 127.27 40.18 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.187 -0.672 . . . . 66.180000000000007 109.187 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.05 108.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.134 0.896 . . . . 50.240000000000002 112.683 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.576 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.0 mt-30 -85.61 -43.04 13.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.468 -0.567 . . . . 128.65000000000001 109.468 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.23 178.56 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.435 -0.791 . . . . 67.609999999999999 111.815 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.34 -35.06 25.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.185 -0.916 . . . . 78.629999999999995 109.76 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -79.53 3.79 17.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.634 -0.712 . . . . 42.490000000000002 110.693 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.717 ' OE2' ' HA ' ' B' ' 73' ' ' LEU . 73.9 mt-10 -117.14 146.29 43.27 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.853 -0.612 . . . . 53.210000000000001 109.522 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.7 tp -83.08 140.98 32.35 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.613 -0.721 . . . . 57.0 110.032 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.426 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.2 m -95.66 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 118.514 -1.275 . . . . 53.009999999999998 107.765 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.21 141.79 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.555 -0.906 . . . . 56.119999999999997 108.555 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 31.7 mmtt -118.93 162.0 19.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.628 -0.879 . . . . 97.849999999999994 108.628 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.36 141.52 43.29 Favored 'General case' 0 CA--C 1.483 -1.619 0 C-N-CA 118.114 -1.434 . . . . 88.319999999999993 108.68 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.61 21.53 21.41 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.667 -0.973 . . . . 35.810000000000002 110.667 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.47 151.89 50.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 118.377 1.089 . . . . 61.780000000000001 109.87 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.551 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.1 mm -109.54 133.97 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.77 -1.196 . . . . 105.08 107.77 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 91.9 t -122.79 134.82 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.704 -0.85 . . . . 48.770000000000003 108.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.87 126.54 34.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.814 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.01 113.33 8.93 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.937 -0.764 . . . . 81.370000000000005 108.937 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.44 -52.41 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 123.682 0.793 . . . . 70.599999999999994 110.869 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.0 149.19 27.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.394 -0.965 . . . . 65.189999999999998 108.394 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.609 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.78 23.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.465 0.65 . . . . 125.5 110.585 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.663 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.12 172.74 8.87 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.847 1.659 . . . . 66.569999999999993 109.884 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' CYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 5.7 p -61.93 -149.5 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.939 -1.028 . . . . 91.459999999999994 111.402 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.405 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 47.9 mm -69.02 -55.44 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.248 0.833 . . . . 103.65000000000001 113.248 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -56.65 117.74 4.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.336 0.589 . . . . 115.16 112.277 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.6 t -82.92 113.21 21.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.434 -0.803 . . . . 50.439999999999998 110.254 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 166.8 -22.97 0.12 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.951 -0.642 . . . . 34.159999999999997 111.827 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.663 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 15.7 m95 -112.75 154.36 26.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.48 -0.563 . . . . 81.450000000000003 109.48 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.609 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 0.8 OUTLIER -164.7 174.5 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.352 -0.61 . . . . 93.810000000000002 109.352 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.98 143.13 42.65 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.85 -0.796 . . . . 89.719999999999999 108.85 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.91 168.96 31.87 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.452 -1.859 . . . . 24.219999999999999 108.452 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.79 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.91 129.64 56.4 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.628 -0.829 . . . . 56.969999999999999 109.684 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 287' ' ' THR . 62.2 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.08 -1.081 . . . . 59.329999999999998 108.08 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.06 37.79 29.22 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.503 -0.554 . . . . 46.140000000000001 109.503 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.05 88.06 Favored Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.698 -0.961 . . . . 26.489999999999998 110.698 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.79 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.1 mmm-85 -132.43 160.29 36.84 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 118.348 1.074 . . . . 98.989999999999995 108.649 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -129.25 124.69 35.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.773 -1.195 . . . . 109.22 107.773 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.49 36.32 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.06 -1.616 . . . . 26.510000000000002 109.06 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.761 HG21 ' HB2' ' B' ' 74' ' ' ARG . 0.7 OUTLIER -95.37 148.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.691 0.281 . . . . 54.609999999999999 111.27 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.53 151.4 23.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 120.982 0.42 . . . . 74.469999999999999 110.375 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.44 8.05 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.113 0.542 . . . . 111.89 112.027 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.12 -0.9 56.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.253 0.971 . . . . 119.27 112.018 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -62.24 -37.91 87.21 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.38 -0.6 . . . . 96.629999999999995 109.38 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 6.5 m-30 -56.87 -7.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.231 -0.895 . . . . 74.849999999999994 112.135 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 274' ' ' VAL . 0.8 OUTLIER -132.17 142.77 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 109.205 -0.665 . . . . 67.239999999999995 109.205 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -96.49 179.31 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.852 -0.425 . . . . 130.62 109.852 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.555 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.2 mt -89.15 135.19 33.7 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 108.086 -1.079 . . . . 63.159999999999997 108.086 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.4 129.05 44.52 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 105.817 -1.92 . . . . 97.620000000000005 105.817 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.8 Cg_exo -63.87 -33.85 62.65 Favored 'Trans proline' 0 N--CA 1.436 -1.911 0 N-CA-C 115.601 1.346 . . . . 152.83000000000001 115.601 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.947 0 CA-C-N 121.35 1.518 . . . . 59.969999999999999 109.234 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.488 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.94 140.68 31.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.42 0.629 . . . . 29.010000000000002 110.117 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -117.83 165.2 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.818 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.423 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -121.41 139.31 53.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.618 0.247 . . . . 0.0 111.059 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.546 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.23 124.18 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.661 -0.866 . . . . 4.9900000000000002 108.661 177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.3 mttt -101.01 137.89 38.78 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.026 0.441 . . . . 5.6799999999999997 110.487 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -90.35 -146.35 0.18 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.595 -0.73 . . . . 26.890000000000001 111.854 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.478 ' HG ' HD12 ' B' ' 71' ' ' LEU . 1.0 OUTLIER -66.8 -45.89 76.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.969 -0.56 . . . . 23.289999999999999 111.832 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -93.15 2.47 56.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.3 . . . . 0.0 111.511 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.33 16.6 49.38 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.426 -0.416 . . . . 0.0 113.915 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 80.1 tttt -46.96 154.41 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.317 -0.519 . . . . 8.5099999999999998 111.699 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -107.31 128.19 54.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.682 -0.858 . . . . 1.8799999999999999 108.682 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 77.3 mt -120.31 122.8 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 123.343 0.402 . . . . 37.689999999999998 111.039 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.75 131.24 48.15 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -127.25 149.92 49.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.69 0.281 . . . . 9.4600000000000009 110.905 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.57 122.19 43.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.19 -1.782 . . . . 1.54 106.19 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.98 168.34 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.495 0.664 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.88 149.3 45.07 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.18 -24.53 59.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 CA-C-N 120.767 1.31 . . . . 0.0 112.901 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 p -85.21 -2.6 58.22 Favored 'General case' 0 CA--C 1.526 0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.04 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -71.17 142.53 50.67 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.036 -1.098 . . . . 1.4299999999999999 108.036 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -86.93 157.89 19.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.704 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.25 -39.83 83.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.04 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.12 -37.64 80.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.31 -42.88 87.66 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.534 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.53 -41.72 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.98 -39.96 87.46 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.18 89.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.445 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.28 -39.12 92.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.546 HD11 HG21 ' B' ' 5' ' ' VAL . 33.1 mt -65.03 -40.07 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.1 -43.99 95.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.484 0.659 . . . . 1.3200000000000001 109.416 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.87 -40.35 92.64 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.97 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.56 -41.23 21.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.091 1.145 . . . . 0.82999999999999996 114.091 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.58 13.93 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.115 1.894 . . . . 6.1200000000000001 116.115 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.11 82.86 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.232 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.35 65.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.592 -0.521 . . . . 3.54 109.592 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.63 61.72 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.119 1.213 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -32.16 24.62 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.771 2.314 . . . . 0.0 114.723 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.82 -15.96 62.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.92 0.782 . . . . 2.8799999999999999 112.19 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.14 7.43 44.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.777 0.288 . . . . 7.1699999999999999 111.777 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -110.44 129.24 55.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.806 0.669 . . . . 13.42 112.806 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.625 ' HB2' HG21 ' B' ' 70' ' ' VAL . 7.0 mtt-85 -119.08 121.19 39.25 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.694 -1.225 . . . . 27.09 107.694 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.468 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.2 mt -98.89 129.5 45.24 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.351 0.596 . . . . 1.8700000000000001 110.85 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' B' ' 50' ' ' LEU . 0.6 OUTLIER -144.01 133.47 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.35 -0.387 . . . . 17.75 111.369 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.725 ' CD2' HG12 ' B' ' 61' ' ' ILE . 84.2 t80 -136.48 143.4 43.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.459 -0.337 . . . . 16.98 110.353 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.23 38.72 21.99 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.6 0.563 . . . . 0.0 111.639 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 63.59 18.13 60.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.524 0.97 . . . . 48.659999999999997 115.524 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.84 134.11 55.34 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.898 0.849 . . . . 4.25 111.798 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.446 ' HA ' HG22 ' B' ' 44' ' ' ILE . 97.8 mt-30 -65.2 119.03 10.13 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.149 -0.478 . . . . 30.57 110.87 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.468 HD12 ' HB3' ' B' ' 43' ' ' LEU . 47.4 mt -86.14 126.25 34.09 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.037 0.446 . . . . 22.77 111.829 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -97.84 149.47 22.33 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 9.3399999999999999 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -69.59 -20.22 63.64 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.1 5.96 68.75 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.93 13.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.225 0.513 . . . . 1.8600000000000001 111.585 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.36 10.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.655 0.741 . . . . 0.0 112.625 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.02 -41.8 92.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.69 -1.141 . . . . 2.2799999999999998 110.892 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -61.57 -31.11 71.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 120.053 -0.659 . . . . 2.98 111.794 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.98 -28.95 69.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.614 -0.435 . . . . 1.77 110.526 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.98 14.52 28.85 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.07 39.39 19.06 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.725 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.95 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.097 -1.075 . . . . 4.0099999999999998 108.097 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.98 169.19 8.7 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.249 0.547 . . . . 5.7400000000000002 112.103 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.57 141.4 16.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.185 -0.916 . . . . 4.3099999999999996 111.454 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.95 23.32 9.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.991 -1.004 . . . . 10.130000000000001 112.803 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.477 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.27 145.7 37.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.929 -1.138 . . . . 4.0999999999999996 107.929 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.423 HG23 ' HB2' ' B' ' 4' ' ' PHE . 89.8 m -122.32 134.77 54.65 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.297 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' B' ' 67' ' ' LEU . 0.0 OUTLIER -116.03 -175.27 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 19.210000000000001 110.414 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -118.71 139.08 52.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 50.0 109.941 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 16.5 tp -108.7 163.83 12.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 21.579999999999998 111.163 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.672 HG22 ' HZ ' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -129.47 158.94 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 25.969999999999999 110.503 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.478 HD12 ' HG ' ' B' ' 8' ' ' LEU . 39.4 mt -125.17 -73.02 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 1.6699999999999999 111.07 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.18 -154.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.194 -0.457 . . . . 23.710000000000001 110.352 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.717 ' HA ' ' OE2' ' A' ' 285' ' ' GLU . 1.9 pt? -91.51 -173.2 3.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 15.09 110.083 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.761 ' HB2' HG21 ' A' ' 317' ' ' VAL . 50.2 ttm-85 -64.37 -34.14 77.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.601 0.239 . . . . 0.0 111.353 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.77 22.51 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.917 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.549 -0.739 . . . . 1.8600000000000001 111.317 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.555 0.693 . . . . 137.63999999999999 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.909 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.2 p -64.88 -56.86 10.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.486 -0.779 . . . . 89.760000000000005 111.319 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.909 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.99 166.6 12.61 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 121.784 -0.573 . . . . 143.71000000000001 109.509 -177.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.21 135.83 51.17 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.424 -0.584 . . . . 62.810000000000002 109.424 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.561 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.23 134.45 50.31 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.475 -0.935 . . . . 73.75 108.475 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.61 135.43 48.55 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.756 -0.831 . . . . 54.439999999999998 108.756 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.681 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.74 135.62 33.95 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.245 -1.02 . . . . 88.159999999999997 108.245 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.534 HG22 HG11 ' A' ' 323' ' ' VAL . 92.4 t -101.02 116.27 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 C-N-CA 117.96 -1.496 . . . . 73.900000000000006 110.768 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -4.18 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.68 0.622 . . . . 138.47999999999999 112.68 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -117.16 127.7 26.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.736 0.303 . . . . 67.980000000000004 110.997 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.19 139.51 50.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.212 2.608 . . . . 72.540000000000006 112.188 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -129.97 82.63 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.955 -0.566 . . . . 82.870000000000005 110.585 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.13 126.63 29.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.092 -0.707 . . . . 66.180000000000007 109.092 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.99 104.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.393 1.058 . . . . 50.240000000000002 113.452 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.472 ' HG2' ' HE ' ' B' ' 42' ' ' ARG . 26.1 mt-30 -90.63 -41.34 11.39 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.935 -0.575 . . . . 128.65000000000001 109.491 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.96 177.21 9.31 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.159 -0.963 . . . . 67.609999999999999 111.673 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -82.0 -35.39 28.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.431 -0.804 . . . . 78.629999999999995 110.164 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -77.11 -3.67 40.54 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.684 -0.689 . . . . 42.490000000000002 111.028 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.36 146.54 36.93 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.428 0.632 . . . . 53.210000000000001 109.475 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.76 142.46 28.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 57.0 110.016 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.577 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.7 m -96.03 124.55 40.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.335 -1.346 . . . . 53.009999999999998 107.688 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.21 141.82 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.556 -0.905 . . . . 56.119999999999997 108.556 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 65.7 mmtt -116.2 156.61 26.23 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.428 -0.953 . . . . 97.849999999999994 108.428 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.67 141.56 42.72 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 118.275 -1.37 . . . . 88.319999999999993 108.697 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.54 21.36 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.65 -0.98 . . . . 35.810000000000002 110.65 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.52 151.94 50.45 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.397 1.098 . . . . 61.780000000000001 109.805 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.681 HD13 ' HA ' ' A' ' 273' ' ' LYS . 43.9 mm -109.52 134.02 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.807 -1.183 . . . . 105.08 107.807 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.82 134.84 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.671 -0.863 . . . . 48.770000000000003 108.671 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.85 126.61 34.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.799 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.02 113.29 8.89 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.877 -0.786 . . . . 81.370000000000005 108.877 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.8 mt -74.43 -52.43 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 123.596 0.758 . . . . 70.599999999999994 110.866 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.93 149.18 27.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.362 -0.977 . . . . 65.189999999999998 108.362 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.453 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.37 163.89 23.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.515 0.674 . . . . 125.5 110.554 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.22 173.65 8.29 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.856 1.663 . . . . 66.569999999999993 109.936 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 2.5 p -61.8 -158.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.514 -0.766 . . . . 91.459999999999994 111.398 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.416 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 48.7 mm -59.94 -50.48 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.19 1.182 . . . . 103.65000000000001 114.19 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.27 123.11 10.97 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.63 0.604 . . . . 115.16 112.63 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.67 111.7 24.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.563 -0.744 . . . . 50.439999999999998 110.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 158.74 -16.8 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.06 -0.816 . . . . 34.159999999999997 111.06 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.607 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 98.6 m95 -118.79 148.26 43.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.175 -0.513 . . . . 81.450000000000003 110.377 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.453 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 2.9 m0 -157.49 174.48 15.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.712 -0.847 . . . . 93.810000000000002 108.712 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.633 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -132.42 143.11 49.58 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.829 -0.804 . . . . 89.719999999999999 108.829 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 169.0 31.83 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 108.437 -1.865 . . . . 24.219999999999999 108.437 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.97 129.63 56.42 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 119.571 -0.851 . . . . 56.969999999999999 109.684 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.61 135.66 28.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.088 -1.079 . . . . 59.329999999999998 108.088 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.75 29.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.584 -0.524 . . . . 46.140000000000001 109.584 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.07 88.11 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.19 -1.005 . . . . 26.489999999999998 110.623 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.51 160.27 36.99 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 118.397 1.099 . . . . 98.989999999999995 108.627 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.19 124.77 35.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.758 -1.201 . . . . 109.22 107.758 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.81 164.12 36.77 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.028 -1.629 . . . . 26.510000000000002 109.028 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.633 HG12 ' HG2' ' A' ' 308' ' ' GLU . 5.0 m -90.72 146.8 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.377 -0.412 . . . . 54.609999999999999 111.511 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.77 151.41 23.36 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.461 -0.495 . . . . 74.469999999999999 110.436 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.607 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.1 122.38 8.96 Favored 'Trans proline' 0 CA--C 1.488 -1.8 0 C-N-CA 120.139 0.559 . . . . 111.89 112.068 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.58 -10.41 43.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.321 1.013 . . . . 119.27 111.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -62.42 -38.91 91.5 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.417 -0.586 . . . . 96.629999999999995 109.417 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.96 -1.38 0.29 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.379 -1.282 . . . . 74.849999999999994 112.325 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.534 HG11 HG22 ' A' ' 274' ' ' VAL . 0.7 OUTLIER -131.94 155.2 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.491 -0.559 . . . . 67.239999999999995 109.491 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -108.04 152.76 24.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.428 -0.582 . . . . 130.62 109.428 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.546 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.4 mt -88.0 135.19 33.52 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.097 -1.075 . . . . 63.159999999999997 108.097 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.14 44.15 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.752 -1.944 . . . . 97.620000000000005 105.752 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.86 -33.96 62.46 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 N-CA-C 115.547 1.326 . . . . 152.83000000000001 115.547 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.3 -1.987 0 CA-C-N 121.386 1.531 . . . . 59.969999999999999 109.292 179.528 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.93 140.46 32.25 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.336 0.589 . . . . 29.010000000000002 110.062 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -118.73 163.4 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.051 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.478 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -120.26 139.27 52.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.601 0.239 . . . . 0.0 111.007 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.652 HG21 HD11 ' B' ' 30' ' ' ILE . 47.2 t -121.29 124.21 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.643 -0.873 . . . . 4.9900000000000002 108.643 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.1 mttt -101.1 135.93 41.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.989 0.423 . . . . 5.6799999999999997 110.483 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -78.97 -140.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.547 -0.751 . . . . 26.890000000000001 111.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' B' ' 76' ' ' CYS . 0.7 OUTLIER -81.16 -41.65 22.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 23.289999999999999 111.044 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -89.93 2.41 55.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.519 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.47 16.18 50.42 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.865 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 65.4 tttt -50.09 157.84 0.6 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.454 -0.439 . . . . 8.5099999999999998 111.557 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.4 m -106.37 127.95 53.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.72 -0.844 . . . . 1.8799999999999999 108.72 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 88.8 mt -123.06 123.6 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.315 . . . . 37.689999999999998 110.82 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.79 131.19 48.24 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.17 149.94 49.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.578 0.228 . . . . 9.4600000000000009 110.988 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.64 122.16 43.86 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.258 -1.756 . . . . 1.54 106.258 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.93 168.3 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.485 0.659 . . . . 0.0 111.511 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.83 149.35 45.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.3 -24.42 59.81 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 CA-C-N 120.764 1.308 . . . . 0.0 112.966 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 p -85.18 -2.63 58.24 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.046 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.24 142.64 50.57 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.003 -1.11 . . . . 1.4299999999999999 108.003 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -87.03 157.82 19.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.679 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.26 -39.85 84.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.954 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.13 -37.57 80.46 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.4 -42.85 87.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.55 -41.7 88.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -60.08 -39.87 87.6 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.29 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.457 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.531 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.24 -39.22 92.43 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.652 HD11 HG21 ' B' ' 5' ' ' VAL . 33.0 mt -64.99 -40.04 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -44.13 94.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.614 0.721 . . . . 1.3200000000000001 109.407 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.33 92.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.994 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -81.59 -41.23 21.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.01 1.115 . . . . 0.82999999999999996 114.01 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.91 -14.65 13.93 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.052 1.871 . . . . 6.1200000000000001 116.052 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.11 82.92 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.263 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.77 116.49 65.87 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 109.518 -0.549 . . . . 3.54 109.518 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.83 134.68 61.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.062 1.174 . . . . 0.0 112.39 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 -32.28 24.87 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.8 2.333 . . . . 0.0 114.699 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.67 -16.06 62.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 118.955 0.798 . . . . 2.8799999999999999 112.205 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.06 6.09 44.99 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.783 0.29 . . . . 7.1699999999999999 111.783 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.434 ' HB3' HD11 ' B' ' 69' ' ' LEU . 75.1 mt-30 -105.79 153.49 21.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.039 0.755 . . . . 13.42 113.039 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.472 ' HE ' ' HG2' ' A' ' 281' ' ' GLN . 4.0 mtt180 -146.68 118.55 8.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.8 -1.091 . . . . 27.09 108.316 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.406 ' C ' HG13 ' B' ' 44' ' ' ILE . 84.8 mt -100.59 129.41 46.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.315 0.579 . . . . 1.8700000000000001 110.831 -177.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.469 HG23 ' O ' ' B' ' 48' ' ' LYS . 17.2 mt -141.08 136.23 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.084 -0.385 . . . . 17.75 111.194 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.591 ' CD2' HG12 ' B' ' 61' ' ' ILE . 62.2 t80 -135.0 137.62 43.19 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.597 -0.274 . . . . 16.98 110.27 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.69 39.34 21.52 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 123.405 0.441 . . . . 0.0 111.674 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 22.62 68.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.576 0.99 . . . . 48.659999999999997 115.576 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.469 ' O ' HG23 ' B' ' 44' ' ' ILE . 44.8 mtmt -117.19 132.64 56.6 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.999 0.9 . . . . 4.25 111.775 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -68.45 116.6 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 30.57 110.295 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -85.94 130.22 34.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.201 0.524 . . . . 22.77 112.047 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.22 149.55 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.459 -0.791 . . . . 9.3399999999999999 111.471 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.66 -20.17 63.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.2 5.99 68.53 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.514 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 164.0 13.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.204 0.502 . . . . 1.8600000000000001 111.652 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -105.45 166.41 10.45 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.582 0.706 . . . . 0.0 112.572 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.97 -42.01 93.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.707 -1.133 . . . . 2.2799999999999998 110.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.41 -31.13 71.05 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.138 -0.625 . . . . 2.98 111.77 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.1 -28.94 69.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.689 -0.405 . . . . 1.77 110.468 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.04 14.6 28.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.611 0.244 . . . . 0.0 111.629 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.01 39.39 18.8 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.918 0.487 . . . . 0.0 112.22 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.43 123.93 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.136 -1.061 . . . . 4.0099999999999998 108.136 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.97 169.18 8.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.326 0.584 . . . . 5.7400000000000002 112.114 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.54 141.42 16.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.234 -0.894 . . . . 4.3099999999999996 111.443 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.01 23.26 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.937 -1.029 . . . . 10.130000000000001 112.824 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.34 146.69 36.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.898 -1.149 . . . . 4.0999999999999996 107.898 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.478 HG23 ' HB2' ' B' ' 4' ' ' PHE . 99.8 m -121.52 135.0 55.06 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' B' ' 45' ' ' PHE . 1.2 mp -112.6 -176.2 2.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 19.210000000000001 110.584 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -125.35 148.77 48.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 50.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' B' ' 41' ' ' GLN . 15.7 tp -133.72 139.6 46.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.048 0.452 . . . . 21.579999999999998 111.727 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.93 157.13 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.82 -0.627 . . . . 25.969999999999999 110.321 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.4 -76.79 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.648 -0.251 . . . . 1.6699999999999999 111.556 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.409 ' HB3' ' H ' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -173.38 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.495 -0.32 . . . . 23.710000000000001 110.558 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' B' ' 72' ' ' ARG . 9.8 tp -135.45 -30.52 1.01 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.164 -0.214 . . . . 15.09 111.432 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -165.45 146.25 7.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.73 -0.213 . . . . 0.0 110.755 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.37 -165.61 24.93 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.935 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' B' ' 8' ' ' LEU . 8.8 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.498 -0.763 . . . . 1.8600000000000001 111.479 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 121.528 0.68 . . . . 137.63999999999999 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.914 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.7 p -64.86 -56.8 11.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.527 -0.761 . . . . 89.760000000000005 111.413 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.914 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.51 12.64 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.726 -0.609 . . . . 143.71000000000001 109.482 -177.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.12 135.78 51.13 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.448 -0.575 . . . . 62.810000000000002 109.448 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.504 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.8 m-85 -107.2 134.5 50.22 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.513 -0.921 . . . . 73.75 108.513 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.442 ' SG ' HD22 ' A' ' 325' ' ' LEU . 50.2 m -129.59 135.37 48.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.791 -0.818 . . . . 54.439999999999998 108.791 -175.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.731 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.61 33.96 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.214 -1.032 . . . . 88.159999999999997 108.214 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 91.2 t -100.87 115.95 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 118.11 -1.436 . . . . 73.900000000000006 110.722 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -96.59 4.89 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.647 0.98 . . . . 138.47999999999999 113.647 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 276' ' ' PHE . . . . . 0.718 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -126.2 135.02 26.55 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 117.97 0.35 . . . . 67.980000000000004 110.924 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.21 134.74 19.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 72.540000000000006 111.861 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.452 ' HB3' HG13 ' A' ' 288' ' ' ILE . 81.2 t80 -128.18 137.85 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 82.870000000000005 110.793 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -113.63 121.52 44.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.088 -0.506 . . . . 66.180000000000007 109.658 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -32.64 114.43 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.005 0.815 . . . . 50.240000000000002 113.133 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.553 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.35 -41.73 12.66 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.411 -0.588 . . . . 128.65000000000001 109.411 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.98 179.91 7.68 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.288 -0.882 . . . . 67.609999999999999 111.328 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -83.03 -33.25 26.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.412 -0.813 . . . . 78.629999999999995 109.994 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -75.13 -5.19 42.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.714 -0.676 . . . . 42.490000000000002 111.153 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -112.48 147.14 37.17 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.368 0.604 . . . . 53.210000000000001 109.47 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.6 tp -78.1 135.2 37.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.523 -0.762 . . . . 57.0 110.194 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.534 ' O ' HD23 ' A' ' 311' ' ' LEU . 90.0 m -94.87 124.52 38.96 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 118.343 -1.343 . . . . 53.009999999999998 107.805 -176.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.1 pt -128.28 141.88 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.483 -0.932 . . . . 56.119999999999997 108.483 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.3 mmtt -118.55 160.69 21.31 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.56 -0.904 . . . . 97.849999999999994 108.56 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.53 141.53 41.18 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.065 -1.454 . . . . 88.319999999999993 108.75 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.68 21.5 21.32 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.692 -0.963 . . . . 35.810000000000002 110.692 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -130.54 151.91 50.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 118.348 1.074 . . . . 61.780000000000001 109.768 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.55 133.99 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.775 -1.194 . . . . 105.08 107.775 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.81 134.8 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.746 -0.835 . . . . 48.770000000000003 108.746 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.504 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 12.9 t -85.82 126.5 34.08 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.153 -1.019 . . . . 128.84 108.858 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -71.91 113.24 8.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.964 -0.754 . . . . 81.370000000000005 108.964 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.635 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.3 mt -74.39 -52.43 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.639 0.776 . . . . 70.599999999999994 110.946 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.95 149.22 28.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.387 -0.968 . . . . 65.189999999999998 108.387 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.633 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.84 23.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.441 0.639 . . . . 125.5 110.585 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 39.6 t0 -89.24 174.77 7.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.834 1.654 . . . . 66.569999999999993 109.895 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 20.7 p -55.79 -155.95 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.044 -0.98 . . . . 91.459999999999994 112.222 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.99 -68.16 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 113.742 1.016 . . . . 103.65000000000001 113.742 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.61 134.43 57.01 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.521 0.563 . . . . 115.16 112.521 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.8 36.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.629 -0.714 . . . . 50.439999999999998 110.814 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 178.71 -28.75 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.355 -0.839 . . . . 34.159999999999997 111.05 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 85.7 m95 -123.24 156.83 34.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.458 -0.371 . . . . 81.450000000000003 110.775 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.633 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.1 m0 -163.61 -179.05 6.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.797 -0.816 . . . . 93.810000000000002 108.797 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.708 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.1 mt-10 -137.59 143.04 41.31 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.833 -0.803 . . . . 89.719999999999999 108.833 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.93 31.81 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 108.418 -1.873 . . . . 24.219999999999999 108.418 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.8 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.89 129.58 56.41 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.567 -0.853 . . . . 56.969999999999999 109.728 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.49 135.69 28.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.038 -1.097 . . . . 59.329999999999998 108.038 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.69 29.11 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.588 -0.523 . . . . 46.140000000000001 109.588 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.0 87.79 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.659 -0.977 . . . . 26.489999999999998 110.659 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.8 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.43 160.37 36.61 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 118.957 -1.097 . . . . 98.989999999999995 108.583 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.25 124.71 35.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.704 -1.221 . . . . 109.22 107.704 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.95 36.6 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.09 -1.604 . . . . 26.510000000000002 109.09 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.708 HG12 ' HG2' ' A' ' 308' ' ' GLU . 2.4 m -94.19 151.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.053 0.541 . . . . 54.609999999999999 111.716 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -153.4 151.42 25.55 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 120.55 -0.46 . . . . 74.469999999999999 110.439 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.566 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.12 122.13 8.72 Favored 'Trans proline' 0 CA--C 1.488 -1.819 0 C-N-CA 120.103 0.535 . . . . 111.89 112.111 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -77.63 -0.83 28.08 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.92 0.762 . . . . 119.27 111.893 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.75 -39.99 90.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.391 -0.596 . . . . 96.629999999999995 109.391 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.718 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 4.7 m-30 -77.93 10.34 2.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.135 -0.939 . . . . 74.849999999999994 112.167 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.25 163.9 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.339 -0.615 . . . . 67.239999999999995 109.339 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -139.34 147.27 41.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.93 -0.767 . . . . 130.62 108.93 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 mt -87.62 135.23 33.45 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.102 -1.073 . . . . 63.159999999999997 108.102 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.33 129.07 44.57 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.847 -1.909 . . . . 97.620000000000005 105.847 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 74.7 Cg_exo -63.86 -34.0 62.31 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.516 1.314 . . . . 152.83000000000001 115.516 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.958 0 CA-C-N 121.408 1.539 . . . . 59.969999999999999 109.283 179.547 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.89 139.83 33.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.223 0.535 . . . . 29.010000000000002 110.108 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.7 pt -123.62 167.81 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.415 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -119.94 139.35 52.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.7 0.286 . . . . 0.0 111.0 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.5 HG21 HD11 ' B' ' 30' ' ' ILE . 47.0 t -121.25 124.22 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.643 -0.873 . . . . 4.9900000000000002 108.643 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.11 137.31 39.65 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.988 0.423 . . . . 5.6799999999999997 110.444 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -84.91 -149.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.468 -0.787 . . . . 26.890000000000001 111.355 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.488 HD11 ' HE1' ' A' ' 306' ' ' TRP . 0.5 OUTLIER -67.41 -43.27 81.65 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.966 0.358 . . . . 23.289999999999999 111.966 -179.003 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.1 p -92.85 2.38 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.6 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.4 16.74 48.66 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.909 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 74.1 tttt -49.22 157.2 0.48 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.468 -0.431 . . . . 8.5099999999999998 111.578 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.42 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.6 m -106.35 127.82 53.55 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.701 -0.852 . . . . 1.8799999999999999 108.701 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.04 123.64 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.49 -0.323 . . . . 37.689999999999998 110.813 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.79 131.23 48.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -127.16 149.89 49.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 9.4600000000000009 110.96 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.63 122.15 43.84 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 106.204 -1.776 . . . . 1.54 106.204 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.9 168.32 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 111.542 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.92 149.29 45.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.23 -24.5 59.73 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 CA-C-N 120.808 1.324 . . . . 0.0 112.869 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.1 p -85.2 -2.56 58.17 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.01 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.29 142.67 50.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.001 -1.111 . . . . 1.4299999999999999 108.001 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -87.01 157.83 19.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.709 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.28 -39.8 83.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.029 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.06 -37.65 80.49 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.37 -42.83 87.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.57 -41.79 89.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.97 -40.04 87.71 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.18 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.442 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.3 -39.16 92.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.5 HD11 HG21 ' B' ' 5' ' ' VAL . 33.2 mt -64.98 -40.1 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -60.06 -44.08 94.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.577 0.703 . . . . 1.3200000000000001 109.395 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.82 -40.34 92.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.021 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.6 -41.05 22.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.096 1.147 . . . . 0.82999999999999996 114.096 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -111.09 -14.57 13.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.01 1.855 . . . . 6.1200000000000001 116.01 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.04 11.12 82.97 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.345 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.7 116.29 65.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.511 -0.551 . . . . 3.54 109.511 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.77 134.66 61.93 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.107 1.204 . . . . 0.0 112.35 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.37 -32.13 25.25 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 122.758 2.306 . . . . 0.0 114.679 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.71 -16.03 62.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.964 0.802 . . . . 2.8799999999999999 112.197 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.407 ' CD ' ' HD3' ' B' ' 72' ' ' ARG . 25.3 mt-30 -100.08 5.85 44.96 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.698 0.258 . . . . 7.1699999999999999 111.698 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -98.24 127.51 44.22 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.599 0.592 . . . . 13.42 112.599 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 281' ' ' GLN . 0.8 OUTLIER -117.71 109.79 17.05 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 27.09 108.398 177.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.583 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.0 mt -99.58 128.99 45.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.353 0.597 . . . . 1.8700000000000001 110.746 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.422 ' HA ' ' HG ' ' B' ' 50' ' ' LEU . 1.0 OUTLIER -146.32 133.78 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.129 -0.487 . . . . 17.75 111.545 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.664 ' CD2' HG12 ' B' ' 61' ' ' ILE . 88.0 t80 -135.59 140.34 44.55 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.469 -0.332 . . . . 16.98 110.245 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 38.68 23.73 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.444 0.465 . . . . 0.0 111.65 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.97 19.8 66.08 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 115.47 0.948 . . . . 48.659999999999997 115.47 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -117.38 133.75 55.62 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.664 0.732 . . . . 4.25 111.759 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.84 120.26 12.73 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.739 -0.664 . . . . 30.57 111.017 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' B' ' 43' ' ' LEU . 59.4 mt -86.96 124.19 32.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.117 0.484 . . . . 22.77 112.208 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -99.06 149.5 22.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 9.3399999999999999 111.412 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -69.66 -20.08 63.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.24 5.97 68.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.575 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 163.96 13.81 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.124 0.462 . . . . 1.8600000000000001 111.619 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -105.46 166.28 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.688 0.756 . . . . 0.0 112.542 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.99 -41.85 92.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.616 -1.174 . . . . 2.2799999999999998 110.781 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -61.5 -31.08 71.06 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 120.045 -0.662 . . . . 2.98 111.875 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.05 -28.96 69.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.773 -0.371 . . . . 1.77 110.489 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.98 14.5 28.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.39 19.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.961 0.504 . . . . 0.0 112.161 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.664 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.175 -1.046 . . . . 4.0099999999999998 108.175 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -106.95 169.09 8.76 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.367 0.604 . . . . 5.7400000000000002 112.044 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.49 141.37 15.97 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.108 -0.951 . . . . 4.3099999999999996 111.489 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.99 23.34 9.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.072 -0.967 . . . . 10.130000000000001 112.818 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.31 145.52 37.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.933 -1.136 . . . . 4.0999999999999996 107.933 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.415 HG23 ' HB2' ' B' ' 4' ' ' PHE . 31.9 m -126.94 141.75 51.72 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.629 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 -165.89 1.46 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.27 -0.423 . . . . 19.210000000000001 110.473 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.34 160.72 35.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.99 -0.374 . . . . 50.0 109.99 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 69' ' ' LEU . 4.8 mt -135.42 172.11 13.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.19 0.519 . . . . 21.579999999999998 111.513 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.524 HG23 ' CZ ' ' A' ' 322' ' ' PHE . 2.8 t -120.26 134.74 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.366 -0.834 . . . . 25.969999999999999 110.401 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 71' ' ' LEU . 1.5 mm? -118.42 -172.43 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.208 -0.451 . . . . 1.6699999999999999 110.942 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.407 ' HD3' ' CD ' ' B' ' 40' ' ' GLN . 17.9 mtm180 -138.55 99.84 3.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.005 -0.543 . . . . 23.710000000000001 109.879 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 tp -132.78 -34.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 15.09 110.814 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.502 HH21 ' HB2' ' A' ' 306' ' ' TRP . 31.2 ttp-105 -152.95 91.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.31 -123.73 2.73 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.33 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.225 -0.893 . . . . 1.8600000000000001 111.235 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 121.532 0.682 . . . . 137.63999999999999 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.906 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.95 -56.88 10.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.581 -0.736 . . . . 89.760000000000005 111.281 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.906 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.03 166.6 12.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 O-C-N 121.753 -0.592 . . . . 143.71000000000001 109.525 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -111.13 135.82 51.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.4 -0.593 . . . . 62.810000000000002 109.4 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.513 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.2 134.44 50.3 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.534 -0.913 . . . . 73.75 108.534 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.559 ' SG ' HD22 ' A' ' 325' ' ' LEU . 51.2 m -129.61 135.42 48.53 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.697 -0.853 . . . . 54.439999999999998 108.697 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.54 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.6 33.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.197 -1.038 . . . . 88.159999999999997 108.197 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 323' ' ' VAL . 92.2 t -100.97 118.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 117.981 -1.488 . . . . 73.900000000000006 110.744 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 42.7 mm -82.74 -66.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.652 -0.704 . . . . 138.47999999999999 111.313 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.39 126.34 87.78 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 67.980000000000004 110.633 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.458 ' HD2' ' HA2' ' B' ' 47' ' ' GLY . 30.6 Cg_endo -63.05 150.01 89.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.505 . . . . 72.540000000000006 112.279 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.52 ' HE1' HE21 ' A' ' 281' ' ' GLN . 89.2 t80 -129.7 107.91 9.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 82.870000000000005 111.184 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -84.01 120.51 26.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.564 -0.532 . . . . 66.180000000000007 109.564 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -34.34 110.46 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.178 0.924 . . . . 50.240000000000002 112.832 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.691 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 79.6 mt-30 -82.38 -41.58 19.76 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.725 -0.671 . . . . 128.65000000000001 109.458 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -137.21 172.41 13.04 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.003 -1.06 . . . . 67.609999999999999 112.035 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.37 -38.25 56.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.262 -0.881 . . . . 78.629999999999995 110.058 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -76.41 3.07 11.89 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.601 -0.727 . . . . 42.490000000000002 110.94 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.691 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -109.74 146.43 34.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.448 0.642 . . . . 53.210000000000001 109.475 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 16.1 tp -77.02 141.07 40.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.696 . . . . 57.0 110.11 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.7 m -96.06 124.57 40.12 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.331 -1.347 . . . . 53.009999999999998 107.771 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.22 142.15 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.507 -0.923 . . . . 56.119999999999997 108.507 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -113.35 157.27 22.06 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 108.507 -0.923 . . . . 97.849999999999994 108.507 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.27 141.51 41.65 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.199 -1.4 . . . . 88.319999999999993 108.634 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.52 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.637 -0.985 . . . . 35.810000000000002 110.637 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -130.53 151.92 50.47 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 118.389 1.095 . . . . 61.780000000000001 109.791 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.63 133.99 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 107.799 -1.186 . . . . 105.08 107.799 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.85 134.76 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.735 -0.839 . . . . 48.770000000000003 108.735 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.496 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.76 126.53 34.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.822 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.92 113.18 8.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.974 -0.75 . . . . 81.370000000000005 108.974 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.3 mt -74.4 -52.35 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 123.624 0.77 . . . . 70.599999999999994 110.942 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.99 149.24 27.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.345 -0.983 . . . . 65.189999999999998 108.345 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.482 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.42 163.89 23.48 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.485 0.66 . . . . 125.5 110.515 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.2 172.54 8.99 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.782 1.633 . . . . 66.569999999999993 109.907 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 23.2 p -59.79 -136.4 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.934 -1.03 . . . . 91.459999999999994 112.269 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 18.1 mm -84.73 -22.79 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 121.693 -0.63 . . . . 103.65000000000001 112.121 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.62 119.28 7.8 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.098 0.407 . . . . 115.16 112.098 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 25.2 t -92.89 92.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.899 -0.591 . . . . 50.439999999999998 110.011 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 160.21 -12.15 0.17 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.358 -0.837 . . . . 34.159999999999997 111.294 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.575 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 96.6 m95 -117.45 150.2 39.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.872 0.368 . . . . 81.450000000000003 111.093 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.482 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 1.1 m0 -159.76 174.4 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.109 -0.951 . . . . 93.810000000000002 108.739 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.59 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -133.68 143.13 48.35 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.767 -0.827 . . . . 89.719999999999999 108.767 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.9 168.95 31.87 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.38 -1.888 . . . . 24.219999999999999 108.38 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.803 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.86 129.59 56.4 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.588 -0.845 . . . . 56.969999999999999 109.707 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 61.9 tp -142.52 135.65 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.104 -1.073 . . . . 59.329999999999998 108.104 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.14 37.69 29.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.546 -0.538 . . . . 46.140000000000001 109.546 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.02 87.78 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.148 -1.025 . . . . 26.489999999999998 110.723 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.803 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.5 160.29 36.92 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.378 1.089 . . . . 98.989999999999995 108.632 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.2 124.85 35.63 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.655 -1.239 . . . . 109.22 107.655 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.8 164.12 36.76 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.125 -1.59 . . . . 26.510000000000002 109.125 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.59 HG12 ' HG2' ' A' ' 308' ' ' GLU . 11.5 m -89.17 145.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 122.75 0.42 . . . . 54.609999999999999 111.497 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.11 151.36 24.32 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 120.525 -0.47 . . . . 74.469999999999999 110.47 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.469 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.2 Cg_endo -70.23 123.37 9.88 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.071 0.514 . . . . 111.89 112.062 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.87 -15.27 18.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.518 1.136 . . . . 119.27 111.462 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 323' ' ' VAL . 12.5 m-20 -62.52 -39.35 93.28 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 109.347 -0.612 . . . . 96.629999999999995 109.347 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -56.76 -4.16 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.363 -0.835 . . . . 74.849999999999994 112.642 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 274' ' ' VAL . 0.7 OUTLIER -127.56 145.91 34.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.684 -0.487 . . . . 67.239999999999995 109.684 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER -90.07 139.96 30.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.122 -0.695 . . . . 130.62 109.122 178.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.559 HD22 ' SG ' ' A' ' 272' ' ' CYS . 36.5 mt -89.1 135.21 33.68 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.116 -1.068 . . . . 63.159999999999997 108.116 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.08 44.5 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 105.751 -1.944 . . . . 97.620000000000005 105.751 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.1 Cg_exo -64.02 -33.8 61.13 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.547 1.326 . . . . 152.83000000000001 115.547 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.301 -1.933 0 CA-C-N 121.352 1.519 . . . . 59.969999999999999 109.279 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.86 140.22 32.55 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.292 0.568 . . . . 29.010000000000002 110.136 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -120.61 168.21 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.011 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.38 139.26 53.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.598 0.237 . . . . 0.0 111.045 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.492 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.23 124.19 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.659 -0.867 . . . . 4.9900000000000002 108.659 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.08 135.75 42.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.008 0.432 . . . . 5.6799999999999997 110.422 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -79.89 -155.05 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.615 -0.72 . . . . 26.890000000000001 111.274 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' B' ' 71' ' ' LEU . 4.0 mt -66.61 -40.81 89.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.658 0.614 . . . . 23.289999999999999 112.658 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -92.14 2.41 56.61 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.762 0.315 . . . . 0.0 111.581 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.42 15.73 52.2 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.335 -0.459 . . . . 0.0 113.957 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 73.5 tttt -49.76 157.99 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.2 -0.588 . . . . 8.5099999999999998 111.619 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -106.33 128.24 53.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.682 -0.858 . . . . 1.8799999999999999 108.682 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.03 122.64 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 123.31 0.381 . . . . 37.689999999999998 110.83 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -101.97 131.26 48.49 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.21 149.85 49.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.592 0.234 . . . . 9.4600000000000009 110.998 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.53 122.19 43.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.25 -1.759 . . . . 1.54 106.25 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.07 168.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.486 0.66 . . . . 0.0 111.467 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.86 149.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.12 -24.45 58.53 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 CA-C-N 120.836 1.334 . . . . 0.0 112.97 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -85.25 -2.6 58.22 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.001 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.5 50.53 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.961 -1.126 . . . . 1.4299999999999999 107.961 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -86.88 157.79 19.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.747 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.2 -39.89 84.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.947 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.08 -37.69 80.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.24 -42.85 88.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.61 -41.79 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.0 -39.93 87.46 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.25 89.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.31 -39.07 92.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.492 HD11 HG21 ' B' ' 5' ' ' VAL . 33.0 mt -65.11 -40.03 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.05 -44.05 94.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.493 0.663 . . . . 1.3200000000000001 109.36 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.88 -40.4 92.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.957 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.081 1.141 . . . . 0.82999999999999996 114.081 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.95 -14.51 13.94 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.156 1.91 . . . . 6.1200000000000001 116.156 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.2 11.02 82.95 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.245 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.26 64.94 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.632 -0.507 . . . . 3.54 109.632 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.65 134.68 62.33 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.098 1.199 . . . . 0.0 112.433 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.33 -32.21 25.17 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.887 2.391 . . . . 0.0 114.643 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.85 -15.91 62.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.913 0.779 . . . . 2.8799999999999999 112.126 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.12 8.13 44.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.754 0.279 . . . . 7.1699999999999999 111.754 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.81 144.29 31.34 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.598 0.592 . . . . 13.42 112.598 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -138.82 114.8 10.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.341 -0.985 . . . . 27.09 108.341 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 130.39 43.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.364 0.602 . . . . 1.8700000000000001 110.837 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -139.43 130.66 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.932 -0.48 . . . . 17.75 110.931 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.59 ' CD2' HG12 ' B' ' 61' ' ' ILE . 91.5 t80 -132.25 136.4 46.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.555 -0.293 . . . . 16.98 110.244 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.9 39.77 26.6 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 123.474 0.484 . . . . 0.0 111.709 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 65.35 22.27 69.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 115.605 1.002 . . . . 48.659999999999997 115.605 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.94 132.1 56.44 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.07 0.935 . . . . 4.25 111.737 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -68.2 115.58 7.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.896 -0.593 . . . . 30.57 110.158 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -81.93 134.22 35.37 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.122 0.487 . . . . 22.77 111.787 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.81 149.43 24.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.5 -0.773 . . . . 9.3399999999999999 111.467 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.64 -20.12 63.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.22 6.03 68.49 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.533 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.89 13.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.152 0.476 . . . . 1.8600000000000001 111.621 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.6 p -105.37 166.43 10.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.657 0.741 . . . . 0.0 112.596 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.11 -41.9 93.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.674 -1.148 . . . . 2.2799999999999998 110.659 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.55 -30.98 71.0 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.063 -0.655 . . . . 2.98 111.811 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.14 -29.0 70.04 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.715 -0.394 . . . . 1.77 110.419 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.94 14.52 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.03 39.4 18.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.095 -1.076 . . . . 4.0099999999999998 108.095 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.17 8.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.303 0.573 . . . . 5.7400000000000002 112.155 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.55 141.37 16.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.222 -0.899 . . . . 4.3099999999999996 111.458 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 67.12 23.15 9.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.978 -1.01 . . . . 10.130000000000001 112.81 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.2 m -77.27 146.72 36.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.972 -1.121 . . . . 4.0999999999999996 107.972 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m -120.86 131.35 54.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.75 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mp -111.09 -177.68 3.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.667 -0.697 . . . . 19.210000000000001 110.669 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -124.45 144.15 50.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.978 -0.379 . . . . 50.0 109.978 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 69' ' ' LEU . 4.2 mt -129.95 154.55 47.24 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.08 0.467 . . . . 21.579999999999998 111.638 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.86 167.03 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.693 -0.685 . . . . 25.969999999999999 110.07 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.512 ' HB2' ' CD1' ' B' ' 8' ' ' LEU . 3.8 mt -135.68 -79.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.007 0.373 . . . . 1.6699999999999999 112.007 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -158.51 -166.14 1.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.87 0.367 . . . . 23.710000000000001 111.009 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.58 -46.96 57.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.888 -0.596 . . . . 15.09 110.409 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.472 ' NH2' ' OD2' ' A' ' 300' ' ' ASP . 1.1 ttt85 -174.21 159.69 3.22 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.751 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.85 -100.47 1.87 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.661 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.566 -0.731 . . . . 1.8600000000000001 111.372 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 121.585 0.707 . . . . 137.63999999999999 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.897 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.523 -0.762 . . . . 89.760000000000005 111.346 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.897 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.6 12.62 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 121.777 -0.577 . . . . 143.71000000000001 109.549 -177.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.21 135.8 51.21 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.454 -0.573 . . . . 62.810000000000002 109.454 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.599 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.9 m-85 -107.23 134.44 50.32 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.505 -0.924 . . . . 73.75 108.505 176.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 52.1 m -129.63 135.45 48.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.726 -0.842 . . . . 54.439999999999998 108.726 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.678 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.71 135.57 33.99 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.203 -1.036 . . . . 88.159999999999997 108.203 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 276' ' ' PHE . 89.8 t -100.85 115.95 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 C-N-CA 118.028 -1.469 . . . . 73.900000000000006 110.823 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.707 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -98.12 16.58 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.655 0.983 . . . . 138.47999999999999 113.655 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 276' ' ' PHE . . . . . 0.717 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 10.8 m-85 -136.63 143.01 41.22 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 122.261 -0.275 . . . . 67.980000000000004 110.456 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.86 134.53 12.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.573 2.182 . . . . 72.540000000000006 112.281 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.61 96.39 4.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.794 -0.639 . . . . 82.870000000000005 110.776 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.55 120.58 21.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.125 -0.488 . . . . 66.180000000000007 109.732 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.52 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.288 0.847 . . . . 50.240000000000002 113.288 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.542 ' OE1' HG21 ' B' ' 70' ' ' VAL . 26.1 mt-30 -85.17 -41.99 15.14 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.448 -0.575 . . . . 128.65000000000001 109.448 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -146.83 176.39 9.92 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.872 -1.143 . . . . 67.609999999999999 111.455 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.89 -30.82 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.152 -0.931 . . . . 78.629999999999995 110.621 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.37 -6.26 57.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.924 -0.58 . . . . 42.490000000000002 110.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.404 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -108.75 147.09 32.52 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.31 0.576 . . . . 53.210000000000001 109.479 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.405 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 13.9 tp -83.42 137.93 33.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.599 -0.728 . . . . 57.0 110.014 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.6 m -95.78 124.53 39.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.311 -1.356 . . . . 53.009999999999998 107.793 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.25 141.68 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.489 -0.93 . . . . 56.119999999999997 108.489 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 50.3 mmtt -120.7 162.98 18.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.713 -0.847 . . . . 97.849999999999994 108.713 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.19 141.53 41.78 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 118.028 -1.469 . . . . 88.319999999999993 108.744 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.64 21.59 21.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.582 -1.007 . . . . 35.810000000000002 110.582 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.5 151.91 50.46 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 118.459 1.13 . . . . 61.780000000000001 109.873 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.54 133.99 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.724 -1.213 . . . . 105.08 107.724 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.82 134.75 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.759 -0.83 . . . . 48.770000000000003 108.759 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.599 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.1 t -85.74 126.56 34.07 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.886 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.97 113.23 8.79 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.885 -0.783 . . . . 81.370000000000005 108.885 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.6 mt -74.49 -52.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.655 0.782 . . . . 70.599999999999994 110.891 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.96 149.21 27.97 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.471 -0.937 . . . . 65.189999999999998 108.471 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.719 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.32 163.79 23.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.551 0.691 . . . . 125.5 110.533 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 306' ' ' TRP . 39.7 t0 -89.2 170.6 10.46 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.795 1.638 . . . . 66.569999999999993 109.908 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 14.5 p -60.16 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.72 -1.127 . . . . 91.459999999999994 111.769 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.87 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 121.733 -0.604 . . . . 103.65000000000001 112.49 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -59.52 116.3 3.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.224 0.535 . . . . 115.16 111.757 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.4 t -79.26 115.61 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.604 -0.725 . . . . 50.439999999999998 110.123 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 175.74 -21.2 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.69 -0.686 . . . . 34.159999999999997 111.688 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.646 ' O ' ' HB2' ' A' ' 300' ' ' ASP . 99.0 m95 -118.48 153.25 34.45 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.391 0.139 . . . . 81.450000000000003 110.877 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.719 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.9 m0 -165.46 175.71 8.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.447 -0.946 . . . . 93.810000000000002 108.447 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.694 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -137.02 143.16 42.58 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.792 -0.818 . . . . 89.719999999999999 108.792 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.97 31.88 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 108.404 -1.878 . . . . 24.219999999999999 108.404 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.96 129.67 56.4 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 119.521 -0.872 . . . . 56.969999999999999 109.652 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 62.1 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.128 -1.064 . . . . 59.329999999999998 108.128 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.08 37.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.625 -0.509 . . . . 46.140000000000001 109.625 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.11 35.06 88.23 Favored Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.231 -0.985 . . . . 26.489999999999998 110.71 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.35 36.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 118.358 1.079 . . . . 98.989999999999995 108.609 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.27 124.71 35.13 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.744 -1.206 . . . . 109.22 107.744 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.405 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.78 164.31 36.87 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.077 -1.609 . . . . 26.510000000000002 109.077 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 308' ' ' GLU . 1.7 m -96.52 150.97 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.327 0.651 . . . . 54.609999999999999 111.887 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -153.69 151.37 25.0 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 120.287 -0.565 . . . . 74.469999999999999 110.495 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.88 8.47 Favored 'Trans proline' 0 CA--C 1.488 -1.824 0 C-N-CA 120.087 0.524 . . . . 111.89 112.085 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.524 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -71.08 -2.44 15.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 124.35 1.031 . . . . 119.27 112.035 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -61.94 -39.92 93.76 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.361 -0.607 . . . . 96.629999999999995 109.361 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 9.3 m-30 -74.98 7.24 3.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 74.849999999999994 112.061 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 274' ' ' VAL . 1.0 OUTLIER -136.01 159.29 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.252 -0.647 . . . . 67.239999999999995 109.252 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.88 146.66 43.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.688 -0.856 . . . . 130.62 108.688 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -86.79 135.29 33.41 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 108.104 -1.073 . . . . 63.159999999999997 108.104 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.06 44.44 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 105.748 -1.945 . . . . 97.620000000000005 105.748 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.7 Cg_exo -63.97 -33.76 61.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 N-CA-C 115.564 1.332 . . . . 152.83000000000001 115.564 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.302 -1.895 0 CA-C-N 121.385 1.531 . . . . 59.969999999999999 109.223 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.59 32.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.377 0.608 . . . . 29.010000000000002 110.158 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -119.3 164.38 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.946 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.464 ' O ' HD12 ' B' ' 67' ' ' LEU . 97.9 m-85 -120.73 139.34 53.22 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.644 0.259 . . . . 0.0 111.03 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.659 HG21 HD11 ' B' ' 30' ' ' ILE . 47.2 t -121.36 124.27 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.623 -0.881 . . . . 4.9900000000000002 108.623 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.07 138.4 38.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.948 0.404 . . . . 5.6799999999999997 110.428 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -81.21 -153.21 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.618 -0.719 . . . . 26.890000000000001 111.899 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -36.11 72.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.285 -0.416 . . . . 23.289999999999999 111.837 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -96.38 2.37 52.62 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.587 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.97 51.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.365 -0.445 . . . . 0.0 113.856 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 78.9 tttt -49.8 157.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.33 -0.512 . . . . 8.5099999999999998 111.649 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -106.69 127.99 53.82 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.785 -0.821 . . . . 1.8799999999999999 108.785 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.14 123.07 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 123.347 0.404 . . . . 37.689999999999998 110.9 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.87 131.25 48.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -127.13 149.99 49.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.644 0.259 . . . . 9.4600000000000009 110.906 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.72 122.14 43.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.14 -1.8 . . . . 1.54 106.14 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.93 168.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.563 0.697 . . . . 0.0 111.503 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.74 149.26 44.82 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.19 -24.48 59.27 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.872 1.347 . . . . 0.0 112.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.27 -2.48 58.1 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.97 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 142.6 50.35 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.961 -1.126 . . . . 1.4299999999999999 107.961 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -86.96 157.91 19.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.631 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.35 -39.82 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.942 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.19 -37.45 80.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.4 t-20 -66.41 -42.91 87.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.6 -41.71 88.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -59.94 -39.97 87.37 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.427 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.27 -39.08 92.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.659 HD11 HG21 ' B' ' 5' ' ' VAL . 32.2 mt -65.13 -40.02 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.06 -44.0 95.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.517 0.675 . . . . 1.3200000000000001 109.424 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.9 -40.4 92.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.963 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.44 -41.2 22.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.129 1.159 . . . . 0.82999999999999996 114.129 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.63 13.92 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.163 1.912 . . . . 6.1200000000000001 116.163 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.0 82.95 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.31 65.15 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.58 -0.526 . . . . 3.54 109.58 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.71 134.67 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.167 1.244 . . . . 0.0 112.444 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.46 -32.07 25.69 Favored 'Trans proline' 0 N--CA 1.507 2.307 0 C-N-CA 122.789 2.326 . . . . 0.0 114.662 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.78 -16.09 62.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 118.973 0.806 . . . . 2.8799999999999999 112.068 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.02 6.33 45.06 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.707 0.262 . . . . 7.1699999999999999 111.707 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.575 ' HB3' HD11 ' B' ' 69' ' ' LEU . 67.4 mt-30 -106.67 131.28 53.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.47 0.544 . . . . 13.42 112.47 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.539 ' HB3' HG12 ' B' ' 70' ' ' VAL . 40.2 ttm180 -117.72 114.73 23.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 27.09 107.811 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -100.57 128.99 46.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.37 0.605 . . . . 1.8700000000000001 110.825 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' B' ' 49' ' ' GLN . 2.6 pt -149.7 132.59 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.85 -0.614 . . . . 17.75 111.609 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.683 ' CD2' HG12 ' B' ' 61' ' ' ILE . 83.2 t80 -124.99 139.72 53.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.413 -0.358 . . . . 16.98 110.247 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.96 39.06 21.98 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 123.54 0.525 . . . . 0.0 111.717 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 65.35 21.75 68.75 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 115.865 1.106 . . . . 48.659999999999997 115.865 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.43 134.28 55.24 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.992 0.896 . . . . 4.25 111.879 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.521 ' HA ' HG22 ' B' ' 44' ' ' ILE . 88.5 mt-30 -65.89 119.2 10.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.911 -0.586 . . . . 30.57 111.053 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.449 ' HG ' ' HA ' ' B' ' 44' ' ' ILE . 63.5 mt -89.3 125.54 35.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.065 0.459 . . . . 22.77 112.009 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -99.35 149.54 23.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 9.3399999999999999 111.386 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.67 -20.15 63.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.18 6.03 68.59 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.609 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.98 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.162 0.481 . . . . 1.8600000000000001 111.706 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -105.45 166.48 10.4 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.753 0.787 . . . . 0.0 112.523 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.3 mt -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.662 -1.154 . . . . 2.2799999999999998 110.803 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.54 -31.04 71.04 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.086 -0.646 . . . . 2.98 111.809 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.09 -28.96 69.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.744 -0.383 . . . . 1.77 110.448 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.02 14.53 28.89 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.09 39.33 19.01 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.879 0.472 . . . . 0.0 112.19 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.683 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.4 124.09 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.049 -1.093 . . . . 4.0099999999999998 108.049 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 169.13 8.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.318 0.58 . . . . 5.7400000000000002 112.083 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.48 141.47 15.75 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.127 -0.942 . . . . 4.3099999999999996 111.485 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.97 23.19 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.04 -0.982 . . . . 10.130000000000001 112.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.456 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.21 146.7 36.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.963 -1.125 . . . . 4.0999999999999996 107.963 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 52.9 m -125.47 136.93 53.89 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.533 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' B' ' 45' ' ' PHE . 0.2 OUTLIER -112.25 -172.71 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.294 -0.412 . . . . 19.210000000000001 110.208 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.56 153.67 50.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.939 -0.393 . . . . 50.0 109.939 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' B' ' 41' ' ' GLN . 9.3 tp -126.55 158.05 37.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.835 0.35 . . . . 21.579999999999998 111.436 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 322' ' ' PHE . 7.8 p -115.11 140.7 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 25.969999999999999 110.607 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 70' ' ' VAL . 1.1 mp -147.6 114.92 6.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.313 -0.403 . . . . 1.6699999999999999 111.014 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -83.04 87.25 6.89 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.191 0.519 . . . . 23.710000000000001 110.05 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -151.57 -157.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.502 -0.772 . . . . 15.09 110.108 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.52 20.83 4.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 0.0 110.62 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.22 105.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.977 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.252 -0.88 . . . . 1.8600000000000001 110.391 179.185 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.515 0.674 . . . . 137.63999999999999 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.894 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.8 p -64.93 -56.75 11.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.523 -0.762 . . . . 89.760000000000005 111.375 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.894 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.07 166.57 12.6 Favored 'General case' 0 CA--C 1.494 -1.189 0 O-C-N 121.762 -0.586 . . . . 143.71000000000001 109.481 -177.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.19 135.77 51.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.489 -0.56 . . . . 62.810000000000002 109.489 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.464 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.9 m-85 -107.16 134.39 50.34 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.484 -0.932 . . . . 73.75 108.484 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' CYS . . . . . 0.404 ' SG ' HD22 ' A' ' 325' ' ' LEU . 50.4 m -129.55 135.39 48.53 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.789 -0.819 . . . . 54.439999999999998 108.789 -176.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.738 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.72 135.58 33.98 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.217 -1.031 . . . . 88.159999999999997 108.217 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.73 HG11 HD12 ' A' ' 288' ' ' ILE . 91.3 t -100.89 116.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 117.956 -1.498 . . . . 73.900000000000006 110.801 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -81.99 -41.62 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 121.622 -0.674 . . . . 138.47999999999999 112.277 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 276' ' ' PHE . . . . . 0.646 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -102.44 122.5 46.23 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 121.143 -0.223 . . . . 67.980000000000004 110.862 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.81 159.56 52.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.591 2.194 . . . . 72.540000000000006 112.264 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -124.45 86.74 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.626 -0.715 . . . . 82.870000000000005 109.995 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -56.78 116.46 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.414 -0.587 . . . . 66.180000000000007 109.414 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.59 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.646 1.216 . . . . 50.240000000000002 113.309 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 79.6 mt-30 -87.02 -39.18 15.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.844 -0.616 . . . . 128.65000000000001 109.369 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -148.38 175.52 11.04 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.064 -1.022 . . . . 67.609999999999999 111.736 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.04 -33.63 29.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.228 -0.896 . . . . 78.629999999999995 110.235 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.23 -2.77 42.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.688 -0.687 . . . . 42.490000000000002 111.087 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.379 0.609 . . . . 53.210000000000001 109.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.5 tp -85.57 135.82 33.65 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.343 -0.844 . . . . 57.0 110.156 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.529 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.7 m -95.68 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.106 -1.438 . . . . 53.009999999999998 107.805 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.73 HD12 HG11 ' A' ' 274' ' ' VAL . 49.1 pt -128.21 141.68 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.556 -0.905 . . . . 56.119999999999997 108.556 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.4 mmtt -117.04 158.96 23.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.419 -0.956 . . . . 97.849999999999994 108.419 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -76.08 141.56 41.98 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 118.458 -1.297 . . . . 88.319999999999993 108.665 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.58 21.66 21.11 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.65 -0.98 . . . . 35.810000000000002 110.65 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -130.51 151.91 50.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 118.393 1.097 . . . . 61.780000000000001 109.818 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.738 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.56 133.93 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.834 -1.173 . . . . 105.08 107.834 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 310' ' ' GLU . 92.4 t -122.73 134.81 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.743 -0.836 . . . . 48.770000000000003 108.743 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.81 126.64 34.17 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.189 -1.004 . . . . 128.84 108.783 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.08 113.27 8.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.894 -0.78 . . . . 81.370000000000005 108.894 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.46 -52.37 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 123.562 0.745 . . . . 70.599999999999994 110.919 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.95 149.15 27.92 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.474 -0.936 . . . . 65.189999999999998 108.474 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.572 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.43 163.82 23.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.533 0.683 . . . . 125.5 110.498 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.529 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.13 172.83 8.8 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.77 1.628 . . . . 66.569999999999993 109.868 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 4.7 p -60.77 -155.54 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.498 -0.774 . . . . 91.459999999999994 111.546 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 43.4 mm -64.42 -50.41 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 113.883 1.068 . . . . 103.65000000000001 113.883 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.18 120.67 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.647 0.61 . . . . 115.16 112.647 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -89.41 106.27 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.61 -0.723 . . . . 50.439999999999998 110.245 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 168.4 -14.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.217 -0.902 . . . . 34.159999999999997 110.88 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.529 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 92.6 m95 -126.33 156.06 41.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.279 -0.461 . . . . 81.450000000000003 111.253 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.572 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.2 m0 -163.81 -171.3 2.44 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.817 0.847 . . . . 93.810000000000002 108.772 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.694 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.1 mt-10 -145.85 143.06 29.38 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.869 -0.789 . . . . 89.719999999999999 108.869 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.88 168.97 31.86 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 108.448 -1.861 . . . . 24.219999999999999 108.448 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.795 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.92 129.7 56.38 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.558 -0.857 . . . . 56.969999999999999 109.688 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.65 135.69 28.35 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.039 -1.097 . . . . 59.329999999999998 108.039 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.01 37.82 29.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.597 -0.519 . . . . 46.140000000000001 109.597 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.01 35.18 88.97 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 110.683 -0.967 . . . . 26.489999999999998 110.683 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ARG . . . . . 0.795 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.31 36.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 118.349 1.074 . . . . 98.989999999999995 108.627 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.24 124.72 35.2 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.761 -1.199 . . . . 109.22 107.761 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.77 164.48 36.97 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 108.997 -1.641 . . . . 26.510000000000002 108.997 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.727 HG21 ' HG3' ' B' ' 74' ' ' ARG . 3.3 m -94.68 151.94 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.309 0.643 . . . . 54.609999999999999 112.041 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -152.98 151.41 26.21 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 120.206 -0.598 . . . . 74.469999999999999 110.49 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.946 ' HB3' HG11 ' B' ' 70' ' ' VAL . 6.2 Cg_endo -70.17 122.12 8.7 Favored 'Trans proline' 0 CA--C 1.488 -1.793 0 C-N-CA 120.105 0.537 . . . . 111.89 112.081 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -71.07 -14.71 62.41 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.3 1.0 . . . . 119.27 111.98 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -61.57 -40.34 94.38 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.926 -0.71 . . . . 96.629999999999995 109.422 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 2.9 m-30 -64.51 0.08 1.19 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.213 -0.903 . . . . 74.849999999999994 111.706 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 274' ' ' VAL . 1.0 OUTLIER -136.53 171.46 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.513 -0.551 . . . . 67.239999999999995 109.513 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HB2' HD11 ' A' ' 275' ' ' ILE . 0.6 OUTLIER -145.96 146.41 31.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 130.62 108.869 178.098 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.557 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -87.95 135.22 33.5 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 108.052 -1.092 . . . . 63.159999999999997 108.052 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.12 44.36 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 105.813 -1.921 . . . . 97.620000000000005 105.813 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.3 Cg_exo -64.0 -33.86 61.17 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 N-CA-C 115.54 1.323 . . . . 152.83000000000001 115.54 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.925 0 CA-C-N 121.393 1.533 . . . . 59.969999999999999 109.234 179.502 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.472 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.47 32.19 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.287 0.565 . . . . 29.010000000000002 110.149 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.9 pt -120.95 162.31 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.966 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' B' ' 66' ' ' THR . 97.9 m-85 -120.92 139.36 53.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.618 0.247 . . . . 0.0 110.977 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.646 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.33 124.13 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.64 -0.874 . . . . 4.9900000000000002 108.64 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.3 mttt -101.02 138.92 37.42 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.966 0.412 . . . . 5.6799999999999997 110.458 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -77.61 -157.65 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.693 -0.685 . . . . 26.890000000000001 111.898 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.937 ' HG ' HG13 ' B' ' 70' ' ' VAL . 1.3 tt -68.35 -37.81 80.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.705 -0.679 . . . . 23.289999999999999 111.671 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -94.94 2.44 55.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.555 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.9 51.71 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.365 -0.445 . . . . 0.0 113.905 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 79.6 tttt -50.42 158.36 0.61 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.329 -0.513 . . . . 8.5099999999999998 111.492 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -106.61 128.06 53.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.741 -0.837 . . . . 1.8799999999999999 108.741 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.42 121.93 56.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 O-C-N 123.372 0.42 . . . . 37.689999999999998 110.836 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.96 131.34 48.42 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -127.24 149.95 49.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.61 0.243 . . . . 9.4600000000000009 110.943 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.64 122.17 43.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.223 -1.769 . . . . 1.54 106.223 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.03 168.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.455 0.645 . . . . 0.0 111.478 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.86 149.35 45.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.29 -24.46 59.91 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 CA-C-N 120.799 1.321 . . . . 0.0 112.899 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -85.22 -2.54 58.16 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.071 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.28 142.59 50.5 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.906 -1.146 . . . . 1.4299999999999999 107.906 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -86.92 157.79 19.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.79 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.22 -39.93 84.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.948 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.67 80.29 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.33 -42.91 87.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.56 -41.76 89.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.495 ' HG2' HD11 ' B' ' 43' ' ' LEU . 20.5 mttt -60.01 -39.85 87.25 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.26 89.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.458 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.19 -39.2 92.53 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.646 HD11 HG21 ' B' ' 5' ' ' VAL . 32.8 mt -65.01 -40.07 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.03 -44.1 94.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.493 0.663 . . . . 1.3200000000000001 109.344 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.87 -40.29 92.44 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.98 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -81.58 -41.34 21.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.009 1.114 . . . . 0.82999999999999996 114.009 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.86 -14.59 13.96 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.167 1.914 . . . . 6.1200000000000001 116.167 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.07 82.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.244 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.411 HG23 HD21 ' B' ' 71' ' ' LEU . 17.1 mt -85.69 116.36 65.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.612 -0.514 . . . . 3.54 109.612 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.8 134.68 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 CA-C-N 120.361 1.165 . . . . 0.0 112.373 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.22 -32.31 24.65 Favored 'Trans proline' 0 N--CA 1.506 2.255 0 C-N-CA 122.818 2.345 . . . . 0.0 114.716 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.7 -16.02 62.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.829 0.74 . . . . 2.8799999999999999 112.171 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -100.07 6.3 44.98 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.741 0.274 . . . . 7.1699999999999999 111.741 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.33 121.23 42.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.82 0.674 . . . . 13.42 112.82 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -103.94 115.07 29.78 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.286 -1.005 . . . . 27.09 108.286 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.495 HD11 ' HG2' ' B' ' 27' ' ' LYS . 84.8 mt -102.59 127.64 49.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.305 0.574 . . . . 1.8700000000000001 110.886 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.594 HG22 ' O ' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -153.84 130.45 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.142 -0.481 . . . . 17.75 111.406 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.721 ' CD2' HG12 ' B' ' 61' ' ' ILE . 59.2 t80 -124.95 142.76 51.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.561 -0.29 . . . . 16.98 110.368 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' HE2' ' B' ' 48' ' ' LYS . . . 49.79 38.78 16.48 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.501 0.5 . . . . 0.0 111.653 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 60.3 28.25 66.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 115.164 0.826 . . . . 48.659999999999997 115.164 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.594 ' O ' HG22 ' B' ' 44' ' ' ILE . 44.8 mtmt -119.2 134.29 55.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 117.474 0.637 . . . . 4.25 111.747 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -64.47 114.69 4.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.424 -0.807 . . . . 30.57 110.684 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.59 125.75 34.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.943 0.402 . . . . 22.77 111.79 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -100.21 149.47 23.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.867 -0.606 . . . . 9.3399999999999999 111.493 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.67 -20.05 63.58 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.8 68.6 Favored Glycine 0 N--CA 1.476 1.309 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.491 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.36 163.93 13.85 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.295 0.548 . . . . 1.8600000000000001 111.674 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 49.6 p -105.35 166.3 10.52 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.679 0.752 . . . . 0.0 112.602 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.01 -41.91 93.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.664 -1.153 . . . . 2.2799999999999998 110.794 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.0 70.96 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 120.058 -0.657 . . . . 2.98 111.902 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.05 -29.09 70.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.728 -0.389 . . . . 1.77 110.467 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.87 14.45 28.9 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.13 39.36 19.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.923 0.489 . . . . 0.0 112.218 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.721 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.189 -1.041 . . . . 4.0099999999999998 108.189 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.09 8.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.27 0.557 . . . . 5.7400000000000002 112.191 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.46 141.38 15.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.25 -0.887 . . . . 4.3099999999999996 111.471 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.03 23.23 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.074 -0.967 . . . . 10.130000000000001 112.856 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.425 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.3 m -77.28 146.27 36.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.984 -1.117 . . . . 4.0999999999999996 107.984 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 53.2 m -126.31 136.29 52.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.596 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' B' ' 45' ' ' PHE . 0.0 OUTLIER -109.01 -177.78 3.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.232 -0.44 . . . . 19.210000000000001 110.256 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -118.55 147.33 43.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.956 -0.387 . . . . 50.0 109.956 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.2 113.91 3.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.945 0.402 . . . . 21.579999999999998 110.973 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.946 HG11 ' HB3' ' A' ' 319' ' ' PRO . 72.4 t -123.14 135.68 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 25.969999999999999 110.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.411 HD21 HG23 ' B' ' 36' ' ' ILE . 11.6 mt -84.13 130.65 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 1.6699999999999999 111.636 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -63.68 135.98 57.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.868 -0.606 . . . . 23.710000000000001 110.59 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.89 -63.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 15.09 110.745 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.727 ' HG3' HG21 ' A' ' 317' ' ' VAL . 6.0 ptp180 -99.02 10.66 41.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.87 33.13 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.821 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.492 -0.766 . . . . 1.8600000000000001 110.823 179.304 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 121.571 0.7 . . . . 137.63999999999999 110.331 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.91 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.85 -56.86 10.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.515 -0.766 . . . . 89.760000000000005 111.381 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.91 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.54 12.65 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.81 -0.556 . . . . 143.71000000000001 109.59 -177.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.13 135.78 51.13 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.445 -0.576 . . . . 62.810000000000002 109.445 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.455 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.7 m-85 -107.16 134.46 50.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.529 -0.915 . . . . 73.75 108.529 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.64 135.38 48.46 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.723 -0.844 . . . . 54.439999999999998 108.723 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.545 ' H ' ' CD1' ' A' ' 326' ' ' LEU . 40.7 tttp -92.7 135.59 33.97 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.254 -1.017 . . . . 88.159999999999997 108.254 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 323' ' ' VAL . 93.0 t -100.99 114.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 117.93 -1.508 . . . . 73.900000000000006 110.724 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 276' ' ' PHE . 8.3 pt -79.25 -34.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.954 -1.021 . . . . 138.47999999999999 112.981 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . 0.584 ' CG ' ' HD2' ' B' ' 68' ' ' HIS . 2.4 m-85 -108.23 90.52 6.96 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.478 0.18 . . . . 67.980000000000004 110.806 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 290' ' ' GLU . 65.6 Cg_endo -72.28 141.37 35.49 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.762 2.308 . . . . 72.540000000000006 113.375 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.402 ' CZ ' HD11 ' B' ' 44' ' ' ILE . 0.2 OUTLIER -101.74 -150.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.393 -0.821 . . . . 82.870000000000005 109.435 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -159.62 144.3 15.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.522 -0.918 . . . . 66.180000000000007 108.522 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -28.67 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.497 1.123 . . . . 50.240000000000002 113.574 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.569 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.48 -42.53 12.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.831 -0.622 . . . . 128.65000000000001 109.421 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.34 177.26 9.58 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.77 -0.582 . . . . 67.609999999999999 111.377 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.45 -34.4 28.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.309 -0.859 . . . . 78.629999999999995 110.443 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.13 -5.43 59.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 42.490000000000002 111.151 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.569 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 73.9 mt-10 -102.55 147.51 26.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.329 0.585 . . . . 53.210000000000001 109.533 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 309' ' ' GLY . 17.3 tp -85.69 133.12 34.04 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.135 -0.939 . . . . 57.0 110.196 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.442 ' O ' HD23 ' A' ' 311' ' ' LEU . 90.1 m -96.72 124.58 40.75 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.812 -1.555 . . . . 53.009999999999998 107.739 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.404 HD12 HG21 ' A' ' 274' ' ' VAL . 49.2 pt -128.29 141.42 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.554 -0.906 . . . . 56.119999999999997 108.554 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 14.4 mmtt -118.69 162.72 17.96 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.798 -0.815 . . . . 97.849999999999994 108.798 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . 0.529 ' N ' ' HB3' ' A' ' 277' ' ' PRO . 13.5 pt-20 -75.18 141.53 43.62 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.101 -1.439 . . . . 88.319999999999993 108.734 -174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.44 21.48 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.646 -0.982 . . . . 35.810000000000002 110.646 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.49 151.9 50.46 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.398 1.099 . . . . 61.780000000000001 109.829 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.455 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.0 mm -109.52 134.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.777 -1.194 . . . . 105.08 107.777 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.3 t -122.8 134.84 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.669 -0.863 . . . . 48.770000000000003 108.669 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.84 126.56 34.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.096 -1.042 . . . . 128.84 108.846 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -72.0 113.27 8.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.886 -0.783 . . . . 81.370000000000005 108.886 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.38 -52.45 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 123.765 0.826 . . . . 70.599999999999994 110.924 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.03 149.12 27.83 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.42 -0.955 . . . . 65.189999999999998 108.42 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.646 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.87 23.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.546 0.688 . . . . 125.5 110.581 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.714 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.19 171.22 9.96 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 125.86 1.664 . . . . 66.569999999999993 109.961 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 6.2 p -64.12 -133.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.665 -0.698 . . . . 91.459999999999994 112.29 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.9 mm -79.85 -53.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 112.898 0.703 . . . . 103.65000000000001 112.898 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.91 113.26 1.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.419 0.526 . . . . 115.16 112.419 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.87 106.48 13.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.583 -0.735 . . . . 50.439999999999998 109.971 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 165.21 -11.06 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.458 -0.792 . . . . 34.159999999999997 111.292 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.714 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 83.4 m95 -122.74 156.04 35.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.273 . . . . 81.450000000000003 110.485 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.646 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.6 m0 -168.22 -175.71 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 93.810000000000002 108.328 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.655 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -144.41 143.05 30.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.847 -0.797 . . . . 89.719999999999999 108.847 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -152.8 169.03 31.82 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.441 -1.864 . . . . 24.219999999999999 108.441 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.803 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.93 129.66 56.4 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.567 -0.853 . . . . 56.969999999999999 109.649 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 287' ' ' THR . 61.9 tp -142.63 135.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.102 -1.073 . . . . 59.329999999999998 108.102 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.11 37.77 29.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.552 -0.536 . . . . 46.140000000000001 109.552 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.09 35.07 88.39 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.269 -0.967 . . . . 26.489999999999998 110.745 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.803 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.44 160.35 36.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.989 -1.084 . . . . 98.989999999999995 108.521 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.29 124.74 35.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.749 -1.204 . . . . 109.22 107.749 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.74 163.71 36.47 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.082 -1.607 . . . . 26.510000000000002 109.082 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 308' ' ' GLU . 0.8 OUTLIER -98.09 151.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.65 0.38 . . . . 54.609999999999999 111.445 -178.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.75 151.43 26.63 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 120.999 0.428 . . . . 74.469999999999999 110.42 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.2 Cg_endo -70.19 122.02 8.6 Favored 'Trans proline' 0 CA--C 1.487 -1.825 0 C-N-CA 120.097 0.532 . . . . 111.89 112.041 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -78.92 -6.25 55.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 123.995 0.809 . . . . 119.27 111.833 -178.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.1 -40.77 97.01 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.386 -0.598 . . . . 96.629999999999995 109.386 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.42 2.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.852 -1.067 . . . . 74.849999999999994 111.788 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.637 ' HB ' HG22 ' A' ' 274' ' ' VAL . 1.9 m -132.24 155.54 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.555 -0.535 . . . . 67.239999999999995 109.555 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -116.61 163.96 15.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.143 -0.688 . . . . 130.62 109.143 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.557 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -93.67 135.17 35.22 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 108.127 -1.064 . . . . 63.159999999999997 108.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.07 44.55 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 105.785 -1.931 . . . . 97.620000000000005 105.785 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.3 Cg_exo -63.88 -33.87 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 N-CA-C 115.523 1.316 . . . . 152.83000000000001 115.523 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--N 1.302 -1.918 0 CA-C-N 121.387 1.531 . . . . 59.969999999999999 109.248 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.541 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.9 140.23 32.57 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.397 0.618 . . . . 29.010000000000002 110.121 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' B' ' 65' ' ' SER . 12.7 pt -119.21 156.15 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.021 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.577 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -121.12 139.31 53.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.931 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.528 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.29 124.16 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.671 -0.863 . . . . 4.9900000000000002 108.671 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -100.99 137.56 39.2 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.059 0.457 . . . . 5.6799999999999997 110.411 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -90.87 -149.95 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.543 -0.753 . . . . 26.890000000000001 111.6 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 306' ' ' TRP . 0.4 OUTLIER -62.57 -47.89 81.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.856 -0.611 . . . . 23.289999999999999 111.448 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -91.27 2.26 56.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.556 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.48 16.37 49.75 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.881 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 82.6 tttt -43.62 150.05 0.25 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 122.223 -0.574 . . . . 8.5099999999999998 111.778 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -106.54 128.1 53.85 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.718 -0.845 . . . . 1.8799999999999999 108.718 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' B' ' 4' ' ' PHE . 69.4 mt -123.96 121.67 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 O-C-N 123.289 0.368 . . . . 37.689999999999998 110.953 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.47 131.22 47.72 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -127.19 149.9 49.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.624 0.25 . . . . 9.4600000000000009 110.935 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.57 122.13 43.77 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.271 -1.751 . . . . 1.54 106.271 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.95 168.32 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.487 0.66 . . . . 0.0 111.493 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.84 149.2 44.82 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.2 -24.47 59.27 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 CA-C-N 120.772 1.311 . . . . 0.0 112.954 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.21 -2.56 58.17 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.069 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.63 50.52 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.94 -1.133 . . . . 1.4299999999999999 107.94 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -87.03 157.89 19.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.687 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.447 HG23 HD12 ' B' ' 43' ' ' LEU . 35.8 mm -61.29 -39.91 84.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.921 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.04 -37.64 80.38 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.36 -42.85 87.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.64 -41.68 89.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.27 89.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.451 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.3 -39.13 92.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.528 HD11 HG21 ' B' ' 5' ' ' VAL . 32.6 mt -65.05 -40.04 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.04 -44.04 94.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.518 0.675 . . . . 1.3200000000000001 109.39 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.85 -40.35 92.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.036 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -41.22 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.033 1.123 . . . . 0.82999999999999996 114.033 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -110.93 -14.7 13.92 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.049 1.87 . . . . 6.1200000000000001 116.049 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.06 82.93 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.322 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -85.82 116.48 65.83 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 109.507 -0.553 . . . . 3.54 109.507 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.93 134.64 61.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.086 1.19 . . . . 0.0 112.339 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.32 -32.22 25.08 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.751 2.301 . . . . 0.0 114.654 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.71 -15.99 62.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.976 0.807 . . . . 2.8799999999999999 112.182 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.08 8.69 43.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.732 0.271 . . . . 7.1699999999999999 111.732 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.469 ' OE1' HG21 ' B' ' 30' ' ' ILE . 44.0 mt-30 -117.65 125.84 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.13 0.789 . . . . 13.42 113.13 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -111.83 124.03 51.49 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.019 -1.104 . . . . 27.09 108.019 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.447 HD12 HG23 ' B' ' 23' ' ' ILE . 84.8 mt -98.41 132.69 43.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.289 0.566 . . . . 1.8700000000000001 110.836 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.402 HD11 ' CZ ' ' A' ' 278' ' ' TYR . 3.6 mp -132.04 135.57 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.062 -0.399 . . . . 17.75 111.631 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.52 ' CD1' HG12 ' B' ' 61' ' ' ILE . 15.0 t80 -152.92 143.26 22.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.114 -0.494 . . . . 16.98 109.944 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.5 34.75 25.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.681 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.487 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 73.1 -10.74 5.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.013 -0.994 . . . . 48.659999999999997 114.863 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -107.94 132.64 53.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 120.005 -0.678 . . . . 4.25 111.76 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -58.82 116.98 4.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.14 -0.482 . . . . 30.57 110.126 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 45' ' ' PHE . 21.3 mt -66.6 131.49 46.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.957 -0.565 . . . . 22.77 112.046 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -97.53 149.43 22.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.851 -0.613 . . . . 9.3399999999999999 111.45 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.64 -20.2 63.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.96 68.7 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.54 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.43 163.91 13.89 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.17 0.485 . . . . 1.8600000000000001 111.581 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.2 p -105.33 166.33 10.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.611 0.719 . . . . 0.0 112.604 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.9 mt -60.04 -41.99 93.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.672 -1.149 . . . . 2.2799999999999998 110.763 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.33 -31.21 71.07 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.111 -0.636 . . . . 2.98 111.763 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -62.14 -28.87 69.94 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.687 -0.405 . . . . 1.77 110.477 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.98 14.56 28.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.4 19.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.9 0.48 . . . . 0.0 112.207 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.52 HG12 ' CD1' ' B' ' 45' ' ' PHE . 96.8 mt -81.46 123.92 38.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.106 -1.072 . . . . 4.0099999999999998 108.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.88 169.21 8.68 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.281 0.563 . . . . 5.7400000000000002 112.097 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 56.9 pttt -51.59 141.41 16.31 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.184 -0.916 . . . . 4.3099999999999996 111.502 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.04 23.21 9.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.05 -0.977 . . . . 10.130000000000001 112.845 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' B' ' 3' ' ' ILE . 38.1 m -77.3 146.93 36.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.87 -1.159 . . . . 4.0999999999999996 107.87 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.577 HG23 ' HB2' ' B' ' 4' ' ' PHE . 78.0 m -122.64 132.2 54.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.4 171.74 7.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 19.210000000000001 109.789 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . 0.584 ' HD2' ' CG ' ' A' ' 276' ' ' PHE . 1.3 m-70 -119.96 135.59 54.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 12.6 tp -138.42 157.18 46.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.043 0.449 . . . . 21.579999999999998 111.193 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' HG3' ' A' ' 319' ' ' PRO . 2.1 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.873 -0.603 . . . . 25.969999999999999 109.848 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 121.589 0.709 . . . . 137.63999999999999 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.9 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 51.8 p -64.87 -56.99 10.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.528 -0.76 . . . . 89.760000000000005 111.26 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.9 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.88 166.63 12.63 Favored 'General case' 0 CA--C 1.491 -1.302 0 O-C-N 121.826 -0.546 . . . . 143.71000000000001 109.592 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.18 135.8 51.17 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.437 -0.579 . . . . 62.810000000000002 109.437 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 61.0 m-85 -107.18 134.44 50.29 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.515 -0.921 . . . . 73.75 108.515 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.6 135.4 48.5 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.747 -0.834 . . . . 54.439999999999998 108.747 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.651 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.7 tttp -92.66 135.52 34.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.251 -1.018 . . . . 88.159999999999997 108.251 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 288' ' ' ILE . 90.4 t -100.84 116.46 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 118.038 -1.465 . . . . 73.900000000000006 110.782 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 33.0 mm -78.38 -78.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.9 -0.591 . . . . 138.47999999999999 112.099 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' B' ' 68' ' ' HIS . 20.7 m-85 -68.95 131.71 90.79 Favored Pre-proline 0 N--CA 1.462 0.147 0 N-CA-C 109.692 -0.484 . . . . 67.980000000000004 109.692 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.532 ' CD ' ' HA2' ' B' ' 47' ' ' GLY . 30.8 Cg_endo -63.78 149.75 90.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.727 2.285 . . . . 72.540000000000006 111.807 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 288' ' ' ILE . 63.6 t80 -121.41 92.45 3.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.955 -0.566 . . . . 82.870000000000005 110.446 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -68.18 116.14 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.873 -0.603 . . . . 66.180000000000007 109.729 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.35 104.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.403 1.065 . . . . 50.240000000000002 112.98 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.541 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -81.71 -40.28 23.0 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.398 -0.593 . . . . 128.65000000000001 109.398 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -144.85 175.39 10.23 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.281 -0.887 . . . . 67.609999999999999 111.691 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.67 -31.03 32.43 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.334 -0.848 . . . . 78.629999999999995 109.696 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 -3.59 43.96 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.327 -0.851 . . . . 42.490000000000002 110.939 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.5 146.51 37.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.401 0.62 . . . . 53.210000000000001 109.486 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.432 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.7 tp -76.79 138.72 40.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.525 -0.762 . . . . 57.0 110.066 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.8 m -96.45 124.49 40.47 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.33 -1.348 . . . . 53.009999999999998 107.767 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.2 142.16 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.542 -0.91 . . . . 56.119999999999997 108.542 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -113.82 158.3 21.19 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.396 -0.964 . . . . 97.849999999999994 108.396 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.48 141.52 41.26 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 118.077 -1.449 . . . . 88.319999999999993 108.642 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.63 21.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.572 -1.011 . . . . 35.810000000000002 110.572 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.49 151.87 50.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.436 1.118 . . . . 61.780000000000001 109.825 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.3 mm -109.56 133.95 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.817 -1.179 . . . . 105.08 107.817 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.74 134.8 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.718 -0.845 . . . . 48.770000000000003 108.718 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.82 126.61 34.16 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.131 -1.028 . . . . 128.84 108.825 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.97 113.22 8.78 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.899 -0.778 . . . . 81.370000000000005 108.899 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.41 -52.43 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.733 0.813 . . . . 70.599999999999994 110.92 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.97 149.2 27.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.475 -0.935 . . . . 65.189999999999998 108.475 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.524 ' HG3' ' NE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.79 23.62 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.433 0.635 . . . . 125.5 110.594 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.18 174.3 7.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.801 1.64 . . . . 66.569999999999993 109.93 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 3.9 p -58.0 -144.72 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.994 0.739 . . . . 91.459999999999994 112.994 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.414 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 45.8 mm -71.02 -57.52 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.907 1.077 . . . . 103.65000000000001 113.907 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -50.53 127.57 18.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.096 0.776 . . . . 115.16 113.096 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.88 112.82 26.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.408 -0.815 . . . . 50.439999999999998 110.446 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 158.3 -13.56 0.25 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.922 -0.871 . . . . 34.159999999999997 110.922 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 92.4 m95 -122.7 147.56 46.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.372 -0.414 . . . . 81.450000000000003 110.913 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.626 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 7.2 m0 -157.81 -177.48 6.61 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.782 0.676 . . . . 93.810000000000002 109.435 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.763 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -138.14 143.06 40.14 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.851 -0.796 . . . . 89.719999999999999 108.851 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.86 168.89 31.84 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 108.448 -1.861 . . . . 24.219999999999999 108.448 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.792 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.84 129.75 56.34 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 119.503 -0.879 . . . . 56.969999999999999 109.673 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.68 135.57 28.17 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.1 -1.074 . . . . 59.329999999999998 108.1 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.13 37.78 29.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.499 -0.556 . . . . 46.140000000000001 109.499 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.13 35.04 88.1 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.193 -1.004 . . . . 26.489999999999998 110.699 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.792 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.4 160.3 36.78 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 119.029 -1.069 . . . . 98.989999999999995 108.598 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -129.22 124.78 35.38 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.738 -1.208 . . . . 109.22 107.738 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.82 163.96 36.67 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.071 -1.612 . . . . 26.510000000000002 109.071 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.763 HG12 ' HG2' ' A' ' 308' ' ' GLU . 1.6 m -96.42 151.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 122.734 0.413 . . . . 54.609999999999999 111.456 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -155.23 151.4 22.68 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 120.634 -0.427 . . . . 74.469999999999999 110.425 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.22 121.89 8.46 Favored 'Trans proline' 0 CA--C 1.486 -1.88 0 C-N-CA 120.053 0.502 . . . . 111.89 112.094 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.626 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.1 OUTLIER -74.76 -0.44 18.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 124.158 0.912 . . . . 119.27 111.976 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.512 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.95 -42.64 98.61 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.448 -0.575 . . . . 96.629999999999995 109.448 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 68' ' ' HIS . 4.6 m-85 -73.55 9.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.523 -0.762 . . . . 74.849999999999994 112.683 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.57 164.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.589 -0.523 . . . . 67.239999999999995 109.589 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.08 154.67 47.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.341 -0.614 . . . . 130.62 109.341 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -92.22 135.26 34.15 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.11 -1.07 . . . . 63.159999999999997 108.11 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.05 44.61 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 105.803 -1.925 . . . . 97.620000000000005 105.803 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.97 -33.82 61.64 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.59 1.342 . . . . 152.83000000000001 115.59 -175.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 CA--C 1.486 -1.908 0 CA-C-N 121.385 1.53 . . . . 59.969999999999999 109.308 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.88 140.7 31.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.243 0.545 . . . . 29.010000000000002 110.197 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.8 pt -116.27 161.55 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.827 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.84 139.3 53.79 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.585 0.231 . . . . 0.0 110.975 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.577 HG21 HD11 ' B' ' 30' ' ' ILE . 46.9 t -121.24 124.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.641 -0.874 . . . . 4.9900000000000002 108.641 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.13 139.57 36.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 5.6799999999999997 110.471 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -91.3 -142.59 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.612 -0.722 . . . . 26.890000000000001 111.788 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 8' ' ' LEU . 1.1 tm? -73.49 -42.13 62.23 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.119 -0.491 . . . . 23.289999999999999 111.572 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -94.25 2.35 55.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.527 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.46 16.32 49.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.786 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 77.6 tttt -46.8 153.45 0.4 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.363 -0.492 . . . . 8.5099999999999998 111.568 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -107.06 127.77 53.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.722 -0.844 . . . . 1.8799999999999999 108.722 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.82 121.75 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.233 0.333 . . . . 37.689999999999998 110.931 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.45 131.18 47.7 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -127.12 149.94 49.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.678 0.275 . . . . 9.4600000000000009 110.935 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.6 122.12 43.75 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 106.185 -1.783 . . . . 1.54 106.185 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.92 168.41 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.524 0.678 . . . . 0.0 111.468 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.94 149.28 45.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.24 -24.43 59.36 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 CA-C-N 120.832 1.333 . . . . 0.0 112.93 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.28 -2.59 58.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.001 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.22 142.57 50.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.958 -1.127 . . . . 1.4299999999999999 107.958 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.91 157.79 19.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.704 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.24 -39.88 84.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.011 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.71 80.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.32 -42.87 87.59 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -60.64 -41.7 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.96 -40.0 87.52 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.18 89.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.516 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.15 -39.25 92.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.577 HD11 HG21 ' B' ' 5' ' ' VAL . 32.6 mt -65.09 -40.03 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.98 -44.08 94.72 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.609 0.719 . . . . 1.3200000000000001 109.441 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.82 -40.37 92.5 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.026 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -41.13 22.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.108 1.151 . . . . 0.82999999999999996 114.108 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.95 -14.57 13.93 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.15 1.907 . . . . 6.1200000000000001 116.15 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.1 82.95 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.393 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.81 116.4 65.52 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.566 -0.531 . . . . 3.54 109.566 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.67 61.97 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.101 1.201 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.48 -32.02 25.69 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.78 2.32 . . . . 0.0 114.694 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.75 -15.99 62.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.971 0.805 . . . . 2.8799999999999999 112.189 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.07 5.65 44.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.709 0.262 . . . . 7.1699999999999999 111.709 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -103.74 131.29 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.873 0.694 . . . . 13.42 112.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -119.3 113.86 21.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.256 -1.016 . . . . 27.09 108.256 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.417 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.3 mt -101.72 128.7 47.92 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.336 0.589 . . . . 1.8700000000000001 110.815 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 67.8 mt -143.87 136.05 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.278 -0.419 . . . . 17.75 111.109 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.605 ' CD2' HG12 ' B' ' 61' ' ' ILE . 94.5 t80 -131.72 134.92 46.4 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.307 -0.257 . . . . 16.98 110.307 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 39.31 21.7 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 123.435 0.459 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.532 ' HA2' ' CD ' ' A' ' 277' ' ' PRO . . . 66.98 22.85 72.55 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.522 0.969 . . . . 48.659999999999997 115.522 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.5 132.55 56.52 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.605 -0.938 . . . . 4.25 111.784 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -67.51 118.58 11.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.82 -0.627 . . . . 30.57 110.703 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' B' ' 43' ' ' LEU . 50.3 mt -86.25 126.11 34.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.229 0.455 . . . . 22.77 112.229 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -100.07 149.53 23.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.835 -0.62 . . . . 9.3399999999999999 111.433 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -69.65 -20.26 63.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.05 5.91 68.85 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.572 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.92 13.87 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.179 0.49 . . . . 1.8600000000000001 111.637 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.33 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.576 0.703 . . . . 0.0 112.67 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.91 -42.05 93.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.759 -1.109 . . . . 2.2799999999999998 110.747 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.4 -31.13 71.04 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.187 -0.605 . . . . 2.98 111.826 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.06 -28.94 69.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.773 -0.371 . . . . 1.77 110.459 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.01 14.51 28.93 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.16 39.28 19.16 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 122.977 0.511 . . . . 0.0 112.207 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.605 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.37 123.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.092 -1.077 . . . . 4.0099999999999998 108.092 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.96 169.15 8.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.23 0.538 . . . . 5.7400000000000002 112.114 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.0 pttt -51.56 141.45 16.11 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.19 -0.914 . . . . 4.3099999999999996 111.482 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.9 23.34 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.01 -0.996 . . . . 10.130000000000001 112.817 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.27 146.57 36.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 4.0999999999999996 107.952 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -123.45 133.06 54.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.13 179.01 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 19.210000000000001 109.927 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . 1.1 m170 -115.96 139.17 50.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.964 -0.384 . . . . 50.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -133.19 144.73 50.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 21.579999999999998 111.012 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.408 HG13 ' CZ ' ' A' ' 322' ' ' PHE . 3.7 m . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 25.969999999999999 110.661 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 121.529 0.681 . . . . 137.63999999999999 110.358 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.914 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.506 -0.77 . . . . 89.760000000000005 111.342 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.914 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.56 12.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 O-C-N 121.739 -0.601 . . . . 143.71000000000001 109.508 -177.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.11 135.81 51.08 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.48 -0.563 . . . . 62.810000000000002 109.48 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.551 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.0 m-85 -107.25 134.48 50.28 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.413 -0.958 . . . . 73.75 108.413 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.57 135.37 48.49 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.784 -0.821 . . . . 54.439999999999998 108.784 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.525 ' HB3' HD21 ' A' ' 326' ' ' LEU . 40.6 tttp -92.76 135.65 33.93 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.151 -1.055 . . . . 88.159999999999997 108.151 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.5 HG22 HG11 ' A' ' 323' ' ' VAL . 91.6 t -100.98 117.13 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 117.96 -1.496 . . . . 73.900000000000006 110.833 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.1 OUTLIER -96.71 -0.54 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.668 0.988 . . . . 138.47999999999999 113.668 -178.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . 0.675 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 5.1 m-85 -117.67 145.31 36.14 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 117.98 0.355 . . . . 67.980000000000004 111.089 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' B' ' 44' ' ' ILE . 68.5 Cg_endo -76.35 135.22 16.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.575 2.183 . . . . 72.540000000000006 112.352 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.47 ' HB3' HG13 ' A' ' 288' ' ' ILE . 64.6 t80 -130.58 111.2 12.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 82.870000000000005 110.585 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.39 127.27 40.18 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.187 -0.672 . . . . 66.180000000000007 109.187 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.05 108.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.134 0.896 . . . . 50.240000000000002 112.683 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.576 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.0 mt-30 -85.61 -43.04 13.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.468 -0.567 . . . . 128.65000000000001 109.468 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.23 178.56 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.435 -0.791 . . . . 67.609999999999999 111.815 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.34 -35.06 25.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.185 -0.916 . . . . 78.629999999999995 109.76 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -79.53 3.79 17.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.634 -0.712 . . . . 42.490000000000002 110.693 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.576 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 73.9 mt-10 -117.14 146.29 43.27 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.853 -0.612 . . . . 53.210000000000001 109.522 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.7 tp -83.08 140.98 32.35 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.613 -0.721 . . . . 57.0 110.032 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.426 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.2 m -95.66 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 118.514 -1.275 . . . . 53.009999999999998 107.765 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.21 141.79 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.555 -0.906 . . . . 56.119999999999997 108.555 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 31.7 mmtt -118.93 162.0 19.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.628 -0.879 . . . . 97.849999999999994 108.628 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.36 141.52 43.29 Favored 'General case' 0 CA--C 1.483 -1.619 0 C-N-CA 118.114 -1.434 . . . . 88.319999999999993 108.68 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.61 21.53 21.41 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.667 -0.973 . . . . 35.810000000000002 110.667 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.47 151.89 50.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 118.377 1.089 . . . . 61.780000000000001 109.87 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.551 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.1 mm -109.54 133.97 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.77 -1.196 . . . . 105.08 107.77 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 91.9 t -122.79 134.82 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.704 -0.85 . . . . 48.770000000000003 108.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.87 126.54 34.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.814 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.01 113.33 8.93 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.937 -0.764 . . . . 81.370000000000005 108.937 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.44 -52.41 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 123.682 0.793 . . . . 70.599999999999994 110.869 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.0 149.19 27.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.394 -0.965 . . . . 65.189999999999998 108.394 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.609 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.78 23.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.465 0.65 . . . . 125.5 110.585 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.663 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.12 172.74 8.87 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.847 1.659 . . . . 66.569999999999993 109.884 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 5.7 p -61.93 -149.5 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.939 -1.028 . . . . 91.459999999999994 111.402 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.405 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 47.9 mm -69.02 -55.44 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.248 0.833 . . . . 103.65000000000001 113.248 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -56.65 117.74 4.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.336 0.589 . . . . 115.16 112.277 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.6 t -82.92 113.21 21.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.434 -0.803 . . . . 50.439999999999998 110.254 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . 0.455 ' HA2' HD21 ' A' ' 321' ' ' ASN . . . 166.8 -22.97 0.12 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.951 -0.642 . . . . 34.159999999999997 111.827 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.663 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 15.7 m95 -112.75 154.36 26.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.48 -0.563 . . . . 81.450000000000003 109.48 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.609 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 0.8 OUTLIER -164.7 174.5 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.352 -0.61 . . . . 93.810000000000002 109.352 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.98 143.13 42.65 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.85 -0.796 . . . . 89.719999999999999 108.85 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.91 168.96 31.87 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.452 -1.859 . . . . 24.219999999999999 108.452 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.79 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.91 129.64 56.4 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.628 -0.829 . . . . 56.969999999999999 109.684 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 287' ' ' THR . 62.2 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.08 -1.081 . . . . 59.329999999999998 108.08 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.06 37.79 29.22 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.503 -0.554 . . . . 46.140000000000001 109.503 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.05 88.06 Favored Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.698 -0.961 . . . . 26.489999999999998 110.698 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.79 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.1 mmm-85 -132.43 160.29 36.84 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 118.348 1.074 . . . . 98.989999999999995 108.649 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -129.25 124.69 35.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.773 -1.195 . . . . 109.22 107.773 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.49 36.32 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.06 -1.616 . . . . 26.510000000000002 109.06 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.37 148.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.691 0.281 . . . . 54.609999999999999 111.27 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.53 151.4 23.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 120.982 0.42 . . . . 74.469999999999999 110.375 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.44 8.05 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.113 0.542 . . . . 111.89 112.027 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.12 -0.9 56.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.253 0.971 . . . . 119.27 112.018 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.514 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.24 -37.91 87.21 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.38 -0.6 . . . . 96.629999999999995 109.38 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 6.5 m-30 -56.87 -7.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.231 -0.895 . . . . 74.849999999999994 112.135 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 274' ' ' VAL . 0.8 OUTLIER -132.17 142.77 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 109.205 -0.665 . . . . 67.239999999999995 109.205 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -96.49 179.31 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.852 -0.425 . . . . 130.62 109.852 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.555 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.2 mt -89.15 135.19 33.7 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 108.086 -1.079 . . . . 63.159999999999997 108.086 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.4 129.05 44.52 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 105.817 -1.92 . . . . 97.620000000000005 105.817 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.8 Cg_exo -63.87 -33.85 62.65 Favored 'Trans proline' 0 N--CA 1.436 -1.911 0 N-CA-C 115.601 1.346 . . . . 152.83000000000001 115.601 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.947 0 CA-C-N 121.35 1.518 . . . . 59.969999999999999 109.234 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.488 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.94 140.68 31.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.42 0.629 . . . . 29.010000000000002 110.117 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -117.83 165.2 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.818 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.423 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -121.41 139.31 53.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.618 0.247 . . . . 0.0 111.059 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.546 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.23 124.18 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.661 -0.866 . . . . 4.9900000000000002 108.661 177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.3 mttt -101.01 137.89 38.78 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.026 0.441 . . . . 5.6799999999999997 110.487 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -90.35 -146.35 0.18 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.595 -0.73 . . . . 26.890000000000001 111.854 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -45.89 76.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.969 -0.56 . . . . 23.289999999999999 111.832 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -93.15 2.47 56.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.3 . . . . 0.0 111.511 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.33 16.6 49.38 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.426 -0.416 . . . . 0.0 113.915 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 80.1 tttt -46.96 154.41 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.317 -0.519 . . . . 8.5099999999999998 111.699 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -107.31 128.19 54.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.682 -0.858 . . . . 1.8799999999999999 108.682 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 77.3 mt -120.31 122.8 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 123.343 0.402 . . . . 37.689999999999998 111.039 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.75 131.24 48.15 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -127.25 149.92 49.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.69 0.281 . . . . 9.4600000000000009 110.905 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.57 122.19 43.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.19 -1.782 . . . . 1.54 106.19 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.98 168.34 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.495 0.664 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.88 149.3 45.07 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.18 -24.53 59.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 CA-C-N 120.767 1.31 . . . . 0.0 112.901 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 p -85.21 -2.6 58.22 Favored 'General case' 0 CA--C 1.526 0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.04 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -71.17 142.53 50.67 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.036 -1.098 . . . . 1.4299999999999999 108.036 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -86.93 157.89 19.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.704 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.25 -39.83 83.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.04 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.12 -37.64 80.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.31 -42.88 87.66 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.534 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.53 -41.72 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.98 -39.96 87.46 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.18 89.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.445 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.28 -39.12 92.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.546 HD11 HG21 ' B' ' 5' ' ' VAL . 33.1 mt -65.03 -40.07 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.1 -43.99 95.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.484 0.659 . . . . 1.3200000000000001 109.416 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.87 -40.35 92.64 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.97 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.56 -41.23 21.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.091 1.145 . . . . 0.82999999999999996 114.091 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.58 13.93 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.115 1.894 . . . . 6.1200000000000001 116.115 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.11 82.86 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.232 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.35 65.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.592 -0.521 . . . . 3.54 109.592 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.63 61.72 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.119 1.213 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -32.16 24.62 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.771 2.314 . . . . 0.0 114.723 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.82 -15.96 62.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.92 0.782 . . . . 2.8799999999999999 112.19 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.14 7.43 44.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.777 0.288 . . . . 7.1699999999999999 111.777 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -110.44 129.24 55.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.806 0.669 . . . . 13.42 112.806 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.625 ' HB2' HG21 ' B' ' 70' ' ' VAL . 7.0 mtt-85 -119.08 121.19 39.25 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.694 -1.225 . . . . 27.09 107.694 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.468 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.2 mt -98.89 129.5 45.24 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.351 0.596 . . . . 1.8700000000000001 110.85 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' B' ' 50' ' ' LEU . 0.6 OUTLIER -144.01 133.47 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.35 -0.387 . . . . 17.75 111.369 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.725 ' CD2' HG12 ' B' ' 61' ' ' ILE . 84.2 t80 -136.48 143.4 43.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.459 -0.337 . . . . 16.98 110.353 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.23 38.72 21.99 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.6 0.563 . . . . 0.0 111.639 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 63.59 18.13 60.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.524 0.97 . . . . 48.659999999999997 115.524 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.84 134.11 55.34 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.898 0.849 . . . . 4.25 111.798 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.446 ' HA ' HG22 ' B' ' 44' ' ' ILE . 23.6 mt-30 -65.2 119.03 10.13 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.149 -0.478 . . . . 30.57 110.87 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.468 HD12 ' HB3' ' B' ' 43' ' ' LEU . 47.4 mt -86.14 126.25 34.09 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.037 0.446 . . . . 22.77 111.829 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -97.84 149.47 22.33 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 9.3399999999999999 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -69.59 -20.22 63.64 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.1 5.96 68.75 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.93 13.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.225 0.513 . . . . 1.8600000000000001 111.585 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.36 10.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.655 0.741 . . . . 0.0 112.625 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.02 -41.8 92.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.69 -1.141 . . . . 2.2799999999999998 110.892 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -61.57 -31.11 71.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 120.053 -0.659 . . . . 2.98 111.794 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.98 -28.95 69.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.614 -0.435 . . . . 1.77 110.526 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.98 14.52 28.85 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.07 39.39 19.06 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.725 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.95 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.097 -1.075 . . . . 4.0099999999999998 108.097 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.98 169.19 8.7 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.249 0.547 . . . . 5.7400000000000002 112.103 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.57 141.4 16.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.185 -0.916 . . . . 4.3099999999999996 111.454 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.95 23.32 9.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.991 -1.004 . . . . 10.130000000000001 112.803 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.477 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.27 145.7 37.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.929 -1.138 . . . . 4.0999999999999996 107.929 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.423 HG23 ' HB2' ' B' ' 4' ' ' PHE . 89.8 m -122.32 134.77 54.65 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.297 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' B' ' 67' ' ' LEU . 0.0 OUTLIER -116.03 -175.27 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 19.210000000000001 110.414 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -118.71 139.08 52.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 50.0 109.941 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 16.5 tp -108.7 163.83 12.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 21.579999999999998 111.163 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.672 HG22 ' HZ ' ' A' ' 322' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 25.969999999999999 110.503 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.555 0.693 . . . . 137.63999999999999 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.909 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.2 p -64.88 -56.86 10.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.486 -0.779 . . . . 89.760000000000005 111.319 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.909 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.99 166.6 12.61 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 121.784 -0.573 . . . . 143.71000000000001 109.509 -177.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.21 135.83 51.17 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.424 -0.584 . . . . 62.810000000000002 109.424 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.561 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.23 134.45 50.31 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.475 -0.935 . . . . 73.75 108.475 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.61 135.43 48.55 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.756 -0.831 . . . . 54.439999999999998 108.756 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.681 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.74 135.62 33.95 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.245 -1.02 . . . . 88.159999999999997 108.245 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.534 HG22 HG11 ' A' ' 323' ' ' VAL . 92.4 t -101.02 116.27 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 C-N-CA 117.96 -1.496 . . . . 73.900000000000006 110.768 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -4.18 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.68 0.622 . . . . 138.47999999999999 112.68 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -117.16 127.7 26.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.736 0.303 . . . . 67.980000000000004 110.997 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.19 139.51 50.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.212 2.608 . . . . 72.540000000000006 112.188 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -129.97 82.63 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.955 -0.566 . . . . 82.870000000000005 110.585 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.13 126.63 29.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.092 -0.707 . . . . 66.180000000000007 109.092 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.99 104.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.393 1.058 . . . . 50.240000000000002 113.452 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.472 ' HG2' ' HE ' ' B' ' 42' ' ' ARG . 26.1 mt-30 -90.63 -41.34 11.39 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.935 -0.575 . . . . 128.65000000000001 109.491 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -146.96 177.21 9.31 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.159 -0.963 . . . . 67.609999999999999 111.673 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -82.0 -35.39 28.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.431 -0.804 . . . . 78.629999999999995 110.164 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -77.11 -3.67 40.54 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.684 -0.689 . . . . 42.490000000000002 111.028 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.36 146.54 36.93 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.428 0.632 . . . . 53.210000000000001 109.475 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.76 142.46 28.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 57.0 110.016 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.577 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.7 m -96.03 124.55 40.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.335 -1.346 . . . . 53.009999999999998 107.688 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.21 141.82 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.556 -0.905 . . . . 56.119999999999997 108.556 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 65.7 mmtt -116.2 156.61 26.23 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.428 -0.953 . . . . 97.849999999999994 108.428 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.67 141.56 42.72 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 118.275 -1.37 . . . . 88.319999999999993 108.697 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.54 21.36 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.65 -0.98 . . . . 35.810000000000002 110.65 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.52 151.94 50.45 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.397 1.098 . . . . 61.780000000000001 109.805 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.681 HD13 ' HA ' ' A' ' 273' ' ' LYS . 43.9 mm -109.52 134.02 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.807 -1.183 . . . . 105.08 107.807 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.82 134.84 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.671 -0.863 . . . . 48.770000000000003 108.671 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.85 126.61 34.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.799 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.02 113.29 8.89 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.877 -0.786 . . . . 81.370000000000005 108.877 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.8 mt -74.43 -52.43 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 123.596 0.758 . . . . 70.599999999999994 110.866 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.93 149.18 27.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.362 -0.977 . . . . 65.189999999999998 108.362 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.453 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.37 163.89 23.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.515 0.674 . . . . 125.5 110.554 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.22 173.65 8.29 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.856 1.663 . . . . 66.569999999999993 109.936 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 2.5 p -61.8 -158.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.514 -0.766 . . . . 91.459999999999994 111.398 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.416 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 48.7 mm -59.94 -50.48 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.19 1.182 . . . . 103.65000000000001 114.19 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.27 123.11 10.97 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.63 0.604 . . . . 115.16 112.63 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.67 111.7 24.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.563 -0.744 . . . . 50.439999999999998 110.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . 0.5 ' HA2' ' ND2' ' A' ' 321' ' ' ASN . . . 158.74 -16.8 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.06 -0.816 . . . . 34.159999999999997 111.06 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.607 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 98.6 m95 -118.79 148.26 43.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.175 -0.513 . . . . 81.450000000000003 110.377 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.453 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 2.9 m0 -157.49 174.48 15.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.712 -0.847 . . . . 93.810000000000002 108.712 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.633 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -132.42 143.11 49.58 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.829 -0.804 . . . . 89.719999999999999 108.829 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 169.0 31.83 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 108.437 -1.865 . . . . 24.219999999999999 108.437 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.97 129.63 56.42 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 119.571 -0.851 . . . . 56.969999999999999 109.684 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.61 135.66 28.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.088 -1.079 . . . . 59.329999999999998 108.088 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.75 29.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.584 -0.524 . . . . 46.140000000000001 109.584 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.07 88.11 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.19 -1.005 . . . . 26.489999999999998 110.623 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.51 160.27 36.99 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 118.397 1.099 . . . . 98.989999999999995 108.627 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.19 124.77 35.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.758 -1.201 . . . . 109.22 107.758 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.81 164.12 36.77 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.028 -1.629 . . . . 26.510000000000002 109.028 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.633 HG12 ' HG2' ' A' ' 308' ' ' GLU . 5.0 m -90.72 146.8 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.377 -0.412 . . . . 54.609999999999999 111.511 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.77 151.41 23.36 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.461 -0.495 . . . . 74.469999999999999 110.436 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.607 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.1 122.38 8.96 Favored 'Trans proline' 0 CA--C 1.488 -1.8 0 C-N-CA 120.139 0.559 . . . . 111.89 112.068 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.58 -10.41 43.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.321 1.013 . . . . 119.27 111.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.42 -38.91 91.5 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.417 -0.586 . . . . 96.629999999999995 109.417 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.96 -1.38 0.29 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.379 -1.282 . . . . 74.849999999999994 112.325 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.534 HG11 HG22 ' A' ' 274' ' ' VAL . 0.7 OUTLIER -131.94 155.2 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.491 -0.559 . . . . 67.239999999999995 109.491 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -108.04 152.76 24.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.428 -0.582 . . . . 130.62 109.428 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.546 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.4 mt -88.0 135.19 33.52 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.097 -1.075 . . . . 63.159999999999997 108.097 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.14 44.15 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.752 -1.944 . . . . 97.620000000000005 105.752 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.86 -33.96 62.46 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 N-CA-C 115.547 1.326 . . . . 152.83000000000001 115.547 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.3 -1.987 0 CA-C-N 121.386 1.531 . . . . 59.969999999999999 109.292 179.528 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.93 140.46 32.25 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.336 0.589 . . . . 29.010000000000002 110.062 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -118.73 163.4 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.051 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.478 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -120.26 139.27 52.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.601 0.239 . . . . 0.0 111.007 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.652 HG21 HD11 ' B' ' 30' ' ' ILE . 47.2 t -121.29 124.21 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.643 -0.873 . . . . 4.9900000000000002 108.643 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.1 mttt -101.1 135.93 41.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.989 0.423 . . . . 5.6799999999999997 110.483 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -78.97 -140.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.547 -0.751 . . . . 26.890000000000001 111.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' B' ' 8' ' ' LEU . 0.7 OUTLIER -81.16 -41.65 22.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 23.289999999999999 111.044 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -89.93 2.41 55.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.519 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.47 16.18 50.42 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.865 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 65.4 tttt -50.09 157.84 0.6 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.454 -0.439 . . . . 8.5099999999999998 111.557 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.4 m -106.37 127.95 53.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.72 -0.844 . . . . 1.8799999999999999 108.72 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 88.8 mt -123.06 123.6 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.315 . . . . 37.689999999999998 110.82 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.79 131.19 48.24 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.17 149.94 49.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.578 0.228 . . . . 9.4600000000000009 110.988 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.64 122.16 43.86 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.258 -1.756 . . . . 1.54 106.258 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.93 168.3 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.485 0.659 . . . . 0.0 111.511 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.83 149.35 45.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.3 -24.42 59.81 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 CA-C-N 120.764 1.308 . . . . 0.0 112.966 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 p -85.18 -2.63 58.24 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.046 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.24 142.64 50.57 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.003 -1.11 . . . . 1.4299999999999999 108.003 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -87.03 157.82 19.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.679 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.26 -39.85 84.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.954 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.13 -37.57 80.46 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.4 -42.85 87.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.55 -41.7 88.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -60.08 -39.87 87.6 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.29 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.457 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.531 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.24 -39.22 92.43 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.652 HD11 HG21 ' B' ' 5' ' ' VAL . 33.0 mt -64.99 -40.04 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -44.13 94.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.614 0.721 . . . . 1.3200000000000001 109.407 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.33 92.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.994 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -81.59 -41.23 21.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.01 1.115 . . . . 0.82999999999999996 114.01 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.91 -14.65 13.93 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.052 1.871 . . . . 6.1200000000000001 116.052 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.11 82.92 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.263 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.77 116.49 65.87 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 109.518 -0.549 . . . . 3.54 109.518 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.83 134.68 61.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.062 1.174 . . . . 0.0 112.39 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 -32.28 24.87 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.8 2.333 . . . . 0.0 114.699 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.67 -16.06 62.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 118.955 0.798 . . . . 2.8799999999999999 112.205 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -100.06 6.09 44.99 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.783 0.29 . . . . 7.1699999999999999 111.783 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.434 ' HB3' HD11 ' B' ' 69' ' ' LEU . 75.1 mt-30 -105.79 153.49 21.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.039 0.755 . . . . 13.42 113.039 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.472 ' HE ' ' HG2' ' A' ' 281' ' ' GLN . 4.0 mtt180 -146.68 118.55 8.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.8 -1.091 . . . . 27.09 108.316 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.406 ' C ' HG13 ' B' ' 44' ' ' ILE . 84.8 mt -100.59 129.41 46.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.315 0.579 . . . . 1.8700000000000001 110.831 -177.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.469 HG23 ' O ' ' B' ' 48' ' ' LYS . 17.2 mt -141.08 136.23 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.084 -0.385 . . . . 17.75 111.194 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.591 ' CD2' HG12 ' B' ' 61' ' ' ILE . 62.2 t80 -135.0 137.62 43.19 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.597 -0.274 . . . . 16.98 110.27 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.69 39.34 21.52 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 123.405 0.441 . . . . 0.0 111.674 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 22.62 68.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.576 0.99 . . . . 48.659999999999997 115.576 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.469 ' O ' HG23 ' B' ' 44' ' ' ILE . 44.8 mtmt -117.19 132.64 56.6 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.999 0.9 . . . . 4.25 111.775 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -68.45 116.6 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 30.57 110.295 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -85.94 130.22 34.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.201 0.524 . . . . 22.77 112.047 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.22 149.55 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.459 -0.791 . . . . 9.3399999999999999 111.471 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.66 -20.17 63.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.2 5.99 68.53 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.514 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 164.0 13.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.204 0.502 . . . . 1.8600000000000001 111.652 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -105.45 166.41 10.45 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.582 0.706 . . . . 0.0 112.572 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.97 -42.01 93.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.707 -1.133 . . . . 2.2799999999999998 110.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.41 -31.13 71.05 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.138 -0.625 . . . . 2.98 111.77 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.1 -28.94 69.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.689 -0.405 . . . . 1.77 110.468 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.04 14.6 28.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.611 0.244 . . . . 0.0 111.629 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.01 39.39 18.8 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.918 0.487 . . . . 0.0 112.22 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.43 123.93 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.136 -1.061 . . . . 4.0099999999999998 108.136 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.97 169.18 8.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.326 0.584 . . . . 5.7400000000000002 112.114 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.54 141.42 16.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.234 -0.894 . . . . 4.3099999999999996 111.443 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.01 23.26 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.937 -1.029 . . . . 10.130000000000001 112.824 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.34 146.69 36.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.898 -1.149 . . . . 4.0999999999999996 107.898 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.478 HG23 ' HB2' ' B' ' 4' ' ' PHE . 99.8 m -121.52 135.0 55.06 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' B' ' 45' ' ' PHE . 1.2 mp -112.6 -176.2 2.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 19.210000000000001 110.584 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -125.35 148.77 48.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 50.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' B' ' 41' ' ' GLN . 15.7 tp -133.72 139.6 46.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.048 0.452 . . . . 21.579999999999998 111.727 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.53 0.201 0 CA-C-N 115.82 -0.627 . . . . 25.969999999999999 110.321 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 121.528 0.68 . . . . 137.63999999999999 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.914 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.7 p -64.86 -56.8 11.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.527 -0.761 . . . . 89.760000000000005 111.413 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.914 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.51 12.64 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.726 -0.609 . . . . 143.71000000000001 109.482 -177.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.12 135.78 51.13 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.448 -0.575 . . . . 62.810000000000002 109.448 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.504 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.8 m-85 -107.2 134.5 50.22 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.513 -0.921 . . . . 73.75 108.513 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.442 ' SG ' HD22 ' A' ' 325' ' ' LEU . 50.2 m -129.59 135.37 48.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.791 -0.818 . . . . 54.439999999999998 108.791 -175.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.731 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.61 33.96 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.214 -1.032 . . . . 88.159999999999997 108.214 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 91.2 t -100.87 115.95 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 118.11 -1.436 . . . . 73.900000000000006 110.722 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -96.59 4.89 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.647 0.98 . . . . 138.47999999999999 113.647 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . 0.718 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -126.2 135.02 26.55 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 117.97 0.35 . . . . 67.980000000000004 110.924 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.21 134.74 19.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 72.540000000000006 111.861 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.452 ' HB3' HG13 ' A' ' 288' ' ' ILE . 81.2 t80 -128.18 137.85 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 82.870000000000005 110.793 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -113.63 121.52 44.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.088 -0.506 . . . . 66.180000000000007 109.658 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -32.64 114.43 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.005 0.815 . . . . 50.240000000000002 113.133 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.553 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.35 -41.73 12.66 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.411 -0.588 . . . . 128.65000000000001 109.411 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.98 179.91 7.68 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.288 -0.882 . . . . 67.609999999999999 111.328 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -83.03 -33.25 26.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.412 -0.813 . . . . 78.629999999999995 109.994 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -75.13 -5.19 42.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.714 -0.676 . . . . 42.490000000000002 111.153 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -112.48 147.14 37.17 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.368 0.604 . . . . 53.210000000000001 109.47 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.6 tp -78.1 135.2 37.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.523 -0.762 . . . . 57.0 110.194 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.534 ' O ' HD23 ' A' ' 311' ' ' LEU . 90.0 m -94.87 124.52 38.96 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 118.343 -1.343 . . . . 53.009999999999998 107.805 -176.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.1 pt -128.28 141.88 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.483 -0.932 . . . . 56.119999999999997 108.483 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.3 mmtt -118.55 160.69 21.31 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.56 -0.904 . . . . 97.849999999999994 108.56 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.53 141.53 41.18 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.065 -1.454 . . . . 88.319999999999993 108.75 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.68 21.5 21.32 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.692 -0.963 . . . . 35.810000000000002 110.692 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -130.54 151.91 50.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 118.348 1.074 . . . . 61.780000000000001 109.768 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.55 133.99 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.775 -1.194 . . . . 105.08 107.775 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.81 134.8 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.746 -0.835 . . . . 48.770000000000003 108.746 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.504 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 12.9 t -85.82 126.5 34.08 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.153 -1.019 . . . . 128.84 108.858 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -71.91 113.24 8.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.964 -0.754 . . . . 81.370000000000005 108.964 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.635 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.3 mt -74.39 -52.43 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.639 0.776 . . . . 70.599999999999994 110.946 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.95 149.22 28.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.387 -0.968 . . . . 65.189999999999998 108.387 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.633 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.84 23.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.441 0.639 . . . . 125.5 110.585 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 39.6 t0 -89.24 174.77 7.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.834 1.654 . . . . 66.569999999999993 109.895 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 20.7 p -55.79 -155.95 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.044 -0.98 . . . . 91.459999999999994 112.222 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.99 -68.16 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 113.742 1.016 . . . . 103.65000000000001 113.742 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.61 134.43 57.01 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.521 0.563 . . . . 115.16 112.521 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.8 36.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.629 -0.714 . . . . 50.439999999999998 110.814 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 178.71 -28.75 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.355 -0.839 . . . . 34.159999999999997 111.05 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 85.7 m95 -123.24 156.83 34.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.458 -0.371 . . . . 81.450000000000003 110.775 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.633 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.1 m0 -163.61 -179.05 6.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.797 -0.816 . . . . 93.810000000000002 108.797 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.708 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.1 mt-10 -137.59 143.04 41.31 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.833 -0.803 . . . . 89.719999999999999 108.833 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.93 31.81 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 108.418 -1.873 . . . . 24.219999999999999 108.418 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.8 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.89 129.58 56.41 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.567 -0.853 . . . . 56.969999999999999 109.728 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.49 135.69 28.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.038 -1.097 . . . . 59.329999999999998 108.038 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.69 29.11 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.588 -0.523 . . . . 46.140000000000001 109.588 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.0 87.79 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.659 -0.977 . . . . 26.489999999999998 110.659 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.8 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.43 160.37 36.61 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 118.957 -1.097 . . . . 98.989999999999995 108.583 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.25 124.71 35.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.704 -1.221 . . . . 109.22 107.704 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.95 36.6 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.09 -1.604 . . . . 26.510000000000002 109.09 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.708 HG12 ' HG2' ' A' ' 308' ' ' GLU . 2.4 m -94.19 151.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.053 0.541 . . . . 54.609999999999999 111.716 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -153.4 151.42 25.55 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 120.55 -0.46 . . . . 74.469999999999999 110.439 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.566 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.12 122.13 8.72 Favored 'Trans proline' 0 CA--C 1.488 -1.819 0 C-N-CA 120.103 0.535 . . . . 111.89 112.111 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -77.63 -0.83 28.08 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.92 0.762 . . . . 119.27 111.893 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.75 -39.99 90.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.391 -0.596 . . . . 96.629999999999995 109.391 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.718 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 4.7 m-30 -77.93 10.34 2.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.135 -0.939 . . . . 74.849999999999994 112.167 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.25 163.9 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.339 -0.615 . . . . 67.239999999999995 109.339 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -139.34 147.27 41.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.93 -0.767 . . . . 130.62 108.93 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 mt -87.62 135.23 33.45 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.102 -1.073 . . . . 63.159999999999997 108.102 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.33 129.07 44.57 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.847 -1.909 . . . . 97.620000000000005 105.847 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 74.7 Cg_exo -63.86 -34.0 62.31 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.516 1.314 . . . . 152.83000000000001 115.516 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.958 0 CA-C-N 121.408 1.539 . . . . 59.969999999999999 109.283 179.547 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.89 139.83 33.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.223 0.535 . . . . 29.010000000000002 110.108 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.7 pt -123.62 167.81 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.415 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -119.94 139.35 52.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.7 0.286 . . . . 0.0 111.0 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.5 HG21 HD11 ' B' ' 30' ' ' ILE . 47.0 t -121.25 124.22 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.643 -0.873 . . . . 4.9900000000000002 108.643 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.11 137.31 39.65 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.988 0.423 . . . . 5.6799999999999997 110.444 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -84.91 -149.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.468 -0.787 . . . . 26.890000000000001 111.355 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.488 HD11 ' HE1' ' A' ' 306' ' ' TRP . 0.5 OUTLIER -67.41 -43.27 81.65 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.966 0.358 . . . . 23.289999999999999 111.966 -179.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.1 p -92.85 2.38 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.6 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.4 16.74 48.66 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.909 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 74.1 tttt -49.22 157.2 0.48 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.468 -0.431 . . . . 8.5099999999999998 111.578 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.42 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.6 m -106.35 127.82 53.55 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.701 -0.852 . . . . 1.8799999999999999 108.701 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.04 123.64 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.49 -0.323 . . . . 37.689999999999998 110.813 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.79 131.23 48.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -127.16 149.89 49.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 9.4600000000000009 110.96 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.63 122.15 43.84 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 106.204 -1.776 . . . . 1.54 106.204 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.9 168.32 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 111.542 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.92 149.29 45.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.23 -24.5 59.73 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 CA-C-N 120.808 1.324 . . . . 0.0 112.869 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.1 p -85.2 -2.56 58.17 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.01 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.29 142.67 50.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.001 -1.111 . . . . 1.4299999999999999 108.001 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -87.01 157.83 19.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.709 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.28 -39.8 83.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.029 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.06 -37.65 80.49 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.37 -42.83 87.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.57 -41.79 89.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.97 -40.04 87.71 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.18 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.442 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.3 -39.16 92.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.5 HD11 HG21 ' B' ' 5' ' ' VAL . 33.2 mt -64.98 -40.1 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -60.06 -44.08 94.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.577 0.703 . . . . 1.3200000000000001 109.395 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.82 -40.34 92.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.021 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.6 -41.05 22.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.096 1.147 . . . . 0.82999999999999996 114.096 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -111.09 -14.57 13.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.01 1.855 . . . . 6.1200000000000001 116.01 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.04 11.12 82.97 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.345 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.7 116.29 65.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.511 -0.551 . . . . 3.54 109.511 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.77 134.66 61.93 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.107 1.204 . . . . 0.0 112.35 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.37 -32.13 25.25 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 122.758 2.306 . . . . 0.0 114.679 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.71 -16.03 62.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.964 0.802 . . . . 2.8799999999999999 112.197 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.08 5.85 44.96 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.698 0.258 . . . . 7.1699999999999999 111.698 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -98.24 127.51 44.22 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.599 0.592 . . . . 13.42 112.599 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 281' ' ' GLN . 0.8 OUTLIER -117.71 109.79 17.05 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 27.09 108.398 177.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.583 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.0 mt -99.58 128.99 45.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.353 0.597 . . . . 1.8700000000000001 110.746 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.422 ' HA ' ' HG ' ' B' ' 50' ' ' LEU . 1.0 OUTLIER -146.32 133.78 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.129 -0.487 . . . . 17.75 111.545 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.664 ' CD2' HG12 ' B' ' 61' ' ' ILE . 88.0 t80 -135.59 140.34 44.55 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.469 -0.332 . . . . 16.98 110.245 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 38.68 23.73 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.444 0.465 . . . . 0.0 111.65 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.97 19.8 66.08 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 115.47 0.948 . . . . 48.659999999999997 115.47 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -117.38 133.75 55.62 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.664 0.732 . . . . 4.25 111.759 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' B' ' 49' ' ' GLN . 0.0 OUTLIER -65.84 120.26 12.73 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.739 -0.664 . . . . 30.57 111.017 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' B' ' 43' ' ' LEU . 59.4 mt -86.96 124.19 32.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.117 0.484 . . . . 22.77 112.208 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -99.06 149.5 22.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 9.3399999999999999 111.412 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -69.66 -20.08 63.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.24 5.97 68.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.575 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 163.96 13.81 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.124 0.462 . . . . 1.8600000000000001 111.619 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -105.46 166.28 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.688 0.756 . . . . 0.0 112.542 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.99 -41.85 92.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.616 -1.174 . . . . 2.2799999999999998 110.781 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -61.5 -31.08 71.06 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 120.045 -0.662 . . . . 2.98 111.875 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.05 -28.96 69.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.773 -0.371 . . . . 1.77 110.489 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.98 14.5 28.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.39 19.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.961 0.504 . . . . 0.0 112.161 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.664 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.175 -1.046 . . . . 4.0099999999999998 108.175 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -106.95 169.09 8.76 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.367 0.604 . . . . 5.7400000000000002 112.044 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.49 141.37 15.97 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.108 -0.951 . . . . 4.3099999999999996 111.489 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.99 23.34 9.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.072 -0.967 . . . . 10.130000000000001 112.818 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.31 145.52 37.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.933 -1.136 . . . . 4.0999999999999996 107.933 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.415 HG23 ' HB2' ' B' ' 4' ' ' PHE . 31.9 m -126.94 141.75 51.72 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.629 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 -165.89 1.46 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.27 -0.423 . . . . 19.210000000000001 110.473 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.34 160.72 35.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.99 -0.374 . . . . 50.0 109.99 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 69' ' ' LEU . 4.8 mt -135.42 172.11 13.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.19 0.519 . . . . 21.579999999999998 111.513 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.524 HG23 ' CZ ' ' A' ' 322' ' ' PHE . 2.8 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.366 -0.834 . . . . 25.969999999999999 110.401 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 121.532 0.682 . . . . 137.63999999999999 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.906 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.95 -56.88 10.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.581 -0.736 . . . . 89.760000000000005 111.281 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.906 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.03 166.6 12.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 O-C-N 121.753 -0.592 . . . . 143.71000000000001 109.525 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -111.13 135.82 51.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.4 -0.593 . . . . 62.810000000000002 109.4 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.513 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.2 134.44 50.3 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.534 -0.913 . . . . 73.75 108.534 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.559 ' SG ' HD22 ' A' ' 325' ' ' LEU . 51.2 m -129.61 135.42 48.53 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.697 -0.853 . . . . 54.439999999999998 108.697 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.54 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.6 33.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.197 -1.038 . . . . 88.159999999999997 108.197 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 323' ' ' VAL . 92.2 t -100.97 118.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 117.981 -1.488 . . . . 73.900000000000006 110.744 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 42.7 mm -82.74 -66.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.652 -0.704 . . . . 138.47999999999999 111.313 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.39 126.34 87.78 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 67.980000000000004 110.633 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.458 ' HD2' ' HA2' ' B' ' 47' ' ' GLY . 30.6 Cg_endo -63.05 150.01 89.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.505 . . . . 72.540000000000006 112.279 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -129.7 107.91 9.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 82.870000000000005 111.184 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -84.01 120.51 26.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.564 -0.532 . . . . 66.180000000000007 109.564 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -34.34 110.46 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.178 0.924 . . . . 50.240000000000002 112.832 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.691 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -82.38 -41.58 19.76 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.725 -0.671 . . . . 128.65000000000001 109.458 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 284' ' ' ASP . 3.2 t30 -137.21 172.41 13.04 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.003 -1.06 . . . . 67.609999999999999 112.035 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.37 -38.25 56.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.262 -0.881 . . . . 78.629999999999995 110.058 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . 0.493 ' H ' HD22 ' A' ' 282' ' ' ASN . 11.5 m-20 -76.41 3.07 11.89 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.601 -0.727 . . . . 42.490000000000002 110.94 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.691 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -109.74 146.43 34.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.448 0.642 . . . . 53.210000000000001 109.475 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 16.1 tp -77.02 141.07 40.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.696 . . . . 57.0 110.11 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.7 m -96.06 124.57 40.12 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.331 -1.347 . . . . 53.009999999999998 107.771 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.22 142.15 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.507 -0.923 . . . . 56.119999999999997 108.507 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -113.35 157.27 22.06 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 108.507 -0.923 . . . . 97.849999999999994 108.507 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.27 141.51 41.65 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.199 -1.4 . . . . 88.319999999999993 108.634 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.52 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.637 -0.985 . . . . 35.810000000000002 110.637 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -130.53 151.92 50.47 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 118.389 1.095 . . . . 61.780000000000001 109.791 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.63 133.99 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 107.799 -1.186 . . . . 105.08 107.799 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.85 134.76 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.735 -0.839 . . . . 48.770000000000003 108.735 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.496 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.76 126.53 34.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.822 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.92 113.18 8.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.974 -0.75 . . . . 81.370000000000005 108.974 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.3 mt -74.4 -52.35 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 123.624 0.77 . . . . 70.599999999999994 110.942 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.99 149.24 27.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.345 -0.983 . . . . 65.189999999999998 108.345 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.482 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.42 163.89 23.48 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.485 0.66 . . . . 125.5 110.515 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.2 172.54 8.99 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.782 1.633 . . . . 66.569999999999993 109.907 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 23.2 p -59.79 -136.4 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.934 -1.03 . . . . 91.459999999999994 112.269 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 18.1 mm -84.73 -22.79 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 121.693 -0.63 . . . . 103.65000000000001 112.121 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.62 119.28 7.8 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.098 0.407 . . . . 115.16 112.098 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 25.2 t -92.89 92.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.899 -0.591 . . . . 50.439999999999998 110.011 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . 0.514 ' HA2' ' ND2' ' A' ' 321' ' ' ASN . . . 160.21 -12.15 0.17 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.358 -0.837 . . . . 34.159999999999997 111.294 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.575 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 96.6 m95 -117.45 150.2 39.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.872 0.368 . . . . 81.450000000000003 111.093 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.482 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 1.1 m0 -159.76 174.4 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.109 -0.951 . . . . 93.810000000000002 108.739 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.59 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -133.68 143.13 48.35 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.767 -0.827 . . . . 89.719999999999999 108.767 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.9 168.95 31.87 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.38 -1.888 . . . . 24.219999999999999 108.38 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.803 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.86 129.59 56.4 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.588 -0.845 . . . . 56.969999999999999 109.707 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 61.9 tp -142.52 135.65 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.104 -1.073 . . . . 59.329999999999998 108.104 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.14 37.69 29.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.546 -0.538 . . . . 46.140000000000001 109.546 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.02 87.78 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.148 -1.025 . . . . 26.489999999999998 110.723 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.803 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.5 160.29 36.92 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.378 1.089 . . . . 98.989999999999995 108.632 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.2 124.85 35.63 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.655 -1.239 . . . . 109.22 107.655 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.8 164.12 36.76 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.125 -1.59 . . . . 26.510000000000002 109.125 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.59 HG12 ' HG2' ' A' ' 308' ' ' GLU . 11.5 m -89.17 145.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 122.75 0.42 . . . . 54.609999999999999 111.497 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.11 151.36 24.32 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 120.525 -0.47 . . . . 74.469999999999999 110.47 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.469 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.2 Cg_endo -70.23 123.37 9.88 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.071 0.514 . . . . 111.89 112.062 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.87 -15.27 18.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.518 1.136 . . . . 119.27 111.462 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.514 ' ND2' ' HA2' ' A' ' 305' ' ' GLY . 1.3 m120 -62.52 -39.35 93.28 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 109.347 -0.612 . . . . 96.629999999999995 109.347 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -56.76 -4.16 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.363 -0.835 . . . . 74.849999999999994 112.642 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 274' ' ' VAL . 0.7 OUTLIER -127.56 145.91 34.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.684 -0.487 . . . . 67.239999999999995 109.684 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER -90.07 139.96 30.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.122 -0.695 . . . . 130.62 109.122 178.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.559 HD22 ' SG ' ' A' ' 272' ' ' CYS . 36.5 mt -89.1 135.21 33.68 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.116 -1.068 . . . . 63.159999999999997 108.116 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.08 44.5 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 105.751 -1.944 . . . . 97.620000000000005 105.751 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.1 Cg_exo -64.02 -33.8 61.13 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.547 1.326 . . . . 152.83000000000001 115.547 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.301 -1.933 0 CA-C-N 121.352 1.519 . . . . 59.969999999999999 109.279 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.86 140.22 32.55 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.292 0.568 . . . . 29.010000000000002 110.136 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -120.61 168.21 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.011 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.38 139.26 53.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.598 0.237 . . . . 0.0 111.045 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.492 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.23 124.19 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.659 -0.867 . . . . 4.9900000000000002 108.659 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.08 135.75 42.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.008 0.432 . . . . 5.6799999999999997 110.422 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -79.89 -155.05 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.615 -0.72 . . . . 26.890000000000001 111.274 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.61 -40.81 89.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.658 0.614 . . . . 23.289999999999999 112.658 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -92.14 2.41 56.61 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.762 0.315 . . . . 0.0 111.581 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.42 15.73 52.2 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.335 -0.459 . . . . 0.0 113.957 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 73.5 tttt -49.76 157.99 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.2 -0.588 . . . . 8.5099999999999998 111.619 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -106.33 128.24 53.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.682 -0.858 . . . . 1.8799999999999999 108.682 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.03 122.64 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 123.31 0.381 . . . . 37.689999999999998 110.83 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -101.97 131.26 48.49 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.21 149.85 49.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.592 0.234 . . . . 9.4600000000000009 110.998 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.53 122.19 43.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.25 -1.759 . . . . 1.54 106.25 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.07 168.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.486 0.66 . . . . 0.0 111.467 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.86 149.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.12 -24.45 58.53 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 CA-C-N 120.836 1.334 . . . . 0.0 112.97 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -85.25 -2.6 58.22 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.001 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.5 50.53 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.961 -1.126 . . . . 1.4299999999999999 107.961 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -86.88 157.79 19.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.747 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.2 -39.89 84.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.947 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.08 -37.69 80.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.24 -42.85 88.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.61 -41.79 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.0 -39.93 87.46 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.25 89.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.31 -39.07 92.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.492 HD11 HG21 ' B' ' 5' ' ' VAL . 33.0 mt -65.11 -40.03 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.05 -44.05 94.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.493 0.663 . . . . 1.3200000000000001 109.36 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.88 -40.4 92.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.957 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.081 1.141 . . . . 0.82999999999999996 114.081 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.95 -14.51 13.94 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.156 1.91 . . . . 6.1200000000000001 116.156 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.2 11.02 82.95 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.245 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.26 64.94 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.632 -0.507 . . . . 3.54 109.632 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.65 134.68 62.33 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.098 1.199 . . . . 0.0 112.433 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.33 -32.21 25.17 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.887 2.391 . . . . 0.0 114.643 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.85 -15.91 62.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.913 0.779 . . . . 2.8799999999999999 112.126 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -100.12 8.13 44.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.754 0.279 . . . . 7.1699999999999999 111.754 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.81 144.29 31.34 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.598 0.592 . . . . 13.42 112.598 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -138.82 114.8 10.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.341 -0.985 . . . . 27.09 108.341 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 130.39 43.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.364 0.602 . . . . 1.8700000000000001 110.837 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -139.43 130.66 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.932 -0.48 . . . . 17.75 110.931 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.59 ' CD2' HG12 ' B' ' 61' ' ' ILE . 91.5 t80 -132.25 136.4 46.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.555 -0.293 . . . . 16.98 110.244 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.9 39.77 26.6 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 123.474 0.484 . . . . 0.0 111.709 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 65.35 22.27 69.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 115.605 1.002 . . . . 48.659999999999997 115.605 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.94 132.1 56.44 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.07 0.935 . . . . 4.25 111.737 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -68.2 115.58 7.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.896 -0.593 . . . . 30.57 110.158 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -81.93 134.22 35.37 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.122 0.487 . . . . 22.77 111.787 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.81 149.43 24.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.5 -0.773 . . . . 9.3399999999999999 111.467 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.64 -20.12 63.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.22 6.03 68.49 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.533 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.89 13.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.152 0.476 . . . . 1.8600000000000001 111.621 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.6 p -105.37 166.43 10.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.657 0.741 . . . . 0.0 112.596 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.11 -41.9 93.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.674 -1.148 . . . . 2.2799999999999998 110.659 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.55 -30.98 71.0 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.063 -0.655 . . . . 2.98 111.811 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.14 -29.0 70.04 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.715 -0.394 . . . . 1.77 110.419 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.94 14.52 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.03 39.4 18.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.095 -1.076 . . . . 4.0099999999999998 108.095 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.17 8.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.303 0.573 . . . . 5.7400000000000002 112.155 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.55 141.37 16.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.222 -0.899 . . . . 4.3099999999999996 111.458 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 67.12 23.15 9.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.978 -1.01 . . . . 10.130000000000001 112.81 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.2 m -77.27 146.72 36.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.972 -1.121 . . . . 4.0999999999999996 107.972 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m -120.86 131.35 54.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.75 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mp -111.09 -177.68 3.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.667 -0.697 . . . . 19.210000000000001 110.669 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -124.45 144.15 50.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.978 -0.379 . . . . 50.0 109.978 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 69' ' ' LEU . 4.2 mt -129.95 154.55 47.24 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.08 0.467 . . . . 21.579999999999998 111.638 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.693 -0.685 . . . . 25.969999999999999 110.07 178.879 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 121.585 0.707 . . . . 137.63999999999999 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.897 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.523 -0.762 . . . . 89.760000000000005 111.346 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.897 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.6 12.62 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 121.777 -0.577 . . . . 143.71000000000001 109.549 -177.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.21 135.8 51.21 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.454 -0.573 . . . . 62.810000000000002 109.454 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.599 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.9 m-85 -107.23 134.44 50.32 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.505 -0.924 . . . . 73.75 108.505 176.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 52.1 m -129.63 135.45 48.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.726 -0.842 . . . . 54.439999999999998 108.726 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.678 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.71 135.57 33.99 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.203 -1.036 . . . . 88.159999999999997 108.203 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 276' ' ' PHE . 89.8 t -100.85 115.95 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 C-N-CA 118.028 -1.469 . . . . 73.900000000000006 110.823 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.707 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -98.12 16.58 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.655 0.983 . . . . 138.47999999999999 113.655 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . 0.717 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 10.8 m-85 -136.63 143.01 41.22 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 122.261 -0.275 . . . . 67.980000000000004 110.456 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.86 134.53 12.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.573 2.182 . . . . 72.540000000000006 112.281 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.61 96.39 4.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.794 -0.639 . . . . 82.870000000000005 110.776 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.55 120.58 21.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.125 -0.488 . . . . 66.180000000000007 109.732 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.52 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.288 0.847 . . . . 50.240000000000002 113.288 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.542 ' OE1' HG21 ' B' ' 70' ' ' VAL . 26.1 mt-30 -85.17 -41.99 15.14 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.448 -0.575 . . . . 128.65000000000001 109.448 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -146.83 176.39 9.92 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.872 -1.143 . . . . 67.609999999999999 111.455 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.89 -30.82 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.152 -0.931 . . . . 78.629999999999995 110.621 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.37 -6.26 57.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.924 -0.58 . . . . 42.490000000000002 110.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.404 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -108.75 147.09 32.52 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.31 0.576 . . . . 53.210000000000001 109.479 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.405 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 13.9 tp -83.42 137.93 33.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.599 -0.728 . . . . 57.0 110.014 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.6 m -95.78 124.53 39.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.311 -1.356 . . . . 53.009999999999998 107.793 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.25 141.68 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.489 -0.93 . . . . 56.119999999999997 108.489 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 50.3 mmtt -120.7 162.98 18.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.713 -0.847 . . . . 97.849999999999994 108.713 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.19 141.53 41.78 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 118.028 -1.469 . . . . 88.319999999999993 108.744 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.64 21.59 21.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.582 -1.007 . . . . 35.810000000000002 110.582 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.5 151.91 50.46 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 118.459 1.13 . . . . 61.780000000000001 109.873 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.54 133.99 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.724 -1.213 . . . . 105.08 107.724 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.82 134.75 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.759 -0.83 . . . . 48.770000000000003 108.759 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.599 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.1 t -85.74 126.56 34.07 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.886 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.97 113.23 8.79 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.885 -0.783 . . . . 81.370000000000005 108.885 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.6 mt -74.49 -52.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.655 0.782 . . . . 70.599999999999994 110.891 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.96 149.21 27.97 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.471 -0.937 . . . . 65.189999999999998 108.471 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.719 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.32 163.79 23.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.551 0.691 . . . . 125.5 110.533 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 306' ' ' TRP . 39.7 t0 -89.2 170.6 10.46 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.795 1.638 . . . . 66.569999999999993 109.908 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 14.5 p -60.16 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.72 -1.127 . . . . 91.459999999999994 111.769 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.87 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 121.733 -0.604 . . . . 103.65000000000001 112.49 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -59.52 116.3 3.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.224 0.535 . . . . 115.16 111.757 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.4 t -79.26 115.61 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.604 -0.725 . . . . 50.439999999999998 110.123 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 175.74 -21.2 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.69 -0.686 . . . . 34.159999999999997 111.688 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.646 ' O ' ' HB2' ' A' ' 300' ' ' ASP . 99.0 m95 -118.48 153.25 34.45 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.391 0.139 . . . . 81.450000000000003 110.877 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.719 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.9 m0 -165.46 175.71 8.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.447 -0.946 . . . . 93.810000000000002 108.447 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.694 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -137.02 143.16 42.58 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.792 -0.818 . . . . 89.719999999999999 108.792 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.97 31.88 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 108.404 -1.878 . . . . 24.219999999999999 108.404 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.96 129.67 56.4 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 119.521 -0.872 . . . . 56.969999999999999 109.652 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 62.1 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.128 -1.064 . . . . 59.329999999999998 108.128 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.08 37.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.625 -0.509 . . . . 46.140000000000001 109.625 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.11 35.06 88.23 Favored Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.231 -0.985 . . . . 26.489999999999998 110.71 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.35 36.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 118.358 1.079 . . . . 98.989999999999995 108.609 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.27 124.71 35.13 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.744 -1.206 . . . . 109.22 107.744 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.405 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.78 164.31 36.87 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.077 -1.609 . . . . 26.510000000000002 109.077 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 308' ' ' GLU . 1.7 m -96.52 150.97 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.327 0.651 . . . . 54.609999999999999 111.887 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -153.69 151.37 25.0 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 120.287 -0.565 . . . . 74.469999999999999 110.495 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.88 8.47 Favored 'Trans proline' 0 CA--C 1.488 -1.824 0 C-N-CA 120.087 0.524 . . . . 111.89 112.085 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.524 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -71.08 -2.44 15.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 124.35 1.031 . . . . 119.27 112.035 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -61.94 -39.92 93.76 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.361 -0.607 . . . . 96.629999999999995 109.361 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 9.3 m-30 -74.98 7.24 3.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 74.849999999999994 112.061 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 274' ' ' VAL . 1.0 OUTLIER -136.01 159.29 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.252 -0.647 . . . . 67.239999999999995 109.252 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.88 146.66 43.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.688 -0.856 . . . . 130.62 108.688 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -86.79 135.29 33.41 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 108.104 -1.073 . . . . 63.159999999999997 108.104 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.06 44.44 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 105.748 -1.945 . . . . 97.620000000000005 105.748 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.7 Cg_exo -63.97 -33.76 61.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 N-CA-C 115.564 1.332 . . . . 152.83000000000001 115.564 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.302 -1.895 0 CA-C-N 121.385 1.531 . . . . 59.969999999999999 109.223 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.59 32.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.377 0.608 . . . . 29.010000000000002 110.158 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -119.3 164.38 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.946 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.464 ' O ' HD12 ' B' ' 67' ' ' LEU . 97.9 m-85 -120.73 139.34 53.22 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.644 0.259 . . . . 0.0 111.03 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.659 HG21 HD11 ' B' ' 30' ' ' ILE . 47.2 t -121.36 124.27 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.623 -0.881 . . . . 4.9900000000000002 108.623 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.07 138.4 38.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.948 0.404 . . . . 5.6799999999999997 110.428 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -81.21 -153.21 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.618 -0.719 . . . . 26.890000000000001 111.899 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -36.11 72.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.285 -0.416 . . . . 23.289999999999999 111.837 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -96.38 2.37 52.62 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.587 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.97 51.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.365 -0.445 . . . . 0.0 113.856 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 78.9 tttt -49.8 157.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.33 -0.512 . . . . 8.5099999999999998 111.649 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -106.69 127.99 53.82 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.785 -0.821 . . . . 1.8799999999999999 108.785 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.14 123.07 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 123.347 0.404 . . . . 37.689999999999998 110.9 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.87 131.25 48.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -127.13 149.99 49.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.644 0.259 . . . . 9.4600000000000009 110.906 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.72 122.14 43.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.14 -1.8 . . . . 1.54 106.14 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.93 168.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.563 0.697 . . . . 0.0 111.503 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.74 149.26 44.82 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.19 -24.48 59.27 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.872 1.347 . . . . 0.0 112.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.27 -2.48 58.1 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.97 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 142.6 50.35 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.961 -1.126 . . . . 1.4299999999999999 107.961 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -86.96 157.91 19.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.631 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.35 -39.82 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.942 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.19 -37.45 80.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.4 t-20 -66.41 -42.91 87.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.6 -41.71 88.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -59.94 -39.97 87.37 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.427 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.27 -39.08 92.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.659 HD11 HG21 ' B' ' 5' ' ' VAL . 32.2 mt -65.13 -40.02 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.06 -44.0 95.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.517 0.675 . . . . 1.3200000000000001 109.424 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.9 -40.4 92.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.963 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.44 -41.2 22.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.129 1.159 . . . . 0.82999999999999996 114.129 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.63 13.92 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.163 1.912 . . . . 6.1200000000000001 116.163 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.0 82.95 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.31 65.15 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.58 -0.526 . . . . 3.54 109.58 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.71 134.67 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.167 1.244 . . . . 0.0 112.444 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.46 -32.07 25.69 Favored 'Trans proline' 0 N--CA 1.507 2.307 0 C-N-CA 122.789 2.326 . . . . 0.0 114.662 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.78 -16.09 62.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 118.973 0.806 . . . . 2.8799999999999999 112.068 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.02 6.33 45.06 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.707 0.262 . . . . 7.1699999999999999 111.707 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.575 ' HB3' HD11 ' B' ' 69' ' ' LEU . 67.4 mt-30 -106.67 131.28 53.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.47 0.544 . . . . 13.42 112.47 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.539 ' HB3' HG12 ' B' ' 70' ' ' VAL . 40.2 ttm180 -117.72 114.73 23.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 27.09 107.811 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -100.57 128.99 46.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.37 0.605 . . . . 1.8700000000000001 110.825 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' B' ' 49' ' ' GLN . 2.6 pt -149.7 132.59 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.85 -0.614 . . . . 17.75 111.609 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.683 ' CD2' HG12 ' B' ' 61' ' ' ILE . 83.2 t80 -124.99 139.72 53.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.413 -0.358 . . . . 16.98 110.247 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.96 39.06 21.98 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 123.54 0.525 . . . . 0.0 111.717 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 65.35 21.75 68.75 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 115.865 1.106 . . . . 48.659999999999997 115.865 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.43 134.28 55.24 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.992 0.896 . . . . 4.25 111.879 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.521 ' HA ' HG22 ' B' ' 44' ' ' ILE . 24.8 mt-30 -65.89 119.2 10.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.911 -0.586 . . . . 30.57 111.053 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.449 ' HG ' ' HA ' ' B' ' 44' ' ' ILE . 63.5 mt -89.3 125.54 35.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.065 0.459 . . . . 22.77 112.009 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -99.35 149.54 23.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 9.3399999999999999 111.386 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.67 -20.15 63.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.18 6.03 68.59 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.609 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.98 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.162 0.481 . . . . 1.8600000000000001 111.706 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -105.45 166.48 10.4 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.753 0.787 . . . . 0.0 112.523 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.3 mt -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.662 -1.154 . . . . 2.2799999999999998 110.803 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.54 -31.04 71.04 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.086 -0.646 . . . . 2.98 111.809 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.09 -28.96 69.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.744 -0.383 . . . . 1.77 110.448 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.02 14.53 28.89 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.09 39.33 19.01 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.879 0.472 . . . . 0.0 112.19 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.683 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.4 124.09 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.049 -1.093 . . . . 4.0099999999999998 108.049 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 169.13 8.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.318 0.58 . . . . 5.7400000000000002 112.083 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.48 141.47 15.75 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.127 -0.942 . . . . 4.3099999999999996 111.485 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.97 23.19 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.04 -0.982 . . . . 10.130000000000001 112.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.456 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.21 146.7 36.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.963 -1.125 . . . . 4.0999999999999996 107.963 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 52.9 m -125.47 136.93 53.89 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.533 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' B' ' 45' ' ' PHE . 0.2 OUTLIER -112.25 -172.71 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.294 -0.412 . . . . 19.210000000000001 110.208 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . 0.495 ' CD2' ' HB3' ' A' ' 321' ' ' ASN . 0.0 OUTLIER -132.56 153.67 50.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.939 -0.393 . . . . 50.0 109.939 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' B' ' 41' ' ' GLN . 9.3 tp -126.55 158.05 37.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.835 0.35 . . . . 21.579999999999998 111.436 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 322' ' ' PHE . 7.8 p . . . . . 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 25.969999999999999 110.607 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.515 0.674 . . . . 137.63999999999999 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.894 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.8 p -64.93 -56.75 11.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.523 -0.762 . . . . 89.760000000000005 111.375 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.894 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.07 166.57 12.6 Favored 'General case' 0 CA--C 1.494 -1.189 0 O-C-N 121.762 -0.586 . . . . 143.71000000000001 109.481 -177.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.19 135.77 51.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.489 -0.56 . . . . 62.810000000000002 109.489 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.464 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.9 m-85 -107.16 134.39 50.34 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.484 -0.932 . . . . 73.75 108.484 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' CYS . . . . . 0.404 ' SG ' HD22 ' A' ' 325' ' ' LEU . 50.4 m -129.55 135.39 48.53 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.789 -0.819 . . . . 54.439999999999998 108.789 -176.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.738 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.72 135.58 33.98 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.217 -1.031 . . . . 88.159999999999997 108.217 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.73 HG11 HD12 ' A' ' 288' ' ' ILE . 91.3 t -100.89 116.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 117.956 -1.498 . . . . 73.900000000000006 110.801 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -81.99 -41.62 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 121.622 -0.674 . . . . 138.47999999999999 112.277 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' PHE . . . . . 0.646 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -102.44 122.5 46.23 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 121.143 -0.223 . . . . 67.980000000000004 110.862 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.81 159.56 52.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.591 2.194 . . . . 72.540000000000006 112.264 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -124.45 86.74 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.626 -0.715 . . . . 82.870000000000005 109.995 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -56.78 116.46 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.414 -0.587 . . . . 66.180000000000007 109.414 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.59 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.646 1.216 . . . . 50.240000000000002 113.309 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -87.02 -39.18 15.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.844 -0.616 . . . . 128.65000000000001 109.369 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -148.38 175.52 11.04 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.064 -1.022 . . . . 67.609999999999999 111.736 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.04 -33.63 29.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.228 -0.896 . . . . 78.629999999999995 110.235 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.23 -2.77 42.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.688 -0.687 . . . . 42.490000000000002 111.087 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.379 0.609 . . . . 53.210000000000001 109.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.5 tp -85.57 135.82 33.65 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.343 -0.844 . . . . 57.0 110.156 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.529 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.7 m -95.68 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.106 -1.438 . . . . 53.009999999999998 107.805 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.73 HD12 HG11 ' A' ' 274' ' ' VAL . 49.1 pt -128.21 141.68 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.556 -0.905 . . . . 56.119999999999997 108.556 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.4 mmtt -117.04 158.96 23.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.419 -0.956 . . . . 97.849999999999994 108.419 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -76.08 141.56 41.98 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 118.458 -1.297 . . . . 88.319999999999993 108.665 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.58 21.66 21.11 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.65 -0.98 . . . . 35.810000000000002 110.65 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -130.51 151.91 50.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 118.393 1.097 . . . . 61.780000000000001 109.818 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.738 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.56 133.93 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.834 -1.173 . . . . 105.08 107.834 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 310' ' ' GLU . 92.4 t -122.73 134.81 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.743 -0.836 . . . . 48.770000000000003 108.743 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.81 126.64 34.17 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.189 -1.004 . . . . 128.84 108.783 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.08 113.27 8.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.894 -0.78 . . . . 81.370000000000005 108.894 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.46 -52.37 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 123.562 0.745 . . . . 70.599999999999994 110.919 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.95 149.15 27.92 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.474 -0.936 . . . . 65.189999999999998 108.474 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.572 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.43 163.82 23.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.533 0.683 . . . . 125.5 110.498 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.529 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.13 172.83 8.8 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.77 1.628 . . . . 66.569999999999993 109.868 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 4.7 p -60.77 -155.54 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.498 -0.774 . . . . 91.459999999999994 111.546 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 43.4 mm -64.42 -50.41 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 113.883 1.068 . . . . 103.65000000000001 113.883 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.18 120.67 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.647 0.61 . . . . 115.16 112.647 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -89.41 106.27 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.61 -0.723 . . . . 50.439999999999998 110.245 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 168.4 -14.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.217 -0.902 . . . . 34.159999999999997 110.88 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.529 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 92.6 m95 -126.33 156.06 41.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.279 -0.461 . . . . 81.450000000000003 111.253 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.572 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.2 m0 -163.81 -171.3 2.44 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.817 0.847 . . . . 93.810000000000002 108.772 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.694 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.1 mt-10 -145.85 143.06 29.38 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.869 -0.789 . . . . 89.719999999999999 108.869 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.88 168.97 31.86 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 108.448 -1.861 . . . . 24.219999999999999 108.448 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.795 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.92 129.7 56.38 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.558 -0.857 . . . . 56.969999999999999 109.688 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.65 135.69 28.35 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.039 -1.097 . . . . 59.329999999999998 108.039 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.01 37.82 29.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.597 -0.519 . . . . 46.140000000000001 109.597 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.01 35.18 88.97 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 110.683 -0.967 . . . . 26.489999999999998 110.683 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ARG . . . . . 0.795 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.31 36.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 118.349 1.074 . . . . 98.989999999999995 108.627 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.24 124.72 35.2 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.761 -1.199 . . . . 109.22 107.761 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.77 164.48 36.97 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 108.997 -1.641 . . . . 26.510000000000002 108.997 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 308' ' ' GLU . 3.3 m -94.68 151.94 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.309 0.643 . . . . 54.609999999999999 112.041 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -152.98 151.41 26.21 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 120.206 -0.598 . . . . 74.469999999999999 110.49 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.946 ' HB3' HG11 ' B' ' 70' ' ' VAL . 6.2 Cg_endo -70.17 122.12 8.7 Favored 'Trans proline' 0 CA--C 1.488 -1.793 0 C-N-CA 120.105 0.537 . . . . 111.89 112.081 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -71.07 -14.71 62.41 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.3 1.0 . . . . 119.27 111.98 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -61.57 -40.34 94.38 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.926 -0.71 . . . . 96.629999999999995 109.422 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 2.9 m-30 -64.51 0.08 1.19 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.213 -0.903 . . . . 74.849999999999994 111.706 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 274' ' ' VAL . 1.0 OUTLIER -136.53 171.46 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.513 -0.551 . . . . 67.239999999999995 109.513 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HB2' HD11 ' A' ' 275' ' ' ILE . 0.6 OUTLIER -145.96 146.41 31.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 130.62 108.869 178.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.557 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -87.95 135.22 33.5 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 108.052 -1.092 . . . . 63.159999999999997 108.052 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.12 44.36 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 105.813 -1.921 . . . . 97.620000000000005 105.813 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.3 Cg_exo -64.0 -33.86 61.17 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 N-CA-C 115.54 1.323 . . . . 152.83000000000001 115.54 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.925 0 CA-C-N 121.393 1.533 . . . . 59.969999999999999 109.234 179.502 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.472 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.47 32.19 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.287 0.565 . . . . 29.010000000000002 110.149 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.9 pt -120.95 162.31 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.966 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' B' ' 66' ' ' THR . 97.9 m-85 -120.92 139.36 53.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.618 0.247 . . . . 0.0 110.977 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.646 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.33 124.13 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.64 -0.874 . . . . 4.9900000000000002 108.64 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.3 mttt -101.02 138.92 37.42 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.966 0.412 . . . . 5.6799999999999997 110.458 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -77.61 -157.65 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.693 -0.685 . . . . 26.890000000000001 111.898 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.937 ' HG ' HG13 ' B' ' 70' ' ' VAL . 1.3 tt -68.35 -37.81 80.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.705 -0.679 . . . . 23.289999999999999 111.671 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -94.94 2.44 55.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.555 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.9 51.71 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.365 -0.445 . . . . 0.0 113.905 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 79.6 tttt -50.42 158.36 0.61 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.329 -0.513 . . . . 8.5099999999999998 111.492 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -106.61 128.06 53.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.741 -0.837 . . . . 1.8799999999999999 108.741 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.42 121.93 56.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 O-C-N 123.372 0.42 . . . . 37.689999999999998 110.836 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.96 131.34 48.42 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -127.24 149.95 49.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.61 0.243 . . . . 9.4600000000000009 110.943 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.64 122.17 43.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.223 -1.769 . . . . 1.54 106.223 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.03 168.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.455 0.645 . . . . 0.0 111.478 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.86 149.35 45.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.29 -24.46 59.91 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 CA-C-N 120.799 1.321 . . . . 0.0 112.899 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -85.22 -2.54 58.16 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.071 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.28 142.59 50.5 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.906 -1.146 . . . . 1.4299999999999999 107.906 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -86.92 157.79 19.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.79 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.22 -39.93 84.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.948 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.67 80.29 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.33 -42.91 87.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.56 -41.76 89.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.495 ' HG2' HD11 ' B' ' 43' ' ' LEU . 20.5 mttt -60.01 -39.85 87.25 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.26 89.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.458 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.19 -39.2 92.53 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.646 HD11 HG21 ' B' ' 5' ' ' VAL . 32.8 mt -65.01 -40.07 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.03 -44.1 94.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.493 0.663 . . . . 1.3200000000000001 109.344 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.87 -40.29 92.44 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.98 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -81.58 -41.34 21.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.009 1.114 . . . . 0.82999999999999996 114.009 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.86 -14.59 13.96 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.167 1.914 . . . . 6.1200000000000001 116.167 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.07 82.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.244 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.69 116.36 65.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.612 -0.514 . . . . 3.54 109.612 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.8 134.68 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 CA-C-N 120.361 1.165 . . . . 0.0 112.373 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.22 -32.31 24.65 Favored 'Trans proline' 0 N--CA 1.506 2.255 0 C-N-CA 122.818 2.345 . . . . 0.0 114.716 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.7 -16.02 62.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.829 0.74 . . . . 2.8799999999999999 112.171 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.07 6.3 44.98 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.741 0.274 . . . . 7.1699999999999999 111.741 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.33 121.23 42.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.82 0.674 . . . . 13.42 112.82 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -103.94 115.07 29.78 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.286 -1.005 . . . . 27.09 108.286 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.495 HD11 ' HG2' ' B' ' 27' ' ' LYS . 84.8 mt -102.59 127.64 49.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.305 0.574 . . . . 1.8700000000000001 110.886 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.594 HG22 ' O ' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -153.84 130.45 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.142 -0.481 . . . . 17.75 111.406 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.721 ' CD2' HG12 ' B' ' 61' ' ' ILE . 59.2 t80 -124.95 142.76 51.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.561 -0.29 . . . . 16.98 110.368 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' HE2' ' B' ' 48' ' ' LYS . . . 49.79 38.78 16.48 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.501 0.5 . . . . 0.0 111.653 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 60.3 28.25 66.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 115.164 0.826 . . . . 48.659999999999997 115.164 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.594 ' O ' HG22 ' B' ' 44' ' ' ILE . 44.8 mtmt -119.2 134.29 55.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 117.474 0.637 . . . . 4.25 111.747 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -64.47 114.69 4.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.424 -0.807 . . . . 30.57 110.684 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.59 125.75 34.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.943 0.402 . . . . 22.77 111.79 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -100.21 149.47 23.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.867 -0.606 . . . . 9.3399999999999999 111.493 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.67 -20.05 63.58 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.8 68.6 Favored Glycine 0 N--CA 1.476 1.309 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.491 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.36 163.93 13.85 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.295 0.548 . . . . 1.8600000000000001 111.674 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 49.6 p -105.35 166.3 10.52 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.679 0.752 . . . . 0.0 112.602 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.01 -41.91 93.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.664 -1.153 . . . . 2.2799999999999998 110.794 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.0 70.96 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 120.058 -0.657 . . . . 2.98 111.902 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.05 -29.09 70.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.728 -0.389 . . . . 1.77 110.467 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.87 14.45 28.9 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.13 39.36 19.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.923 0.489 . . . . 0.0 112.218 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.721 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.189 -1.041 . . . . 4.0099999999999998 108.189 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.09 8.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.27 0.557 . . . . 5.7400000000000002 112.191 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.46 141.38 15.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.25 -0.887 . . . . 4.3099999999999996 111.471 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.03 23.23 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.074 -0.967 . . . . 10.130000000000001 112.856 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.425 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.3 m -77.28 146.27 36.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.984 -1.117 . . . . 4.0999999999999996 107.984 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 53.2 m -126.31 136.29 52.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.596 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' B' ' 45' ' ' PHE . 0.0 OUTLIER -109.01 -177.78 3.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.232 -0.44 . . . . 19.210000000000001 110.256 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -118.55 147.33 43.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.956 -0.387 . . . . 50.0 109.956 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.2 113.91 3.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.945 0.402 . . . . 21.579999999999998 110.973 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.946 HG11 ' HB3' ' A' ' 319' ' ' PRO . 72.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 25.969999999999999 110.821 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 121.571 0.7 . . . . 137.63999999999999 110.331 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.91 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.85 -56.86 10.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.515 -0.766 . . . . 89.760000000000005 111.381 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.91 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.54 12.65 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.81 -0.556 . . . . 143.71000000000001 109.59 -177.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.13 135.78 51.13 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.445 -0.576 . . . . 62.810000000000002 109.445 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.455 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.7 m-85 -107.16 134.46 50.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.529 -0.915 . . . . 73.75 108.529 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.64 135.38 48.46 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.723 -0.844 . . . . 54.439999999999998 108.723 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.545 ' H ' ' CD1' ' A' ' 326' ' ' LEU . 40.7 tttp -92.7 135.59 33.97 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.254 -1.017 . . . . 88.159999999999997 108.254 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 323' ' ' VAL . 93.0 t -100.99 114.78 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 117.93 -1.508 . . . . 73.900000000000006 110.724 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 276' ' ' PHE . 8.3 pt -79.25 -34.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.954 -1.021 . . . . 138.47999999999999 112.981 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . 0.584 ' CG ' ' HD2' ' B' ' 68' ' ' HIS . 2.4 m-85 -108.23 90.52 6.96 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.478 0.18 . . . . 67.980000000000004 110.806 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 290' ' ' GLU . 65.6 Cg_endo -72.28 141.37 35.49 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.762 2.308 . . . . 72.540000000000006 113.375 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.402 ' CZ ' HD11 ' B' ' 44' ' ' ILE . 0.2 OUTLIER -101.74 -150.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.393 -0.821 . . . . 82.870000000000005 109.435 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -159.62 144.3 15.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.522 -0.918 . . . . 66.180000000000007 108.522 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -28.67 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.497 1.123 . . . . 50.240000000000002 113.574 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.569 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.48 -42.53 12.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.831 -0.622 . . . . 128.65000000000001 109.421 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -148.34 177.26 9.58 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.77 -0.582 . . . . 67.609999999999999 111.377 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -82.45 -34.4 28.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.309 -0.859 . . . . 78.629999999999995 110.443 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.13 -5.43 59.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 42.490000000000002 111.151 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.603 ' HG2' HH21 ' B' ' 74' ' ' ARG . 73.9 mt-10 -102.55 147.51 26.68 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.329 0.585 . . . . 53.210000000000001 109.533 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 309' ' ' GLY . 17.3 tp -85.69 133.12 34.04 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.135 -0.939 . . . . 57.0 110.196 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.442 ' O ' HD23 ' A' ' 311' ' ' LEU . 90.1 m -96.72 124.58 40.75 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.812 -1.555 . . . . 53.009999999999998 107.739 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.404 HD12 HG21 ' A' ' 274' ' ' VAL . 49.2 pt -128.29 141.42 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.554 -0.906 . . . . 56.119999999999997 108.554 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 14.4 mmtt -118.69 162.72 17.96 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.798 -0.815 . . . . 97.849999999999994 108.798 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . 0.529 ' N ' ' HB3' ' A' ' 277' ' ' PRO . 13.5 pt-20 -75.18 141.53 43.62 Favored 'General case' 0 CA--C 1.483 -1.628 0 C-N-CA 118.101 -1.439 . . . . 88.319999999999993 108.734 -174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.44 21.48 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.646 -0.982 . . . . 35.810000000000002 110.646 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.49 151.9 50.46 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.398 1.099 . . . . 61.780000000000001 109.829 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.455 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.0 mm -109.52 134.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.777 -1.194 . . . . 105.08 107.777 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.3 t -122.8 134.84 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.669 -0.863 . . . . 48.770000000000003 108.669 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.84 126.56 34.13 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.096 -1.042 . . . . 128.84 108.846 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -72.0 113.27 8.85 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.886 -0.783 . . . . 81.370000000000005 108.886 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.38 -52.45 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 123.765 0.826 . . . . 70.599999999999994 110.924 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.03 149.12 27.83 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.42 -0.955 . . . . 65.189999999999998 108.42 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.646 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.87 23.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.546 0.688 . . . . 125.5 110.581 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.714 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.19 171.22 9.96 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 125.86 1.664 . . . . 66.569999999999993 109.961 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 6.2 p -64.12 -133.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.665 -0.698 . . . . 91.459999999999994 112.29 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 36.9 mm -79.85 -53.78 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 112.898 0.703 . . . . 103.65000000000001 112.898 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.91 113.26 1.15 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.419 0.526 . . . . 115.16 112.419 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.87 106.48 13.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.583 -0.735 . . . . 50.439999999999998 109.971 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 165.21 -11.06 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.458 -0.792 . . . . 34.159999999999997 111.292 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.714 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 83.4 m95 -122.74 156.04 35.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.273 . . . . 81.450000000000003 110.485 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.646 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.6 m0 -168.22 -175.71 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 93.810000000000002 108.328 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.655 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -144.41 143.05 30.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.847 -0.797 . . . . 89.719999999999999 108.847 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 286' ' ' LEU . . . -152.8 169.03 31.82 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 108.441 -1.864 . . . . 24.219999999999999 108.441 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.803 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.93 129.66 56.4 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.567 -0.853 . . . . 56.969999999999999 109.649 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 287' ' ' THR . 61.9 tp -142.63 135.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.102 -1.073 . . . . 59.329999999999998 108.102 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.11 37.77 29.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.552 -0.536 . . . . 46.140000000000001 109.552 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.09 35.07 88.39 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.269 -0.967 . . . . 26.489999999999998 110.745 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.803 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.44 160.35 36.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.989 -1.084 . . . . 98.989999999999995 108.521 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.29 124.74 35.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.749 -1.204 . . . . 109.22 107.749 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.74 163.71 36.47 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.082 -1.607 . . . . 26.510000000000002 109.082 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 308' ' ' GLU . 0.8 OUTLIER -98.09 151.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.65 0.38 . . . . 54.609999999999999 111.445 -178.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.75 151.43 26.63 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 120.999 0.428 . . . . 74.469999999999999 110.42 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.2 Cg_endo -70.19 122.02 8.6 Favored 'Trans proline' 0 CA--C 1.487 -1.825 0 C-N-CA 120.097 0.532 . . . . 111.89 112.041 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -78.92 -6.25 55.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 123.995 0.809 . . . . 119.27 111.833 -178.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.1 -40.77 97.01 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.386 -0.598 . . . . 96.629999999999995 109.386 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.42 2.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.852 -1.067 . . . . 74.849999999999994 111.788 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.637 ' HB ' HG22 ' A' ' 274' ' ' VAL . 1.9 m -132.24 155.54 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.555 -0.535 . . . . 67.239999999999995 109.555 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -116.61 163.96 15.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.143 -0.688 . . . . 130.62 109.143 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.557 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -93.67 135.17 35.22 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 108.127 -1.064 . . . . 63.159999999999997 108.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.07 44.55 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 105.785 -1.931 . . . . 97.620000000000005 105.785 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.3 Cg_exo -63.88 -33.87 62.47 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 N-CA-C 115.523 1.316 . . . . 152.83000000000001 115.523 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--N 1.302 -1.918 0 CA-C-N 121.387 1.531 . . . . 59.969999999999999 109.248 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.541 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.9 140.23 32.57 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.397 0.618 . . . . 29.010000000000002 110.121 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' B' ' 65' ' ' SER . 12.7 pt -119.21 156.15 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.021 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.577 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -121.12 139.31 53.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.931 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.528 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.29 124.16 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.671 -0.863 . . . . 4.9900000000000002 108.671 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -100.99 137.56 39.2 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.059 0.457 . . . . 5.6799999999999997 110.411 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -90.87 -149.95 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.543 -0.753 . . . . 26.890000000000001 111.6 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.787 HD12 HD22 ' B' ' 71' ' ' LEU . 0.4 OUTLIER -62.57 -47.89 81.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.856 -0.611 . . . . 23.289999999999999 111.448 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -91.27 2.26 56.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.556 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.48 16.37 49.75 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.881 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 82.6 tttt -43.62 150.05 0.25 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 122.223 -0.574 . . . . 8.5099999999999998 111.778 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.5 m -106.54 128.1 53.85 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.718 -0.845 . . . . 1.8799999999999999 108.718 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' B' ' 4' ' ' PHE . 69.4 mt -123.96 121.67 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 O-C-N 123.289 0.368 . . . . 37.689999999999998 110.953 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.47 131.22 47.72 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -127.19 149.9 49.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.624 0.25 . . . . 9.4600000000000009 110.935 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.57 122.13 43.77 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.271 -1.751 . . . . 1.54 106.271 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.95 168.32 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.487 0.66 . . . . 0.0 111.493 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.84 149.2 44.82 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.2 -24.47 59.27 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 CA-C-N 120.772 1.311 . . . . 0.0 112.954 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.21 -2.56 58.17 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.069 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.63 50.52 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.94 -1.133 . . . . 1.4299999999999999 107.94 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -87.03 157.89 19.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.687 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.447 HG23 HD12 ' B' ' 43' ' ' LEU . 35.8 mm -61.29 -39.91 84.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.921 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.04 -37.64 80.38 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.36 -42.85 87.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.64 -41.68 89.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.27 89.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.451 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.3 -39.13 92.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.528 HD11 HG21 ' B' ' 5' ' ' VAL . 32.6 mt -65.05 -40.04 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.04 -44.04 94.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.518 0.675 . . . . 1.3200000000000001 109.39 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.85 -40.35 92.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.036 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -41.22 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.033 1.123 . . . . 0.82999999999999996 114.033 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -110.93 -14.7 13.92 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.049 1.87 . . . . 6.1200000000000001 116.049 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.06 82.93 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.322 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -85.82 116.48 65.83 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 109.507 -0.553 . . . . 3.54 109.507 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.93 134.64 61.44 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.086 1.19 . . . . 0.0 112.339 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.32 -32.22 25.08 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.751 2.301 . . . . 0.0 114.654 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.71 -15.99 62.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.976 0.807 . . . . 2.8799999999999999 112.182 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.08 8.69 43.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.732 0.271 . . . . 7.1699999999999999 111.732 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.469 ' OE1' HG21 ' B' ' 30' ' ' ILE . 44.0 mt-30 -117.65 125.84 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.13 0.789 . . . . 13.42 113.13 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -111.83 124.03 51.49 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.019 -1.104 . . . . 27.09 108.019 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.447 HD12 HG23 ' B' ' 23' ' ' ILE . 84.8 mt -98.41 132.69 43.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.289 0.566 . . . . 1.8700000000000001 110.836 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.402 HD11 ' CZ ' ' A' ' 278' ' ' TYR . 3.6 mp -132.04 135.57 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.062 -0.399 . . . . 17.75 111.631 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.52 ' CD1' HG12 ' B' ' 61' ' ' ILE . 15.0 t80 -152.92 143.26 22.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.114 -0.494 . . . . 16.98 109.944 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.5 34.75 25.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.681 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.487 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 73.1 -10.74 5.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.013 -0.994 . . . . 48.659999999999997 114.863 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -107.94 132.64 53.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 120.005 -0.678 . . . . 4.25 111.76 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -58.82 116.98 4.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.14 -0.482 . . . . 30.57 110.126 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 45' ' ' PHE . 21.3 mt -66.6 131.49 46.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.957 -0.565 . . . . 22.77 112.046 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -97.53 149.43 22.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.851 -0.613 . . . . 9.3399999999999999 111.45 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.64 -20.2 63.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.96 68.7 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.54 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.43 163.91 13.89 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.17 0.485 . . . . 1.8600000000000001 111.581 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.2 p -105.33 166.33 10.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.611 0.719 . . . . 0.0 112.604 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.9 mt -60.04 -41.99 93.44 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.672 -1.149 . . . . 2.2799999999999998 110.763 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.33 -31.21 71.07 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.111 -0.636 . . . . 2.98 111.763 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -62.14 -28.87 69.94 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.687 -0.405 . . . . 1.77 110.477 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.98 14.56 28.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.4 19.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.9 0.48 . . . . 0.0 112.207 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.52 HG12 ' CD1' ' B' ' 45' ' ' PHE . 96.8 mt -81.46 123.92 38.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.106 -1.072 . . . . 4.0099999999999998 108.106 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.88 169.21 8.68 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.281 0.563 . . . . 5.7400000000000002 112.097 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 56.9 pttt -51.59 141.41 16.31 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.184 -0.916 . . . . 4.3099999999999996 111.502 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.04 23.21 9.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.05 -0.977 . . . . 10.130000000000001 112.845 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' B' ' 3' ' ' ILE . 38.1 m -77.3 146.93 36.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.87 -1.159 . . . . 4.0999999999999996 107.87 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.577 HG23 ' HB2' ' B' ' 4' ' ' PHE . 78.0 m -122.64 132.2 54.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.4 171.74 7.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 19.210000000000001 109.789 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.584 ' HD2' ' CG ' ' A' ' 276' ' ' PHE . 1.3 m-70 -119.96 135.59 54.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 12.6 tp -138.42 157.18 46.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.043 0.449 . . . . 21.579999999999998 111.193 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' HG3' ' A' ' 319' ' ' PRO . 2.1 t -110.03 164.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.873 -0.603 . . . . 25.969999999999999 109.848 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.787 HD22 HD12 ' B' ' 8' ' ' LEU . 37.4 tp -78.46 -96.16 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 119.461 -0.304 . . . . 1.6699999999999999 110.285 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' B' ' 71' ' ' LEU . 0.2 OUTLIER 156.69 64.04 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.114 0.884 . . . . 23.710000000000001 110.518 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.404 HD12 ' NE1' ' A' ' 306' ' ' TRP . 18.5 mt -95.06 -26.62 15.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.955 0.407 . . . . 15.09 110.235 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.603 HH21 ' HG2' ' A' ' 285' ' ' GLU . 3.1 tmm_? -131.37 -60.89 0.93 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.766 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 34.0 1.02 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.594 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.546 -0.74 . . . . 1.8600000000000001 111.072 -179.81 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 121.589 0.709 . . . . 137.63999999999999 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.9 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 51.8 p -64.87 -56.99 10.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.528 -0.76 . . . . 89.760000000000005 111.26 -177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.9 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.88 166.63 12.63 Favored 'General case' 0 CA--C 1.491 -1.302 0 O-C-N 121.826 -0.546 . . . . 143.71000000000001 109.592 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.18 135.8 51.17 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.437 -0.579 . . . . 62.810000000000002 109.437 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 61.0 m-85 -107.18 134.44 50.29 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.515 -0.921 . . . . 73.75 108.515 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.6 135.4 48.5 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.747 -0.834 . . . . 54.439999999999998 108.747 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.651 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.7 tttp -92.66 135.52 34.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.251 -1.018 . . . . 88.159999999999997 108.251 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 288' ' ' ILE . 90.4 t -100.84 116.46 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 118.038 -1.465 . . . . 73.900000000000006 110.782 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 33.0 mm -78.38 -78.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.9 -0.591 . . . . 138.47999999999999 112.099 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' B' ' 68' ' ' HIS . 20.7 m-85 -68.95 131.71 90.79 Favored Pre-proline 0 N--CA 1.462 0.147 0 N-CA-C 109.692 -0.484 . . . . 67.980000000000004 109.692 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.532 ' CD ' ' HA2' ' B' ' 47' ' ' GLY . 30.8 Cg_endo -63.78 149.75 90.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.727 2.285 . . . . 72.540000000000006 111.807 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 288' ' ' ILE . 63.6 t80 -121.41 92.45 3.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.955 -0.566 . . . . 82.870000000000005 110.446 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -68.18 116.14 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.873 -0.603 . . . . 66.180000000000007 109.729 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.35 104.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.403 1.065 . . . . 50.240000000000002 112.98 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.541 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -81.71 -40.28 23.0 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.398 -0.593 . . . . 128.65000000000001 109.398 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -144.85 175.39 10.23 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.281 -0.887 . . . . 67.609999999999999 111.691 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.67 -31.03 32.43 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.334 -0.848 . . . . 78.629999999999995 109.696 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 -3.59 43.96 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.327 -0.851 . . . . 42.490000000000002 110.939 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.5 146.51 37.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.401 0.62 . . . . 53.210000000000001 109.486 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.432 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.7 tp -76.79 138.72 40.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.525 -0.762 . . . . 57.0 110.066 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.8 m -96.45 124.49 40.47 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.33 -1.348 . . . . 53.009999999999998 107.767 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.2 142.16 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.542 -0.91 . . . . 56.119999999999997 108.542 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -113.82 158.3 21.19 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.396 -0.964 . . . . 97.849999999999994 108.396 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.48 141.52 41.26 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 118.077 -1.449 . . . . 88.319999999999993 108.642 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.63 21.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.572 -1.011 . . . . 35.810000000000002 110.572 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.49 151.87 50.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.436 1.118 . . . . 61.780000000000001 109.825 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.3 mm -109.56 133.95 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.817 -1.179 . . . . 105.08 107.817 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.74 134.8 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.718 -0.845 . . . . 48.770000000000003 108.718 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.82 126.61 34.16 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.131 -1.028 . . . . 128.84 108.825 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.97 113.22 8.78 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.899 -0.778 . . . . 81.370000000000005 108.899 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.41 -52.43 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.733 0.813 . . . . 70.599999999999994 110.92 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.97 149.2 27.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.475 -0.935 . . . . 65.189999999999998 108.475 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.524 ' HG3' ' NE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.79 23.62 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.433 0.635 . . . . 125.5 110.594 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.18 174.3 7.93 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.801 1.64 . . . . 66.569999999999993 109.93 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 3.9 p -58.0 -144.72 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.994 0.739 . . . . 91.459999999999994 112.994 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.414 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 45.8 mm -71.02 -57.52 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.907 1.077 . . . . 103.65000000000001 113.907 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -50.53 127.57 18.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.096 0.776 . . . . 115.16 113.096 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.88 112.82 26.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.408 -0.815 . . . . 50.439999999999998 110.446 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 158.3 -13.56 0.25 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.922 -0.871 . . . . 34.159999999999997 110.922 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.555 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 92.4 m95 -122.7 147.56 46.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.372 -0.414 . . . . 81.450000000000003 110.913 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.626 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 7.2 m0 -157.81 -177.48 6.61 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.782 0.676 . . . . 93.810000000000002 109.435 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.763 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -138.14 143.06 40.14 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.851 -0.796 . . . . 89.719999999999999 108.851 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.86 168.89 31.84 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 108.448 -1.861 . . . . 24.219999999999999 108.448 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.792 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.84 129.75 56.34 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 119.503 -0.879 . . . . 56.969999999999999 109.673 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.68 135.57 28.17 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.1 -1.074 . . . . 59.329999999999998 108.1 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.13 37.78 29.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.499 -0.556 . . . . 46.140000000000001 109.499 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.13 35.04 88.1 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.193 -1.004 . . . . 26.489999999999998 110.699 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.792 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.4 160.3 36.78 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 119.029 -1.069 . . . . 98.989999999999995 108.598 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -129.22 124.78 35.38 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.738 -1.208 . . . . 109.22 107.738 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.82 163.96 36.67 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.071 -1.612 . . . . 26.510000000000002 109.071 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.763 HG12 ' HG2' ' A' ' 308' ' ' GLU . 1.6 m -96.42 151.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 122.734 0.413 . . . . 54.609999999999999 111.456 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -155.23 151.4 22.68 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 120.634 -0.427 . . . . 74.469999999999999 110.425 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.22 121.89 8.46 Favored 'Trans proline' 0 CA--C 1.486 -1.88 0 C-N-CA 120.053 0.502 . . . . 111.89 112.094 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.626 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.1 OUTLIER -74.76 -0.44 18.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 124.158 0.912 . . . . 119.27 111.976 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.512 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.95 -42.64 98.61 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 109.448 -0.575 . . . . 96.629999999999995 109.448 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 68' ' ' HIS . 4.6 m-85 -73.55 9.9 1.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.523 -0.762 . . . . 74.849999999999994 112.683 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.57 164.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.589 -0.523 . . . . 67.239999999999995 109.589 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.08 154.67 47.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.341 -0.614 . . . . 130.62 109.341 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -92.22 135.26 34.15 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.11 -1.07 . . . . 63.159999999999997 108.11 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.05 44.61 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 105.803 -1.925 . . . . 97.620000000000005 105.803 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.97 -33.82 61.64 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.59 1.342 . . . . 152.83000000000001 115.59 -175.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 CA--C 1.486 -1.908 0 CA-C-N 121.385 1.53 . . . . 59.969999999999999 109.308 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.88 140.7 31.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.243 0.545 . . . . 29.010000000000002 110.197 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.8 pt -116.27 161.55 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.827 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.84 139.3 53.79 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.585 0.231 . . . . 0.0 110.975 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.577 HG21 HD11 ' B' ' 30' ' ' ILE . 46.9 t -121.24 124.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.641 -0.874 . . . . 4.9900000000000002 108.641 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.13 139.57 36.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 5.6799999999999997 110.471 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -91.3 -142.59 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.612 -0.722 . . . . 26.890000000000001 111.788 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 8' ' ' LEU . 1.1 tm? -73.49 -42.13 62.23 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.119 -0.491 . . . . 23.289999999999999 111.572 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.7 p -94.25 2.35 55.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.527 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.46 16.32 49.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.786 177.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 77.6 tttt -46.8 153.45 0.4 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.363 -0.492 . . . . 8.5099999999999998 111.568 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -107.06 127.77 53.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.722 -0.844 . . . . 1.8799999999999999 108.722 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.82 121.75 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.233 0.333 . . . . 37.689999999999998 110.931 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.45 131.18 47.7 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -127.12 149.94 49.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.678 0.275 . . . . 9.4600000000000009 110.935 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.6 122.12 43.75 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 106.185 -1.783 . . . . 1.54 106.185 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.92 168.41 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.524 0.678 . . . . 0.0 111.468 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.94 149.28 45.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.24 -24.43 59.36 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 CA-C-N 120.832 1.333 . . . . 0.0 112.93 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 p -85.28 -2.59 58.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.001 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.22 142.57 50.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.958 -1.127 . . . . 1.4299999999999999 107.958 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.91 157.79 19.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.704 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.24 -39.88 84.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.011 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.71 80.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.32 -42.87 87.59 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -60.64 -41.7 89.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.96 -40.0 87.52 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.18 89.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.516 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.15 -39.25 92.73 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.577 HD11 HG21 ' B' ' 5' ' ' VAL . 32.6 mt -65.09 -40.03 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.98 -44.08 94.72 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.609 0.719 . . . . 1.3200000000000001 109.441 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.82 -40.37 92.5 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.026 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -41.13 22.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.108 1.151 . . . . 0.82999999999999996 114.108 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.95 -14.57 13.93 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.15 1.907 . . . . 6.1200000000000001 116.15 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.1 82.95 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.393 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.81 116.4 65.52 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.566 -0.531 . . . . 3.54 109.566 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.67 61.97 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.101 1.201 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.48 -32.02 25.69 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.78 2.32 . . . . 0.0 114.694 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.75 -15.99 62.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.971 0.805 . . . . 2.8799999999999999 112.189 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.07 5.65 44.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.709 0.262 . . . . 7.1699999999999999 111.709 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -103.74 131.29 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.873 0.694 . . . . 13.42 112.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 mtt85 -119.3 113.86 21.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.256 -1.016 . . . . 27.09 108.256 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.417 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.3 mt -101.72 128.7 47.92 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.336 0.589 . . . . 1.8700000000000001 110.815 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 67.8 mt -143.87 136.05 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.278 -0.419 . . . . 17.75 111.109 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.605 ' CD2' HG12 ' B' ' 61' ' ' ILE . 94.5 t80 -131.72 134.92 46.4 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.307 -0.257 . . . . 16.98 110.307 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 39.31 21.7 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 123.435 0.459 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.532 ' HA2' ' CD ' ' A' ' 277' ' ' PRO . . . 66.98 22.85 72.55 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.522 0.969 . . . . 48.659999999999997 115.522 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.5 132.55 56.52 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.605 -0.938 . . . . 4.25 111.784 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -67.51 118.58 11.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.82 -0.627 . . . . 30.57 110.703 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.417 HD12 ' HB3' ' B' ' 43' ' ' LEU . 50.3 mt -86.25 126.11 34.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.229 0.455 . . . . 22.77 112.229 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -100.07 149.53 23.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.835 -0.62 . . . . 9.3399999999999999 111.433 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -69.65 -20.26 63.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.05 5.91 68.85 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.572 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.92 13.87 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.179 0.49 . . . . 1.8600000000000001 111.637 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.33 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.576 0.703 . . . . 0.0 112.67 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.91 -42.05 93.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.759 -1.109 . . . . 2.2799999999999998 110.747 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.4 -31.13 71.04 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.187 -0.605 . . . . 2.98 111.826 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.06 -28.94 69.95 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.773 -0.371 . . . . 1.77 110.459 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.01 14.51 28.93 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.16 39.28 19.16 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 122.977 0.511 . . . . 0.0 112.207 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.605 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.37 123.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.092 -1.077 . . . . 4.0099999999999998 108.092 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.96 169.15 8.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.23 0.538 . . . . 5.7400000000000002 112.114 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.0 pttt -51.56 141.45 16.11 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.19 -0.914 . . . . 4.3099999999999996 111.482 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.9 23.34 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.01 -0.996 . . . . 10.130000000000001 112.817 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.27 146.57 36.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 4.0999999999999996 107.952 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -123.45 133.06 54.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.13 179.01 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 19.210000000000001 109.927 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 322' ' ' PHE . 1.1 m170 -115.96 139.17 50.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.964 -0.384 . . . . 50.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -133.19 144.73 50.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 21.579999999999998 111.012 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.408 HG13 ' CZ ' ' A' ' 322' ' ' PHE . 3.7 m -99.92 152.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 25.969999999999999 110.661 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 tp -144.93 107.98 4.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.504 -0.317 . . . . 1.6699999999999999 111.368 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.432 ' CZ ' ' HA ' ' B' ' 76' ' ' CYS . 1.3 mmp_? -64.44 125.38 24.46 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.968 -0.56 . . . . 23.710000000000001 110.516 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 -62.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 15.09 110.832 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.07 147.73 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.521 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.54 -87.09 1.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.873 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.432 ' HA ' ' CZ ' ' B' ' 72' ' ' ARG . 36.9 m . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.968 -1.015 . . . . 1.8600000000000001 111.508 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 121.529 0.681 . . . . 137.63999999999999 110.358 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.914 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.506 -0.77 . . . . 89.760000000000005 111.342 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.914 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.56 12.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 O-C-N 121.739 -0.601 . . . . 143.71000000000001 109.508 -177.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.11 135.81 51.08 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.48 -0.563 . . . . 62.810000000000002 109.48 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.551 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.0 m-85 -107.25 134.48 50.28 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.413 -0.958 . . . . 73.75 108.413 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.57 135.37 48.49 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.784 -0.821 . . . . 54.439999999999998 108.784 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.525 ' HB3' HD21 ' A' ' 326' ' ' LEU . 40.6 tttp -92.76 135.65 33.93 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.151 -1.055 . . . . 88.159999999999997 108.151 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.5 HG22 HG11 ' A' ' 323' ' ' VAL . 91.6 t -100.98 117.13 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 117.96 -1.496 . . . . 73.900000000000006 110.833 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.1 OUTLIER -96.71 -0.54 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.668 0.988 . . . . 138.47999999999999 113.668 -178.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . 0.675 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 5.1 m-85 -117.67 145.31 36.14 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 117.98 0.355 . . . . 67.980000000000004 111.089 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' B' ' 44' ' ' ILE . 68.5 Cg_endo -76.35 135.22 16.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.575 2.183 . . . . 72.540000000000006 112.352 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.47 ' HB3' HG13 ' A' ' 288' ' ' ILE . 64.6 t80 -130.58 111.2 12.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 82.870000000000005 110.585 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.39 127.27 40.18 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.187 -0.672 . . . . 66.180000000000007 109.187 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.05 108.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.134 0.896 . . . . 50.240000000000002 112.683 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.576 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.0 mt-30 -85.61 -43.04 13.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.468 -0.567 . . . . 128.65000000000001 109.468 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.23 178.56 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.435 -0.791 . . . . 67.609999999999999 111.815 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.34 -35.06 25.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.185 -0.916 . . . . 78.629999999999995 109.76 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -79.53 3.79 17.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.634 -0.712 . . . . 42.490000000000002 110.693 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.717 ' OE2' ' HA ' ' B' ' 73' ' ' LEU . 73.9 mt-10 -117.14 146.29 43.27 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.853 -0.612 . . . . 53.210000000000001 109.522 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.7 tp -83.08 140.98 32.35 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.613 -0.721 . . . . 57.0 110.032 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.426 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.2 m -95.66 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 118.514 -1.275 . . . . 53.009999999999998 107.765 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.2 pt -128.21 141.79 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.555 -0.906 . . . . 56.119999999999997 108.555 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 31.7 mmtt -118.93 162.0 19.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.628 -0.879 . . . . 97.849999999999994 108.628 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.36 141.52 43.29 Favored 'General case' 0 CA--C 1.483 -1.619 0 C-N-CA 118.114 -1.434 . . . . 88.319999999999993 108.68 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.61 21.53 21.41 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 110.667 -0.973 . . . . 35.810000000000002 110.667 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.47 151.89 50.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 118.377 1.089 . . . . 61.780000000000001 109.87 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.551 ' CG2' ' HD1' ' A' ' 271' ' ' TYR . 44.1 mm -109.54 133.97 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.77 -1.196 . . . . 105.08 107.77 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 91.9 t -122.79 134.82 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.704 -0.85 . . . . 48.770000000000003 108.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.87 126.54 34.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.814 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.01 113.33 8.93 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.937 -0.764 . . . . 81.370000000000005 108.937 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.44 -52.41 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 123.682 0.793 . . . . 70.599999999999994 110.869 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -153.0 149.19 27.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.394 -0.965 . . . . 65.189999999999998 108.394 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.609 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.31 163.78 23.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.465 0.65 . . . . 125.5 110.585 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.663 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.12 172.74 8.87 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.847 1.659 . . . . 66.569999999999993 109.884 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 5.7 p -61.93 -149.5 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.939 -1.028 . . . . 91.459999999999994 111.402 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.405 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 47.9 mm -69.02 -55.44 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.248 0.833 . . . . 103.65000000000001 113.248 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -56.65 117.74 4.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.336 0.589 . . . . 115.16 112.277 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.6 t -82.92 113.21 21.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.434 -0.803 . . . . 50.439999999999998 110.254 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . 0.455 ' HA2' HD21 ' A' ' 321' ' ' ASN . . . 166.8 -22.97 0.12 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.951 -0.642 . . . . 34.159999999999997 111.827 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.663 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 15.7 m95 -112.75 154.36 26.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.48 -0.563 . . . . 81.450000000000003 109.48 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.609 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 0.8 OUTLIER -164.7 174.5 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.352 -0.61 . . . . 93.810000000000002 109.352 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.98 143.13 42.65 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.85 -0.796 . . . . 89.719999999999999 108.85 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.91 168.96 31.87 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 108.452 -1.859 . . . . 24.219999999999999 108.452 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.79 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.91 129.64 56.4 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.628 -0.829 . . . . 56.969999999999999 109.684 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 287' ' ' THR . 62.2 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.08 -1.081 . . . . 59.329999999999998 108.08 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 56.06 37.79 29.22 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.503 -0.554 . . . . 46.140000000000001 109.503 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.05 88.06 Favored Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.698 -0.961 . . . . 26.489999999999998 110.698 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.79 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.1 mmm-85 -132.43 160.29 36.84 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 118.348 1.074 . . . . 98.989999999999995 108.649 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -129.25 124.69 35.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.773 -1.195 . . . . 109.22 107.773 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.49 36.32 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.06 -1.616 . . . . 26.510000000000002 109.06 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.761 HG21 ' HB2' ' B' ' 74' ' ' ARG . 0.7 OUTLIER -95.37 148.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.691 0.281 . . . . 54.609999999999999 111.27 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.53 151.4 23.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 120.982 0.42 . . . . 74.469999999999999 110.375 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.44 8.05 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.113 0.542 . . . . 111.89 112.027 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.12 -0.9 56.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.253 0.971 . . . . 119.27 112.018 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.514 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.24 -37.91 87.21 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.38 -0.6 . . . . 96.629999999999995 109.38 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 6.5 m-30 -56.87 -7.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.231 -0.895 . . . . 74.849999999999994 112.135 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 274' ' ' VAL . 0.8 OUTLIER -132.17 142.77 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 109.205 -0.665 . . . . 67.239999999999995 109.205 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -96.49 179.31 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.852 -0.425 . . . . 130.62 109.852 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.555 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.2 mt -89.15 135.19 33.7 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 108.086 -1.079 . . . . 63.159999999999997 108.086 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.4 129.05 44.52 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 105.817 -1.92 . . . . 97.620000000000005 105.817 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.8 Cg_exo -63.87 -33.85 62.65 Favored 'Trans proline' 0 N--CA 1.436 -1.911 0 N-CA-C 115.601 1.346 . . . . 152.83000000000001 115.601 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.947 0 CA-C-N 121.35 1.518 . . . . 59.969999999999999 109.234 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.488 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.94 140.68 31.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.42 0.629 . . . . 29.010000000000002 110.117 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 pt -117.83 165.2 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.818 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.423 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -121.41 139.31 53.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.618 0.247 . . . . 0.0 111.059 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.546 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.23 124.18 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.661 -0.866 . . . . 4.9900000000000002 108.661 177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.3 mttt -101.01 137.89 38.78 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.026 0.441 . . . . 5.6799999999999997 110.487 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -90.35 -146.35 0.18 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.595 -0.73 . . . . 26.890000000000001 111.854 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.478 ' HG ' HD12 ' B' ' 71' ' ' LEU . 1.0 OUTLIER -66.8 -45.89 76.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.969 -0.56 . . . . 23.289999999999999 111.832 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -93.15 2.47 56.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.3 . . . . 0.0 111.511 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.33 16.6 49.38 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.426 -0.416 . . . . 0.0 113.915 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 80.1 tttt -46.96 154.41 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.317 -0.519 . . . . 8.5099999999999998 111.699 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -107.31 128.19 54.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.682 -0.858 . . . . 1.8799999999999999 108.682 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 77.3 mt -120.31 122.8 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 123.343 0.402 . . . . 37.689999999999998 111.039 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.75 131.24 48.15 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -127.25 149.92 49.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.69 0.281 . . . . 9.4600000000000009 110.905 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.57 122.19 43.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.19 -1.782 . . . . 1.54 106.19 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.98 168.34 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.495 0.664 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.88 149.3 45.07 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.18 -24.53 59.5 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 CA-C-N 120.767 1.31 . . . . 0.0 112.901 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 p -85.21 -2.6 58.22 Favored 'General case' 0 CA--C 1.526 0.03 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.04 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -71.17 142.53 50.67 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.036 -1.098 . . . . 1.4299999999999999 108.036 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -86.93 157.89 19.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.704 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.25 -39.83 83.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.04 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.12 -37.64 80.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.31 -42.88 87.66 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.534 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.53 -41.72 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.98 -39.96 87.46 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.18 89.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.445 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.28 -39.12 92.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.546 HD11 HG21 ' B' ' 5' ' ' VAL . 33.1 mt -65.03 -40.07 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.1 -43.99 95.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.484 0.659 . . . . 1.3200000000000001 109.416 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.87 -40.35 92.64 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.97 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.56 -41.23 21.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.091 1.145 . . . . 0.82999999999999996 114.091 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.58 13.93 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.115 1.894 . . . . 6.1200000000000001 116.115 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.16 11.11 82.86 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.232 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.35 65.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 109.592 -0.521 . . . . 3.54 109.592 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.78 134.63 61.72 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.119 1.213 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -32.16 24.62 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 122.771 2.314 . . . . 0.0 114.723 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.82 -15.96 62.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.92 0.782 . . . . 2.8799999999999999 112.19 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.14 7.43 44.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.777 0.288 . . . . 7.1699999999999999 111.777 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -110.44 129.24 55.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.806 0.669 . . . . 13.42 112.806 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.625 ' HB2' HG21 ' B' ' 70' ' ' VAL . 7.0 mtt-85 -119.08 121.19 39.25 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.694 -1.225 . . . . 27.09 107.694 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.468 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.2 mt -98.89 129.5 45.24 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.351 0.596 . . . . 1.8700000000000001 110.85 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' B' ' 50' ' ' LEU . 0.6 OUTLIER -144.01 133.47 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.35 -0.387 . . . . 17.75 111.369 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.725 ' CD2' HG12 ' B' ' 61' ' ' ILE . 84.2 t80 -136.48 143.4 43.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.459 -0.337 . . . . 16.98 110.353 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.23 38.72 21.99 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.6 0.563 . . . . 0.0 111.639 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 63.59 18.13 60.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.524 0.97 . . . . 48.659999999999997 115.524 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.84 134.11 55.34 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.898 0.849 . . . . 4.25 111.798 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.446 ' HA ' HG22 ' B' ' 44' ' ' ILE . 23.6 mt-30 -65.2 119.03 10.13 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.149 -0.478 . . . . 30.57 110.87 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.468 HD12 ' HB3' ' B' ' 43' ' ' LEU . 47.4 mt -86.14 126.25 34.09 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.037 0.446 . . . . 22.77 111.829 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -97.84 149.47 22.33 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 9.3399999999999999 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -69.59 -20.22 63.64 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.1 5.96 68.75 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.93 13.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.225 0.513 . . . . 1.8600000000000001 111.585 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.0 p -105.42 166.36 10.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.655 0.741 . . . . 0.0 112.625 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.02 -41.8 92.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.69 -1.141 . . . . 2.2799999999999998 110.892 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -61.57 -31.11 71.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 120.053 -0.659 . . . . 2.98 111.794 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.98 -28.95 69.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.614 -0.435 . . . . 1.77 110.526 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.98 14.52 28.85 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.07 39.39 19.06 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.725 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.95 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.097 -1.075 . . . . 4.0099999999999998 108.097 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.98 169.19 8.7 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.249 0.547 . . . . 5.7400000000000002 112.103 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.57 141.4 16.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.185 -0.916 . . . . 4.3099999999999996 111.454 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.95 23.32 9.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.991 -1.004 . . . . 10.130000000000001 112.803 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.477 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.27 145.7 37.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.929 -1.138 . . . . 4.0999999999999996 107.929 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.423 HG23 ' HB2' ' B' ' 4' ' ' PHE . 89.8 m -122.32 134.77 54.65 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.297 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' B' ' 67' ' ' LEU . 0.0 OUTLIER -116.03 -175.27 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 19.210000000000001 110.414 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -118.71 139.08 52.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 50.0 109.941 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' B' ' 70' ' ' VAL . 16.5 tp -108.7 163.83 12.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 21.579999999999998 111.163 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.672 HG22 ' HZ ' ' A' ' 322' ' ' PHE . 0.6 OUTLIER -129.47 158.94 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 25.969999999999999 110.503 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.478 HD12 ' HG ' ' B' ' 8' ' ' LEU . 39.4 mt -125.17 -73.02 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 1.6699999999999999 111.07 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.18 -154.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.194 -0.457 . . . . 23.710000000000001 110.352 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.717 ' HA ' ' OE2' ' A' ' 285' ' ' GLU . 1.9 pt? -91.51 -173.2 3.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 15.09 110.083 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.761 ' HB2' HG21 ' A' ' 317' ' ' VAL . 50.2 ttm-85 -64.37 -34.14 77.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.601 0.239 . . . . 0.0 111.353 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.77 22.51 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.917 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.549 -0.739 . . . . 1.8600000000000001 111.317 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.555 0.693 . . . . 137.63999999999999 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.909 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.2 p -64.88 -56.86 10.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.486 -0.779 . . . . 89.760000000000005 111.319 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.909 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.99 166.6 12.61 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 121.784 -0.573 . . . . 143.71000000000001 109.509 -177.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -111.21 135.83 51.17 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.424 -0.584 . . . . 62.810000000000002 109.424 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.561 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.23 134.45 50.31 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.475 -0.935 . . . . 73.75 108.475 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 51.7 m -129.61 135.43 48.55 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.756 -0.831 . . . . 54.439999999999998 108.756 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.681 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.74 135.62 33.95 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 108.245 -1.02 . . . . 88.159999999999997 108.245 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.534 HG22 HG11 ' A' ' 323' ' ' VAL . 92.4 t -101.02 116.27 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 C-N-CA 117.96 -1.496 . . . . 73.900000000000006 110.768 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -4.18 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.68 0.622 . . . . 138.47999999999999 112.68 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -117.16 127.7 26.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.736 0.303 . . . . 67.980000000000004 110.997 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.19 139.51 50.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.212 2.608 . . . . 72.540000000000006 112.188 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -129.97 82.63 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.955 -0.566 . . . . 82.870000000000005 110.585 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.13 126.63 29.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.092 -0.707 . . . . 66.180000000000007 109.092 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.99 104.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.393 1.058 . . . . 50.240000000000002 113.452 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.472 ' HG2' ' HE ' ' B' ' 42' ' ' ARG . 26.1 mt-30 -90.63 -41.34 11.39 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.935 -0.575 . . . . 128.65000000000001 109.491 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -146.96 177.21 9.31 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.159 -0.963 . . . . 67.609999999999999 111.673 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -82.0 -35.39 28.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.431 -0.804 . . . . 78.629999999999995 110.164 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -77.11 -3.67 40.54 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.684 -0.689 . . . . 42.490000000000002 111.028 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -111.36 146.54 36.93 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.428 0.632 . . . . 53.210000000000001 109.475 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.76 142.46 28.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.369 -0.832 . . . . 57.0 110.016 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.577 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.7 m -96.03 124.55 40.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.335 -1.346 . . . . 53.009999999999998 107.688 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.21 141.82 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.556 -0.905 . . . . 56.119999999999997 108.556 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 65.7 mmtt -116.2 156.61 26.23 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.428 -0.953 . . . . 97.849999999999994 108.428 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -75.67 141.56 42.72 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 118.275 -1.37 . . . . 88.319999999999993 108.697 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.54 21.36 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 110.65 -0.98 . . . . 35.810000000000002 110.65 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.52 151.94 50.45 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.397 1.098 . . . . 61.780000000000001 109.805 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.681 HD13 ' HA ' ' A' ' 273' ' ' LYS . 43.9 mm -109.52 134.02 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.807 -1.183 . . . . 105.08 107.807 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.82 134.84 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.671 -0.863 . . . . 48.770000000000003 108.671 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.85 126.61 34.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.151 -1.02 . . . . 128.84 108.799 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.9 tp -72.02 113.29 8.89 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.877 -0.786 . . . . 81.370000000000005 108.877 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.8 mt -74.43 -52.43 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 123.596 0.758 . . . . 70.599999999999994 110.866 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.93 149.18 27.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.362 -0.977 . . . . 65.189999999999998 108.362 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.453 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.37 163.89 23.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.515 0.674 . . . . 125.5 110.554 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.22 173.65 8.29 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.856 1.663 . . . . 66.569999999999993 109.936 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 302' ' ' ILE . 2.5 p -61.8 -158.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.514 -0.766 . . . . 91.459999999999994 111.398 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.416 ' H ' ' HB2' ' A' ' 301' ' ' CYS . 48.7 mm -59.94 -50.48 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.19 1.182 . . . . 103.65000000000001 114.19 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.27 123.11 10.97 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.63 0.604 . . . . 115.16 112.63 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.67 111.7 24.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.563 -0.744 . . . . 50.439999999999998 110.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . 0.5 ' HA2' ' ND2' ' A' ' 321' ' ' ASN . . . 158.74 -16.8 0.26 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.06 -0.816 . . . . 34.159999999999997 111.06 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.607 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 98.6 m95 -118.79 148.26 43.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.175 -0.513 . . . . 81.450000000000003 110.377 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.453 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 2.9 m0 -157.49 174.48 15.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.712 -0.847 . . . . 93.810000000000002 108.712 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.633 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -132.42 143.11 49.58 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.829 -0.804 . . . . 89.719999999999999 108.829 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 169.0 31.83 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 108.437 -1.865 . . . . 24.219999999999999 108.437 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.97 129.63 56.42 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 119.571 -0.851 . . . . 56.969999999999999 109.684 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.61 135.66 28.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.088 -1.079 . . . . 59.329999999999998 108.088 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.75 29.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.584 -0.524 . . . . 46.140000000000001 109.584 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.14 35.07 88.11 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.19 -1.005 . . . . 26.489999999999998 110.623 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.51 160.27 36.99 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 118.397 1.099 . . . . 98.989999999999995 108.627 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.19 124.77 35.42 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.758 -1.201 . . . . 109.22 107.758 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.81 164.12 36.77 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.028 -1.629 . . . . 26.510000000000002 109.028 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.633 HG12 ' HG2' ' A' ' 308' ' ' GLU . 5.0 m -90.72 146.8 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.377 -0.412 . . . . 54.609999999999999 111.511 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.77 151.41 23.36 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.461 -0.495 . . . . 74.469999999999999 110.436 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.607 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.1 122.38 8.96 Favored 'Trans proline' 0 CA--C 1.488 -1.8 0 C-N-CA 120.139 0.559 . . . . 111.89 112.068 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -90.58 -10.41 43.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.321 1.013 . . . . 119.27 111.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -62.42 -38.91 91.5 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.417 -0.586 . . . . 96.629999999999995 109.417 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.96 -1.38 0.29 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.379 -1.282 . . . . 74.849999999999994 112.325 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.534 HG11 HG22 ' A' ' 274' ' ' VAL . 0.7 OUTLIER -131.94 155.2 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.491 -0.559 . . . . 67.239999999999995 109.491 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -108.04 152.76 24.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.428 -0.582 . . . . 130.62 109.428 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.546 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.4 mt -88.0 135.19 33.52 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.097 -1.075 . . . . 63.159999999999997 108.097 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.14 44.15 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.752 -1.944 . . . . 97.620000000000005 105.752 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 75.0 Cg_exo -63.86 -33.96 62.46 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 N-CA-C 115.547 1.326 . . . . 152.83000000000001 115.547 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.3 -1.987 0 CA-C-N 121.386 1.531 . . . . 59.969999999999999 109.292 179.528 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.93 140.46 32.25 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.336 0.589 . . . . 29.010000000000002 110.062 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -118.73 163.4 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.051 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.478 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -120.26 139.27 52.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.601 0.239 . . . . 0.0 111.007 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.652 HG21 HD11 ' B' ' 30' ' ' ILE . 47.2 t -121.29 124.21 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.643 -0.873 . . . . 4.9900000000000002 108.643 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.1 mttt -101.1 135.93 41.76 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.989 0.423 . . . . 5.6799999999999997 110.483 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -78.97 -140.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.547 -0.751 . . . . 26.890000000000001 111.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' B' ' 76' ' ' CYS . 0.7 OUTLIER -81.16 -41.65 22.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 23.289999999999999 111.044 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -89.93 2.41 55.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.519 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.47 16.18 50.42 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.865 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 65.4 tttt -50.09 157.84 0.6 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.454 -0.439 . . . . 8.5099999999999998 111.557 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.4 m -106.37 127.95 53.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.72 -0.844 . . . . 1.8799999999999999 108.72 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 88.8 mt -123.06 123.6 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.315 . . . . 37.689999999999998 110.82 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -101.79 131.19 48.24 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.17 149.94 49.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.578 0.228 . . . . 9.4600000000000009 110.988 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.64 122.16 43.86 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.258 -1.756 . . . . 1.54 106.258 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.93 168.3 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.485 0.659 . . . . 0.0 111.511 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.83 149.35 45.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.3 -24.42 59.81 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 CA-C-N 120.764 1.308 . . . . 0.0 112.966 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 p -85.18 -2.63 58.24 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.046 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -71.24 142.64 50.57 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.003 -1.11 . . . . 1.4299999999999999 108.003 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -87.03 157.82 19.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.679 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -61.26 -39.85 84.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.954 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.13 -37.57 80.46 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.4 -42.85 87.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.55 -41.7 88.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -60.08 -39.87 87.6 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.29 89.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.457 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.531 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.24 -39.22 92.43 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.652 HD11 HG21 ' B' ' 5' ' ' VAL . 33.0 mt -64.99 -40.04 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -44.13 94.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.614 0.721 . . . . 1.3200000000000001 109.407 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.33 92.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.994 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -81.59 -41.23 21.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.01 1.115 . . . . 0.82999999999999996 114.01 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.91 -14.65 13.93 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.052 1.871 . . . . 6.1200000000000001 116.052 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.09 11.11 82.92 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.263 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.77 116.49 65.87 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 109.518 -0.549 . . . . 3.54 109.518 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.83 134.68 61.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.062 1.174 . . . . 0.0 112.39 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 -32.28 24.87 Favored 'Trans proline' 0 N--CA 1.507 2.282 0 C-N-CA 122.8 2.333 . . . . 0.0 114.699 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.67 -16.06 62.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 118.955 0.798 . . . . 2.8799999999999999 112.205 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -100.06 6.09 44.99 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.783 0.29 . . . . 7.1699999999999999 111.783 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.434 ' HB3' HD11 ' B' ' 69' ' ' LEU . 75.1 mt-30 -105.79 153.49 21.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.039 0.755 . . . . 13.42 113.039 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.472 ' HE ' ' HG2' ' A' ' 281' ' ' GLN . 4.0 mtt180 -146.68 118.55 8.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.8 -1.091 . . . . 27.09 108.316 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.406 ' C ' HG13 ' B' ' 44' ' ' ILE . 84.8 mt -100.59 129.41 46.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.315 0.579 . . . . 1.8700000000000001 110.831 -177.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.469 HG23 ' O ' ' B' ' 48' ' ' LYS . 17.2 mt -141.08 136.23 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.084 -0.385 . . . . 17.75 111.194 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.591 ' CD2' HG12 ' B' ' 61' ' ' ILE . 62.2 t80 -135.0 137.62 43.19 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.597 -0.274 . . . . 16.98 110.27 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.69 39.34 21.52 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 123.405 0.441 . . . . 0.0 111.674 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 22.62 68.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.576 0.99 . . . . 48.659999999999997 115.576 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.469 ' O ' HG23 ' B' ' 44' ' ' ILE . 44.8 mtmt -117.19 132.64 56.6 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.999 0.9 . . . . 4.25 111.775 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -68.45 116.6 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 30.57 110.295 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -85.94 130.22 34.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.201 0.524 . . . . 22.77 112.047 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.22 149.55 23.88 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.459 -0.791 . . . . 9.3399999999999999 111.471 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.66 -20.17 63.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.2 5.99 68.53 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.514 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 164.0 13.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.204 0.502 . . . . 1.8600000000000001 111.652 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -105.45 166.41 10.45 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.582 0.706 . . . . 0.0 112.572 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.97 -42.01 93.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.707 -1.133 . . . . 2.2799999999999998 110.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.41 -31.13 71.05 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.138 -0.625 . . . . 2.98 111.77 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.1 -28.94 69.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.689 -0.405 . . . . 1.77 110.468 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.04 14.6 28.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.611 0.244 . . . . 0.0 111.629 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.01 39.39 18.8 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.918 0.487 . . . . 0.0 112.22 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.43 123.93 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.136 -1.061 . . . . 4.0099999999999998 108.136 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.97 169.18 8.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.326 0.584 . . . . 5.7400000000000002 112.114 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.54 141.42 16.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.234 -0.894 . . . . 4.3099999999999996 111.443 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.01 23.26 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.937 -1.029 . . . . 10.130000000000001 112.824 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.34 146.69 36.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.898 -1.149 . . . . 4.0999999999999996 107.898 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.478 HG23 ' HB2' ' B' ' 4' ' ' PHE . 99.8 m -121.52 135.0 55.06 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' B' ' 45' ' ' PHE . 1.2 mp -112.6 -176.2 2.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 19.210000000000001 110.584 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -125.35 148.77 48.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 50.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' B' ' 41' ' ' GLN . 15.7 tp -133.72 139.6 46.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.048 0.452 . . . . 21.579999999999998 111.727 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.93 157.13 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.82 -0.627 . . . . 25.969999999999999 110.321 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.4 -76.79 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.648 -0.251 . . . . 1.6699999999999999 111.556 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.409 ' HB3' ' H ' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -173.38 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.495 -0.32 . . . . 23.710000000000001 110.558 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' B' ' 72' ' ' ARG . 9.8 tp -135.45 -30.52 1.01 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.164 -0.214 . . . . 15.09 111.432 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -165.45 146.25 7.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.73 -0.213 . . . . 0.0 110.755 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.37 -165.61 24.93 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.935 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' B' ' 8' ' ' LEU . 8.8 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.498 -0.763 . . . . 1.8600000000000001 111.479 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 121.528 0.68 . . . . 137.63999999999999 110.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.914 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.7 p -64.86 -56.8 11.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.527 -0.761 . . . . 89.760000000000005 111.413 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.914 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.04 166.51 12.64 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.726 -0.609 . . . . 143.71000000000001 109.482 -177.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -111.12 135.78 51.13 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.448 -0.575 . . . . 62.810000000000002 109.448 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.504 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.8 m-85 -107.2 134.5 50.22 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.513 -0.921 . . . . 73.75 108.513 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.442 ' SG ' HD22 ' A' ' 325' ' ' LEU . 50.2 m -129.59 135.37 48.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.791 -0.818 . . . . 54.439999999999998 108.791 -175.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.731 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.61 33.96 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.214 -1.032 . . . . 88.159999999999997 108.214 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 91.2 t -100.87 115.95 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 118.11 -1.436 . . . . 73.900000000000006 110.722 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -96.59 4.89 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.647 0.98 . . . . 138.47999999999999 113.647 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . 0.718 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -126.2 135.02 26.55 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 117.97 0.35 . . . . 67.980000000000004 110.924 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.21 134.74 19.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 72.540000000000006 111.861 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.452 ' HB3' HG13 ' A' ' 288' ' ' ILE . 81.2 t80 -128.18 137.85 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 82.870000000000005 110.793 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -113.63 121.52 44.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.088 -0.506 . . . . 66.180000000000007 109.658 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -32.64 114.43 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.005 0.815 . . . . 50.240000000000002 113.133 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.553 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -88.35 -41.73 12.66 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.411 -0.588 . . . . 128.65000000000001 109.411 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.98 179.91 7.68 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.288 -0.882 . . . . 67.609999999999999 111.328 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -83.03 -33.25 26.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.412 -0.813 . . . . 78.629999999999995 109.994 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -75.13 -5.19 42.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.714 -0.676 . . . . 42.490000000000002 111.153 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -112.48 147.14 37.17 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.368 0.604 . . . . 53.210000000000001 109.47 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.6 tp -78.1 135.2 37.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.523 -0.762 . . . . 57.0 110.194 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.534 ' O ' HD23 ' A' ' 311' ' ' LEU . 90.0 m -94.87 124.52 38.96 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 118.343 -1.343 . . . . 53.009999999999998 107.805 -176.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 278' ' ' TYR . 49.1 pt -128.28 141.88 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.483 -0.932 . . . . 56.119999999999997 108.483 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.3 mmtt -118.55 160.69 21.31 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.56 -0.904 . . . . 97.849999999999994 108.56 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.53 141.53 41.18 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.065 -1.454 . . . . 88.319999999999993 108.75 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.68 21.5 21.32 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.692 -0.963 . . . . 35.810000000000002 110.692 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -130.54 151.91 50.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 118.348 1.074 . . . . 61.780000000000001 109.768 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.731 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.55 133.99 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.775 -1.194 . . . . 105.08 107.775 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.81 134.8 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.746 -0.835 . . . . 48.770000000000003 108.746 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.504 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 12.9 t -85.82 126.5 34.08 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.153 -1.019 . . . . 128.84 108.858 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -71.91 113.24 8.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.964 -0.754 . . . . 81.370000000000005 108.964 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.635 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.3 mt -74.39 -52.43 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.639 0.776 . . . . 70.599999999999994 110.946 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.95 149.22 28.0 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.387 -0.968 . . . . 65.189999999999998 108.387 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.633 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.36 163.84 23.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.441 0.639 . . . . 125.5 110.585 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 39.6 t0 -89.24 174.77 7.66 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 125.834 1.654 . . . . 66.569999999999993 109.895 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 20.7 p -55.79 -155.95 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.044 -0.98 . . . . 91.459999999999994 112.222 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.99 -68.16 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 113.742 1.016 . . . . 103.65000000000001 113.742 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.61 134.43 57.01 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.521 0.563 . . . . 115.16 112.521 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.8 36.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.629 -0.714 . . . . 50.439999999999998 110.814 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 178.71 -28.75 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.355 -0.839 . . . . 34.159999999999997 111.05 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 319' ' ' PRO . 85.7 m95 -123.24 156.83 34.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.458 -0.371 . . . . 81.450000000000003 110.775 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.633 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.1 m0 -163.61 -179.05 6.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.797 -0.816 . . . . 93.810000000000002 108.797 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.708 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.1 mt-10 -137.59 143.04 41.31 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 108.833 -0.803 . . . . 89.719999999999999 108.833 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.93 31.81 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 108.418 -1.873 . . . . 24.219999999999999 108.418 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.8 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.89 129.58 56.41 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.567 -0.853 . . . . 56.969999999999999 109.728 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 287' ' ' THR . 62.0 tp -142.49 135.69 28.64 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.038 -1.097 . . . . 59.329999999999998 108.038 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.1 37.69 29.11 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.588 -0.523 . . . . 46.140000000000001 109.588 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.0 87.79 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.659 -0.977 . . . . 26.489999999999998 110.659 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.8 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.43 160.37 36.61 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 118.957 -1.097 . . . . 98.989999999999995 108.583 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.25 124.71 35.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.704 -1.221 . . . . 109.22 107.704 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -164.71 163.95 36.6 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.09 -1.604 . . . . 26.510000000000002 109.09 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.708 HG12 ' HG2' ' A' ' 308' ' ' GLU . 2.4 m -94.19 151.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.053 0.541 . . . . 54.609999999999999 111.716 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -153.4 151.42 25.55 Favored Pre-proline 0 N--CA 1.44 -0.937 0 C-N-CA 120.55 -0.46 . . . . 74.469999999999999 110.439 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.566 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.3 Cg_endo -70.12 122.13 8.72 Favored 'Trans proline' 0 CA--C 1.488 -1.819 0 C-N-CA 120.103 0.535 . . . . 111.89 112.111 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -77.63 -0.83 28.08 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.92 0.762 . . . . 119.27 111.893 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -60.75 -39.99 90.79 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.391 -0.596 . . . . 96.629999999999995 109.391 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.718 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 4.7 m-30 -77.93 10.34 2.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.135 -0.939 . . . . 74.849999999999994 112.167 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.25 163.9 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.339 -0.615 . . . . 67.239999999999995 109.339 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -139.34 147.27 41.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.93 -0.767 . . . . 130.62 108.93 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 mt -87.62 135.23 33.45 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.102 -1.073 . . . . 63.159999999999997 108.102 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.33 129.07 44.57 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.847 -1.909 . . . . 97.620000000000005 105.847 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 74.7 Cg_exo -63.86 -34.0 62.31 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.516 1.314 . . . . 152.83000000000001 115.516 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.958 0 CA-C-N 121.408 1.539 . . . . 59.969999999999999 109.283 179.547 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.89 139.83 33.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.223 0.535 . . . . 29.010000000000002 110.108 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 21.7 pt -123.62 167.81 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.415 ' HB2' HG23 ' B' ' 66' ' ' THR . 97.9 m-85 -119.94 139.35 52.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.7 0.286 . . . . 0.0 111.0 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.5 HG21 HD11 ' B' ' 30' ' ' ILE . 47.0 t -121.25 124.22 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.643 -0.873 . . . . 4.9900000000000002 108.643 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 10' ' ' GLY . 76.2 mttt -101.11 137.31 39.65 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.988 0.423 . . . . 5.6799999999999997 110.444 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -84.91 -149.67 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.468 -0.787 . . . . 26.890000000000001 111.355 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.488 HD11 ' HE1' ' A' ' 306' ' ' TRP . 0.5 OUTLIER -67.41 -43.27 81.65 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.966 0.358 . . . . 23.289999999999999 111.966 -179.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.1 p -92.85 2.38 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.6 ' O ' ' HG2' ' B' ' 6' ' ' LYS . . . 92.4 16.74 48.66 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.909 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 74.1 tttt -49.22 157.2 0.48 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.468 -0.431 . . . . 8.5099999999999998 111.578 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.42 ' N ' ' HG2' ' B' ' 11' ' ' LYS . 93.6 m -106.35 127.82 53.55 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.701 -0.852 . . . . 1.8799999999999999 108.701 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.04 123.64 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.49 -0.323 . . . . 37.689999999999998 110.813 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -101.79 131.23 48.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -127.16 149.89 49.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 9.4600000000000009 110.96 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.63 122.15 43.84 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 106.204 -1.776 . . . . 1.54 106.204 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.9 168.32 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 111.542 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.92 149.29 45.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.23 -24.5 59.73 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 CA-C-N 120.808 1.324 . . . . 0.0 112.869 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.1 p -85.2 -2.56 58.17 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.01 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.29 142.67 50.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.001 -1.111 . . . . 1.4299999999999999 108.001 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -87.01 157.83 19.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.709 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.28 -39.8 83.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.029 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.06 -37.65 80.49 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.2 t-20 -66.37 -42.83 87.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.57 -41.79 89.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -59.97 -40.04 87.71 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.18 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.442 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.2 mttp -65.3 -39.16 92.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.5 HD11 HG21 ' B' ' 5' ' ' VAL . 33.2 mt -64.98 -40.1 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -60.06 -44.08 94.97 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.577 0.703 . . . . 1.3200000000000001 109.395 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.82 -40.34 92.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.021 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.6 -41.05 22.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.096 1.147 . . . . 0.82999999999999996 114.096 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -111.09 -14.57 13.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.01 1.855 . . . . 6.1200000000000001 116.01 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.04 11.12 82.97 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.345 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.7 116.29 65.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.511 -0.551 . . . . 3.54 109.511 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.77 134.66 61.93 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.107 1.204 . . . . 0.0 112.35 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.37 -32.13 25.25 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 122.758 2.306 . . . . 0.0 114.679 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.71 -16.03 62.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.964 0.802 . . . . 2.8799999999999999 112.197 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.407 ' CD ' ' HD3' ' B' ' 72' ' ' ARG . 25.3 mt-30 -100.08 5.85 44.96 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.698 0.258 . . . . 7.1699999999999999 111.698 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -98.24 127.51 44.22 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.599 0.592 . . . . 13.42 112.599 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 281' ' ' GLN . 0.8 OUTLIER -117.71 109.79 17.05 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 27.09 108.398 177.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.583 ' HB3' HD12 ' B' ' 50' ' ' LEU . 85.0 mt -99.58 128.99 45.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.353 0.597 . . . . 1.8700000000000001 110.746 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.422 ' HA ' ' HG ' ' B' ' 50' ' ' LEU . 1.0 OUTLIER -146.32 133.78 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.129 -0.487 . . . . 17.75 111.545 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.664 ' CD2' HG12 ' B' ' 61' ' ' ILE . 88.0 t80 -135.59 140.34 44.55 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.469 -0.332 . . . . 16.98 110.245 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 38.68 23.73 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.444 0.465 . . . . 0.0 111.65 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.97 19.8 66.08 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 115.47 0.948 . . . . 48.659999999999997 115.47 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -117.38 133.75 55.62 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.664 0.732 . . . . 4.25 111.759 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' B' ' 49' ' ' GLN . 0.0 OUTLIER -65.84 120.26 12.73 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.739 -0.664 . . . . 30.57 111.017 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' B' ' 43' ' ' LEU . 59.4 mt -86.96 124.19 32.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.117 0.484 . . . . 22.77 112.208 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -99.06 149.5 22.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 9.3399999999999999 111.412 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -69.66 -20.08 63.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.24 5.97 68.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.575 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.37 163.96 13.81 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.124 0.462 . . . . 1.8600000000000001 111.619 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -105.46 166.28 10.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.688 0.756 . . . . 0.0 112.542 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.99 -41.85 92.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.616 -1.174 . . . . 2.2799999999999998 110.781 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -61.5 -31.08 71.06 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 120.045 -0.662 . . . . 2.98 111.875 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.05 -28.96 69.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.773 -0.371 . . . . 1.77 110.489 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.98 14.5 28.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.06 39.39 19.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.961 0.504 . . . . 0.0 112.161 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.664 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.175 -1.046 . . . . 4.0099999999999998 108.175 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -106.95 169.09 8.76 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.367 0.604 . . . . 5.7400000000000002 112.044 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.49 141.37 15.97 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.108 -0.951 . . . . 4.3099999999999996 111.489 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.99 23.34 9.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.072 -0.967 . . . . 10.130000000000001 112.818 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 38.5 m -77.31 145.52 37.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.933 -1.136 . . . . 4.0999999999999996 107.933 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.415 HG23 ' HB2' ' B' ' 4' ' ' PHE . 31.9 m -126.94 141.75 51.72 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.629 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 -165.89 1.46 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.27 -0.423 . . . . 19.210000000000001 110.473 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.34 160.72 35.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.99 -0.374 . . . . 50.0 109.99 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 69' ' ' LEU . 4.8 mt -135.42 172.11 13.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.19 0.519 . . . . 21.579999999999998 111.513 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.524 HG23 ' CZ ' ' A' ' 322' ' ' PHE . 2.8 t -120.26 134.74 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.366 -0.834 . . . . 25.969999999999999 110.401 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 71' ' ' LEU . 1.5 mm? -118.42 -172.43 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.208 -0.451 . . . . 1.6699999999999999 110.942 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.407 ' HD3' ' CD ' ' B' ' 40' ' ' GLN . 17.9 mtm180 -138.55 99.84 3.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.005 -0.543 . . . . 23.710000000000001 109.879 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 tp -132.78 -34.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 15.09 110.814 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.502 HH21 ' HB2' ' A' ' 306' ' ' TRP . 31.2 ttp-105 -152.95 91.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.31 -123.73 2.73 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.33 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.225 -0.893 . . . . 1.8600000000000001 111.235 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 121.532 0.682 . . . . 137.63999999999999 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.906 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.4 p -64.95 -56.88 10.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.581 -0.736 . . . . 89.760000000000005 111.281 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.906 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.03 166.6 12.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 O-C-N 121.753 -0.592 . . . . 143.71000000000001 109.525 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -111.13 135.82 51.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.4 -0.593 . . . . 62.810000000000002 109.4 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.513 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 61.1 m-85 -107.2 134.44 50.3 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.534 -0.913 . . . . 73.75 108.534 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.559 ' SG ' HD22 ' A' ' 325' ' ' LEU . 51.2 m -129.61 135.42 48.53 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.697 -0.853 . . . . 54.439999999999998 108.697 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.54 ' HA ' ' CD1' ' A' ' 293' ' ' ILE . 40.7 tttp -92.73 135.6 33.97 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.197 -1.038 . . . . 88.159999999999997 108.197 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 323' ' ' VAL . 92.2 t -100.97 118.57 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 117.981 -1.488 . . . . 73.900000000000006 110.744 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 42.7 mm -82.74 -66.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.652 -0.704 . . . . 138.47999999999999 111.313 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.39 126.34 87.78 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 67.980000000000004 110.633 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.458 ' HD2' ' HA2' ' B' ' 47' ' ' GLY . 30.6 Cg_endo -63.05 150.01 89.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.505 . . . . 72.540000000000006 112.279 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -129.7 107.91 9.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 82.870000000000005 111.184 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -84.01 120.51 26.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.564 -0.532 . . . . 66.180000000000007 109.564 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -34.34 110.46 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.178 0.924 . . . . 50.240000000000002 112.832 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.691 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -82.38 -41.58 19.76 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.725 -0.671 . . . . 128.65000000000001 109.458 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 284' ' ' ASP . 3.2 t30 -137.21 172.41 13.04 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.003 -1.06 . . . . 67.609999999999999 112.035 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.37 -38.25 56.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.262 -0.881 . . . . 78.629999999999995 110.058 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.493 ' H ' HD22 ' A' ' 282' ' ' ASN . 11.5 m-20 -76.41 3.07 11.89 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.601 -0.727 . . . . 42.490000000000002 110.94 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.691 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -109.74 146.43 34.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.448 0.642 . . . . 53.210000000000001 109.475 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 16.1 tp -77.02 141.07 40.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.696 . . . . 57.0 110.11 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.7 m -96.06 124.57 40.12 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.331 -1.347 . . . . 53.009999999999998 107.771 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.22 142.15 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.507 -0.923 . . . . 56.119999999999997 108.507 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -113.35 157.27 22.06 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 108.507 -0.923 . . . . 97.849999999999994 108.507 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.27 141.51 41.65 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.199 -1.4 . . . . 88.319999999999993 108.634 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.69 21.52 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.637 -0.985 . . . . 35.810000000000002 110.637 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -130.53 151.92 50.47 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 118.389 1.095 . . . . 61.780000000000001 109.791 176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.63 133.99 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 107.799 -1.186 . . . . 105.08 107.799 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 310' ' ' GLU . 91.9 t -122.85 134.76 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.735 -0.839 . . . . 48.770000000000003 108.735 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.496 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.0 t -85.76 126.53 34.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.822 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 308' ' ' GLU . 23.8 tp -71.92 113.18 8.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.974 -0.75 . . . . 81.370000000000005 108.974 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.3 mt -74.4 -52.35 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 123.624 0.77 . . . . 70.599999999999994 110.942 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.99 149.24 27.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.345 -0.983 . . . . 65.189999999999998 108.345 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.482 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.42 163.89 23.48 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.485 0.66 . . . . 125.5 110.515 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.6 t0 -89.2 172.54 8.99 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 125.782 1.633 . . . . 66.569999999999993 109.907 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 23.2 p -59.79 -136.4 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.934 -1.03 . . . . 91.459999999999994 112.269 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 18.1 mm -84.73 -22.79 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 121.693 -0.63 . . . . 103.65000000000001 112.121 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.62 119.28 7.8 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.098 0.407 . . . . 115.16 112.098 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 25.2 t -92.89 92.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.899 -0.591 . . . . 50.439999999999998 110.011 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . 0.514 ' HA2' ' ND2' ' A' ' 321' ' ' ASN . . . 160.21 -12.15 0.17 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.358 -0.837 . . . . 34.159999999999997 111.294 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.575 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 96.6 m95 -117.45 150.2 39.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.872 0.368 . . . . 81.450000000000003 111.093 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.482 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 1.1 m0 -159.76 174.4 14.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.109 -0.951 . . . . 93.810000000000002 108.739 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.59 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -133.68 143.13 48.35 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.767 -0.827 . . . . 89.719999999999999 108.767 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.9 168.95 31.87 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 108.38 -1.888 . . . . 24.219999999999999 108.38 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.803 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.2 tt0 -112.86 129.59 56.4 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.588 -0.845 . . . . 56.969999999999999 109.707 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 61.9 tp -142.52 135.65 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.104 -1.073 . . . . 59.329999999999998 108.104 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.14 37.69 29.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.546 -0.538 . . . . 46.140000000000001 109.546 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.18 35.02 87.78 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.148 -1.025 . . . . 26.489999999999998 110.723 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.803 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.5 160.29 36.92 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.378 1.089 . . . . 98.989999999999995 108.632 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.2 124.85 35.63 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.655 -1.239 . . . . 109.22 107.655 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.8 164.12 36.76 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.125 -1.59 . . . . 26.510000000000002 109.125 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.59 HG12 ' HG2' ' A' ' 308' ' ' GLU . 11.5 m -89.17 145.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 122.75 0.42 . . . . 54.609999999999999 111.497 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.11 151.36 24.32 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 120.525 -0.47 . . . . 74.469999999999999 110.47 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.469 ' HD3' ' CZ3' ' A' ' 306' ' ' TRP . 6.2 Cg_endo -70.23 123.37 9.88 Favored 'Trans proline' 0 CA--C 1.487 -1.835 0 C-N-CA 120.071 0.514 . . . . 111.89 112.062 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.87 -15.27 18.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.518 1.136 . . . . 119.27 111.462 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.514 ' ND2' ' HA2' ' A' ' 305' ' ' GLY . 1.3 m120 -62.52 -39.35 93.28 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 109.347 -0.612 . . . . 96.629999999999995 109.347 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -56.76 -4.16 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.363 -0.835 . . . . 74.849999999999994 112.642 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 274' ' ' VAL . 0.7 OUTLIER -127.56 145.91 34.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.684 -0.487 . . . . 67.239999999999995 109.684 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER -90.07 139.96 30.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.122 -0.695 . . . . 130.62 109.122 178.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.559 HD22 ' SG ' ' A' ' 272' ' ' CYS . 36.5 mt -89.1 135.21 33.68 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.116 -1.068 . . . . 63.159999999999997 108.116 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.08 44.5 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 105.751 -1.944 . . . . 97.620000000000005 105.751 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.1 Cg_exo -64.02 -33.8 61.13 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 N-CA-C 115.547 1.326 . . . . 152.83000000000001 115.547 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.301 -1.933 0 CA-C-N 121.352 1.519 . . . . 59.969999999999999 109.279 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.86 140.22 32.55 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.292 0.568 . . . . 29.010000000000002 110.136 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -120.61 168.21 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.011 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.38 139.26 53.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.598 0.237 . . . . 0.0 111.045 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.492 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.23 124.19 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.659 -0.867 . . . . 4.9900000000000002 108.659 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.08 135.75 42.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.008 0.432 . . . . 5.6799999999999997 110.422 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -79.89 -155.05 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.615 -0.72 . . . . 26.890000000000001 111.274 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' B' ' 71' ' ' LEU . 4.0 mt -66.61 -40.81 89.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.658 0.614 . . . . 23.289999999999999 112.658 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -92.14 2.41 56.61 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.762 0.315 . . . . 0.0 111.581 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.42 15.73 52.2 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.335 -0.459 . . . . 0.0 113.957 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 73.5 tttt -49.76 157.99 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.2 -0.588 . . . . 8.5099999999999998 111.619 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -106.33 128.24 53.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.682 -0.858 . . . . 1.8799999999999999 108.682 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.03 122.64 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 123.31 0.381 . . . . 37.689999999999998 110.83 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -101.97 131.26 48.49 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.21 149.85 49.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.592 0.234 . . . . 9.4600000000000009 110.998 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.53 122.19 43.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.25 -1.759 . . . . 1.54 106.25 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.07 168.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.486 0.66 . . . . 0.0 111.467 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.86 149.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.12 -24.45 58.53 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 CA-C-N 120.836 1.334 . . . . 0.0 112.97 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -85.25 -2.6 58.22 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.001 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.27 142.5 50.53 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.961 -1.126 . . . . 1.4299999999999999 107.961 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -86.88 157.79 19.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.747 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.2 -39.89 84.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.947 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.08 -37.69 80.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.24 -42.85 88.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -60.61 -41.79 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -60.0 -39.93 87.46 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.25 89.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.441 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.31 -39.07 92.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.492 HD11 HG21 ' B' ' 5' ' ' VAL . 33.0 mt -65.11 -40.03 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.05 -44.05 94.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.493 0.663 . . . . 1.3200000000000001 109.36 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.88 -40.4 92.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.957 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.081 1.141 . . . . 0.82999999999999996 114.081 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.95 -14.51 13.94 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.156 1.91 . . . . 6.1200000000000001 116.156 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.2 11.02 82.95 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.245 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.26 64.94 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.632 -0.507 . . . . 3.54 109.632 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.65 134.68 62.33 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.098 1.199 . . . . 0.0 112.433 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.33 -32.21 25.17 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.887 2.391 . . . . 0.0 114.643 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.85 -15.91 62.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.913 0.779 . . . . 2.8799999999999999 112.126 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -100.12 8.13 44.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.754 0.279 . . . . 7.1699999999999999 111.754 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -102.81 144.29 31.34 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.598 0.592 . . . . 13.42 112.598 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -138.82 114.8 10.13 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.341 -0.985 . . . . 27.09 108.341 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 130.39 43.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.364 0.602 . . . . 1.8700000000000001 110.837 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -139.43 130.66 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.932 -0.48 . . . . 17.75 110.931 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.59 ' CD2' HG12 ' B' ' 61' ' ' ILE . 91.5 t80 -132.25 136.4 46.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.555 -0.293 . . . . 16.98 110.244 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.9 39.77 26.6 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 123.474 0.484 . . . . 0.0 111.709 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 277' ' ' PRO . . . 65.35 22.27 69.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 115.605 1.002 . . . . 48.659999999999997 115.605 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -117.94 132.1 56.44 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.07 0.935 . . . . 4.25 111.737 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -68.2 115.58 7.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.896 -0.593 . . . . 30.57 110.158 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -81.93 134.22 35.37 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.122 0.487 . . . . 22.77 111.787 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.81 149.43 24.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.5 -0.773 . . . . 9.3399999999999999 111.467 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.64 -20.12 63.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.22 6.03 68.49 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.533 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.41 163.89 13.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.152 0.476 . . . . 1.8600000000000001 111.621 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 50.6 p -105.37 166.43 10.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.657 0.741 . . . . 0.0 112.596 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.11 -41.9 93.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.674 -1.148 . . . . 2.2799999999999998 110.659 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.55 -30.98 71.0 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.063 -0.655 . . . . 2.98 111.811 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.14 -29.0 70.04 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.715 -0.394 . . . . 1.77 110.419 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.94 14.52 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.03 39.4 18.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.44 123.96 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.095 -1.076 . . . . 4.0099999999999998 108.095 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.17 8.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.303 0.573 . . . . 5.7400000000000002 112.155 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.55 141.37 16.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.222 -0.899 . . . . 4.3099999999999996 111.458 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 67.12 23.15 9.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.978 -1.01 . . . . 10.130000000000001 112.81 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.2 m -77.27 146.72 36.69 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.972 -1.121 . . . . 4.0999999999999996 107.972 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 60.3 m -120.86 131.35 54.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.75 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mp -111.09 -177.68 3.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.667 -0.697 . . . . 19.210000000000001 110.669 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -124.45 144.15 50.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.978 -0.379 . . . . 50.0 109.978 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 69' ' ' LEU . 4.2 mt -129.95 154.55 47.24 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.08 0.467 . . . . 21.579999999999998 111.638 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.86 167.03 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.693 -0.685 . . . . 25.969999999999999 110.07 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.512 ' HB2' ' CD1' ' B' ' 8' ' ' LEU . 3.8 mt -135.68 -79.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.007 0.373 . . . . 1.6699999999999999 112.007 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -158.51 -166.14 1.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.87 0.367 . . . . 23.710000000000001 111.009 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.58 -46.96 57.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.888 -0.596 . . . . 15.09 110.409 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.472 ' NH2' ' OD2' ' A' ' 300' ' ' ASP . 1.1 ttt85 -174.21 159.69 3.22 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.751 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.85 -100.47 1.87 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.661 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.566 -0.731 . . . . 1.8600000000000001 111.372 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 121.585 0.707 . . . . 137.63999999999999 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.897 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.3 p -64.88 -56.84 10.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.523 -0.762 . . . . 89.760000000000005 111.346 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.897 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -91.97 166.6 12.62 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 121.777 -0.577 . . . . 143.71000000000001 109.549 -177.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.21 135.8 51.21 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.454 -0.573 . . . . 62.810000000000002 109.454 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.599 ' CE1' ' HB ' ' A' ' 295' ' ' THR . 60.9 m-85 -107.23 134.44 50.32 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.505 -0.924 . . . . 73.75 108.505 176.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . . . . . . . . . 52.1 m -129.63 135.45 48.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.726 -0.842 . . . . 54.439999999999998 108.726 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.678 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.71 135.57 33.99 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.203 -1.036 . . . . 88.159999999999997 108.203 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 276' ' ' PHE . 89.8 t -100.85 115.95 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 C-N-CA 118.028 -1.469 . . . . 73.900000000000006 110.823 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.707 ' H ' HD13 ' A' ' 275' ' ' ILE . 0.2 OUTLIER -98.12 16.58 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.655 0.983 . . . . 138.47999999999999 113.655 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . 0.717 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 10.8 m-85 -136.63 143.01 41.22 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 122.261 -0.275 . . . . 67.980000000000004 110.456 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.86 134.53 12.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.573 2.182 . . . . 72.540000000000006 112.281 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.61 96.39 4.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.794 -0.639 . . . . 82.870000000000005 110.776 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.55 120.58 21.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.125 -0.488 . . . . 66.180000000000007 109.732 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -31.52 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.288 0.847 . . . . 50.240000000000002 113.288 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.542 ' OE1' HG21 ' B' ' 70' ' ' VAL . 26.1 mt-30 -85.17 -41.99 15.14 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 109.448 -0.575 . . . . 128.65000000000001 109.448 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -146.83 176.39 9.92 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.872 -1.143 . . . . 67.609999999999999 111.455 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.89 -30.82 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.152 -0.931 . . . . 78.629999999999995 110.621 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.37 -6.26 57.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.924 -0.58 . . . . 42.490000000000002 110.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.404 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -108.75 147.09 32.52 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.31 0.576 . . . . 53.210000000000001 109.479 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.405 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 13.9 tp -83.42 137.93 33.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.599 -0.728 . . . . 57.0 110.014 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 89.6 m -95.78 124.53 39.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 118.311 -1.356 . . . . 53.009999999999998 107.793 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 49.1 pt -128.25 141.68 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.489 -0.93 . . . . 56.119999999999997 108.489 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 50.3 mmtt -120.7 162.98 18.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.713 -0.847 . . . . 97.849999999999994 108.713 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.19 141.53 41.78 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 118.028 -1.469 . . . . 88.319999999999993 108.744 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.64 21.59 21.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.582 -1.007 . . . . 35.810000000000002 110.582 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -130.5 151.91 50.46 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 118.459 1.13 . . . . 61.780000000000001 109.873 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.1 mm -109.54 133.99 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.724 -1.213 . . . . 105.08 107.724 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.82 134.75 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.759 -0.83 . . . . 48.770000000000003 108.759 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.599 ' HB ' ' CE1' ' A' ' 271' ' ' TYR . 13.1 t -85.74 126.56 34.07 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 119.162 -1.015 . . . . 128.84 108.886 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.97 113.23 8.79 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.885 -0.783 . . . . 81.370000000000005 108.885 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 65.6 mt -74.49 -52.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.655 0.782 . . . . 70.599999999999994 110.891 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -152.96 149.21 27.97 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.471 -0.937 . . . . 65.189999999999998 108.471 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.719 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.32 163.79 23.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.551 0.691 . . . . 125.5 110.533 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 306' ' ' TRP . 39.7 t0 -89.2 170.6 10.46 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.795 1.638 . . . . 66.569999999999993 109.908 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 14.5 p -60.16 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.72 -1.127 . . . . 91.459999999999994 111.769 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.87 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 121.733 -0.604 . . . . 103.65000000000001 112.49 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -59.52 116.3 3.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.224 0.535 . . . . 115.16 111.757 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.4 t -79.26 115.61 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.604 -0.725 . . . . 50.439999999999998 110.123 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 175.74 -21.2 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.69 -0.686 . . . . 34.159999999999997 111.688 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.646 ' O ' ' HB2' ' A' ' 300' ' ' ASP . 99.0 m95 -118.48 153.25 34.45 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.391 0.139 . . . . 81.450000000000003 110.877 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.719 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 5.9 m0 -165.46 175.71 8.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.447 -0.946 . . . . 93.810000000000002 108.447 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.694 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.0 mt-10 -137.02 143.16 42.58 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.792 -0.818 . . . . 89.719999999999999 108.792 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.97 31.88 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 108.404 -1.878 . . . . 24.219999999999999 108.404 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.791 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.3 tt0 -112.96 129.67 56.4 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 119.521 -0.872 . . . . 56.969999999999999 109.652 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 62.1 tp -142.57 135.63 28.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.128 -1.064 . . . . 59.329999999999998 108.128 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.08 37.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.625 -0.509 . . . . 46.140000000000001 109.625 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.11 35.06 88.23 Favored Glycine 0 N--CA 1.433 -1.501 0 C-N-CA 120.231 -0.985 . . . . 26.489999999999998 110.71 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.791 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.35 36.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 118.358 1.079 . . . . 98.989999999999995 108.609 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -129.27 124.71 35.13 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.744 -1.206 . . . . 109.22 107.744 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.405 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.78 164.31 36.87 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.077 -1.609 . . . . 26.510000000000002 109.077 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 308' ' ' GLU . 1.7 m -96.52 150.97 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.327 0.651 . . . . 54.609999999999999 111.887 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -153.69 151.37 25.0 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 120.287 -0.565 . . . . 74.469999999999999 110.495 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 305' ' ' GLY . 6.3 Cg_endo -70.16 121.88 8.47 Favored 'Trans proline' 0 CA--C 1.488 -1.824 0 C-N-CA 120.087 0.524 . . . . 111.89 112.085 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.524 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.0 OUTLIER -71.08 -2.44 15.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 124.35 1.031 . . . . 119.27 112.035 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -61.94 -39.92 93.76 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.361 -0.607 . . . . 96.629999999999995 109.361 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 9.3 m-30 -74.98 7.24 3.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 74.849999999999994 112.061 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 274' ' ' VAL . 1.0 OUTLIER -136.01 159.29 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.252 -0.647 . . . . 67.239999999999995 109.252 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -137.88 146.66 43.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.688 -0.856 . . . . 130.62 108.688 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.559 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.6 mt -86.79 135.29 33.41 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 108.104 -1.073 . . . . 63.159999999999997 108.104 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.42 129.06 44.44 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 105.748 -1.945 . . . . 97.620000000000005 105.748 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.7 Cg_exo -63.97 -33.76 61.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 N-CA-C 115.564 1.332 . . . . 152.83000000000001 115.564 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.302 -1.895 0 CA-C-N 121.385 1.531 . . . . 59.969999999999999 109.223 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.59 32.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.377 0.608 . . . . 29.010000000000002 110.158 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -119.3 164.38 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.946 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.464 ' O ' HD12 ' B' ' 67' ' ' LEU . 97.9 m-85 -120.73 139.34 53.22 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.644 0.259 . . . . 0.0 111.03 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.659 HG21 HD11 ' B' ' 30' ' ' ILE . 47.2 t -121.36 124.27 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.623 -0.881 . . . . 4.9900000000000002 108.623 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.2 mttt -101.07 138.4 38.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.948 0.404 . . . . 5.6799999999999997 110.428 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -81.21 -153.21 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.618 -0.719 . . . . 26.890000000000001 111.899 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -36.11 72.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.285 -0.416 . . . . 23.289999999999999 111.837 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.5 p -96.38 2.37 52.62 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.587 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.48 15.97 51.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.365 -0.445 . . . . 0.0 113.856 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 78.9 tttt -49.8 157.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.33 -0.512 . . . . 8.5099999999999998 111.649 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -106.69 127.99 53.82 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.785 -0.821 . . . . 1.8799999999999999 108.785 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.14 123.07 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 123.347 0.404 . . . . 37.689999999999998 110.9 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.87 131.25 48.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -127.13 149.99 49.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.644 0.259 . . . . 9.4600000000000009 110.906 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -102.72 122.14 43.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.14 -1.8 . . . . 1.54 106.14 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.93 168.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.563 0.697 . . . . 0.0 111.503 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.74 149.26 44.82 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -57.19 -24.48 59.27 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.872 1.347 . . . . 0.0 112.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.27 -2.48 58.1 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.97 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.38 142.6 50.35 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.961 -1.126 . . . . 1.4299999999999999 107.961 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -86.96 157.91 19.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.631 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.35 -39.82 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.942 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.19 -37.45 80.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.534 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.4 t-20 -66.41 -42.91 87.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -60.6 -41.71 88.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -59.94 -39.97 87.37 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.427 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.3 mttp -65.27 -39.08 92.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.659 HD11 HG21 ' B' ' 5' ' ' VAL . 32.2 mt -65.13 -40.02 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.06 -44.0 95.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.517 0.675 . . . . 1.3200000000000001 109.424 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.9 -40.4 92.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.963 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.44 -41.2 22.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.129 1.159 . . . . 0.82999999999999996 114.129 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.94 -14.63 13.92 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.163 1.912 . . . . 6.1200000000000001 116.163 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.0 82.95 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -85.73 116.31 65.15 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.58 -0.526 . . . . 3.54 109.58 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.71 134.67 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.167 1.244 . . . . 0.0 112.444 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.46 -32.07 25.69 Favored 'Trans proline' 0 N--CA 1.507 2.307 0 C-N-CA 122.789 2.326 . . . . 0.0 114.662 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.78 -16.09 62.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 118.973 0.806 . . . . 2.8799999999999999 112.068 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.02 6.33 45.06 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.707 0.262 . . . . 7.1699999999999999 111.707 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.575 ' HB3' HD11 ' B' ' 69' ' ' LEU . 67.4 mt-30 -106.67 131.28 53.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.47 0.544 . . . . 13.42 112.47 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.539 ' HB3' HG12 ' B' ' 70' ' ' VAL . 40.2 ttm180 -117.72 114.73 23.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 27.09 107.811 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -100.57 128.99 46.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.37 0.605 . . . . 1.8700000000000001 110.825 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' B' ' 49' ' ' GLN . 2.6 pt -149.7 132.59 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.85 -0.614 . . . . 17.75 111.609 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.683 ' CD2' HG12 ' B' ' 61' ' ' ILE . 83.2 t80 -124.99 139.72 53.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.413 -0.358 . . . . 16.98 110.247 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.96 39.06 21.98 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 123.54 0.525 . . . . 0.0 111.717 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 65.35 21.75 68.75 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 115.865 1.106 . . . . 48.659999999999997 115.865 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -115.43 134.28 55.24 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.992 0.896 . . . . 4.25 111.879 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.521 ' HA ' HG22 ' B' ' 44' ' ' ILE . 24.8 mt-30 -65.89 119.2 10.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.911 -0.586 . . . . 30.57 111.053 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.449 ' HG ' ' HA ' ' B' ' 44' ' ' ILE . 63.5 mt -89.3 125.54 35.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.065 0.459 . . . . 22.77 112.009 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -99.35 149.54 23.05 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 9.3399999999999999 111.386 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.67 -20.15 63.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.18 6.03 68.59 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.609 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.39 163.98 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.162 0.481 . . . . 1.8600000000000001 111.706 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -105.45 166.48 10.4 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.753 0.787 . . . . 0.0 112.523 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.3 mt -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.662 -1.154 . . . . 2.2799999999999998 110.803 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.5 t -61.54 -31.04 71.04 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.086 -0.646 . . . . 2.98 111.809 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.09 -28.96 69.98 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.744 -0.383 . . . . 1.77 110.448 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.02 14.53 28.89 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.09 39.33 19.01 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.879 0.472 . . . . 0.0 112.19 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.683 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.4 124.09 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.049 -1.093 . . . . 4.0099999999999998 108.049 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 169.13 8.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.318 0.58 . . . . 5.7400000000000002 112.083 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.48 141.47 15.75 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.127 -0.942 . . . . 4.3099999999999996 111.485 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 66.97 23.19 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.04 -0.982 . . . . 10.130000000000001 112.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.456 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.4 m -77.21 146.7 36.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.963 -1.125 . . . . 4.0999999999999996 107.963 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 52.9 m -125.47 136.93 53.89 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.533 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' B' ' 45' ' ' PHE . 0.2 OUTLIER -112.25 -172.71 2.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.294 -0.412 . . . . 19.210000000000001 110.208 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.495 ' CD2' ' HB3' ' A' ' 321' ' ' ASN . 0.0 OUTLIER -132.56 153.67 50.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.939 -0.393 . . . . 50.0 109.939 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' B' ' 41' ' ' GLN . 9.3 tp -126.55 158.05 37.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.835 0.35 . . . . 21.579999999999998 111.436 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 322' ' ' PHE . 7.8 p -115.11 140.7 35.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 25.969999999999999 110.607 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 70' ' ' VAL . 1.1 mp -147.6 114.92 6.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.313 -0.403 . . . . 1.6699999999999999 111.014 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -83.04 87.25 6.89 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.191 0.519 . . . . 23.710000000000001 110.05 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -151.57 -157.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.502 -0.772 . . . . 15.09 110.108 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.52 20.83 4.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 0.0 110.62 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.22 105.42 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.977 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.252 -0.88 . . . . 1.8600000000000001 110.391 179.185 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.515 0.674 . . . . 137.63999999999999 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.894 ' C ' ' HE2' ' A' ' 269' ' ' LYS . 52.8 p -64.93 -56.75 11.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.523 -0.762 . . . . 89.760000000000005 111.375 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.894 ' HE2' ' C ' ' A' ' 268' ' ' SER . 0.6 OUTLIER -92.07 166.57 12.6 Favored 'General case' 0 CA--C 1.494 -1.189 0 O-C-N 121.762 -0.586 . . . . 143.71000000000001 109.481 -177.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -111.19 135.77 51.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.489 -0.56 . . . . 62.810000000000002 109.489 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.464 ' HD1' ' CG2' ' A' ' 293' ' ' ILE . 60.9 m-85 -107.16 134.39 50.34 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.484 -0.932 . . . . 73.75 108.484 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' CYS . . . . . 0.404 ' SG ' HD22 ' A' ' 325' ' ' LEU . 50.4 m -129.55 135.39 48.53 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.789 -0.819 . . . . 54.439999999999998 108.789 -176.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.738 ' HA ' HD13 ' A' ' 293' ' ' ILE . 40.6 tttp -92.72 135.58 33.98 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.217 -1.031 . . . . 88.159999999999997 108.217 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.73 HG11 HD12 ' A' ' 288' ' ' ILE . 91.3 t -100.89 116.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 117.956 -1.498 . . . . 73.900000000000006 110.801 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -81.99 -41.62 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 121.622 -0.674 . . . . 138.47999999999999 112.277 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' PHE . . . . . 0.646 ' HB2' ' O ' ' A' ' 322' ' ' PHE . 3.2 m-85 -102.44 122.5 46.23 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 121.143 -0.223 . . . . 67.980000000000004 110.862 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.81 159.56 52.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.591 2.194 . . . . 72.540000000000006 112.264 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -124.45 86.74 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.626 -0.715 . . . . 82.870000000000005 109.995 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -56.78 116.46 3.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.414 -0.587 . . . . 66.180000000000007 109.414 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -30.59 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.646 1.216 . . . . 50.240000000000002 113.309 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 285' ' ' GLU . 26.1 mt-30 -87.02 -39.18 15.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.844 -0.616 . . . . 128.65000000000001 109.369 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -148.38 175.52 11.04 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.064 -1.022 . . . . 67.609999999999999 111.736 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.04 -33.63 29.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.228 -0.896 . . . . 78.629999999999995 110.235 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.23 -2.77 42.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.688 -0.687 . . . . 42.490000000000002 111.087 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 281' ' ' GLN . 74.0 mt-10 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.379 0.609 . . . . 53.210000000000001 109.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 316' ' ' GLY . 15.5 tp -85.57 135.82 33.65 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.343 -0.844 . . . . 57.0 110.156 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.529 ' O ' HD23 ' A' ' 311' ' ' LEU . 89.7 m -95.68 124.56 39.75 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.106 -1.438 . . . . 53.009999999999998 107.805 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.73 HD12 HG11 ' A' ' 274' ' ' VAL . 49.1 pt -128.21 141.68 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 108.556 -0.905 . . . . 56.119999999999997 108.556 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 289' ' ' LYS . 43.4 mmtt -117.04 158.96 23.27 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.419 -0.956 . . . . 97.849999999999994 108.419 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -76.08 141.56 41.98 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 118.458 -1.297 . . . . 88.319999999999993 108.665 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.58 21.66 21.11 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.65 -0.98 . . . . 35.810000000000002 110.65 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -130.51 151.91 50.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 118.393 1.097 . . . . 61.780000000000001 109.818 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.738 HD13 ' HA ' ' A' ' 273' ' ' LYS . 44.2 mm -109.56 133.93 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.834 -1.173 . . . . 105.08 107.834 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 310' ' ' GLU . 92.4 t -122.73 134.81 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.743 -0.836 . . . . 48.770000000000003 108.743 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 295' ' ' THR . 13.0 t -85.81 126.64 34.17 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.189 -1.004 . . . . 128.84 108.783 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.08 113.27 8.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.894 -0.78 . . . . 81.370000000000005 108.894 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 310' ' ' GLU . 65.4 mt -74.46 -52.37 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 123.562 0.745 . . . . 70.599999999999994 110.919 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -152.95 149.15 27.92 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.474 -0.936 . . . . 65.189999999999998 108.474 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.572 ' HG3' ' HE1' ' A' ' 307' ' ' TRP . 2.3 ttmt -80.43 163.82 23.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.533 0.683 . . . . 125.5 110.498 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.529 ' OD2' ' HB2' ' A' ' 306' ' ' TRP . 39.7 t0 -89.13 172.83 8.8 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.77 1.628 . . . . 66.569999999999993 109.868 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 4.7 p -60.77 -155.54 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.498 -0.774 . . . . 91.459999999999994 111.546 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 43.4 mm -64.42 -50.41 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 113.883 1.068 . . . . 103.65000000000001 113.883 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.18 120.67 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.647 0.61 . . . . 115.16 112.647 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -89.41 106.27 16.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.61 -0.723 . . . . 50.439999999999998 110.245 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 319' ' ' PRO . . . 168.4 -14.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.217 -0.902 . . . . 34.159999999999997 110.88 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.529 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 92.6 m95 -126.33 156.06 41.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.279 -0.461 . . . . 81.450000000000003 111.253 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.572 ' HE1' ' HG3' ' A' ' 299' ' ' LYS . 6.2 m0 -163.81 -171.3 2.44 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.817 0.847 . . . . 93.810000000000002 108.772 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.694 ' HG2' HG12 ' A' ' 317' ' ' VAL . 23.1 mt-10 -145.85 143.06 29.38 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.869 -0.789 . . . . 89.719999999999999 108.869 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -152.88 168.97 31.86 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 108.448 -1.861 . . . . 24.219999999999999 108.448 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.795 ' HG3' ' O ' ' A' ' 314' ' ' ARG . 32.1 tt0 -112.92 129.7 56.38 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.558 -0.857 . . . . 56.969999999999999 109.688 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 287' ' ' THR . 62.1 tp -142.65 135.69 28.35 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.039 -1.097 . . . . 59.329999999999998 108.039 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 56.01 37.82 29.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.597 -0.519 . . . . 46.140000000000001 109.597 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.01 35.18 88.97 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 110.683 -0.967 . . . . 26.489999999999998 110.683 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ARG . . . . . 0.795 ' O ' ' HG3' ' A' ' 310' ' ' GLU . 20.0 mmm-85 -132.48 160.31 36.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 118.349 1.074 . . . . 98.989999999999995 108.627 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -129.24 124.72 35.2 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.761 -1.199 . . . . 109.22 107.761 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 286' ' ' LEU . . . -164.77 164.48 36.97 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 108.997 -1.641 . . . . 26.510000000000002 108.997 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.727 HG21 ' HG3' ' B' ' 74' ' ' ARG . 3.3 m -94.68 151.94 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 123.309 0.643 . . . . 54.609999999999999 112.041 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -152.98 151.41 26.21 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 120.206 -0.598 . . . . 74.469999999999999 110.49 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.946 ' HB3' HG11 ' B' ' 70' ' ' VAL . 6.2 Cg_endo -70.17 122.12 8.7 Favored 'Trans proline' 0 CA--C 1.488 -1.793 0 C-N-CA 120.105 0.537 . . . . 111.89 112.081 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' A' ' 307' ' ' TRP . 0.7 OUTLIER -71.07 -14.71 62.41 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.3 1.0 . . . . 119.27 111.98 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 321' ' ' ASN . 1.3 m120 -61.57 -40.34 94.38 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.926 -0.71 . . . . 96.629999999999995 109.422 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 276' ' ' PHE . 2.9 m-30 -64.51 0.08 1.19 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.213 -0.903 . . . . 74.849999999999994 111.706 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 274' ' ' VAL . 1.0 OUTLIER -136.53 171.46 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.513 -0.551 . . . . 67.239999999999995 109.513 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HB2' HD11 ' A' ' 275' ' ' ILE . 0.6 OUTLIER -145.96 146.41 31.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 130.62 108.869 178.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.557 ' O ' ' HD3' ' A' ' 327' ' ' PRO . 36.7 mt -87.95 135.22 33.5 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 108.052 -1.092 . . . . 63.159999999999997 108.052 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 326' ' ' LEU . 4.9 mp -91.35 129.12 44.36 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 105.813 -1.921 . . . . 97.620000000000005 105.813 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 325' ' ' LEU . 76.3 Cg_exo -64.0 -33.86 61.17 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 N-CA-C 115.54 1.323 . . . . 152.83000000000001 115.54 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--N 1.301 -1.925 0 CA-C-N 121.393 1.533 . . . . 59.969999999999999 109.234 179.502 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.472 ' HB2' ' HA ' ' B' ' 63' ' ' LYS . 4.1 ptt? . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.88 140.47 32.19 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.287 0.565 . . . . 29.010000000000002 110.149 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 22.9 pt -120.95 162.31 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.966 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' B' ' 66' ' ' THR . 97.9 m-85 -120.92 139.36 53.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.618 0.247 . . . . 0.0 110.977 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.646 HG21 HD11 ' B' ' 30' ' ' ILE . 47.1 t -121.33 124.13 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.64 -0.874 . . . . 4.9900000000000002 108.64 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 76.3 mttt -101.02 138.92 37.42 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.966 0.412 . . . . 5.6799999999999997 110.458 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -77.61 -157.65 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.693 -0.685 . . . . 26.890000000000001 111.898 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.937 ' HG ' HG13 ' B' ' 70' ' ' VAL . 1.3 tt -68.35 -37.81 80.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.705 -0.679 . . . . 23.289999999999999 111.671 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 49.2 p -94.94 2.44 55.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.555 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.38 15.9 51.71 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.365 -0.445 . . . . 0.0 113.905 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' B' ' 6' ' ' LYS . 79.6 tttt -50.42 158.36 0.61 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.329 -0.513 . . . . 8.5099999999999998 111.492 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -106.61 128.06 53.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.741 -0.837 . . . . 1.8799999999999999 108.741 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.42 121.93 56.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 O-C-N 123.372 0.42 . . . . 37.689999999999998 110.836 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -101.96 131.34 48.42 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -127.24 149.95 49.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.61 0.243 . . . . 9.4600000000000009 110.943 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.64 122.17 43.89 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.223 -1.769 . . . . 1.54 106.223 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.03 168.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.455 0.645 . . . . 0.0 111.478 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -117.86 149.35 45.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.29 -24.46 59.91 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 CA-C-N 120.799 1.321 . . . . 0.0 112.899 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -85.22 -2.54 58.16 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.071 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.28 142.59 50.5 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.906 -1.146 . . . . 1.4299999999999999 107.906 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -86.92 157.79 19.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.79 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.22 -39.93 84.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.948 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.98 -37.67 80.29 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' B' ' 29' ' ' LYS . 55.1 t-20 -66.33 -42.91 87.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.56 -41.76 89.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.495 ' HG2' HD11 ' B' ' 43' ' ' LEU . 20.5 mttt -60.01 -39.85 87.25 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.26 89.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.458 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' B' ' 25' ' ' ASN . 47.4 mttp -65.19 -39.2 92.53 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.646 HD11 HG21 ' B' ' 5' ' ' VAL . 32.8 mt -65.01 -40.07 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.03 -44.1 94.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.493 0.663 . . . . 1.3200000000000001 109.344 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.87 -40.29 92.44 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.98 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -81.58 -41.34 21.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.009 1.114 . . . . 0.82999999999999996 114.009 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.86 -14.59 13.96 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.167 1.914 . . . . 6.1200000000000001 116.167 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.07 82.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.244 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.411 HG23 HD21 ' B' ' 71' ' ' LEU . 17.1 mt -85.69 116.36 65.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.612 -0.514 . . . . 3.54 109.612 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.8 134.68 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 CA-C-N 120.361 1.165 . . . . 0.0 112.373 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.22 -32.31 24.65 Favored 'Trans proline' 0 N--CA 1.506 2.255 0 C-N-CA 122.818 2.345 . . . . 0.0 114.716 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.7 -16.02 62.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.829 0.74 . . . . 2.8799999999999999 112.171 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.07 6.3 44.98 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.741 0.274 . . . . 7.1699999999999999 111.741 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.33 121.23 42.33 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.82 0.674 . . . . 13.42 112.82 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -103.94 115.07 29.78 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.286 -1.005 . . . . 27.09 108.286 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.495 HD11 ' HG2' ' B' ' 27' ' ' LYS . 84.8 mt -102.59 127.64 49.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.305 0.574 . . . . 1.8700000000000001 110.886 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.594 HG22 ' O ' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -153.84 130.45 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.142 -0.481 . . . . 17.75 111.406 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.721 ' CD2' HG12 ' B' ' 61' ' ' ILE . 59.2 t80 -124.95 142.76 51.27 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.561 -0.29 . . . . 16.98 110.368 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' HE2' ' B' ' 48' ' ' LYS . . . 49.79 38.78 16.48 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.501 0.5 . . . . 0.0 111.653 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 276' ' ' PHE . . . 60.3 28.25 66.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 115.164 0.826 . . . . 48.659999999999997 115.164 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.594 ' O ' HG22 ' B' ' 44' ' ' ILE . 44.8 mtmt -119.2 134.29 55.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 117.474 0.637 . . . . 4.25 111.747 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -64.47 114.69 4.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.424 -0.807 . . . . 30.57 110.684 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.59 125.75 34.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.943 0.402 . . . . 22.77 111.79 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -100.21 149.47 23.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.867 -0.606 . . . . 9.3399999999999999 111.493 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -69.67 -20.05 63.58 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.12 5.8 68.6 Favored Glycine 0 N--CA 1.476 1.309 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.491 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -112.36 163.93 13.85 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 117.295 0.548 . . . . 1.8600000000000001 111.674 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 49.6 p -105.35 166.3 10.52 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.679 0.752 . . . . 0.0 112.602 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.01 -41.91 93.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 114.664 -1.153 . . . . 2.2799999999999998 110.794 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.0 70.96 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 120.058 -0.657 . . . . 2.98 111.902 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.05 -29.09 70.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.728 -0.389 . . . . 1.77 110.467 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.87 14.45 28.9 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m120 50.13 39.36 19.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.923 0.489 . . . . 0.0 112.218 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.721 HG12 ' CD2' ' B' ' 45' ' ' PHE . 96.9 mt -81.47 123.87 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.189 -1.041 . . . . 4.0099999999999998 108.189 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.92 169.09 8.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.27 0.557 . . . . 5.7400000000000002 112.191 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 57.1 pttt -51.46 141.38 15.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.25 -0.887 . . . . 4.3099999999999996 111.471 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 67.03 23.23 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.074 -0.967 . . . . 10.130000000000001 112.856 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.425 ' HB3' ' CE1' ' B' ' 45' ' ' PHE . 38.3 m -77.28 146.27 36.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.984 -1.117 . . . . 4.0999999999999996 107.984 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' B' ' 4' ' ' PHE . 53.2 m -126.31 136.29 52.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.596 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' B' ' 45' ' ' PHE . 0.0 OUTLIER -109.01 -177.78 3.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.232 -0.44 . . . . 19.210000000000001 110.256 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -118.55 147.33 43.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.956 -0.387 . . . . 50.0 109.956 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.2 113.91 3.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.945 0.402 . . . . 21.579999999999998 110.973 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.946 HG11 ' HB3' ' A' ' 319' ' ' PRO . 72.4 t -123.14 135.68 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 25.969999999999999 110.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.411 HD21 HG23 ' B' ' 36' ' ' ILE . 11.6 mt -84.13 130.65 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.849 -0.614 . . . . 1.6699999999999999 111.636 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -63.68 135.98 57.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.868 -0.606 . . . . 23.710000000000001 110.59 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.89 -63.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 15.09 110.745 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.727 ' HG3' HG21 ' A' ' 317' ' ' VAL . 6.0 ptp180 -99.02 10.66 41.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.87 33.13 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.821 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.492 -0.766 . . . . 1.8600000000000001 110.823 179.304 . . . . . . . . 0 0 . 1 stop_ save_